data_2kjk_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kjk _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 37.2 t70 . . . . . 0 N--CA 1.47 0.562 0 CA-C-O 120.885 0.374 . . . . 1.0 110.031 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -84.18 -148.71 9.23 Favored Glycine 0 C--N 1.339 0.709 0 N-CA-C 110.003 -1.239 . . . . 1.0 110.003 179.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.7 p -127.85 134.59 65.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 N-CA-C 109.014 -0.736 . . . . 1.0 109.014 178.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -89.52 149.41 22.91 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 109.484 -0.562 . . . . 1.0 109.484 -178.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 49.1 t -98.31 128.71 49.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 N-CA-C 108.793 -0.817 . . . . 1.0 108.793 179.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 8.2 tp -75.83 -39.89 55.88 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.986 0.422 . . . . 1.0 110.8 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.441 ' HG ' ' H ' ' A' ' 14' ' ' VAL . 48.2 t -167.55 161.04 13.5 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.9 -0.591 . . . . 1.0 111.859 -178.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.441 ' H ' ' HG ' ' A' ' 13' ' ' SER . 44.0 t -132.87 115.7 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 CA-C-N 115.367 -0.833 . . . . 1.0 109.239 179.018 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.402 ' O ' ' N ' ' A' ' 17' ' ' ASP . 74.1 mmtt -73.26 105.21 4.57 Favored 'General case' 0 C--O 1.221 -0.404 0 N-CA-C 108.906 -0.776 . . . . 1.0 108.906 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -64.94 64.29 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 120.875 0.369 . . . . 1.0 111.698 -178.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.402 ' N ' ' O ' ' A' ' 15' ' ' LYS . 37.0 t70 -175.97 45.68 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 108.136 -1.061 . . . . 1.0 108.136 179.54 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 23.0 m -150.19 160.88 32.45 Favored Pre-proline 0 N--CA 1.483 1.19 0 CA-C-O 118.995 -0.526 . . . . 1.0 109.731 -178.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -47.3 -33.32 16.18 Favored 'Trans proline' 0 N--CA 1.506 2.242 0 C-N-CA 121.252 1.301 . . . . 1.0 112.543 177.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.06 -22.77 67.07 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 116.761 -0.2 . . . . 1.0 111.39 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.59 124.61 21.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.016 0.436 . . . . 1.0 111.008 -178.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.85 -9.71 70.61 Favored Glycine 0 N--CA 1.473 1.138 0 CA-C-N 115.663 -0.699 . . . . 1.0 111.633 179.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 71.0 mt -114.31 -50.9 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 C-N-CA 122.633 0.373 . . . . 1.0 110.289 -179.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 42.7 mt -113.18 148.38 35.54 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 108.777 -0.823 . . . . 1.0 108.777 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -139.92 154.33 47.2 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 115.745 -0.661 . . . . 1.0 110.023 -179.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.44 139.66 52.57 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.858 -0.61 . . . . 1.0 110.918 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 94.55 -6.84 71.14 Favored Glycine 0 N--CA 1.473 1.107 0 N-CA-C 111.083 -0.807 . . . . 1.0 111.083 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -74.49 150.89 39.65 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 109.637 -0.505 . . . . 1.0 109.637 179.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 5.0 mp -120.91 120.66 36.13 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 109.696 -0.483 . . . . 1.0 109.696 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 61.4 mt -89.39 134.63 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 N-CA-C 107.959 -1.126 . . . . 1.0 107.959 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.543 ' HG1' ' N ' ' A' ' 32' ' ' GLU . 65.1 p -97.2 -49.2 5.06 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 116.741 -0.208 . . . . 1.0 111.279 -178.221 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.543 ' N ' ' HG1' ' A' ' 31' ' ' THR . 42.8 tp10 -154.05 159.83 41.73 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 121.256 0.55 . . . . 1.0 111.3 -178.242 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.424 ' O ' ' N ' ' A' ' 35' ' ' GLY . 4.7 mp -135.85 129.59 48.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 N-CA-C 107.611 -1.255 . . . . 1.0 107.611 179.192 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 41.57 20.14 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 113.077 0.769 . . . . 1.0 113.077 179.365 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 33' ' ' ILE . . . 69.22 6.56 54.16 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 111.101 -0.8 . . . . 1.0 111.101 179.521 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 . . . . . 0 N--CA 1.472 0.628 0 CA-C-O 120.82 0.343 . . . . 1.0 110.233 -179.708 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 15.0 m . . . . . 0 N--CA 1.479 0.991 0 N-CA-C 110.084 -0.339 . . . . 1.0 110.084 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 11.7 t -56.21 -40.7 74.43 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.507 0.194 . . . . 1.0 110.543 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -53.8 -28.68 36.69 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.367 -0.379 . . . . 1.0 110.719 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -58.86 -35.31 72.75 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.887 0.375 . . . . 1.0 110.393 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -68.85 -47.53 65.73 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 116.255 -0.43 . . . . 1.0 110.436 -179.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.7 mp -52.69 -31.87 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 N-CA-C 108.998 -0.742 . . . . 1.0 108.998 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 47.3 m-20 -70.98 -37.87 72.74 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.797 -0.638 . . . . 1.0 111.431 -179.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 80.1 t80 -66.79 -52.68 41.19 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 120.8 0.333 . . . . 1.0 111.607 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -62.46 -26.05 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 N-CA-C 109.362 -0.607 . . . . 1.0 109.362 -178.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -90.66 -21.96 21.41 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 116.342 -0.39 . . . . 1.0 111.392 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 47.4 m -81.77 -13.62 57.49 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 122.422 -0.174 . . . . 1.0 111.295 -178.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 43.7 mmtm -95.27 -168.97 1.89 Allowed 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 109.992 -0.373 . . . . 1.0 109.992 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 3.6 mmpt? -131.23 159.26 38.31 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.184 0.594 . . . . 1.0 110.526 -178.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.5 t -64.59 140.43 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-N 115.764 -0.653 . . . . 1.0 110.33 -179.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 94.27 -12.9 68.34 Favored Glycine 0 N--CA 1.476 1.305 0 N-CA-C 110.843 -0.903 . . . . 1.0 110.843 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -67.85 -165.25 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 109.618 -0.512 . . . . 1.0 109.618 179.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 77.3 p -140.75 153.97 46.1 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 108.932 -0.766 . . . . 1.0 108.932 178.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 3.2 p -140.55 154.72 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 CA-C-O 121.102 0.477 . . . . 1.0 110.716 -179.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 49.4 mtmt -121.74 112.39 18.34 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 107.954 -1.128 . . . . 1.0 107.954 177.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.4 mp -99.2 138.65 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 N-CA-C 109.05 -0.722 . . . . 1.0 109.05 -178.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -111.19 113.31 25.72 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 105.607 -1.997 . . . . 1.0 105.607 177.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 17.8 p90 -149.84 156.87 42.53 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 109.611 -0.514 . . . . 1.0 109.611 -178.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 22.7 pttm -125.96 118.2 24.88 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 121.261 0.553 . . . . 1.0 110.053 -179.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -89.63 101.82 14.5 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 107.642 -1.244 . . . . 1.0 107.642 179.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 83.76 -111.94 3.5 Favored Glycine 0 CA--C 1.535 1.296 0 N-CA-C 111.475 -0.65 . . . . 1.0 111.475 -178.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -114.52 -2.43 13.16 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 122.826 0.45 . . . . 1.0 111.821 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 58.0 pttt -105.55 134.28 48.93 Favored 'General case' 0 N--CA 1.484 1.269 0 CA-C-O 121.162 0.506 . . . . 1.0 111.052 -179.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -84.08 119.58 25.13 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 109.747 -0.464 . . . . 1.0 109.747 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 69.7 mt-10 -119.9 152.79 36.84 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-N 115.51 -0.768 . . . . 1.0 110.021 -179.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -139.82 133.52 30.47 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 109.253 -0.647 . . . . 1.0 109.253 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -147.03 152.32 38.39 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.946 -0.57 . . . . 1.0 109.952 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 17.7 t -125.41 136.53 53.51 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.005 -0.998 . . . . 1.0 108.576 179.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.465 ' CD1' ' N ' ' A' ' 72' ' ' ILE . 0.0 OUTLIER -128.68 149.07 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 O-C-N 123.418 0.449 . . . . 1.0 109.965 -178.907 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -78.42 136.34 37.62 Favored 'General case' 0 C--O 1.231 0.084 0 N-CA-C 108.186 -1.042 . . . . 1.0 108.186 178.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -66.74 147.28 53.47 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.119 0.485 . . . . 1.0 110.598 -178.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 30.6 p -140.87 160.73 39.43 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.648 -0.705 . . . . 1.0 109.747 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -80.23 131.15 35.64 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 108.975 -0.75 . . . . 1.0 108.975 178.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -114.0 -52.66 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 123.127 0.571 . . . . 1.0 110.544 -179.287 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 57.4 p30 -99.61 162.55 12.95 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.327 0.584 . . . . 1.0 110.872 -178.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 59.5 pttt -51.15 -31.92 21.33 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.096 -0.956 . . . . 1.0 112.326 -178.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 26.2 ttmt -80.23 12.06 3.14 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 120.672 0.272 . . . . 1.0 110.762 -179.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 52.72 49.09 55.0 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 120.967 -0.635 . . . . 1.0 111.833 179.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 58.6 m -80.3 120.41 79.39 Favored Pre-proline 0 CA--C 1.54 0.573 0 CA-C-O 118.619 -0.705 . . . . 1.0 109.698 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -58.7 134.84 63.27 Favored 'Trans proline' 0 N--CA 1.497 1.693 0 CA-C-N 120.819 1.328 . . . . 1.0 112.122 177.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 148.81 152.53 5.74 Favored Glycine 0 N--CA 1.473 1.123 0 N-CA-C 112.003 -0.439 . . . . 1.0 112.003 178.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 6.5 pt -72.44 176.95 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 N-CA-C 108.369 -0.974 . . . . 1.0 108.369 177.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -103.27 86.92 0.55 Allowed Glycine 0 N--CA 1.473 1.12 0 N-CA-C 111.817 -0.513 . . . . 1.0 111.817 -179.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 48.8 pt -143.7 166.91 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 CA-C-N 115.504 -0.348 . . . . 1.0 110.17 178.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 95.4 m -128.44 128.99 45.47 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 109.182 -0.673 . . . . 1.0 109.182 177.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 12.9 mt -97.89 163.2 12.89 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.057 0.943 . . . . 1.0 109.853 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 24.2 t . . . . . 0 N--CA 1.479 1.024 0 CA-C-N 116.087 -0.506 . . . . 1.0 109.777 -178.735 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 33.7 p-10 . . . . . 0 N--CA 1.471 0.584 0 N-CA-C 109.651 -0.5 . . . . 1.0 109.651 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 161.14 -166.09 35.59 Favored Glycine 0 N--CA 1.461 0.318 0 N-CA-C 108.963 -1.655 . . . . 1.0 108.963 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.1 p -125.72 130.78 72.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 N-CA-C 109.222 -0.659 . . . . 1.0 109.222 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.465 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 0.2 OUTLIER -91.12 151.81 20.85 Favored 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 109.303 -0.628 . . . . 1.0 109.303 -178.863 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 56.1 t -106.0 127.48 61.06 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 N-CA-C 108.5 -0.926 . . . . 1.0 108.5 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 41.2 tp -79.97 -49.56 11.67 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-O 121.169 0.509 . . . . 1.0 111.063 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 97.2 p -167.21 163.19 15.44 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.571 -0.741 . . . . 1.0 111.403 -179.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.444 ' O ' ' O ' ' A' ' 15' ' ' LYS . 39.2 t -119.92 138.37 50.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 CA-C-N 114.952 -1.022 . . . . 1.0 109.659 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.444 ' O ' ' O ' ' A' ' 14' ' ' VAL . 36.3 tptt -39.49 -108.75 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 O-C-N 123.981 0.8 . . . . 1.0 111.778 179.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -159.61 20.01 0.17 Allowed 'General case' 0 N--CA 1.482 1.156 0 O-C-N 121.096 -1.002 . . . . 1.0 112.363 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.752 ' O ' ' O ' ' A' ' 18' ' ' VAL . 4.2 p-10 -169.02 -68.06 0.02 OUTLIER 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 107.109 -1.441 . . . . 1.0 107.109 178.035 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.752 ' O ' ' O ' ' A' ' 17' ' ' ASP . 29.3 m 4.46 148.2 0.0 OUTLIER Pre-proline 0 N--CA 1.504 2.237 0 O-C-N 125.874 1.984 . . . . 1.0 114.091 -177.181 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -56.7 9.18 0.04 OUTLIER 'Trans proline' 0 N--CA 1.496 1.673 0 CA-C-N 120.346 1.159 . . . . 1.0 113.206 -178.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.565 ' H ' ' C ' ' A' ' 18' ' ' VAL . . . -106.48 -24.15 12.29 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 109.435 -0.58 . . . . 1.0 109.435 177.07 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -75.36 134.53 40.96 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-O 121.278 0.561 . . . . 1.0 110.247 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 90.75 -22.03 30.23 Favored Glycine 0 N--CA 1.471 0.977 0 CA-C-N 115.422 -0.808 . . . . 1.0 111.387 179.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 84.9 mt -105.36 -51.32 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 N-CA-C 109.945 -0.391 . . . . 1.0 109.945 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 18.8 mt -99.59 134.42 42.51 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 109.283 -0.636 . . . . 1.0 109.283 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -118.42 144.59 45.84 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 115.919 -0.582 . . . . 1.0 109.659 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -52.48 132.51 35.11 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 116.473 -0.331 . . . . 1.0 110.703 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 101.39 -4.38 54.62 Favored Glycine 0 N--CA 1.474 1.179 0 N-CA-C 111.601 -0.6 . . . . 1.0 111.601 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -72.82 152.38 41.57 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 117.506 0.653 . . . . 1.0 109.599 178.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.4 mp -124.15 122.31 37.48 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 122.753 0.421 . . . . 1.0 110.364 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 31.9 mm -74.78 122.44 28.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 N-CA-C 109.253 -0.647 . . . . 1.0 109.253 179.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 47.8 p -89.85 -43.77 10.4 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 116.4 -0.363 . . . . 1.0 111.023 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 72.9 tt0 -154.69 151.61 28.95 Favored 'General case' 0 N--CA 1.482 1.136 0 CA-C-O 120.991 0.424 . . . . 1.0 111.414 -178.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.6 mt -145.49 133.87 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 CA-C-O 120.977 0.417 . . . . 1.0 110.246 178.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 37.7 t70 54.5 34.94 22.19 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.808 -0.633 . . . . 1.0 111.256 178.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.18 -9.15 13.64 Favored Glycine 0 CA--C 1.531 1.058 0 N-CA-C 111.412 -0.675 . . . . 1.0 111.412 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 . . . . . 0 N--CA 1.478 0.956 0 CA-C-N 116.802 0.301 . . . . 1.0 110.264 -179.998 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 49.0 m . . . . . 0 N--CA 1.481 1.091 0 N-CA-C 110.214 -0.291 . . . . 1.0 110.214 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 46.6 t -64.26 -51.61 62.74 Favored 'General case' 0 C--O 1.219 -0.533 0 CA-C-N 116.417 -0.356 . . . . 1.0 110.575 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -53.88 -34.41 59.36 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 122.277 -0.265 . . . . 1.0 111.226 -179.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.0 tp10 -64.44 -36.81 85.39 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 109.299 -0.63 . . . . 1.0 109.299 179.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -66.69 -48.28 69.76 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.419 0.628 . . . . 1.0 109.537 178.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 26.3 mm -53.62 -27.96 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-N 115.542 -0.754 . . . . 1.0 110.313 -178.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -70.78 -35.23 72.49 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 116.359 -0.382 . . . . 1.0 110.119 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 28.7 t80 -67.18 -46.16 74.76 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.822 0.344 . . . . 1.0 110.997 178.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 25.7 mt -53.74 -38.55 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 115.954 -0.566 . . . . 1.0 109.945 -175.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 52.0 m-70 -80.89 -20.88 41.24 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 116.052 -0.522 . . . . 1.0 110.966 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 11.2 t -78.06 37.14 0.24 Allowed 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 120.748 0.308 . . . . 1.0 111.483 -178.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -146.55 -169.6 3.31 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 109.024 -0.732 . . . . 1.0 109.024 179.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -131.55 166.51 21.24 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 122.955 0.502 . . . . 1.0 109.759 -178.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 22.7 t -68.46 137.76 23.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 115.95 -0.568 . . . . 1.0 110.939 -178.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.75 -2.43 85.93 Favored Glycine 0 N--CA 1.478 1.484 0 N-CA-C 111.217 -0.753 . . . . 1.0 111.217 179.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -62.08 -168.91 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.832 -0.433 . . . . 1.0 109.832 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 23.4 m -146.55 139.88 25.72 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 108.972 -0.751 . . . . 1.0 108.972 179.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 6.0 p -141.46 160.79 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 CA-C-N 116.305 -0.407 . . . . 1.0 110.172 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 21.8 ttpp -112.71 123.28 49.94 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 108.111 -1.07 . . . . 1.0 108.111 177.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 11.5 tt -101.02 143.03 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 C-N-CA 122.776 0.43 . . . . 1.0 111.003 -178.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 17.6 tptp -133.58 113.56 12.56 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 107.661 -1.237 . . . . 1.0 107.661 177.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 25.1 p90 -144.45 157.93 44.0 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 109.226 -0.657 . . . . 1.0 109.226 -179.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -116.24 115.79 26.62 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 117.912 0.324 . . . . 1.0 110.206 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -118.66 115.76 25.18 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 108.108 -1.071 . . . . 1.0 108.108 177.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 73.25 -133.63 18.48 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 110.716 -0.953 . . . . 1.0 110.716 -178.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -107.26 2.1 24.38 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 122.82 0.448 . . . . 1.0 111.072 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 20.8 pttp -122.37 119.5 31.23 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-O 121.593 0.711 . . . . 1.0 111.145 -179.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -82.97 123.92 29.89 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 109.386 -0.598 . . . . 1.0 109.386 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -114.51 142.03 46.94 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.062 0.545 . . . . 1.0 109.943 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -124.87 136.69 54.02 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 109.135 -0.691 . . . . 1.0 109.135 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -148.69 128.42 13.32 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.301 0.572 . . . . 1.0 111.388 -179.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 12.2 m -87.03 139.53 30.48 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 109.146 -0.687 . . . . 1.0 109.146 178.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 11.1 pt -140.11 149.86 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-N 116.086 -0.506 . . . . 1.0 110.534 -178.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 18.4 pttp -93.19 139.03 31.04 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.541 -0.754 . . . . 1.0 109.235 178.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -64.04 150.8 44.59 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 109.665 -0.494 . . . . 1.0 109.665 179.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 72.9 p -137.39 159.36 42.15 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 115.894 -0.594 . . . . 1.0 110.188 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -81.44 135.14 35.62 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 109.313 -0.625 . . . . 1.0 109.313 178.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -134.63 -8.53 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 C-N-CA 122.475 0.31 . . . . 1.0 111.313 -179.363 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -127.66 148.27 50.38 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 122.937 0.495 . . . . 1.0 110.173 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -48.72 -33.26 9.85 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.238 -0.437 . . . . 1.0 111.805 -179.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -79.04 7.45 7.35 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 120.756 0.313 . . . . 1.0 110.846 -179.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 57.4 46.29 92.02 Favored Glycine 0 CA--C 1.529 0.954 0 CA-C-N 116.215 -0.448 . . . . 1.0 112.519 178.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 4.5 m -79.6 119.15 75.9 Favored Pre-proline 0 CA--C 1.551 0.982 0 CA-C-O 118.875 -0.584 . . . . 1.0 109.771 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -52.93 125.98 19.95 Favored 'Trans proline' 0 N--CA 1.504 2.112 0 C-N-CA 121.285 1.323 . . . . 1.0 111.077 177.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 173.74 172.6 39.24 Favored Glycine 0 N--CA 1.469 0.854 0 C-N-CA 120.801 -0.714 . . . . 1.0 112.254 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.19 173.4 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 N-CA-C 106.976 -1.49 . . . . 1.0 106.976 177.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -104.55 83.6 0.4 Allowed Glycine 0 N--CA 1.475 1.264 0 N-CA-C 110.549 -1.02 . . . . 1.0 110.549 -179.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -143.62 168.15 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-O 121.373 0.606 . . . . 1.0 110.746 179.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 26.4 m -128.14 132.72 48.91 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 115.099 -0.955 . . . . 1.0 109.344 178.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.433 ' CD2' ' N ' ' A' ' 89' ' ' LEU . 0.9 OUTLIER -99.61 159.52 14.98 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 123.194 0.598 . . . . 1.0 109.41 -179.99 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.2 m . . . . . 0 N--CA 1.488 1.431 0 CA-C-N 115.672 -0.695 . . . . 1.0 110.018 -178.368 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 . . . . . 0 N--CA 1.463 0.212 0 CA-C-O 120.861 0.363 . . . . 1.0 110.686 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 166.39 -175.36 41.83 Favored Glycine 0 N--CA 1.462 0.418 0 N-CA-C 109.968 -1.253 . . . . 1.0 109.968 -179.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 18.7 m -112.61 130.99 65.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 N-CA-C 108.859 -0.793 . . . . 1.0 108.859 179.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -88.13 137.42 32.34 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 109.828 -0.434 . . . . 1.0 109.828 -177.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 62.1 t -90.28 127.51 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 N-CA-C 108.861 -0.792 . . . . 1.0 108.861 179.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 48.6 tp -81.05 -44.27 18.28 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 120.87 0.366 . . . . 1.0 111.144 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.2 t -163.31 156.87 19.48 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 121.317 0.58 . . . . 1.0 111.187 -178.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.4 p -137.12 134.9 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 CA-C-N 114.969 -1.014 . . . . 1.0 109.314 179.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -76.37 160.22 29.77 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 109.15 -0.685 . . . . 1.0 109.15 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -99.35 -5.63 29.29 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 111.673 0.249 . . . . 1.0 111.673 -178.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 25.0 p-10 -106.68 29.02 7.32 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 122.611 0.364 . . . . 1.0 110.908 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.6 m -130.75 156.13 80.34 Favored Pre-proline 0 N--CA 1.483 1.175 0 C-N-CA 123.137 0.575 . . . . 1.0 109.545 -179.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -56.57 -22.06 41.46 Favored 'Trans proline' 0 N--CA 1.505 2.2 0 C-N-CA 121.688 1.592 . . . . 1.0 112.141 -179.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.4 -26.96 68.76 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.147 0.499 . . . . 1.0 110.536 -179.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.67 125.36 25.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.572 -0.74 . . . . 1.0 110.935 -178.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 95.5 -15.71 62.68 Favored Glycine 0 N--CA 1.475 1.237 0 N-CA-C 111.478 -0.649 . . . . 1.0 111.478 179.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 81.2 mt -113.55 -49.9 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 N-CA-C 110.039 -0.356 . . . . 1.0 110.039 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 16.2 mt -110.75 147.55 34.19 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 109.613 -0.514 . . . . 1.0 109.613 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.605 ' HE2' ' CG ' ' A' ' 63' ' ' HIS . 13.6 p-80 -143.64 156.61 44.61 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.559 -0.746 . . . . 1.0 110.051 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.07 143.41 32.81 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 115.739 -0.664 . . . . 1.0 111.435 -179.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 95.06 -4.6 67.9 Favored Glycine 0 N--CA 1.474 1.168 0 N-CA-C 111.696 -0.562 . . . . 1.0 111.696 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.4 ' OD1' ' CD2' ' A' ' 25' ' ' HIS . 9.7 m-20 -82.8 123.04 28.97 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 117.145 0.473 . . . . 1.0 110.276 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 20.0 mt -97.92 121.07 39.39 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 109.711 -0.477 . . . . 1.0 109.711 179.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 16.0 mm -77.43 127.64 38.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 N-CA-C 108.948 -0.76 . . . . 1.0 108.948 -179.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 75.8 p -77.75 -51.95 9.72 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.291 -0.413 . . . . 1.0 110.678 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -155.14 166.28 34.07 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.032 0.444 . . . . 1.0 109.945 -179.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -134.04 126.59 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-N 115.064 -0.971 . . . . 1.0 109.931 179.319 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 37.5 t70 48.97 16.91 0.13 Allowed 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.699 -0.682 . . . . 1.0 111.624 179.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.82 14.86 78.15 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 111.331 -0.708 . . . . 1.0 111.331 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 . . . . . 0 N--CA 1.476 0.868 0 CA-C-O 120.899 0.381 . . . . 1.0 110.297 -179.614 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.547 ' HG ' ' N ' ' A' ' 41' ' ' SER . 21.2 t . . . . . 0 N--CA 1.465 0.325 0 CA-C-O 120.834 0.349 . . . . 1.0 110.49 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.547 ' N ' ' HG ' ' A' ' 40' ' ' SER . 50.3 m -65.78 -42.23 91.06 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.042 -0.526 . . . . 1.0 109.846 178.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -64.86 -37.88 89.11 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.069 -0.514 . . . . 1.0 111.067 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -54.82 -25.37 27.98 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.027 0.441 . . . . 1.0 110.037 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -70.29 -45.65 65.92 Favored 'General case' 0 C--O 1.221 -0.429 0 N-CA-C 109.154 -0.684 . . . . 1.0 109.154 179.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.6 mp -64.28 -30.13 49.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 N-CA-C 108.896 -0.779 . . . . 1.0 108.896 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -63.13 -34.1 76.88 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.237 -179.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 32.2 t80 -69.14 -44.21 72.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.243 -0.435 . . . . 1.0 111.519 179.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 44.0 mt -57.44 -42.5 80.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.319 -0.401 . . . . 1.0 110.275 -175.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 54.2 m-70 -76.52 -18.76 58.55 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.309 -0.405 . . . . 1.0 111.117 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 13.0 t -92.33 46.48 1.26 Allowed 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 111.564 0.209 . . . . 1.0 111.564 -178.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 13.8 mmtm -149.31 175.74 11.16 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 109.242 -0.651 . . . . 1.0 109.242 179.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -130.1 154.1 47.81 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-O 121.067 0.46 . . . . 1.0 109.787 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 28.5 t -60.83 135.43 25.58 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 115.933 -0.576 . . . . 1.0 110.864 -178.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 97.55 -19.59 54.08 Favored Glycine 0 N--CA 1.477 1.422 0 N-CA-C 110.951 -0.86 . . . . 1.0 110.951 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -65.54 143.41 57.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.594 0.235 . . . . 1.0 110.497 -179.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 68.0 p -96.22 152.56 18.45 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 109.153 -0.684 . . . . 1.0 109.153 179.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 6.6 p -140.49 155.42 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 CA-C-O 121.232 0.539 . . . . 1.0 110.757 -179.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 31.6 mtmm -101.18 123.08 44.75 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.319 -0.855 . . . . 1.0 109.486 178.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -117.71 136.06 56.08 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 C-N-CA 122.84 0.456 . . . . 1.0 110.109 179.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 12.8 ptpt -135.72 120.51 18.48 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 107.745 -1.206 . . . . 1.0 107.745 178.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 34.7 p90 -146.21 149.28 33.64 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 110.146 -0.316 . . . . 1.0 110.146 -179.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 20.9 pttm -111.57 114.49 27.59 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.355 0.598 . . . . 1.0 110.552 -179.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.605 ' CG ' ' HE2' ' A' ' 25' ' ' HIS . 70.5 t60 -98.69 120.87 39.85 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 108.045 -1.094 . . . . 1.0 108.045 178.4 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 61.6 -118.04 13.49 Favored Glycine 0 CA--C 1.531 1.034 0 N-CA-C 111.121 -0.791 . . . . 1.0 111.121 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -114.16 14.55 18.23 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 122.942 0.497 . . . . 1.0 111.544 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 17.1 ptmt -122.75 121.16 35.66 Favored 'General case' 0 N--CA 1.485 1.309 0 CA-C-O 121.38 0.61 . . . . 1.0 111.157 -179.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 30.6 m120 -77.01 124.38 27.71 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 116.079 -0.51 . . . . 1.0 109.889 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -127.81 140.56 51.96 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 115.863 -0.608 . . . . 1.0 110.052 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.4 ' CD ' ' N ' ' A' ' 69' ' ' GLU . 1.9 pm0 -142.18 136.09 29.62 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 115.813 -0.63 . . . . 1.0 110.58 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -161.28 129.44 4.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.788 -0.642 . . . . 1.0 111.188 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 9.4 t -85.54 146.18 27.03 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 108.915 -0.772 . . . . 1.0 108.915 178.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.491 ' CD1' ' N ' ' A' ' 72' ' ' ILE . 0.0 OUTLIER -134.55 149.83 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 CA-C-O 121.425 0.631 . . . . 1.0 110.329 -178.981 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.6 ttmp? -81.2 139.47 35.51 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 115.11 -0.95 . . . . 1.0 109.268 179.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -73.64 149.73 41.81 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.193 0.521 . . . . 1.0 110.0 179.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 27.3 p -140.73 164.17 30.91 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.398 -0.819 . . . . 1.0 110.123 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -79.97 131.95 35.92 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 109.271 -0.641 . . . . 1.0 109.271 178.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.404 HG13 ' H ' ' A' ' 78' ' ' ASP . 1.3 pt -109.63 -55.88 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 CA-C-N 115.946 -0.57 . . . . 1.0 109.794 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.432 ' OD2' ' NZ ' ' A' ' 80' ' ' LYS . 40.9 t0 -98.41 171.53 8.11 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 121.507 0.67 . . . . 1.0 111.48 -178.095 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -60.16 -28.56 68.02 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.811 -1.086 . . . . 1.0 112.045 -179.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.432 ' NZ ' ' OD2' ' A' ' 78' ' ' ASP . 19.6 pttm -80.09 14.58 1.8 Allowed 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 120.619 0.247 . . . . 1.0 110.517 -179.374 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 49.24 41.15 30.77 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 112.169 -0.372 . . . . 1.0 112.169 178.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 15.9 m -80.02 120.51 80.0 Favored Pre-proline 0 CA--C 1.547 0.834 0 N-CA-C 109.544 -0.539 . . . . 1.0 109.544 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -52.95 131.8 44.23 Favored 'Trans proline' 0 N--CA 1.501 1.927 0 C-N-CA 121.463 1.442 . . . . 1.0 112.277 178.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -158.58 146.14 12.72 Favored Glycine 0 N--CA 1.468 0.788 0 N-CA-C 111.474 -0.65 . . . . 1.0 111.474 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 40.7 mm -67.6 -26.05 34.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.455 -0.373 . . . . 1.0 110.418 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 99.47 45.6 2.12 Favored Glycine 0 N--CA 1.475 1.255 0 N-CA-C 110.684 -0.966 . . . . 1.0 110.684 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 38.4 pt -145.15 166.89 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 N-CA-C 109.863 -0.421 . . . . 1.0 109.863 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 77.0 m -127.25 127.07 43.82 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 109.253 -0.647 . . . . 1.0 109.253 177.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.1 mp -99.39 146.69 26.03 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 120.797 0.332 . . . . 1.0 110.525 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.7 p . . . . . 0 N--CA 1.477 0.917 0 CA-C-N 115.777 -0.647 . . . . 1.0 109.744 -179.042 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 48.7 p-10 . . . . . 0 N--CA 1.453 -0.308 0 N-CA-C 109.366 -0.605 . . . . 1.0 109.366 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -69.66 -160.17 2.52 Favored Glycine 0 CA--C 1.52 0.376 0 N-CA-C 110.122 -1.191 . . . . 1.0 110.122 179.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.9 m -112.82 132.41 61.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 N-CA-C 109.362 -0.607 . . . . 1.0 109.362 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -92.27 132.37 36.74 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 115.791 -0.64 . . . . 1.0 110.588 -178.244 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 57.3 t -77.56 134.55 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.126 0 N-CA-C 107.335 -1.357 . . . . 1.0 107.335 177.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.3 tt -81.03 -51.19 8.77 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.056 0.455 . . . . 1.0 111.163 -178.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.0 m -163.61 159.79 22.19 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.151 0.5 . . . . 1.0 111.343 -179.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 26.4 t -109.24 134.75 50.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-N 114.992 -1.004 . . . . 1.0 109.134 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -63.86 -36.55 84.29 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 116.4 -0.364 . . . . 1.0 110.675 -179.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 73.38 25.91 2.1 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.5 1.12 . . . . 1.0 111.835 -179.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -145.75 35.23 1.04 Allowed 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 108.709 -0.848 . . . . 1.0 108.709 178.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 6.5 m -145.08 158.06 52.74 Favored Pre-proline 0 N--CA 1.476 0.851 0 CA-C-N 115.903 -0.589 . . . . 1.0 110.238 -178.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -50.88 -15.08 1.57 Allowed 'Trans proline' 0 N--CA 1.505 2.171 0 C-N-CA 121.781 1.654 . . . . 1.0 112.17 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.55 -35.17 80.12 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.966 0.412 . . . . 1.0 110.591 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.56 129.71 41.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.924 -0.58 . . . . 1.0 111.313 -178.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.44 -7.52 75.06 Favored Glycine 0 N--CA 1.47 0.942 0 N-CA-C 111.109 -0.796 . . . . 1.0 111.109 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 52.9 mt -115.54 -50.61 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 CA-C-O 120.769 0.318 . . . . 1.0 110.498 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 28.4 mt -113.53 153.54 28.59 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.091 0.556 . . . . 1.0 110.101 -179.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 67.6 m80 -144.12 157.03 44.55 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.86 -0.609 . . . . 1.0 111.001 -179.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.05 140.3 38.4 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.924 -0.58 . . . . 1.0 111.134 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 91.81 -4.38 78.74 Favored Glycine 0 N--CA 1.471 0.972 0 N-CA-C 111.283 -0.727 . . . . 1.0 111.283 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -67.63 124.85 24.4 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 109.425 -0.583 . . . . 1.0 109.425 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 10.6 mt -96.61 122.28 39.36 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 109.095 -0.706 . . . . 1.0 109.095 179.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 33.7 mm -83.62 116.48 27.68 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 109.124 -0.695 . . . . 1.0 109.124 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 71.7 p -90.56 -39.78 12.34 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 116.278 -0.419 . . . . 1.0 111.436 -179.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -146.32 148.78 32.75 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 109.826 -0.435 . . . . 1.0 109.826 -179.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.427 ' C ' ' H ' ' A' ' 35' ' ' GLY . 3.6 mt -129.59 128.86 66.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 108.709 -0.848 . . . . 1.0 108.709 179.211 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 26.5 t0 45.8 14.47 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 112.131 0.419 . . . . 1.0 112.131 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.427 ' H ' ' C ' ' A' ' 33' ' ' ILE . . . 65.73 17.9 65.48 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.937 -0.865 . . . . 1.0 110.937 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 . . . . . 0 N--CA 1.477 0.884 0 CA-C-O 120.932 0.396 . . . . 1.0 110.625 -179.002 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.434 ' HG ' ' N ' ' A' ' 41' ' ' SER . 4.5 t . . . . . 0 C--O 1.233 0.189 0 CA-C-O 121.227 0.537 . . . . 1.0 110.122 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.434 ' N ' ' HG ' ' A' ' 40' ' ' SER . 73.1 m -75.93 -33.01 59.84 Favored 'General case' 0 C--O 1.218 -0.566 0 CA-C-N 115.702 -0.681 . . . . 1.0 109.917 179.064 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.407 ' NE2' ' OD2' ' A' ' 46' ' ' ASP . 0.0 OUTLIER -74.05 -45.4 49.74 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 120.948 0.404 . . . . 1.0 111.187 -178.897 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -56.56 -20.86 22.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.123 -0.489 . . . . 1.0 110.49 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -72.1 -52.18 17.99 Favored 'General case' 0 N--CA 1.461 0.097 0 C-N-CA 120.542 -0.463 . . . . 1.0 110.406 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.7 mp -54.05 -31.8 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 N-CA-C 108.651 -0.87 . . . . 1.0 108.651 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.407 ' OD2' ' NE2' ' A' ' 42' ' ' GLN . 61.8 m-20 -72.0 -32.57 67.32 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.018 -0.992 . . . . 1.0 111.227 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.427 ' OH ' ' NZ ' ' A' ' 51' ' ' LYS . 77.3 t80 -69.23 -52.57 26.4 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 120.875 0.369 . . . . 1.0 111.479 -179.4 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -54.92 -25.63 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 N-CA-C 109.53 -0.545 . . . . 1.0 109.53 -177.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 42.5 m170 -94.15 -18.12 22.07 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.58 -0.737 . . . . 1.0 110.558 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 27.6 t -66.75 -22.43 66.04 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.712 0.291 . . . . 1.0 111.448 -178.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.427 ' NZ ' ' OH ' ' A' ' 47' ' ' TYR . 34.9 mmtp -90.48 -169.06 2.27 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 109.649 -0.5 . . . . 1.0 109.649 179.462 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.9 mptp? -122.46 168.29 12.29 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 122.958 0.503 . . . . 1.0 110.658 -179.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 22.1 t -65.2 135.1 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-N 115.738 -0.665 . . . . 1.0 110.732 -178.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.97 -0.88 86.54 Favored Glycine 0 N--CA 1.474 1.172 0 N-CA-C 110.968 -0.853 . . . . 1.0 110.968 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -73.54 147.18 44.2 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 110.235 -0.283 . . . . 1.0 110.235 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 80.7 p -86.51 150.33 24.33 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 109.574 -0.528 . . . . 1.0 109.574 178.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -141.93 161.58 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 CA-C-O 120.933 0.397 . . . . 1.0 111.244 -179.367 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 49.9 mtmt -123.4 114.52 20.26 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.011 -0.995 . . . . 1.0 108.734 177.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 35.3 mm -106.87 140.14 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 CA-C-O 121.004 0.431 . . . . 1.0 110.378 -179.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -131.99 115.77 16.26 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 106.942 -1.503 . . . . 1.0 106.942 177.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 29.5 p90 -143.12 164.23 30.71 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-N 116.123 -0.49 . . . . 1.0 110.073 -176.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 21.2 ttpp -127.31 114.84 18.12 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 123.423 0.452 . . . . 1.0 110.641 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -99.92 108.68 20.98 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 108.075 -1.083 . . . . 1.0 108.075 178.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 74.82 -114.28 4.31 Favored Glycine 0 CA--C 1.532 1.132 0 N-CA-C 111.128 -0.789 . . . . 1.0 111.128 -179.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -113.12 -10.91 13.38 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 122.674 0.39 . . . . 1.0 111.638 -179.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -99.23 133.77 43.04 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-O 120.706 0.289 . . . . 1.0 110.745 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 18.4 p30 -97.15 128.84 44.44 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.902 0.382 . . . . 1.0 110.133 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 74.1 mt-10 -132.94 155.01 49.89 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 115.738 -0.664 . . . . 1.0 109.854 -179.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -140.7 138.09 33.98 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.843 -0.617 . . . . 1.0 110.523 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -146.89 151.38 36.96 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.766 -0.652 . . . . 1.0 110.613 -179.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 50.5 m -102.67 134.02 46.72 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.353 -0.84 . . . . 1.0 109.166 179.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 7.6 mt -135.7 139.94 45.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 CA-C-O 121.298 0.57 . . . . 1.0 110.494 -177.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 52.0 pttt -82.47 141.51 32.64 Favored 'General case' 0 C--N 1.327 -0.376 0 O-C-N 121.905 -0.497 . . . . 1.0 110.192 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -68.62 143.38 54.84 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 120.97 0.414 . . . . 1.0 110.082 178.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 80.5 p -136.32 162.96 31.57 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 115.809 -0.632 . . . . 1.0 110.433 179.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -78.44 122.84 26.34 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.885 -0.598 . . . . 1.0 109.713 179.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.449 ' CG1' ' H ' ' A' ' 78' ' ' ASP . 3.6 pt -96.06 -53.44 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-N 116.795 -0.184 . . . . 1.0 110.587 179.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.449 ' H ' ' CG1' ' A' ' 77' ' ' ILE . 44.3 t0 -98.08 169.65 9.46 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 121.365 0.602 . . . . 1.0 111.579 -178.328 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 47.0 mmtm -61.82 -23.9 66.53 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 114.902 -1.044 . . . . 1.0 111.904 -178.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 35.6 pttt -77.53 -15.55 59.2 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 120.479 0.18 . . . . 1.0 110.626 -178.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 83.03 40.18 9.53 Favored Glycine 0 N--CA 1.467 0.753 0 C-N-CA 121.424 -0.417 . . . . 1.0 112.075 178.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 53.2 m -81.21 120.16 77.74 Favored Pre-proline 0 CA--C 1.545 0.753 0 N-CA-C 109.324 -0.621 . . . . 1.0 109.324 179.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -52.79 130.88 39.35 Favored 'Trans proline' 0 N--CA 1.497 1.717 0 C-N-CA 121.142 1.228 . . . . 1.0 112.909 178.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -169.14 155.03 25.03 Favored Glycine 0 N--CA 1.461 0.318 0 N-CA-C 110.666 -0.974 . . . . 1.0 110.666 178.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 3.3 mt -89.66 26.4 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 N-CA-C 109.501 -0.555 . . . . 1.0 109.501 -179.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 50.52 63.62 4.27 Favored Glycine 0 CA--C 1.531 1.056 0 N-CA-C 111.782 -0.527 . . . . 1.0 111.782 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 18.7 pt -146.62 164.6 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 N-CA-C 109.353 -0.61 . . . . 1.0 109.353 179.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 86.1 m -130.36 125.5 34.77 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 115.477 -0.783 . . . . 1.0 109.581 177.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 12.7 mt -111.01 134.7 52.4 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.282 0.633 . . . . 1.0 109.801 -179.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 16.0 m . . . . . 0 C--N 1.327 -0.385 0 N-CA-C 108.367 -0.975 . . . . 1.0 108.367 179.156 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 41.5 t0 . . . . . 0 N--CA 1.472 0.648 0 N-CA-C 109.747 -0.464 . . . . 1.0 109.747 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -171.23 -159.34 17.11 Favored Glycine 0 CA--C 1.521 0.461 0 N-CA-C 109.948 -1.261 . . . . 1.0 109.948 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 16.6 m -117.96 128.81 75.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 CA-C-O 121.297 0.57 . . . . 1.0 109.731 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -86.7 146.17 26.4 Favored 'General case' 0 C--O 1.221 -0.396 0 N-CA-C 108.639 -0.874 . . . . 1.0 108.639 -178.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 57.0 t -107.96 132.06 56.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 108.951 -0.759 . . . . 1.0 108.951 179.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.61 -50.83 7.33 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 116.287 -0.415 . . . . 1.0 111.245 -179.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 99.7 p -167.79 163.73 14.14 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 121.173 0.511 . . . . 1.0 111.301 -179.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 39.8 t -107.09 128.74 61.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 CA-C-N 115.128 -0.942 . . . . 1.0 108.497 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.413 ' O ' ' CB ' ' A' ' 16' ' ' GLU . 63.6 mttp -59.91 -36.75 77.64 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-N 116.099 -0.501 . . . . 1.0 110.55 -178.584 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.461 ' C ' ' H ' ' A' ' 18' ' ' VAL . 59.5 tt0 93.84 163.93 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.338 0 O-C-N 124.742 1.277 . . . . 1.0 111.129 178.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 70.59 -4.97 1.51 Allowed 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.496 -0.775 . . . . 1.0 109.567 -179.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.461 ' H ' ' C ' ' A' ' 16' ' ' GLU . 11.4 m -96.3 155.61 37.86 Favored Pre-proline 0 CA--C 1.541 0.604 0 CA-C-N 115.727 -0.669 . . . . 1.0 110.44 -178.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -55.92 -23.03 40.82 Favored 'Trans proline' 0 N--CA 1.503 2.058 0 C-N-CA 121.953 1.769 . . . . 1.0 112.226 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.44 -23.73 67.38 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.649 0.261 . . . . 1.0 110.852 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.5 136.0 44.1 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.306 -0.406 . . . . 1.0 110.887 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 91.28 -23.64 23.45 Favored Glycine 0 N--CA 1.469 0.89 0 N-CA-C 111.243 -0.743 . . . . 1.0 111.243 179.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 67.9 mt -102.12 -50.21 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 122.32 0.248 . . . . 1.0 110.489 -179.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 23.5 mt -109.89 157.15 19.53 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-O 121.077 0.465 . . . . 1.0 109.895 -179.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 50.3 t-80 -139.0 153.5 48.15 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.44 -0.8 . . . . 1.0 110.591 -179.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.42 144.39 31.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.369 -0.832 . . . . 1.0 110.812 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 89.01 -11.2 70.03 Favored Glycine 0 CA--C 1.528 0.898 0 N-CA-C 111.06 -0.816 . . . . 1.0 111.06 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -68.27 144.17 54.97 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 110.249 -0.278 . . . . 1.0 110.249 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.5 mp -117.75 121.45 40.87 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 110.127 -0.323 . . . . 1.0 110.127 -179.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 25.4 mm -80.36 125.88 39.29 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 N-CA-C 109.177 -0.675 . . . . 1.0 109.177 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 73.8 p -88.13 -47.36 8.54 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.169 -0.468 . . . . 1.0 110.449 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 71.9 tt0 -155.96 146.54 21.89 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.974 0.416 . . . . 1.0 111.222 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 12.6 tt -141.96 131.76 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 109.404 -0.591 . . . . 1.0 109.404 179.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.412 ' OD2' ' CE1' ' A' ' 47' ' ' TYR . 57.8 m-20 56.82 20.84 5.5 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.112 -0.494 . . . . 1.0 111.581 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.86 2.54 86.36 Favored Glycine 0 N--CA 1.472 1.063 0 CA-C-N 116.483 -0.326 . . . . 1.0 112.384 178.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 . . . . . 0 N--CA 1.474 0.769 0 CA-C-N 117.361 0.58 . . . . 1.0 111.008 -179.917 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.5 m . . . . . 0 N--CA 1.477 0.907 0 CA-C-O 120.798 0.332 . . . . 1.0 110.757 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 50.3 m -52.52 -31.6 36.28 Favored 'General case' 0 N--CA 1.457 -0.089 0 N-CA-C 109.389 -0.597 . . . . 1.0 109.389 178.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.5 tm0? -55.38 -35.18 65.0 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 115.452 -0.795 . . . . 1.0 110.144 179.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -57.98 -27.86 63.85 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 115.963 -0.562 . . . . 1.0 109.779 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -72.59 -47.47 47.66 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.978 -0.555 . . . . 1.0 109.722 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 27.4 mm -63.55 -28.86 45.87 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 CA-C-N 115.797 -0.638 . . . . 1.0 109.833 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -62.62 -37.52 86.62 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.611 -0.722 . . . . 1.0 109.975 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.412 ' CE1' ' OD2' ' A' ' 34' ' ' ASP . 0.0 OUTLIER -66.62 -45.66 78.38 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.059 -0.519 . . . . 1.0 110.681 179.182 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 49.5 mt -60.61 -45.35 97.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 116.518 -0.31 . . . . 1.0 111.016 -176.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -74.16 -22.56 59.38 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.457 -0.338 . . . . 1.0 111.187 -178.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 46.6 t -85.81 -6.76 59.05 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-O 120.566 0.222 . . . . 1.0 111.217 -177.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.4 tptm -99.26 164.91 11.94 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-N 116.188 -0.46 . . . . 1.0 109.869 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -121.58 170.42 9.71 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 123.964 0.79 . . . . 1.0 109.893 -179.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 22.0 t -70.91 132.57 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-N 115.448 -0.797 . . . . 1.0 111.125 -178.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.37 -5.18 80.73 Favored Glycine 0 N--CA 1.469 0.854 0 N-CA-C 111.054 -0.818 . . . . 1.0 111.054 179.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -67.98 144.39 55.19 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.763 0.316 . . . . 1.0 110.751 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 36.3 m -90.19 153.72 20.29 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 108.988 -0.745 . . . . 1.0 108.988 178.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -140.13 161.27 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 CA-C-O 121.402 0.62 . . . . 1.0 110.599 -179.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.576 ' HZ2' ' HZ2' ' A' ' 60' ' ' LYS . 64.1 tttm -117.15 115.68 25.81 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 107.647 -1.242 . . . . 1.0 107.647 177.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.9 tp -103.18 143.13 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 122.332 0.253 . . . . 1.0 111.018 -178.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.576 ' HZ2' ' HZ2' ' A' ' 58' ' ' LYS . 6.9 tppt? -133.1 112.75 12.03 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 108.383 -0.969 . . . . 1.0 108.383 178.041 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 33.8 p90 -149.15 149.2 30.64 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.906 -0.405 . . . . 1.0 109.906 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -110.18 114.12 27.35 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 110.239 -0.282 . . . . 1.0 110.239 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 51.3 t-80 -91.91 112.0 23.76 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 108.013 -1.106 . . . . 1.0 108.013 178.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 62.17 -114.45 6.8 Favored Glycine 0 CA--C 1.532 1.152 0 N-CA-C 110.7 -0.96 . . . . 1.0 110.7 -179.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 23.0 p-10 -112.99 -0.5 14.75 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 122.476 0.31 . . . . 1.0 111.365 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.438 ' NZ ' ' OE2' ' A' ' 68' ' ' GLU . 10.8 ptmm? -110.73 123.42 50.0 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 121.421 0.629 . . . . 1.0 110.75 -179.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 46.4 p-10 -81.93 128.24 33.85 Favored 'General case' 0 C--N 1.339 0.13 0 CA-C-O 121.363 0.601 . . . . 1.0 110.353 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.438 ' OE2' ' NZ ' ' A' ' 66' ' ' LYS . 81.0 mm-40 -126.11 148.83 49.28 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 115.23 -0.895 . . . . 1.0 109.523 -179.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.413 ' OE2' ' NZ ' ' A' ' 58' ' ' LYS . 36.8 tt0 -140.86 135.2 31.11 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 109.186 -0.672 . . . . 1.0 109.186 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -148.1 142.22 26.04 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-O 121.537 0.684 . . . . 1.0 111.222 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 91.5 p -85.7 135.03 33.93 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 108.781 -0.822 . . . . 1.0 108.781 178.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 67.2 mt -129.28 122.37 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 CA-C-O 121.289 0.566 . . . . 1.0 109.963 -178.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 22.3 ttpp -82.29 138.3 34.61 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 109.64 -0.504 . . . . 1.0 109.64 179.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -69.68 143.97 53.0 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.373 0.606 . . . . 1.0 110.304 -178.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 69.7 p -143.28 172.25 13.0 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.064 -0.971 . . . . 1.0 110.435 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -89.3 140.83 29.1 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.343 -0.844 . . . . 1.0 109.583 179.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.427 ' CD1' ' N ' ' A' ' 77' ' ' ILE . 0.1 OUTLIER -131.92 -41.98 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 122.672 0.389 . . . . 1.0 110.839 -179.625 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.409 ' H ' HD11 ' A' ' 77' ' ' ILE . 73.7 m-20 -98.62 157.84 15.99 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 121.521 0.677 . . . . 1.0 110.729 -179.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -52.37 -27.09 14.25 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.845 -1.07 . . . . 1.0 112.046 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.504 ' HZ1' ' CB ' ' A' ' 82' ' ' THR . 18.1 pttp -81.4 13.24 3.07 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 116.303 -0.408 . . . . 1.0 111.039 -179.379 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 47.85 39.59 17.92 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 121.343 -0.456 . . . . 1.0 112.046 178.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.504 ' CB ' ' HZ1' ' A' ' 80' ' ' LYS . 86.8 m -80.17 122.09 82.55 Favored Pre-proline 0 CA--C 1.545 0.779 0 CA-C-N 117.101 0.451 . . . . 1.0 110.215 -179.159 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -57.03 114.86 2.11 Favored 'Trans proline' 0 N--CA 1.505 2.168 0 C-N-CA 121.401 1.4 . . . . 1.0 111.332 177.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -179.8 179.64 48.82 Favored Glycine 0 N--CA 1.463 0.449 0 N-CA-C 111.081 -0.808 . . . . 1.0 111.081 179.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.7 pt -105.69 177.5 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 N-CA-C 109.665 -0.495 . . . . 1.0 109.665 179.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -108.31 84.45 0.37 Allowed Glycine 0 N--CA 1.472 1.079 0 N-CA-C 111.05 -0.82 . . . . 1.0 111.05 -178.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.2 pp -146.77 168.3 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-O 121.272 0.558 . . . . 1.0 109.645 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 62.3 m -132.23 131.39 42.06 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 115.424 -0.807 . . . . 1.0 109.557 179.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 29.2 mt -110.52 147.51 33.99 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.711 -0.677 . . . . 1.0 109.267 -179.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 30.8 m . . . . . 0 N--CA 1.476 0.872 0 CA-C-N 115.773 -0.649 . . . . 1.0 110.395 -179.749 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 36.3 p-10 . . . . . 0 N--CA 1.463 0.193 0 CA-C-O 121.004 0.43 . . . . 1.0 110.049 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 153.67 -175.38 32.03 Favored Glycine 0 N--CA 1.467 0.75 0 N-CA-C 109.858 -1.297 . . . . 1.0 109.858 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 38.9 t -111.64 127.42 68.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 N-CA-C 109.18 -0.674 . . . . 1.0 109.18 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -86.85 143.36 27.49 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 115.962 -0.563 . . . . 1.0 109.634 -178.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 39.0 t -107.93 132.95 54.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 115.405 -0.816 . . . . 1.0 109.208 179.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.67 -44.39 17.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.814 -0.63 . . . . 1.0 111.971 -179.547 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 99.9 p -165.8 162.39 18.47 Favored 'General case' 0 CA--C 1.506 -0.727 0 CA-C-N 116.061 -0.518 . . . . 1.0 110.953 -179.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.44 ' O ' ' O ' ' A' ' 15' ' ' LYS . 40.3 t -120.42 137.62 53.62 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 114.728 -1.124 . . . . 1.0 108.732 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.44 ' O ' ' O ' ' A' ' 14' ' ' VAL . 3.9 mmmm -54.43 -116.6 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.477 0 O-C-N 123.815 0.697 . . . . 1.0 110.294 179.129 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 78.1 tt0 -162.32 -70.13 0.05 Allowed 'General case' 0 C--N 1.33 -0.269 0 O-C-N 121.755 -0.591 . . . . 1.0 111.445 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 29.2 p-10 -89.97 51.7 2.12 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.346 -0.388 . . . . 1.0 110.569 -178.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 32.8 m -124.99 156.71 68.81 Favored Pre-proline 0 N--CA 1.471 0.616 0 CA-C-N 115.841 -0.618 . . . . 1.0 110.151 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -58.86 -13.18 17.3 Favored 'Trans proline' 0 N--CA 1.499 1.827 0 C-N-CA 121.751 1.634 . . . . 1.0 112.054 178.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -81.99 -27.46 33.15 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.068 0.461 . . . . 1.0 110.381 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.91 130.5 41.17 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 115.694 -0.685 . . . . 1.0 110.134 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 98.57 -15.03 61.55 Favored Glycine 0 N--CA 1.472 1.054 0 N-CA-C 111.197 -0.761 . . . . 1.0 111.197 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 71.1 mt -115.23 -52.24 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 CA-C-N 116.616 0.208 . . . . 1.0 110.459 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 12.7 mt -102.0 149.77 23.9 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 109.816 -0.439 . . . . 1.0 109.816 -179.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.626 ' HE2' ' CD2' ' A' ' 63' ' ' HIS . 42.5 p-80 -141.11 154.89 46.13 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.389 0.614 . . . . 1.0 110.433 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.05 134.43 55.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.18 -0.918 . . . . 1.0 110.617 -179.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.27 -4.09 62.16 Favored Glycine 0 N--CA 1.471 0.983 0 N-CA-C 111.197 -0.761 . . . . 1.0 111.197 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -77.85 130.17 36.31 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 117.274 0.537 . . . . 1.0 110.264 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 14.3 mt -99.91 120.05 39.17 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 109.508 -0.552 . . . . 1.0 109.508 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 75.8 mt -92.34 137.51 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 N-CA-C 108.975 -0.75 . . . . 1.0 108.975 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.613 ' HG1' ' N ' ' A' ' 32' ' ' GLU . 51.9 p -102.41 -43.93 5.52 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 116.13 -0.486 . . . . 1.0 111.216 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.613 ' N ' ' HG1' ' A' ' 31' ' ' THR . 73.0 tt0 -153.72 163.09 40.59 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.337 0.589 . . . . 1.0 111.176 -178.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 16.9 tt -149.61 142.56 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-N 115.906 -0.588 . . . . 1.0 110.028 179.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 28.3 t70 50.19 19.99 0.58 Allowed 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 120.994 0.426 . . . . 1.0 111.74 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.95 19.64 77.21 Favored Glycine 0 N--CA 1.47 0.955 0 N-CA-C 111.919 -0.472 . . . . 1.0 111.919 178.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 . . . . . 0 N--CA 1.47 0.552 0 O-C-N 122.473 -0.427 . . . . 1.0 110.329 -179.034 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.459 ' HG ' ' H ' ' A' ' 43' ' ' GLU . 30.6 t . . . . . 0 N--CA 1.481 1.089 0 CA-C-O 120.576 0.227 . . . . 1.0 111.128 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 78.0 p -61.93 -48.65 79.47 Favored 'General case' 0 CA--C 1.513 -0.468 0 N-CA-C 109.404 -0.591 . . . . 1.0 109.404 -178.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 69.3 tp60 -51.43 -38.52 54.03 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.046 -0.525 . . . . 1.0 110.345 -178.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.459 ' H ' ' HG ' ' A' ' 40' ' ' SER . 50.8 tp10 -65.31 -32.64 74.39 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.347 -0.612 . . . . 1.0 109.347 179.044 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 27.8 t80 -72.11 -50.23 29.74 Favored 'General case' 0 C--O 1.219 -0.523 0 CA-C-N 116.337 -0.392 . . . . 1.0 110.204 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.7 mp -59.92 -37.18 70.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 109.247 -0.649 . . . . 1.0 109.247 179.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -60.49 -35.69 76.52 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.652 -0.704 . . . . 1.0 110.408 -178.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 44.4 t80 -68.08 -48.89 64.29 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.213 -0.449 . . . . 1.0 111.621 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 33.6 mt -52.78 -34.28 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-O 120.906 0.384 . . . . 1.0 110.427 -176.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 45.3 m170 -85.9 -22.54 27.43 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.036 -0.529 . . . . 1.0 111.121 -179.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 71.7 p -70.87 -17.98 62.71 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.645 -0.252 . . . . 1.0 111.269 -178.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 18.4 mmmt -90.48 -171.61 3.13 Favored 'General case' 0 CA--C 1.512 -0.492 0 N-CA-C 110.054 -0.35 . . . . 1.0 110.054 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -128.37 168.58 15.36 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 123.618 0.574 . . . . 1.0 110.148 -178.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 25.9 t -70.86 134.99 29.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.448 -0.796 . . . . 1.0 110.946 -178.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 90.31 -4.52 82.68 Favored Glycine 0 N--CA 1.47 0.938 0 N-CA-C 110.637 -0.985 . . . . 1.0 110.637 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -70.34 147.09 50.02 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 110.09 -0.337 . . . . 1.0 110.09 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 23.1 m -105.1 139.29 40.0 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 109.363 -0.606 . . . . 1.0 109.363 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 34.5 m -138.27 164.45 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 CA-C-N 116.12 -0.491 . . . . 1.0 111.535 -179.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.83 117.88 27.6 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 115.065 -0.971 . . . . 1.0 108.972 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.9 tt -97.72 141.79 15.39 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.201 0 O-C-N 123.314 0.384 . . . . 1.0 111.343 -178.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -121.43 119.91 33.43 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 107.721 -1.214 . . . . 1.0 107.721 178.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 18.7 p90 -147.75 161.26 41.59 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 110.065 -0.346 . . . . 1.0 110.065 -179.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 26.1 mtmm -128.27 117.84 22.22 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 123.464 0.477 . . . . 1.0 110.677 179.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.626 ' CD2' ' HE2' ' A' ' 25' ' ' HIS . 17.2 t-80 -107.64 112.15 24.73 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 108.37 -0.974 . . . . 1.0 108.37 178.105 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 73.19 -118.34 6.27 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.944 -0.862 . . . . 1.0 110.944 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 68.0 m-80 -115.95 14.04 16.07 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 122.704 0.401 . . . . 1.0 111.802 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -126.28 119.79 28.29 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 120.82 0.343 . . . . 1.0 110.938 -179.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 61.3 t-20 -84.74 133.16 34.37 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-N 116.116 -0.493 . . . . 1.0 109.845 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -128.67 161.34 29.9 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 115.228 -0.897 . . . . 1.0 110.015 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -141.08 139.79 34.1 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 115.454 -0.794 . . . . 1.0 110.149 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -150.65 161.48 42.51 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 115.664 -0.698 . . . . 1.0 110.493 -178.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 91.0 p -128.27 138.28 52.35 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 109.096 -0.705 . . . . 1.0 109.096 179.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.482 ' CD1' ' N ' ' A' ' 72' ' ' ILE . 0.1 OUTLIER -138.22 147.27 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-O 121.491 0.662 . . . . 1.0 110.535 -178.189 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 7.8 ttpm? -86.57 135.21 33.52 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.387 -0.824 . . . . 1.0 109.846 179.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -68.98 147.58 51.4 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.151 0.5 . . . . 1.0 110.498 179.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 18.6 p -141.17 168.61 19.36 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 115.187 -0.915 . . . . 1.0 110.659 -179.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -80.25 148.34 30.83 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.192 -0.913 . . . . 1.0 109.887 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.461 HG13 ' H ' ' A' ' 78' ' ' ASP . 1.6 pt -128.89 -55.92 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 CA-C-N 115.996 -0.547 . . . . 1.0 110.782 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.461 ' H ' HG13 ' A' ' 77' ' ' ILE . 68.5 m-20 -96.33 165.81 12.02 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 121.466 0.65 . . . . 1.0 110.987 -178.077 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 24.1 pttm -57.03 -18.5 14.2 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.685 -1.143 . . . . 1.0 111.502 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -81.54 -13.95 57.46 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 116.834 -0.166 . . . . 1.0 111.351 -179.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 77.72 30.75 51.84 Favored Glycine 0 N--CA 1.469 0.897 0 N-CA-C 111.366 -0.694 . . . . 1.0 111.366 179.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 85.8 m -79.26 125.51 83.16 Favored Pre-proline 0 CA--C 1.546 0.797 0 C-N-CA 120.455 -0.498 . . . . 1.0 109.761 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_exo -50.73 128.97 25.73 Favored 'Trans proline' 0 N--CA 1.501 1.914 0 C-N-CA 121.595 1.53 . . . . 1.0 112.553 178.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -152.14 130.07 2.98 Favored Glycine 0 N--CA 1.468 0.809 0 N-CA-C 111.078 -0.809 . . . . 1.0 111.078 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 96.1 mt -59.68 -25.52 32.15 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 N-CA-C 110.47 -0.196 . . . . 1.0 110.47 179.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 100.01 46.69 1.86 Allowed Glycine 0 N--CA 1.481 1.659 0 N-CA-C 111.211 -0.755 . . . . 1.0 111.211 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.1 pp -146.93 164.98 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 N-CA-C 109.67 -0.492 . . . . 1.0 109.67 -178.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 15.9 m -128.76 121.94 29.5 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 115.408 -0.814 . . . . 1.0 110.584 178.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.524 ' CD2' ' N ' ' A' ' 89' ' ' LEU . 0.4 OUTLIER -99.73 139.37 35.49 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.389 0.676 . . . . 1.0 109.759 -179.861 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 9.1 m . . . . . 0 C--N 1.324 -0.539 0 CA-C-N 114.884 -1.053 . . . . 1.0 109.424 -179.325 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 34.0 t0 . . . . . 0 CA--C 1.528 0.124 0 N-CA-C 109.544 -0.539 . . . . 1.0 109.544 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -77.53 -161.33 14.76 Favored Glycine 0 N--CA 1.464 0.521 0 N-CA-C 110.243 -1.143 . . . . 1.0 110.243 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.6 t -111.93 129.65 67.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 N-CA-C 109.722 -0.473 . . . . 1.0 109.722 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -85.87 141.65 29.44 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.385 -0.598 . . . . 1.0 109.385 -178.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.6 t -100.45 136.0 33.84 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.31 0 CA-C-N 115.121 -0.945 . . . . 1.0 109.521 179.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 42.3 tp -89.72 -51.84 5.31 Favored 'General case' 0 N--CA 1.458 -0.071 0 CA-C-N 116.052 -0.522 . . . . 1.0 110.778 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 44.4 m -158.6 151.86 22.8 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.285 0.564 . . . . 1.0 110.845 -178.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.4 p -137.42 135.2 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-N 114.821 -1.081 . . . . 1.0 109.623 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -71.28 152.92 42.8 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.93 -0.767 . . . . 1.0 108.93 178.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -96.14 15.3 21.22 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 116.778 -0.192 . . . . 1.0 111.377 -178.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -133.77 41.62 3.01 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 109.132 -0.692 . . . . 1.0 109.132 179.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 8.7 m -141.31 153.13 65.87 Favored Pre-proline 0 CA--C 1.542 0.66 0 CA-C-N 115.786 -0.643 . . . . 1.0 110.0 -179.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -45.1 -30.85 5.17 Favored 'Trans proline' 0 N--CA 1.496 1.633 0 C-N-CA 122.178 1.919 . . . . 1.0 113.109 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.79 -23.82 67.43 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.059 0.457 . . . . 1.0 110.314 -178.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.0 107.44 1.25 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.81 -0.632 . . . . 1.0 110.144 179.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 108.05 -4.62 33.84 Favored Glycine 0 N--CA 1.476 1.304 0 N-CA-C 111.317 -0.713 . . . . 1.0 111.317 -179.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.3 mp -117.19 -50.15 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 122.461 0.304 . . . . 1.0 110.787 179.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 12.1 mt -112.03 150.46 30.6 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 121.242 0.544 . . . . 1.0 110.314 -179.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 -145.46 158.55 43.82 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.293 -0.867 . . . . 1.0 110.852 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.41 124.64 20.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.46 -0.791 . . . . 1.0 110.276 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 99.64 -4.44 58.02 Favored Glycine 0 N--CA 1.471 1.028 0 N-CA-C 111.129 -0.788 . . . . 1.0 111.129 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -74.96 141.94 43.98 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.979 0.39 . . . . 1.0 110.038 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 25.6 mt -115.96 121.13 41.36 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 109.958 -0.386 . . . . 1.0 109.958 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 62.4 mt -91.69 135.94 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 N-CA-C 107.883 -1.154 . . . . 1.0 107.883 178.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 3.0 p -123.72 -23.3 4.74 Favored 'General case' 0 N--CA 1.479 0.978 0 O-C-N 123.416 0.447 . . . . 1.0 111.408 -178.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 59.1 tt0 -152.27 147.21 26.09 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 120.924 -0.311 . . . . 1.0 110.536 -178.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.467 ' O ' ' N ' ' A' ' 35' ' ' GLY . 4.1 mp -135.89 137.11 49.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 N-CA-C 108.742 -0.836 . . . . 1.0 108.742 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 42.73 17.29 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 122.893 0.477 . . . . 1.0 112.118 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 33' ' ' ILE . . . 64.29 17.89 62.28 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 111.493 -0.643 . . . . 1.0 111.493 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.445 ' OE1' ' CE1' ' A' ' 47' ' ' TYR . 12.0 pt20 . . . . . 0 N--CA 1.469 0.491 0 O-C-N 122.532 -0.393 . . . . 1.0 111.81 -178.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 44.2 m . . . . . 0 N--CA 1.473 0.693 0 CA-C-O 121.176 0.512 . . . . 1.0 110.486 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 78.4 p -60.58 -29.82 69.42 Favored 'General case' 0 C--O 1.215 -0.717 0 N-CA-C 109.312 -0.625 . . . . 1.0 109.312 178.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -64.17 -30.71 71.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.925 -0.579 . . . . 1.0 110.741 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -60.33 -26.94 66.96 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.775 0.322 . . . . 1.0 110.444 -178.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -72.28 -51.13 22.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.997 0.427 . . . . 1.0 110.233 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.7 mp -57.39 -28.77 31.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 108.979 -0.749 . . . . 1.0 108.979 -179.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -70.64 -33.77 71.35 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.487 -0.779 . . . . 1.0 110.808 -178.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.445 ' CE1' ' OE1' ' A' ' 36' ' ' GLN . 84.0 t80 -69.48 -52.21 28.7 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 120.69 -0.404 . . . . 1.0 111.888 -178.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -67.08 -39.62 83.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-N 116.257 -0.428 . . . . 1.0 109.996 -178.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 81.0 t60 -59.59 -13.73 10.55 Favored 'General case' 0 CA--C 1.503 -0.838 0 CA-C-N 116.25 -0.432 . . . . 1.0 111.088 -178.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.47 ' HG ' ' H ' ' A' ' 51' ' ' LYS . 21.6 t -96.74 -142.68 0.28 Allowed 'General case' 0 N--CA 1.434 -1.251 0 CA-C-O 122.008 0.909 . . . . 1.0 109.042 178.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.47 ' H ' ' HG ' ' A' ' 50' ' ' SER . 30.1 mmtp 48.2 -169.84 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 114.26 -1.336 . . . . 1.0 110.049 -177.353 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -131.58 154.89 48.38 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.121 0.486 . . . . 1.0 110.319 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.6 t -59.88 142.57 15.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.578 -0.737 . . . . 1.0 111.03 -179.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 102.17 -20.45 45.15 Favored Glycine 0 N--CA 1.474 1.189 0 N-CA-C 110.596 -1.002 . . . . 1.0 110.596 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 -62.0 -174.13 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.794 0.331 . . . . 1.0 110.525 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.9 t -148.9 145.51 27.46 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 109.623 -0.51 . . . . 1.0 109.623 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 23.0 m -140.66 165.82 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 CA-C-O 121.116 0.484 . . . . 1.0 111.442 -178.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -119.68 120.03 35.44 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 114.877 -1.056 . . . . 1.0 108.385 178.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.5 tt -103.82 147.3 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 123.026 0.53 . . . . 1.0 110.907 -178.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 33.3 ttmt -131.02 117.27 18.93 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 108.207 -1.034 . . . . 1.0 108.207 177.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 26.1 p90 -136.49 165.33 26.1 Favored 'General case' 0 C--N 1.34 0.195 0 CA-C-N 115.92 -0.582 . . . . 1.0 110.581 -177.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.566 ' HZ1' ' ND2' ' A' ' 67' ' ' ASN . 67.5 mttm -121.17 139.25 53.61 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.308 -0.86 . . . . 1.0 110.466 -179.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 80.2 t60 -130.64 101.23 5.6 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.756 -0.656 . . . . 1.0 109.336 178.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 60.98 -110.41 3.03 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 110.702 -0.959 . . . . 1.0 110.702 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -112.82 13.72 19.76 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 122.578 0.351 . . . . 1.0 111.396 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 7.6 ttpm? -130.39 116.18 17.91 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 116.636 -0.256 . . . . 1.0 110.546 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.566 ' ND2' ' HZ1' ' A' ' 62' ' ' LYS . 41.5 m-20 -100.85 135.77 41.76 Favored 'General case' 0 C--N 1.341 0.236 0 N-CA-C 109.722 -0.473 . . . . 1.0 109.722 179.465 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -135.47 166.56 22.9 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 109.303 -0.628 . . . . 1.0 109.303 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.418 ' N ' ' CD ' ' A' ' 69' ' ' GLU . 3.0 pm0 -141.24 140.45 33.93 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.706 -0.679 . . . . 1.0 110.574 -179.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.92 154.63 38.61 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.794 -0.639 . . . . 1.0 110.681 -178.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 29.6 m -115.86 139.76 49.89 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 115.181 -0.918 . . . . 1.0 109.352 179.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -136.59 146.86 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-O 121.384 0.612 . . . . 1.0 110.469 -178.089 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -82.39 138.74 34.37 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.201 -0.908 . . . . 1.0 109.576 179.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.417 ' N ' ' CD2' ' A' ' 74' ' ' LEU . 4.1 mm? -67.24 146.45 54.16 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.442 0.639 . . . . 1.0 110.874 -179.356 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 45.4 p -140.91 160.1 40.8 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.052 -0.976 . . . . 1.0 110.796 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -80.32 131.71 35.69 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.346 -0.843 . . . . 1.0 109.537 179.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 10.7 pt -122.68 -44.98 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 122.677 0.391 . . . . 1.0 111.05 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.401 ' OD2' ' NZ ' ' A' ' 80' ' ' LYS . 30.6 t70 -99.81 156.98 16.82 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 121.636 0.732 . . . . 1.0 110.908 -179.118 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 10.3 mmpt? -48.44 -32.3 7.52 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.647 -1.161 . . . . 1.0 111.759 -179.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.401 ' NZ ' ' OD2' ' A' ' 78' ' ' ASP . 29.2 mtmm -82.72 12.42 4.76 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.415 -0.357 . . . . 1.0 111.375 -178.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 56.12 47.32 81.8 Favored Glycine 0 C--N 1.334 0.422 0 N-CA-C 111.635 -0.586 . . . . 1.0 111.635 178.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 86.5 m -79.87 120.37 79.71 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 120.491 -0.484 . . . . 1.0 110.471 -179.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -56.03 132.36 51.51 Favored 'Trans proline' 0 N--CA 1.498 1.787 0 C-N-CA 121.703 1.602 . . . . 1.0 111.738 177.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 154.98 179.41 30.14 Favored Glycine 0 N--CA 1.468 0.774 0 N-CA-C 110.62 -0.992 . . . . 1.0 110.62 178.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -103.92 -177.57 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 N-CA-C 109.037 -0.727 . . . . 1.0 109.037 -179.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -103.84 78.61 0.29 Allowed Glycine 0 C--N 1.339 0.699 0 N-CA-C 110.667 -0.973 . . . . 1.0 110.667 -179.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 49.7 pt -138.08 163.4 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 C-N-CA 122.796 0.438 . . . . 1.0 109.988 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 84.8 m -130.13 128.04 41.0 Favored 'General case' 0 N--CA 1.478 0.948 0 O-C-N 123.72 0.637 . . . . 1.0 109.777 177.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 54.1 mt -110.42 146.16 36.34 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 123.183 0.593 . . . . 1.0 110.153 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 33.7 m . . . . . 0 N--CA 1.473 0.685 0 CA-C-N 115.606 -0.724 . . . . 1.0 110.176 -179.128 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 . . . . . 0 N--CA 1.473 0.722 0 N-CA-C 110.054 -0.35 . . . . 1.0 110.054 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 42.73 -146.38 0.82 Allowed Glycine 0 N--CA 1.473 1.132 0 N-CA-C 111.294 -0.722 . . . . 1.0 111.294 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.9 t -135.23 127.53 47.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 N-CA-C 108.628 -0.879 . . . . 1.0 108.628 178.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -102.08 132.69 47.79 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 121.256 0.55 . . . . 1.0 110.255 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 61.2 t -76.87 132.1 33.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 N-CA-C 108.152 -1.055 . . . . 1.0 108.152 179.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.7 tt -76.14 -51.66 11.71 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-O 121.558 0.694 . . . . 1.0 110.71 -178.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 92.4 p -155.75 153.05 29.29 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.641 -0.709 . . . . 1.0 111.253 -179.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 51.7 t -136.84 113.77 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 108.706 -0.85 . . . . 1.0 108.706 178.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 34.3 mtmm -70.87 163.62 27.0 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 109.662 -0.496 . . . . 1.0 109.662 179.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 28.8 mp0 -98.83 46.36 0.99 Allowed 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 116.402 -0.363 . . . . 1.0 111.199 -179.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -158.36 35.15 0.24 Allowed 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 109.96 -0.385 . . . . 1.0 109.96 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 15.8 m -142.49 157.45 62.46 Favored Pre-proline 0 N--CA 1.481 1.09 0 N-CA-C 108.847 -0.797 . . . . 1.0 108.847 -179.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -45.8 -37.96 17.09 Favored 'Trans proline' 0 N--CA 1.507 2.31 0 CA-C-N 121.049 1.41 . . . . 1.0 112.807 179.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.26 -15.63 60.48 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.159 -0.473 . . . . 1.0 111.589 -179.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.95 139.41 46.74 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-O 121.195 0.521 . . . . 1.0 111.499 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 79.69 -11.13 34.82 Favored Glycine 0 N--CA 1.463 0.469 0 CA-C-N 115.352 -0.84 . . . . 1.0 111.94 176.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 67.2 mt -115.2 -50.85 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 N-CA-C 109.88 -0.415 . . . . 1.0 109.88 -178.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 15.0 mt -107.36 134.36 50.53 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 115.756 -0.656 . . . . 1.0 110.032 -179.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -110.84 132.7 53.98 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.784 -0.644 . . . . 1.0 109.525 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -47.64 137.14 9.56 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 120.751 0.31 . . . . 1.0 111.606 -178.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 94.93 -3.3 67.16 Favored Glycine 0 N--CA 1.471 0.969 0 N-CA-C 111.039 -0.824 . . . . 1.0 111.039 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -65.18 123.72 20.27 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 120.912 0.387 . . . . 1.0 110.545 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 37.8 tp -88.16 131.5 34.7 Favored 'General case' 0 C--O 1.208 -1.087 0 CA-C-O 118.085 -0.959 . . . . 1.0 109.024 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 18.3 mm -87.96 125.4 41.45 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 119.485 1.039 . . . . 1.0 108.988 178.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 82.0 p -97.03 -36.26 10.57 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 122.449 0.3 . . . . 1.0 111.223 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -153.5 149.5 27.77 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 109.867 -0.42 . . . . 1.0 109.867 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -147.17 139.67 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 N-CA-C 107.84 -1.17 . . . . 1.0 107.84 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 36.1 t70 47.79 22.05 0.32 Allowed 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 112.139 0.422 . . . . 1.0 112.139 178.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.34 -8.0 54.9 Favored Glycine 0 CA--C 1.529 0.92 0 N-CA-C 111.411 -0.675 . . . . 1.0 111.411 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 . . . . . 0 N--CA 1.473 0.691 0 N-CA-C 110.016 -0.364 . . . . 1.0 110.016 179.809 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.1 p . . . . . 0 N--CA 1.469 0.482 0 N-CA-C 109.368 -0.604 . . . . 1.0 109.368 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 79.8 p -77.72 -51.78 10.01 Favored 'General case' 0 C--O 1.223 -0.293 0 CA-C-N 116.4 -0.364 . . . . 1.0 110.189 179.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -52.16 -42.38 63.36 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 122.099 -0.376 . . . . 1.0 111.27 -177.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -66.57 -31.34 71.98 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.218 -0.66 . . . . 1.0 109.218 178.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -73.98 -48.97 26.62 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.773 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.8 mp -55.6 -33.94 34.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 N-CA-C 108.319 -0.993 . . . . 1.0 108.319 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -64.4 -38.57 91.48 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.809 -0.632 . . . . 1.0 111.471 -179.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 77.3 t80 -67.57 -52.1 42.63 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 120.748 -0.381 . . . . 1.0 111.653 -178.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -67.78 -44.35 85.7 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 CA-C-O 120.553 0.216 . . . . 1.0 110.714 -179.321 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 63.8 t-80 -65.0 -16.94 64.0 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.668 -0.242 . . . . 1.0 111.365 -178.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 90.2 p -104.97 -4.2 22.36 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 122.319 0.248 . . . . 1.0 111.329 -178.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 14.3 tptp -87.54 135.67 33.25 Favored 'General case' 0 C--O 1.211 -0.95 0 N-CA-C 108.711 -0.848 . . . . 1.0 108.711 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -69.03 153.55 43.59 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 111.884 0.327 . . . . 1.0 111.884 -178.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.6 t -64.74 141.12 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-N 116.388 -0.369 . . . . 1.0 110.931 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 89.95 -23.74 19.05 Favored Glycine 0 N--CA 1.469 0.865 0 CA-C-N 116.011 -0.54 . . . . 1.0 111.963 177.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -53.7 151.9 5.76 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-N 117.354 0.577 . . . . 1.0 111.377 -178.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.0 m -104.96 128.63 53.32 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 121.376 0.607 . . . . 1.0 110.075 179.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 30.7 m -117.61 171.62 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 124.383 1.073 . . . . 1.0 109.829 -178.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 18.1 ttmm -125.43 113.9 18.13 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 107.376 -1.342 . . . . 1.0 107.376 178.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.6 tp -97.55 141.9 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 122.643 0.377 . . . . 1.0 110.53 -178.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.11 112.24 10.99 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 107.379 -1.341 . . . . 1.0 107.379 177.218 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 24.5 p90 -144.77 160.89 40.52 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 110.36 -0.237 . . . . 1.0 110.36 -178.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -134.76 136.9 42.97 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 109.154 -0.684 . . . . 1.0 109.154 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 61.6 t-80 -128.42 126.43 40.56 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 107.835 -1.172 . . . . 1.0 107.835 178.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 62.82 -117.18 10.66 Favored Glycine 0 CA--C 1.531 1.041 0 N-CA-C 110.65 -0.98 . . . . 1.0 110.65 -179.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -113.47 -21.58 10.78 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 122.845 0.458 . . . . 1.0 110.856 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -90.89 123.31 34.31 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 121.593 0.711 . . . . 1.0 111.598 -178.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 57.4 m-20 -92.96 135.94 33.71 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 109.446 -0.575 . . . . 1.0 109.446 -179.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 64.7 mt-10 -137.76 142.1 40.93 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 109.98 -0.378 . . . . 1.0 109.98 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -140.66 138.23 34.15 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 110.067 -0.346 . . . . 1.0 110.067 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -151.16 147.43 27.03 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-O 121.547 0.689 . . . . 1.0 112.778 -177.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 90.6 p -90.97 127.87 36.58 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 109.485 -0.561 . . . . 1.0 109.485 177.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.4 mp -130.44 129.06 64.48 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 N-CA-C 108.772 -0.825 . . . . 1.0 108.772 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 5.4 ptpt -81.38 142.92 32.56 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 122.023 -0.423 . . . . 1.0 110.517 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -61.32 145.14 52.46 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 109.936 -0.394 . . . . 1.0 109.936 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 72.3 p -134.82 155.1 51.22 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 115.972 -0.558 . . . . 1.0 110.259 178.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -79.93 122.28 26.5 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 108.752 -0.833 . . . . 1.0 108.752 178.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.497 ' CD1' ' H ' ' A' ' 77' ' ' ILE . 0.1 OUTLIER -118.07 -14.19 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 C-N-CA 122.597 0.359 . . . . 1.0 111.689 -178.714 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -120.02 145.72 46.56 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.052 0.453 . . . . 1.0 110.347 -179.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 24.0 pttm -47.72 -27.16 1.84 Allowed 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 115.658 -0.701 . . . . 1.0 112.343 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 14.4 pttm -81.29 -16.3 52.91 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-O 120.751 0.31 . . . . 1.0 110.343 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 81.81 50.56 4.89 Favored Glycine 0 N--CA 1.468 0.826 0 N-CA-C 111.891 -0.483 . . . . 1.0 111.891 179.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 32.4 m -81.68 119.42 75.37 Favored Pre-proline 0 CA--C 1.549 0.917 0 CA-C-O 118.915 -0.564 . . . . 1.0 110.062 179.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_exo -53.09 118.32 4.69 Favored 'Trans proline' 0 N--CA 1.505 2.165 0 CA-C-N 120.744 1.301 . . . . 1.0 111.369 177.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 173.1 -174.74 46.0 Favored Glycine 0 N--CA 1.469 0.866 0 C-N-CA 120.581 -0.818 . . . . 1.0 112.676 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -116.48 170.79 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 N-CA-C 107.258 -1.386 . . . . 1.0 107.258 178.491 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -90.91 42.67 2.87 Favored Glycine 0 N--CA 1.475 1.262 0 CA-C-N 118.1 0.409 . . . . 1.0 112.479 -177.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 48.8 pt -111.68 176.09 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 122.405 0.282 . . . . 1.0 110.341 -178.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 62.9 m -132.33 130.18 40.44 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 115.805 -0.634 . . . . 1.0 109.844 178.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 69.1 mt -104.65 143.54 32.94 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.022 0.529 . . . . 1.0 109.927 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.1 m . . . . . 0 N--CA 1.483 1.195 0 C-N-CA 123.379 0.672 . . . . 1.0 111.333 -177.475 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.474 ' CG ' ' H ' ' A' ' 8' ' ' GLY . 9.6 p30 . . . . . 0 CA--C 1.54 0.566 0 N-CA-C 109.798 -0.445 . . . . 1.0 109.798 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.474 ' H ' ' CG ' ' A' ' 7' ' ' ASP . . . 178.61 -159.31 24.41 Favored Glycine 0 CA--C 1.519 0.332 0 N-CA-C 109.86 -1.296 . . . . 1.0 109.86 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.7 m -111.54 128.39 68.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 N-CA-C 109.125 -0.695 . . . . 1.0 109.125 179.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.471 ' N ' ' O ' ' A' ' 90' ' ' VAL . 11.5 m-85 -88.45 132.23 34.56 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 121.329 0.585 . . . . 1.0 109.527 -178.015 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 83.7 t -76.46 134.54 28.69 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.227 0 N-CA-C 107.337 -1.357 . . . . 1.0 107.337 179.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.52 -51.57 6.1 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.578 0.227 . . . . 1.0 110.707 -178.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 40.2 t -154.03 150.68 28.5 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.004 0.431 . . . . 1.0 111.003 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 46.7 t -110.56 113.22 43.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-N 115.191 -0.913 . . . . 1.0 108.952 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.407 ' O ' ' O ' ' A' ' 16' ' ' GLU . 62.5 mttp -86.37 92.19 8.74 Favored 'General case' 0 C--O 1.221 -0.411 0 N-CA-C 108.384 -0.969 . . . . 1.0 108.384 179.327 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.409 ' N ' ' CD ' ' A' ' 16' ' ' GLU . 3.3 pm0 -44.77 -179.24 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.489 0 O-C-N 124.073 0.858 . . . . 1.0 112.689 -178.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 26.7 t70 62.73 30.0 16.78 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.683 -0.69 . . . . 1.0 109.763 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 28.3 m -133.6 157.13 78.72 Favored Pre-proline 0 N--CA 1.484 1.247 0 CA-C-N 115.954 -0.566 . . . . 1.0 110.558 -179.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -49.5 -38.57 44.48 Favored 'Trans proline' 0 N--CA 1.503 2.049 0 C-N-CA 121.253 1.302 . . . . 1.0 112.874 178.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.44 -17.33 62.57 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.505 -0.316 . . . . 1.0 110.929 -178.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.06 118.14 9.4 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 110.352 -0.24 . . . . 1.0 110.352 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 98.83 -3.76 59.0 Favored Glycine 0 N--CA 1.473 1.123 0 N-CA-C 111.604 -0.598 . . . . 1.0 111.604 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 65.1 mt -114.29 -50.48 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 CA-C-N 116.973 0.386 . . . . 1.0 110.247 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 48.1 mt -110.43 151.43 27.5 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.099 0.56 . . . . 1.0 110.114 -179.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.628 ' HE2' ' ND1' ' A' ' 63' ' ' HIS . 18.4 p-80 -143.5 155.1 44.24 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.403 -0.817 . . . . 1.0 110.105 -179.193 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.74 139.14 40.3 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 115.373 -0.831 . . . . 1.0 111.101 -179.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 91.82 -3.48 77.8 Favored Glycine 0 CA--C 1.528 0.889 0 N-CA-C 111.179 -0.769 . . . . 1.0 111.179 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -79.68 126.53 31.05 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 117.148 0.474 . . . . 1.0 110.501 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 17.5 mt -102.54 129.86 49.21 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 109.069 -0.715 . . . . 1.0 109.069 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 30.8 mm -85.17 127.39 39.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 N-CA-C 109.417 -0.586 . . . . 1.0 109.417 179.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 66.4 p -93.12 -42.13 9.56 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 116.599 -0.273 . . . . 1.0 110.708 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 73.1 tt0 -153.71 152.58 30.94 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.694 0.283 . . . . 1.0 110.379 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -137.87 138.53 43.9 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 N-CA-C 108.951 -0.759 . . . . 1.0 108.951 -179.218 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 37.6 t70 46.46 25.85 0.43 Allowed 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.211 0.529 . . . . 1.0 111.732 179.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.94 4.62 49.09 Favored Glycine 0 CA--C 1.527 0.815 0 CA-C-N 115.812 -0.631 . . . . 1.0 111.579 179.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 . . . . . 0 N--CA 1.47 0.54 0 CA-C-O 120.999 0.428 . . . . 1.0 110.635 -179.458 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 96.0 p . . . . . 0 N--CA 1.48 1.051 0 N-CA-C 111.635 0.235 . . . . 1.0 111.635 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 81.2 p -58.71 -50.8 72.55 Favored 'General case' 0 C--O 1.22 -0.45 0 C-N-CA 120.464 -0.494 . . . . 1.0 110.039 -178.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -48.88 -42.65 37.46 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.462 0.172 . . . . 1.0 111.244 -178.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.1 tp10 -69.79 -32.04 70.29 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.315 -0.624 . . . . 1.0 109.315 178.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -71.29 -49.77 39.42 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.9 0.381 . . . . 1.0 110.75 -179.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 38.4 mm -58.53 -29.07 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 115.516 -0.765 . . . . 1.0 109.639 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -66.92 -35.56 80.27 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.703 -0.681 . . . . 1.0 110.702 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -68.68 -46.91 67.82 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-O 121.223 0.535 . . . . 1.0 111.248 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 42.7 mt -52.66 -41.5 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-N 115.687 -0.688 . . . . 1.0 110.267 -175.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 32.3 m-70 -83.91 -18.97 35.6 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.074 -0.512 . . . . 1.0 111.275 -179.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 24.8 t -63.64 -24.94 68.0 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 111.646 0.239 . . . . 1.0 111.646 -178.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 48.7 mttm -94.23 -174.81 3.48 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 120.961 0.41 . . . . 1.0 110.107 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -130.63 161.58 31.27 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 115.46 -0.791 . . . . 1.0 110.536 -178.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 26.2 t -65.81 138.55 22.85 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-N 115.462 -0.79 . . . . 1.0 111.226 -178.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 99.76 -2.36 57.06 Favored Glycine 0 N--CA 1.477 1.421 0 N-CA-C 110.897 -0.881 . . . . 1.0 110.897 179.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -76.65 -172.8 2.35 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.695 -0.483 . . . . 1.0 109.695 179.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.8 t -148.05 141.13 24.96 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 109.479 -0.563 . . . . 1.0 109.479 179.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 27.7 m -142.3 165.88 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 CA-C-N 116.002 -0.545 . . . . 1.0 111.597 -178.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -118.32 121.94 41.63 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 108.003 -1.11 . . . . 1.0 108.003 178.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 13.2 tt -101.8 143.26 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 122.648 0.379 . . . . 1.0 110.887 -178.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -134.04 118.47 17.82 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 107.549 -1.278 . . . . 1.0 107.549 178.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 49.3 p90 -139.35 161.96 36.17 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-N 116.16 -0.473 . . . . 1.0 109.775 -178.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 7.8 ttpm? -118.77 112.83 20.23 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 123.342 0.401 . . . . 1.0 110.346 179.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.628 ' ND1' ' HE2' ' A' ' 25' ' ' HIS . 34.5 t60 -106.78 107.63 18.73 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 108.012 -1.107 . . . . 1.0 108.012 178.302 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 72.27 -115.99 5.65 Favored Glycine 0 CA--C 1.53 1.015 0 N-CA-C 111.054 -0.818 . . . . 1.0 111.054 -178.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -113.51 1.66 15.1 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 122.983 0.513 . . . . 1.0 111.407 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -124.02 124.29 42.23 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-O 121.48 0.657 . . . . 1.0 111.009 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 38.6 p-10 -101.86 143.19 32.06 Favored 'General case' 0 C--N 1.343 0.324 0 N-CA-C 109.33 -0.618 . . . . 1.0 109.33 179.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 68.5 mt-10 -130.5 167.14 19.13 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 115.542 -0.753 . . . . 1.0 109.285 -179.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 78.6 tt0 -136.0 137.68 41.46 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 109.466 -0.568 . . . . 1.0 109.466 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.11 157.32 43.29 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.56 -0.745 . . . . 1.0 110.394 -178.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 94.9 p -122.14 137.54 54.79 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 108.425 -0.954 . . . . 1.0 108.425 179.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.2 mp -135.93 140.32 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 CA-C-N 116.501 -0.318 . . . . 1.0 110.243 -177.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -80.39 137.51 36.54 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 109.061 -0.718 . . . . 1.0 109.061 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.401 ' N ' ' CD2' ' A' ' 74' ' ' LEU . 3.8 mm? -68.26 144.85 54.72 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.935 -0.575 . . . . 1.0 109.978 -179.329 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 79.8 p -139.08 166.16 25.23 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 115.335 -0.848 . . . . 1.0 109.787 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -94.37 146.46 24.04 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.331 -0.85 . . . . 1.0 109.734 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.431 HD11 ' H ' ' A' ' 78' ' ' ASP . 0.1 OUTLIER -144.92 -30.12 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-N 116.323 -0.399 . . . . 1.0 110.914 179.508 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.431 ' H ' HD11 ' A' ' 77' ' ' ILE . 81.8 m-20 -99.44 151.76 20.75 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 121.238 0.542 . . . . 1.0 110.243 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 10.1 ptpp? -48.72 -27.31 2.83 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.268 -0.878 . . . . 1.0 112.628 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -93.08 11.57 27.18 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 120.634 0.254 . . . . 1.0 111.376 -178.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 56.41 41.51 88.07 Favored Glycine 0 CA--C 1.525 0.665 0 C-N-CA 121.068 -0.587 . . . . 1.0 111.856 178.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 16.8 m -80.54 122.88 82.91 Favored Pre-proline 0 CA--C 1.551 0.998 0 CA-C-O 118.882 -0.58 . . . . 1.0 109.975 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_exo -51.63 126.75 20.52 Favored 'Trans proline' 0 N--CA 1.503 2.032 0 C-N-CA 121.363 1.375 . . . . 1.0 111.226 177.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.575 ' C ' ' H ' ' A' ' 86' ' ' GLY . . . -150.7 -13.59 0.09 OUTLIER Glycine 0 N--CA 1.478 1.473 0 C-N-CA 121.334 -0.46 . . . . 1.0 111.956 -179.024 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 41.4 mt 66.07 -30.05 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 O-C-N 123.782 0.342 . . . . 1.0 111.146 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.575 ' H ' ' C ' ' A' ' 84' ' ' GLY . . . 115.18 37.86 1.08 Allowed Glycine 0 N--CA 1.477 1.369 0 N-CA-C 110.473 -1.051 . . . . 1.0 110.473 -179.393 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 48.4 pt -140.87 163.94 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 122.599 0.36 . . . . 1.0 110.288 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 8.9 t -134.3 129.94 36.29 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.663 -0.699 . . . . 1.0 109.511 178.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.453 ' CD2' ' N ' ' A' ' 89' ' ' LEU . 1.3 mm? -106.36 135.31 48.07 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 108.253 -1.018 . . . . 1.0 108.253 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.471 ' O ' ' N ' ' A' ' 10' ' ' TYR . 52.3 t . . . . . 0 C--O 1.217 -0.608 0 N-CA-C 108.395 -0.965 . . . . 1.0 108.395 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 35.0 t0 . . . . . 0 N--CA 1.472 0.64 0 N-CA-C 110.053 -0.351 . . . . 1.0 110.053 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 154.38 -159.67 29.02 Favored Glycine 0 N--CA 1.466 0.634 0 N-CA-C 109.191 -1.563 . . . . 1.0 109.191 -179.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 12.4 m -129.43 127.42 64.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 N-CA-C 108.789 -0.819 . . . . 1.0 108.789 178.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -91.08 127.85 36.67 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 110.028 -0.36 . . . . 1.0 110.028 -177.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 60.4 t -76.41 135.27 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 N-CA-C 107.142 -1.429 . . . . 1.0 107.142 178.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.8 tt -78.8 -51.11 10.22 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 121.119 0.485 . . . . 1.0 110.139 -178.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 95.3 p -157.37 153.3 27.08 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.036 0.446 . . . . 1.0 110.996 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 58.4 t -111.57 136.26 48.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 CA-C-N 115.419 -0.81 . . . . 1.0 108.972 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -96.41 121.74 38.54 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 108.845 -0.798 . . . . 1.0 108.845 178.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.435 ' N ' ' OE1' ' A' ' 16' ' ' GLU . 14.4 pm0 -85.66 63.28 7.97 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 120.85 0.357 . . . . 1.0 111.399 -178.226 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -163.45 27.18 0.09 Allowed 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.335 0.588 . . . . 1.0 109.568 179.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -143.64 160.61 50.16 Favored Pre-proline 0 N--CA 1.479 0.991 0 N-CA-C 108.85 -0.796 . . . . 1.0 108.85 -177.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -53.87 -25.76 36.72 Favored 'Trans proline' 0 N--CA 1.498 1.757 0 C-N-CA 121.358 1.372 . . . . 1.0 112.463 179.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.23 -12.96 62.13 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 120.724 0.297 . . . . 1.0 110.95 179.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.57 135.08 45.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 1.0 111.775 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.34 -4.36 85.75 Favored Glycine 0 N--CA 1.468 0.783 0 CA-C-N 115.908 -0.587 . . . . 1.0 111.951 178.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 67.6 mt -112.76 -50.48 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 CA-C-N 117.028 0.414 . . . . 1.0 109.957 -179.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 21.4 mt -105.78 150.34 25.64 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 115.834 -0.621 . . . . 1.0 109.981 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 63.7 t-80 -127.98 140.24 52.1 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 115.825 -0.625 . . . . 1.0 110.302 -179.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -49.98 140.73 11.8 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.896 0.379 . . . . 1.0 111.428 -179.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 86.7 -7.11 80.98 Favored Glycine 0 N--CA 1.471 0.986 0 N-CA-C 111.116 -0.794 . . . . 1.0 111.116 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.41 ' OD2' ' CD1' ' A' ' 61' ' ' TYR . 23.3 t0 -65.03 134.06 53.03 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 109.937 -0.394 . . . . 1.0 109.937 179.101 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 5.0 mp -95.65 135.42 37.36 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 108.875 -0.787 . . . . 1.0 108.875 179.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 38.6 mm -93.19 131.07 41.23 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 N-CA-C 108.955 -0.757 . . . . 1.0 108.955 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 54.1 p -85.95 -54.43 4.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.863 -0.608 . . . . 1.0 110.181 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 74.7 tt0 -154.92 160.13 40.93 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 120.851 0.357 . . . . 1.0 110.941 -179.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 20.6 tt -143.54 143.96 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 N-CA-C 108.699 -0.852 . . . . 1.0 108.699 178.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 35.0 t70 46.06 17.59 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 112.24 0.459 . . . . 1.0 112.24 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.52 5.35 49.8 Favored Glycine 0 CA--C 1.529 0.961 0 N-CA-C 111.164 -0.774 . . . . 1.0 111.164 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 21.4 mm100 . . . . . 0 N--CA 1.481 1.078 0 CA-C-O 120.826 0.346 . . . . 1.0 110.614 -179.301 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 10.7 t . . . . . 0 N--CA 1.48 1.06 0 CA-C-O 120.886 0.374 . . . . 1.0 110.12 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 11.9 t -73.67 -51.13 17.73 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.106 -0.497 . . . . 1.0 110.718 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -63.44 -39.11 93.61 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.37 -0.377 . . . . 1.0 111.134 -178.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -56.16 -24.2 39.77 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.649 0.262 . . . . 1.0 110.657 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 38.6 t80 -72.36 -46.68 54.35 Favored 'General case' 0 C--O 1.225 -0.236 0 CA-C-O 120.926 0.393 . . . . 1.0 110.305 178.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.7 mp -59.78 -31.37 47.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 N-CA-C 108.788 -0.819 . . . . 1.0 108.788 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -63.58 -37.98 89.38 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 116.104 -0.498 . . . . 1.0 110.613 -179.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -64.49 -43.78 93.06 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.716 0.293 . . . . 1.0 111.297 178.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 38.2 mt -55.43 -42.92 69.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 120.213 -0.595 . . . . 1.0 109.996 -174.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 38.8 m170 -78.29 -22.3 48.44 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.368 -0.378 . . . . 1.0 111.432 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 37.7 m -66.6 -14.75 62.8 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.236 0.458 . . . . 1.0 112.236 -178.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -111.57 147.71 34.84 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 108.754 -0.832 . . . . 1.0 108.754 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -91.39 171.12 9.43 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.182 0.593 . . . . 1.0 111.274 -178.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 14.6 t -67.06 137.72 24.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.218 -179.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 100.82 -27.3 21.17 Favored Glycine 0 N--CA 1.468 0.82 0 N-CA-C 111.369 -0.693 . . . . 1.0 111.369 178.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -55.73 149.64 14.08 Favored 'General case' 0 C--O 1.226 -0.166 0 CA-C-N 117.728 0.764 . . . . 1.0 111.568 -178.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 70.0 p -87.55 136.38 32.97 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 108.557 -0.905 . . . . 1.0 108.557 178.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -121.06 163.17 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 O-C-N 123.529 0.518 . . . . 1.0 110.641 -177.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -129.79 110.85 12.07 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 107.307 -1.368 . . . . 1.0 107.307 178.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 40.6 mm -100.52 137.84 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 109.743 -0.465 . . . . 1.0 109.743 -178.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 6.8 tppt? -128.27 113.87 16.2 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 106.776 -1.564 . . . . 1.0 106.776 177.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.41 ' CD1' ' OD2' ' A' ' 28' ' ' ASP . 27.2 p90 -145.5 157.85 43.93 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.929 0.395 . . . . 1.0 109.939 -178.497 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 25.5 pttm -130.07 135.62 48.44 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 115.757 -0.656 . . . . 1.0 109.733 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 59.4 t-80 -129.31 120.47 25.7 Favored 'General case' 0 C--N 1.347 0.464 0 N-CA-C 107.005 -1.479 . . . . 1.0 107.005 178.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 71.23 -117.18 6.63 Favored Glycine 0 CA--C 1.535 1.338 0 N-CA-C 110.777 -0.929 . . . . 1.0 110.777 -179.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -113.68 -19.93 11.38 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 122.86 0.464 . . . . 1.0 111.557 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 59.5 pttt -99.43 132.43 44.77 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-O 121.015 0.436 . . . . 1.0 111.236 -179.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -102.27 144.37 30.87 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 109.473 -0.565 . . . . 1.0 109.473 179.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -134.29 141.04 46.81 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 109.057 -0.72 . . . . 1.0 109.057 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -124.36 131.22 53.5 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 109.468 -0.567 . . . . 1.0 109.468 179.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -146.31 144.93 30.13 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.965 -0.561 . . . . 1.0 110.278 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 48.7 m -99.12 133.56 43.23 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 108.514 -0.921 . . . . 1.0 108.514 178.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 5.6 mt -138.57 138.97 42.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 CA-C-O 120.77 0.319 . . . . 1.0 111.33 -177.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 47.3 mttm -82.97 141.32 32.2 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 121.78 -0.575 . . . . 1.0 109.897 178.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -62.04 148.32 44.42 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 109.262 -0.644 . . . . 1.0 109.262 179.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 66.9 p -135.93 162.14 33.68 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.15 0.58 . . . . 1.0 109.549 178.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -82.1 116.09 21.52 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 109.302 -0.629 . . . . 1.0 109.302 178.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.5 ' CD1' ' H ' ' A' ' 77' ' ' ILE . 0.1 OUTLIER -102.0 -18.53 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 C-N-CA 122.415 0.286 . . . . 1.0 111.273 -179.753 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -123.08 145.55 48.45 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-O 121.159 0.504 . . . . 1.0 110.915 -179.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 24.6 pttm -49.41 -18.8 0.43 Allowed 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.633 -0.712 . . . . 1.0 112.345 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 30.7 mtmm -80.44 -16.62 53.96 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 120.825 0.345 . . . . 1.0 110.908 -178.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 83.15 39.98 9.6 Favored Glycine 0 N--CA 1.468 0.818 0 N-CA-C 111.778 -0.529 . . . . 1.0 111.778 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 88.7 m -81.98 123.64 79.72 Favored Pre-proline 0 CA--C 1.553 1.058 0 CA-C-O 118.696 -0.668 . . . . 1.0 109.573 179.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -50.54 131.79 33.73 Favored 'Trans proline' 0 N--CA 1.506 2.24 0 C-N-CA 121.357 1.371 . . . . 1.0 111.986 177.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -172.4 163.74 35.92 Favored Glycine 0 CA--C 1.529 0.963 0 N-CA-C 111.136 -0.786 . . . . 1.0 111.136 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -111.87 35.51 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 CA-C-O 121.482 0.658 . . . . 1.0 109.432 -179.263 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 53.17 58.9 10.42 Favored Glycine 0 N--CA 1.468 0.805 0 N-CA-C 111.083 -0.807 . . . . 1.0 111.083 179.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 21.6 pt -143.27 162.8 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-N 114.628 -0.786 . . . . 1.0 109.984 179.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 93.3 m -135.05 116.17 14.3 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-N 114.825 -1.08 . . . . 1.0 111.127 178.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 9.6 mp -97.74 135.99 38.73 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 122.925 0.49 . . . . 1.0 110.226 179.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 12.9 m . . . . . 0 N--CA 1.472 0.636 0 N-CA-C 108.918 -0.771 . . . . 1.0 108.918 178.031 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.0 ptt? . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 109.324 -0.621 . . . . 1.0 109.324 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.6 t -73.16 94.72 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-O 120.872 0.367 . . . . 1.0 110.03 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -87.31 63.1 7.58 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.148 -0.478 . . . . 1.0 109.887 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 12.0 p -67.01 137.38 24.93 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-N 116.2 -0.455 . . . . 1.0 109.781 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 70.1 p -99.27 160.7 14.09 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 109.65 -0.5 . . . . 1.0 109.65 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.402 ' CD2' ' O ' ' A' ' 6' ' ' TYR . 76.8 t80 -168.36 55.01 0.06 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.239 0.542 . . . . 1.0 109.714 179.58 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -150.25 81.35 1.36 Allowed 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.707 -0.679 . . . . 1.0 110.031 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -84.18 -148.71 9.23 Favored Glycine 0 C--N 1.339 0.709 0 N-CA-C 110.003 -1.239 . . . . 1.0 110.003 179.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.7 p -127.85 134.59 65.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 N-CA-C 109.014 -0.736 . . . . 1.0 109.014 178.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -89.52 149.41 22.91 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 109.484 -0.562 . . . . 1.0 109.484 -178.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 49.1 t -98.31 128.71 49.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 N-CA-C 108.793 -0.817 . . . . 1.0 108.793 179.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 8.2 tp -75.83 -39.89 55.88 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.986 0.422 . . . . 1.0 110.8 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.441 ' HG ' ' H ' ' A' ' 14' ' ' VAL . 48.2 t -167.55 161.04 13.5 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.9 -0.591 . . . . 1.0 111.859 -178.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.441 ' H ' ' HG ' ' A' ' 13' ' ' SER . 44.0 t -132.87 115.7 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 CA-C-N 115.367 -0.833 . . . . 1.0 109.239 179.018 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.402 ' O ' ' N ' ' A' ' 17' ' ' ASP . 74.1 mmtt -73.26 105.21 4.57 Favored 'General case' 0 C--O 1.221 -0.404 0 N-CA-C 108.906 -0.776 . . . . 1.0 108.906 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -64.94 64.29 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 120.875 0.369 . . . . 1.0 111.698 -178.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.402 ' N ' ' O ' ' A' ' 15' ' ' LYS . 37.0 t70 -175.97 45.68 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 108.136 -1.061 . . . . 1.0 108.136 179.54 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 23.0 m -150.19 160.88 32.45 Favored Pre-proline 0 N--CA 1.483 1.19 0 CA-C-O 118.995 -0.526 . . . . 1.0 109.731 -178.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -47.3 -33.32 16.18 Favored 'Trans proline' 0 N--CA 1.506 2.242 0 C-N-CA 121.252 1.301 . . . . 1.0 112.543 177.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.06 -22.77 67.07 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 116.761 -0.2 . . . . 1.0 111.39 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.59 124.61 21.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.016 0.436 . . . . 1.0 111.008 -178.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.85 -9.71 70.61 Favored Glycine 0 N--CA 1.473 1.138 0 CA-C-N 115.663 -0.699 . . . . 1.0 111.633 179.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 71.0 mt -114.31 -50.9 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 C-N-CA 122.633 0.373 . . . . 1.0 110.289 -179.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 42.7 mt -113.18 148.38 35.54 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 108.777 -0.823 . . . . 1.0 108.777 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -139.92 154.33 47.2 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 115.745 -0.661 . . . . 1.0 110.023 -179.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.44 139.66 52.57 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.858 -0.61 . . . . 1.0 110.918 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 94.55 -6.84 71.14 Favored Glycine 0 N--CA 1.473 1.107 0 N-CA-C 111.083 -0.807 . . . . 1.0 111.083 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -74.49 150.89 39.65 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 109.637 -0.505 . . . . 1.0 109.637 179.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 5.0 mp -120.91 120.66 36.13 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 109.696 -0.483 . . . . 1.0 109.696 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 61.4 mt -89.39 134.63 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 N-CA-C 107.959 -1.126 . . . . 1.0 107.959 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.543 ' HG1' ' N ' ' A' ' 32' ' ' GLU . 65.1 p -97.2 -49.2 5.06 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 116.741 -0.208 . . . . 1.0 111.279 -178.221 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.543 ' N ' ' HG1' ' A' ' 31' ' ' THR . 42.8 tp10 -154.05 159.83 41.73 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 121.256 0.55 . . . . 1.0 111.3 -178.242 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.424 ' O ' ' N ' ' A' ' 35' ' ' GLY . 4.7 mp -135.85 129.59 48.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 N-CA-C 107.611 -1.255 . . . . 1.0 107.611 179.192 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 41.57 20.14 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 113.077 0.769 . . . . 1.0 113.077 179.365 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 33' ' ' ILE . . . 69.22 6.56 54.16 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 111.101 -0.8 . . . . 1.0 111.101 179.521 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -86.85 134.49 33.54 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 120.82 0.343 . . . . 1.0 110.233 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 43.9 t -154.86 157.35 37.72 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 109.214 -0.661 . . . . 1.0 109.214 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -148.27 -26.14 0.33 Allowed 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.202 -0.454 . . . . 1.0 110.004 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -167.28 -108.37 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.898 0 CA-C-N 116.694 -0.23 . . . . 1.0 110.759 179.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 15.0 m -110.69 -141.8 0.38 Allowed 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.666 0.786 . . . . 1.0 110.084 -178.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 11.7 t -56.21 -40.7 74.43 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.507 0.194 . . . . 1.0 110.543 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -53.8 -28.68 36.69 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.367 -0.379 . . . . 1.0 110.719 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -58.86 -35.31 72.75 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.887 0.375 . . . . 1.0 110.393 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -68.85 -47.53 65.73 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 116.255 -0.43 . . . . 1.0 110.436 -179.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.7 mp -52.69 -31.87 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 N-CA-C 108.998 -0.742 . . . . 1.0 108.998 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 47.3 m-20 -70.98 -37.87 72.74 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.797 -0.638 . . . . 1.0 111.431 -179.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 80.1 t80 -66.79 -52.68 41.19 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 120.8 0.333 . . . . 1.0 111.607 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -62.46 -26.05 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 N-CA-C 109.362 -0.607 . . . . 1.0 109.362 -178.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -90.66 -21.96 21.41 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 116.342 -0.39 . . . . 1.0 111.392 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 47.4 m -81.77 -13.62 57.49 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 122.422 -0.174 . . . . 1.0 111.295 -178.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 43.7 mmtm -95.27 -168.97 1.89 Allowed 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 109.992 -0.373 . . . . 1.0 109.992 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 3.6 mmpt? -131.23 159.26 38.31 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.184 0.594 . . . . 1.0 110.526 -178.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.5 t -64.59 140.43 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-N 115.764 -0.653 . . . . 1.0 110.33 -179.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 94.27 -12.9 68.34 Favored Glycine 0 N--CA 1.476 1.305 0 N-CA-C 110.843 -0.903 . . . . 1.0 110.843 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -67.85 -165.25 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 109.618 -0.512 . . . . 1.0 109.618 179.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 77.3 p -140.75 153.97 46.1 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 108.932 -0.766 . . . . 1.0 108.932 178.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 3.2 p -140.55 154.72 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 CA-C-O 121.102 0.477 . . . . 1.0 110.716 -179.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 49.4 mtmt -121.74 112.39 18.34 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 107.954 -1.128 . . . . 1.0 107.954 177.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.4 mp -99.2 138.65 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 N-CA-C 109.05 -0.722 . . . . 1.0 109.05 -178.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -111.19 113.31 25.72 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 105.607 -1.997 . . . . 1.0 105.607 177.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 17.8 p90 -149.84 156.87 42.53 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 109.611 -0.514 . . . . 1.0 109.611 -178.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 22.7 pttm -125.96 118.2 24.88 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 121.261 0.553 . . . . 1.0 110.053 -179.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -89.63 101.82 14.5 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 107.642 -1.244 . . . . 1.0 107.642 179.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 83.76 -111.94 3.5 Favored Glycine 0 CA--C 1.535 1.296 0 N-CA-C 111.475 -0.65 . . . . 1.0 111.475 -178.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -114.52 -2.43 13.16 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 122.826 0.45 . . . . 1.0 111.821 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 58.0 pttt -105.55 134.28 48.93 Favored 'General case' 0 N--CA 1.484 1.269 0 CA-C-O 121.162 0.506 . . . . 1.0 111.052 -179.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -84.08 119.58 25.13 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 109.747 -0.464 . . . . 1.0 109.747 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 69.7 mt-10 -119.9 152.79 36.84 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-N 115.51 -0.768 . . . . 1.0 110.021 -179.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -139.82 133.52 30.47 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 109.253 -0.647 . . . . 1.0 109.253 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -147.03 152.32 38.39 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.946 -0.57 . . . . 1.0 109.952 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 17.7 t -125.41 136.53 53.51 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.005 -0.998 . . . . 1.0 108.576 179.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.465 ' CD1' ' N ' ' A' ' 72' ' ' ILE . 0.0 OUTLIER -128.68 149.07 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 O-C-N 123.418 0.449 . . . . 1.0 109.965 -178.907 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -78.42 136.34 37.62 Favored 'General case' 0 C--O 1.231 0.084 0 N-CA-C 108.186 -1.042 . . . . 1.0 108.186 178.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -66.74 147.28 53.47 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.119 0.485 . . . . 1.0 110.598 -178.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 30.6 p -140.87 160.73 39.43 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.648 -0.705 . . . . 1.0 109.747 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -80.23 131.15 35.64 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 108.975 -0.75 . . . . 1.0 108.975 178.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -114.0 -52.66 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 123.127 0.571 . . . . 1.0 110.544 -179.287 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 57.4 p30 -99.61 162.55 12.95 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.327 0.584 . . . . 1.0 110.872 -178.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 59.5 pttt -51.15 -31.92 21.33 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.096 -0.956 . . . . 1.0 112.326 -178.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 26.2 ttmt -80.23 12.06 3.14 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 120.672 0.272 . . . . 1.0 110.762 -179.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 52.72 49.09 55.0 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 120.967 -0.635 . . . . 1.0 111.833 179.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 58.6 m -80.3 120.41 79.39 Favored Pre-proline 0 CA--C 1.54 0.573 0 CA-C-O 118.619 -0.705 . . . . 1.0 109.698 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -58.7 134.84 63.27 Favored 'Trans proline' 0 N--CA 1.497 1.693 0 CA-C-N 120.819 1.328 . . . . 1.0 112.122 177.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 148.81 152.53 5.74 Favored Glycine 0 N--CA 1.473 1.123 0 N-CA-C 112.003 -0.439 . . . . 1.0 112.003 178.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 6.5 pt -72.44 176.95 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 N-CA-C 108.369 -0.974 . . . . 1.0 108.369 177.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -103.27 86.92 0.55 Allowed Glycine 0 N--CA 1.473 1.12 0 N-CA-C 111.817 -0.513 . . . . 1.0 111.817 -179.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 48.8 pt -143.7 166.91 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 CA-C-N 115.504 -0.348 . . . . 1.0 110.17 178.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 95.4 m -128.44 128.99 45.47 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 109.182 -0.673 . . . . 1.0 109.182 177.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 12.9 mt -97.89 163.2 12.89 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.057 0.943 . . . . 1.0 109.853 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 24.2 t -103.05 141.46 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 CA-C-N 116.087 -0.506 . . . . 1.0 109.777 -178.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 22.0 p-10 -163.21 58.14 0.19 Allowed 'General case' 0 C--N 1.334 -0.104 0 CA-C-N 115.696 -0.684 . . . . 1.0 109.542 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 49.7 t0 57.99 107.64 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.213 -0.903 . . . . 1.0 110.592 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 75.6 mt -47.18 -83.24 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 111.858 0.318 . . . . 1.0 111.858 -178.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 49.9 -165.53 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 110.296 -0.261 . . . . 1.0 110.296 -179.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 44.1 m80 -88.19 -21.0 24.8 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 122.462 -0.149 . . . . 1.0 110.868 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 60.3 t-80 40.53 75.28 0.08 Allowed 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 122.577 0.351 . . . . 1.0 111.295 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 50.3 t-80 -166.7 90.71 0.4 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.859 0.362 . . . . 1.0 110.278 -178.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -66.1 -42.8 88.79 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.066 -0.516 . . . . 1.0 109.99 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -168.75 -55.12 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.332 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 56.4 t-80 . . . . . 0 C--O 1.219 -0.509 0 CA-C-O 118.034 -0.984 . . . . 1.0 110.937 -179.607 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.1 mtm . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 108.912 -0.773 . . . . 1.0 108.912 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 23.0 t -74.12 95.0 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 N-CA-C 109.697 -0.483 . . . . 1.0 109.697 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -138.72 -35.91 0.57 Allowed 'General case' 0 N--CA 1.48 1.036 0 CA-C-O 120.946 0.403 . . . . 1.0 110.261 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 12.3 p -65.03 -38.38 82.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.926 -0.579 . . . . 1.0 110.416 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 68.4 p -63.27 137.0 58.05 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.101 -0.499 . . . . 1.0 110.494 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 50.3 70.29 0.53 Allowed 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.362 -0.381 . . . . 1.0 111.259 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 33.7 p-10 -123.52 -130.16 0.26 Allowed 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 122.988 0.515 . . . . 1.0 109.651 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 161.14 -166.09 35.59 Favored Glycine 0 N--CA 1.461 0.318 0 N-CA-C 108.963 -1.655 . . . . 1.0 108.963 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.1 p -125.72 130.78 72.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 N-CA-C 109.222 -0.659 . . . . 1.0 109.222 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.465 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 0.2 OUTLIER -91.12 151.81 20.85 Favored 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 109.303 -0.628 . . . . 1.0 109.303 -178.863 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 56.1 t -106.0 127.48 61.06 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 N-CA-C 108.5 -0.926 . . . . 1.0 108.5 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 41.2 tp -79.97 -49.56 11.67 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-O 121.169 0.509 . . . . 1.0 111.063 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 97.2 p -167.21 163.19 15.44 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.571 -0.741 . . . . 1.0 111.403 -179.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.444 ' O ' ' O ' ' A' ' 15' ' ' LYS . 39.2 t -119.92 138.37 50.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 CA-C-N 114.952 -1.022 . . . . 1.0 109.659 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.444 ' O ' ' O ' ' A' ' 14' ' ' VAL . 36.3 tptt -39.49 -108.75 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 O-C-N 123.981 0.8 . . . . 1.0 111.778 179.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -159.61 20.01 0.17 Allowed 'General case' 0 N--CA 1.482 1.156 0 O-C-N 121.096 -1.002 . . . . 1.0 112.363 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.752 ' O ' ' O ' ' A' ' 18' ' ' VAL . 4.2 p-10 -169.02 -68.06 0.02 OUTLIER 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 107.109 -1.441 . . . . 1.0 107.109 178.035 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.752 ' O ' ' O ' ' A' ' 17' ' ' ASP . 29.3 m 4.46 148.2 0.0 OUTLIER Pre-proline 0 N--CA 1.504 2.237 0 O-C-N 125.874 1.984 . . . . 1.0 114.091 -177.181 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -56.7 9.18 0.04 OUTLIER 'Trans proline' 0 N--CA 1.496 1.673 0 CA-C-N 120.346 1.159 . . . . 1.0 113.206 -178.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.565 ' H ' ' C ' ' A' ' 18' ' ' VAL . . . -106.48 -24.15 12.29 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 109.435 -0.58 . . . . 1.0 109.435 177.07 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -75.36 134.53 40.96 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-O 121.278 0.561 . . . . 1.0 110.247 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 90.75 -22.03 30.23 Favored Glycine 0 N--CA 1.471 0.977 0 CA-C-N 115.422 -0.808 . . . . 1.0 111.387 179.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 84.9 mt -105.36 -51.32 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 N-CA-C 109.945 -0.391 . . . . 1.0 109.945 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 18.8 mt -99.59 134.42 42.51 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 109.283 -0.636 . . . . 1.0 109.283 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -118.42 144.59 45.84 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 115.919 -0.582 . . . . 1.0 109.659 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -52.48 132.51 35.11 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 116.473 -0.331 . . . . 1.0 110.703 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 101.39 -4.38 54.62 Favored Glycine 0 N--CA 1.474 1.179 0 N-CA-C 111.601 -0.6 . . . . 1.0 111.601 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -72.82 152.38 41.57 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 117.506 0.653 . . . . 1.0 109.599 178.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.4 mp -124.15 122.31 37.48 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 122.753 0.421 . . . . 1.0 110.364 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 31.9 mm -74.78 122.44 28.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 N-CA-C 109.253 -0.647 . . . . 1.0 109.253 179.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 47.8 p -89.85 -43.77 10.4 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 116.4 -0.363 . . . . 1.0 111.023 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 72.9 tt0 -154.69 151.61 28.95 Favored 'General case' 0 N--CA 1.482 1.136 0 CA-C-O 120.991 0.424 . . . . 1.0 111.414 -178.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.6 mt -145.49 133.87 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 CA-C-O 120.977 0.417 . . . . 1.0 110.246 178.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 37.7 t70 54.5 34.94 22.19 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.808 -0.633 . . . . 1.0 111.256 178.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.18 -9.15 13.64 Favored Glycine 0 CA--C 1.531 1.058 0 N-CA-C 111.412 -0.675 . . . . 1.0 111.412 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -99.82 130.32 46.01 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 116.802 0.301 . . . . 1.0 110.264 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 90.6 p -103.52 102.71 12.61 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 122.583 0.353 . . . . 1.0 110.068 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -77.14 139.07 39.85 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 110.167 -0.309 . . . . 1.0 110.167 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 30.3 mtmm -94.79 -15.39 23.83 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 116.587 -0.279 . . . . 1.0 111.137 -179.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 49.0 m -129.57 150.46 50.9 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 122.678 0.391 . . . . 1.0 110.214 -179.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 46.6 t -64.26 -51.61 62.74 Favored 'General case' 0 C--O 1.219 -0.533 0 CA-C-N 116.417 -0.356 . . . . 1.0 110.575 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -53.88 -34.41 59.36 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 122.277 -0.265 . . . . 1.0 111.226 -179.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.0 tp10 -64.44 -36.81 85.39 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 109.299 -0.63 . . . . 1.0 109.299 179.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -66.69 -48.28 69.76 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.419 0.628 . . . . 1.0 109.537 178.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 26.3 mm -53.62 -27.96 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-N 115.542 -0.754 . . . . 1.0 110.313 -178.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -70.78 -35.23 72.49 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 116.359 -0.382 . . . . 1.0 110.119 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 28.7 t80 -67.18 -46.16 74.76 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.822 0.344 . . . . 1.0 110.997 178.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 25.7 mt -53.74 -38.55 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 115.954 -0.566 . . . . 1.0 109.945 -175.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 52.0 m-70 -80.89 -20.88 41.24 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 116.052 -0.522 . . . . 1.0 110.966 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 11.2 t -78.06 37.14 0.24 Allowed 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 120.748 0.308 . . . . 1.0 111.483 -178.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -146.55 -169.6 3.31 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 109.024 -0.732 . . . . 1.0 109.024 179.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -131.55 166.51 21.24 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 122.955 0.502 . . . . 1.0 109.759 -178.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 22.7 t -68.46 137.76 23.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 115.95 -0.568 . . . . 1.0 110.939 -178.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.75 -2.43 85.93 Favored Glycine 0 N--CA 1.478 1.484 0 N-CA-C 111.217 -0.753 . . . . 1.0 111.217 179.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -62.08 -168.91 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.832 -0.433 . . . . 1.0 109.832 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 23.4 m -146.55 139.88 25.72 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 108.972 -0.751 . . . . 1.0 108.972 179.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 6.0 p -141.46 160.79 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 CA-C-N 116.305 -0.407 . . . . 1.0 110.172 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 21.8 ttpp -112.71 123.28 49.94 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 108.111 -1.07 . . . . 1.0 108.111 177.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 11.5 tt -101.02 143.03 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 C-N-CA 122.776 0.43 . . . . 1.0 111.003 -178.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 17.6 tptp -133.58 113.56 12.56 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 107.661 -1.237 . . . . 1.0 107.661 177.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 25.1 p90 -144.45 157.93 44.0 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 109.226 -0.657 . . . . 1.0 109.226 -179.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -116.24 115.79 26.62 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 117.912 0.324 . . . . 1.0 110.206 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -118.66 115.76 25.18 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 108.108 -1.071 . . . . 1.0 108.108 177.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 73.25 -133.63 18.48 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 110.716 -0.953 . . . . 1.0 110.716 -178.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -107.26 2.1 24.38 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 122.82 0.448 . . . . 1.0 111.072 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 20.8 pttp -122.37 119.5 31.23 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-O 121.593 0.711 . . . . 1.0 111.145 -179.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -82.97 123.92 29.89 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 109.386 -0.598 . . . . 1.0 109.386 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -114.51 142.03 46.94 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.062 0.545 . . . . 1.0 109.943 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -124.87 136.69 54.02 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 109.135 -0.691 . . . . 1.0 109.135 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -148.69 128.42 13.32 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.301 0.572 . . . . 1.0 111.388 -179.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 12.2 m -87.03 139.53 30.48 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 109.146 -0.687 . . . . 1.0 109.146 178.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 11.1 pt -140.11 149.86 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-N 116.086 -0.506 . . . . 1.0 110.534 -178.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 18.4 pttp -93.19 139.03 31.04 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.541 -0.754 . . . . 1.0 109.235 178.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -64.04 150.8 44.59 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 109.665 -0.494 . . . . 1.0 109.665 179.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 72.9 p -137.39 159.36 42.15 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 115.894 -0.594 . . . . 1.0 110.188 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -81.44 135.14 35.62 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 109.313 -0.625 . . . . 1.0 109.313 178.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -134.63 -8.53 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 C-N-CA 122.475 0.31 . . . . 1.0 111.313 -179.363 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -127.66 148.27 50.38 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 122.937 0.495 . . . . 1.0 110.173 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -48.72 -33.26 9.85 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.238 -0.437 . . . . 1.0 111.805 -179.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -79.04 7.45 7.35 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 120.756 0.313 . . . . 1.0 110.846 -179.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 57.4 46.29 92.02 Favored Glycine 0 CA--C 1.529 0.954 0 CA-C-N 116.215 -0.448 . . . . 1.0 112.519 178.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 4.5 m -79.6 119.15 75.9 Favored Pre-proline 0 CA--C 1.551 0.982 0 CA-C-O 118.875 -0.584 . . . . 1.0 109.771 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -52.93 125.98 19.95 Favored 'Trans proline' 0 N--CA 1.504 2.112 0 C-N-CA 121.285 1.323 . . . . 1.0 111.077 177.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 173.74 172.6 39.24 Favored Glycine 0 N--CA 1.469 0.854 0 C-N-CA 120.801 -0.714 . . . . 1.0 112.254 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.19 173.4 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 N-CA-C 106.976 -1.49 . . . . 1.0 106.976 177.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -104.55 83.6 0.4 Allowed Glycine 0 N--CA 1.475 1.264 0 N-CA-C 110.549 -1.02 . . . . 1.0 110.549 -179.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -143.62 168.15 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-O 121.373 0.606 . . . . 1.0 110.746 179.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 26.4 m -128.14 132.72 48.91 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 115.099 -0.955 . . . . 1.0 109.344 178.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.433 ' CD2' ' N ' ' A' ' 89' ' ' LEU . 0.9 OUTLIER -99.61 159.52 14.98 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 123.194 0.598 . . . . 1.0 109.41 -179.99 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.2 m -106.51 150.16 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 CA-C-N 115.672 -0.695 . . . . 1.0 110.018 -178.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 28.9 p-10 -163.38 68.23 0.2 Allowed 'General case' 0 C--O 1.232 0.16 0 CA-C-N 115.726 -0.67 . . . . 1.0 110.305 179.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.498 ' CG ' ' H ' ' A' ' 93' ' ' LEU . 17.8 p-10 -44.45 -79.62 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 115.806 -0.634 . . . . 1.0 111.062 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.498 ' H ' ' CG ' ' A' ' 92' ' ' ASP . 48.0 mt 52.36 64.09 1.99 Allowed 'General case' 0 CA--C 1.54 0.573 0 O-C-N 122.378 -0.201 . . . . 1.0 111.134 178.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 57.04 116.31 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.002 0.43 . . . . 1.0 110.656 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 92.0 m-70 -86.63 -5.38 59.15 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 122.245 -0.284 . . . . 1.0 110.433 -179.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.401 ' O ' ' CD2' ' A' ' 98' ' ' HIS . 96.6 m-70 51.85 39.42 25.71 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.011 0.434 . . . . 1.0 111.102 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 17.9 p80 -64.43 150.06 47.22 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.911 -0.586 . . . . 1.0 110.68 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.401 ' CD2' ' O ' ' A' ' 96' ' ' HIS . 93.4 m-70 -148.25 -34.3 0.23 Allowed 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 116.222 -0.445 . . . . 1.0 110.157 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 85.3 t60 -63.74 -45.61 89.08 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.22 -0.445 . . . . 1.0 110.887 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 63.6 t-80 . . . . . 0 C--O 1.219 -0.515 0 CA-C-O 118.014 -0.993 . . . . 1.0 110.772 -179.2 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.8 mtm . . . . . 0 N--CA 1.491 1.609 0 N-CA-C 109.021 -0.733 . . . . 1.0 109.021 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 27.1 m -67.05 146.21 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-N 116.303 -0.408 . . . . 1.0 110.164 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -153.39 -77.64 0.11 Allowed 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.955 0.407 . . . . 1.0 110.687 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 46.4 t -69.2 131.88 33.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.002 -0.545 . . . . 1.0 109.957 -179.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 57.9 p -68.16 -107.29 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 116.351 -0.386 . . . . 1.0 110.641 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -74.72 124.55 26.96 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.836 0.351 . . . . 1.0 110.074 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -70.12 -78.33 0.07 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.686 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 166.39 -175.36 41.83 Favored Glycine 0 N--CA 1.462 0.418 0 N-CA-C 109.968 -1.253 . . . . 1.0 109.968 -179.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 18.7 m -112.61 130.99 65.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 N-CA-C 108.859 -0.793 . . . . 1.0 108.859 179.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -88.13 137.42 32.34 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 109.828 -0.434 . . . . 1.0 109.828 -177.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 62.1 t -90.28 127.51 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 N-CA-C 108.861 -0.792 . . . . 1.0 108.861 179.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 48.6 tp -81.05 -44.27 18.28 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 120.87 0.366 . . . . 1.0 111.144 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.2 t -163.31 156.87 19.48 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 121.317 0.58 . . . . 1.0 111.187 -178.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.4 p -137.12 134.9 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 CA-C-N 114.969 -1.014 . . . . 1.0 109.314 179.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -76.37 160.22 29.77 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 109.15 -0.685 . . . . 1.0 109.15 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -99.35 -5.63 29.29 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 111.673 0.249 . . . . 1.0 111.673 -178.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 25.0 p-10 -106.68 29.02 7.32 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 122.611 0.364 . . . . 1.0 110.908 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.6 m -130.75 156.13 80.34 Favored Pre-proline 0 N--CA 1.483 1.175 0 C-N-CA 123.137 0.575 . . . . 1.0 109.545 -179.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -56.57 -22.06 41.46 Favored 'Trans proline' 0 N--CA 1.505 2.2 0 C-N-CA 121.688 1.592 . . . . 1.0 112.141 -179.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.4 -26.96 68.76 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.147 0.499 . . . . 1.0 110.536 -179.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.67 125.36 25.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.572 -0.74 . . . . 1.0 110.935 -178.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 95.5 -15.71 62.68 Favored Glycine 0 N--CA 1.475 1.237 0 N-CA-C 111.478 -0.649 . . . . 1.0 111.478 179.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 81.2 mt -113.55 -49.9 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 N-CA-C 110.039 -0.356 . . . . 1.0 110.039 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 16.2 mt -110.75 147.55 34.19 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 109.613 -0.514 . . . . 1.0 109.613 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.605 ' HE2' ' CG ' ' A' ' 63' ' ' HIS . 13.6 p-80 -143.64 156.61 44.61 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.559 -0.746 . . . . 1.0 110.051 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.07 143.41 32.81 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 115.739 -0.664 . . . . 1.0 111.435 -179.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 95.06 -4.6 67.9 Favored Glycine 0 N--CA 1.474 1.168 0 N-CA-C 111.696 -0.562 . . . . 1.0 111.696 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.4 ' OD1' ' CD2' ' A' ' 25' ' ' HIS . 9.7 m-20 -82.8 123.04 28.97 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 117.145 0.473 . . . . 1.0 110.276 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 20.0 mt -97.92 121.07 39.39 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 109.711 -0.477 . . . . 1.0 109.711 179.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 16.0 mm -77.43 127.64 38.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 N-CA-C 108.948 -0.76 . . . . 1.0 108.948 -179.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 75.8 p -77.75 -51.95 9.72 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.291 -0.413 . . . . 1.0 110.678 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -155.14 166.28 34.07 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.032 0.444 . . . . 1.0 109.945 -179.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -134.04 126.59 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-N 115.064 -0.971 . . . . 1.0 109.931 179.319 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 37.5 t70 48.97 16.91 0.13 Allowed 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.699 -0.682 . . . . 1.0 111.624 179.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.82 14.86 78.15 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 111.331 -0.708 . . . . 1.0 111.331 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -138.91 163.29 32.68 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-O 120.899 0.381 . . . . 1.0 110.297 -179.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 24.3 p 58.09 106.37 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.703 -0.68 . . . . 1.0 111.519 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 27.2 p90 -174.18 -1.05 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.202 -0.454 . . . . 1.0 110.851 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 32.6 mtmm -80.34 9.01 6.35 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.602 -0.272 . . . . 1.0 110.846 -179.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.547 ' HG ' ' N ' ' A' ' 41' ' ' SER . 21.2 t -174.29 156.63 2.61 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.49 179.387 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.547 ' N ' ' HG ' ' A' ' 40' ' ' SER . 50.3 m -65.78 -42.23 91.06 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.042 -0.526 . . . . 1.0 109.846 178.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -64.86 -37.88 89.11 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.069 -0.514 . . . . 1.0 111.067 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -54.82 -25.37 27.98 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.027 0.441 . . . . 1.0 110.037 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -70.29 -45.65 65.92 Favored 'General case' 0 C--O 1.221 -0.429 0 N-CA-C 109.154 -0.684 . . . . 1.0 109.154 179.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.6 mp -64.28 -30.13 49.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 N-CA-C 108.896 -0.779 . . . . 1.0 108.896 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -63.13 -34.1 76.88 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.237 -179.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 32.2 t80 -69.14 -44.21 72.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.243 -0.435 . . . . 1.0 111.519 179.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 44.0 mt -57.44 -42.5 80.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.319 -0.401 . . . . 1.0 110.275 -175.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 54.2 m-70 -76.52 -18.76 58.55 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.309 -0.405 . . . . 1.0 111.117 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 13.0 t -92.33 46.48 1.26 Allowed 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 111.564 0.209 . . . . 1.0 111.564 -178.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 13.8 mmtm -149.31 175.74 11.16 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 109.242 -0.651 . . . . 1.0 109.242 179.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -130.1 154.1 47.81 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-O 121.067 0.46 . . . . 1.0 109.787 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 28.5 t -60.83 135.43 25.58 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 115.933 -0.576 . . . . 1.0 110.864 -178.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 97.55 -19.59 54.08 Favored Glycine 0 N--CA 1.477 1.422 0 N-CA-C 110.951 -0.86 . . . . 1.0 110.951 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -65.54 143.41 57.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.594 0.235 . . . . 1.0 110.497 -179.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 68.0 p -96.22 152.56 18.45 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 109.153 -0.684 . . . . 1.0 109.153 179.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 6.6 p -140.49 155.42 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 CA-C-O 121.232 0.539 . . . . 1.0 110.757 -179.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 31.6 mtmm -101.18 123.08 44.75 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.319 -0.855 . . . . 1.0 109.486 178.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -117.71 136.06 56.08 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 C-N-CA 122.84 0.456 . . . . 1.0 110.109 179.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 12.8 ptpt -135.72 120.51 18.48 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 107.745 -1.206 . . . . 1.0 107.745 178.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 34.7 p90 -146.21 149.28 33.64 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 110.146 -0.316 . . . . 1.0 110.146 -179.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 20.9 pttm -111.57 114.49 27.59 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.355 0.598 . . . . 1.0 110.552 -179.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.605 ' CG ' ' HE2' ' A' ' 25' ' ' HIS . 70.5 t60 -98.69 120.87 39.85 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 108.045 -1.094 . . . . 1.0 108.045 178.4 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 61.6 -118.04 13.49 Favored Glycine 0 CA--C 1.531 1.034 0 N-CA-C 111.121 -0.791 . . . . 1.0 111.121 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -114.16 14.55 18.23 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 122.942 0.497 . . . . 1.0 111.544 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 17.1 ptmt -122.75 121.16 35.66 Favored 'General case' 0 N--CA 1.485 1.309 0 CA-C-O 121.38 0.61 . . . . 1.0 111.157 -179.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 30.6 m120 -77.01 124.38 27.71 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 116.079 -0.51 . . . . 1.0 109.889 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -127.81 140.56 51.96 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 115.863 -0.608 . . . . 1.0 110.052 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.4 ' CD ' ' N ' ' A' ' 69' ' ' GLU . 1.9 pm0 -142.18 136.09 29.62 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 115.813 -0.63 . . . . 1.0 110.58 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -161.28 129.44 4.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.788 -0.642 . . . . 1.0 111.188 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 9.4 t -85.54 146.18 27.03 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 108.915 -0.772 . . . . 1.0 108.915 178.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.491 ' CD1' ' N ' ' A' ' 72' ' ' ILE . 0.0 OUTLIER -134.55 149.83 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 CA-C-O 121.425 0.631 . . . . 1.0 110.329 -178.981 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.6 ttmp? -81.2 139.47 35.51 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 115.11 -0.95 . . . . 1.0 109.268 179.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -73.64 149.73 41.81 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.193 0.521 . . . . 1.0 110.0 179.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 27.3 p -140.73 164.17 30.91 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.398 -0.819 . . . . 1.0 110.123 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -79.97 131.95 35.92 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 109.271 -0.641 . . . . 1.0 109.271 178.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.404 HG13 ' H ' ' A' ' 78' ' ' ASP . 1.3 pt -109.63 -55.88 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 CA-C-N 115.946 -0.57 . . . . 1.0 109.794 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.432 ' OD2' ' NZ ' ' A' ' 80' ' ' LYS . 40.9 t0 -98.41 171.53 8.11 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 121.507 0.67 . . . . 1.0 111.48 -178.095 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -60.16 -28.56 68.02 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.811 -1.086 . . . . 1.0 112.045 -179.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.432 ' NZ ' ' OD2' ' A' ' 78' ' ' ASP . 19.6 pttm -80.09 14.58 1.8 Allowed 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 120.619 0.247 . . . . 1.0 110.517 -179.374 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 49.24 41.15 30.77 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 112.169 -0.372 . . . . 1.0 112.169 178.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 15.9 m -80.02 120.51 80.0 Favored Pre-proline 0 CA--C 1.547 0.834 0 N-CA-C 109.544 -0.539 . . . . 1.0 109.544 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -52.95 131.8 44.23 Favored 'Trans proline' 0 N--CA 1.501 1.927 0 C-N-CA 121.463 1.442 . . . . 1.0 112.277 178.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -158.58 146.14 12.72 Favored Glycine 0 N--CA 1.468 0.788 0 N-CA-C 111.474 -0.65 . . . . 1.0 111.474 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 40.7 mm -67.6 -26.05 34.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.455 -0.373 . . . . 1.0 110.418 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 99.47 45.6 2.12 Favored Glycine 0 N--CA 1.475 1.255 0 N-CA-C 110.684 -0.966 . . . . 1.0 110.684 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 38.4 pt -145.15 166.89 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 N-CA-C 109.863 -0.421 . . . . 1.0 109.863 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 77.0 m -127.25 127.07 43.82 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 109.253 -0.647 . . . . 1.0 109.253 177.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.1 mp -99.39 146.69 26.03 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 120.797 0.332 . . . . 1.0 110.525 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.7 p -104.99 164.11 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 CA-C-N 115.777 -0.647 . . . . 1.0 109.744 -179.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -155.94 38.73 0.36 Allowed 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.043 0.449 . . . . 1.0 110.131 -179.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 54.93 44.5 28.2 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.84 -0.618 . . . . 1.0 110.838 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 60.6 mt -59.29 -67.05 0.41 Allowed 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.1 -0.5 . . . . 1.0 110.356 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 69.5 mt-10 53.85 21.13 2.62 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.124 -0.489 . . . . 1.0 111.278 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . 0.419 ' O ' ' N ' ' A' ' 97' ' ' HIS . 65.4 m80 -88.83 -17.81 28.96 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 116.36 -0.382 . . . . 1.0 110.315 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.408 ' O ' ' N ' ' A' ' 98' ' ' HIS . 83.1 t60 54.08 -86.58 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.501 -0.318 . . . . 1.0 111.297 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . 0.419 ' N ' ' O ' ' A' ' 95' ' ' HIS . 83.1 t60 -65.96 72.87 0.07 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.952 0.406 . . . . 1.0 110.586 -179.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.56 ' CG ' ' H ' ' A' ' 99' ' ' HIS . 17.1 t-80 51.48 -122.9 2.05 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 116.322 -0.399 . . . . 1.0 110.977 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . 0.56 ' H ' ' CG ' ' A' ' 98' ' ' HIS . 8.7 t60 -68.99 -44.84 72.02 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 120.65 0.262 . . . . 1.0 111.077 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . 0.401 ' O ' ' CG ' ' A' ' 100' ' ' HIS . 82.2 t60 . . . . . 0 N--CA 1.469 0.483 0 CA-C-O 117.985 -1.007 . . . . 1.0 110.445 -178.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.3 ptt? . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.015 -0.735 . . . . 1.0 109.015 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 56.9 t -61.74 -44.14 98.3 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 N-CA-C 110.265 -0.272 . . . . 1.0 110.265 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -71.02 137.76 49.3 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.382 -0.372 . . . . 1.0 110.103 -179.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 41.1 t -141.88 83.09 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 N-CA-C 110.059 -0.348 . . . . 1.0 110.059 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 22.9 m -65.24 -51.69 59.24 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.443 -0.344 . . . . 1.0 111.483 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 52.3 p90 -69.29 146.6 52.11 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 120.77 0.319 . . . . 1.0 110.578 -179.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 48.7 p-10 -162.56 148.26 12.53 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.366 -0.605 . . . . 1.0 109.366 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -69.66 -160.17 2.52 Favored Glycine 0 CA--C 1.52 0.376 0 N-CA-C 110.122 -1.191 . . . . 1.0 110.122 179.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.9 m -112.82 132.41 61.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 N-CA-C 109.362 -0.607 . . . . 1.0 109.362 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -92.27 132.37 36.74 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 115.791 -0.64 . . . . 1.0 110.588 -178.244 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 57.3 t -77.56 134.55 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.126 0 N-CA-C 107.335 -1.357 . . . . 1.0 107.335 177.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.3 tt -81.03 -51.19 8.77 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.056 0.455 . . . . 1.0 111.163 -178.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.0 m -163.61 159.79 22.19 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.151 0.5 . . . . 1.0 111.343 -179.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 26.4 t -109.24 134.75 50.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-N 114.992 -1.004 . . . . 1.0 109.134 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -63.86 -36.55 84.29 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 116.4 -0.364 . . . . 1.0 110.675 -179.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 73.38 25.91 2.1 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.5 1.12 . . . . 1.0 111.835 -179.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -145.75 35.23 1.04 Allowed 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 108.709 -0.848 . . . . 1.0 108.709 178.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 6.5 m -145.08 158.06 52.74 Favored Pre-proline 0 N--CA 1.476 0.851 0 CA-C-N 115.903 -0.589 . . . . 1.0 110.238 -178.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -50.88 -15.08 1.57 Allowed 'Trans proline' 0 N--CA 1.505 2.171 0 C-N-CA 121.781 1.654 . . . . 1.0 112.17 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.55 -35.17 80.12 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.966 0.412 . . . . 1.0 110.591 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.56 129.71 41.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.924 -0.58 . . . . 1.0 111.313 -178.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.44 -7.52 75.06 Favored Glycine 0 N--CA 1.47 0.942 0 N-CA-C 111.109 -0.796 . . . . 1.0 111.109 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 52.9 mt -115.54 -50.61 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 CA-C-O 120.769 0.318 . . . . 1.0 110.498 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 28.4 mt -113.53 153.54 28.59 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.091 0.556 . . . . 1.0 110.101 -179.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 67.6 m80 -144.12 157.03 44.55 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.86 -0.609 . . . . 1.0 111.001 -179.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.05 140.3 38.4 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.924 -0.58 . . . . 1.0 111.134 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 91.81 -4.38 78.74 Favored Glycine 0 N--CA 1.471 0.972 0 N-CA-C 111.283 -0.727 . . . . 1.0 111.283 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -67.63 124.85 24.4 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 109.425 -0.583 . . . . 1.0 109.425 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 10.6 mt -96.61 122.28 39.36 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 109.095 -0.706 . . . . 1.0 109.095 179.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 33.7 mm -83.62 116.48 27.68 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 109.124 -0.695 . . . . 1.0 109.124 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 71.7 p -90.56 -39.78 12.34 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 116.278 -0.419 . . . . 1.0 111.436 -179.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.433 ' OE2' ' CD2' ' A' ' 38' ' ' PHE . 4.4 tp10 -146.32 148.78 32.75 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 109.826 -0.435 . . . . 1.0 109.826 -179.083 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.427 ' C ' ' H ' ' A' ' 35' ' ' GLY . 3.6 mt -129.59 128.86 66.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 108.709 -0.848 . . . . 1.0 108.709 179.211 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 26.5 t0 45.8 14.47 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 112.131 0.419 . . . . 1.0 112.131 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.427 ' H ' ' C ' ' A' ' 33' ' ' ILE . . . 65.73 17.9 65.48 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.937 -0.865 . . . . 1.0 110.937 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -139.59 163.3 32.92 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-O 120.932 0.396 . . . . 1.0 110.625 -179.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.469 ' C ' ' H ' ' A' ' 39' ' ' LYS . 46.7 t 63.44 -99.99 0.08 Allowed 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.189 -0.914 . . . . 1.0 110.862 -179.246 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.467 ' CG ' ' O ' ' A' ' 37' ' ' SER . 33.3 p90 44.59 13.32 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 112.27 0.47 . . . . 1.0 112.27 -178.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.469 ' H ' ' C ' ' A' ' 37' ' ' SER . 22.5 pttp -92.11 5.32 50.76 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.026 0.53 . . . . 1.0 111.289 -179.291 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.434 ' HG ' ' N ' ' A' ' 41' ' ' SER . 4.5 t -169.43 151.41 4.47 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.227 0.537 . . . . 1.0 110.122 179.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.434 ' N ' ' HG ' ' A' ' 40' ' ' SER . 73.1 m -75.93 -33.01 59.84 Favored 'General case' 0 C--O 1.218 -0.566 0 CA-C-N 115.702 -0.681 . . . . 1.0 109.917 179.064 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.407 ' NE2' ' OD2' ' A' ' 46' ' ' ASP . 0.0 OUTLIER -74.05 -45.4 49.74 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 120.948 0.404 . . . . 1.0 111.187 -178.897 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -56.56 -20.86 22.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.123 -0.489 . . . . 1.0 110.49 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -72.1 -52.18 17.99 Favored 'General case' 0 N--CA 1.461 0.097 0 C-N-CA 120.542 -0.463 . . . . 1.0 110.406 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.7 mp -54.05 -31.8 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 N-CA-C 108.651 -0.87 . . . . 1.0 108.651 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.407 ' OD2' ' NE2' ' A' ' 42' ' ' GLN . 61.8 m-20 -72.0 -32.57 67.32 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.018 -0.992 . . . . 1.0 111.227 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.427 ' OH ' ' NZ ' ' A' ' 51' ' ' LYS . 77.3 t80 -69.23 -52.57 26.4 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 120.875 0.369 . . . . 1.0 111.479 -179.4 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -54.92 -25.63 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 N-CA-C 109.53 -0.545 . . . . 1.0 109.53 -177.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 42.5 m170 -94.15 -18.12 22.07 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.58 -0.737 . . . . 1.0 110.558 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 27.6 t -66.75 -22.43 66.04 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.712 0.291 . . . . 1.0 111.448 -178.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.427 ' NZ ' ' OH ' ' A' ' 47' ' ' TYR . 34.9 mmtp -90.48 -169.06 2.27 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 109.649 -0.5 . . . . 1.0 109.649 179.462 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.9 mptp? -122.46 168.29 12.29 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 122.958 0.503 . . . . 1.0 110.658 -179.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 22.1 t -65.2 135.1 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-N 115.738 -0.665 . . . . 1.0 110.732 -178.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.97 -0.88 86.54 Favored Glycine 0 N--CA 1.474 1.172 0 N-CA-C 110.968 -0.853 . . . . 1.0 110.968 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -73.54 147.18 44.2 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 110.235 -0.283 . . . . 1.0 110.235 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 80.7 p -86.51 150.33 24.33 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 109.574 -0.528 . . . . 1.0 109.574 178.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -141.93 161.58 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 CA-C-O 120.933 0.397 . . . . 1.0 111.244 -179.367 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 49.9 mtmt -123.4 114.52 20.26 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.011 -0.995 . . . . 1.0 108.734 177.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 35.3 mm -106.87 140.14 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 CA-C-O 121.004 0.431 . . . . 1.0 110.378 -179.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -131.99 115.77 16.26 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 106.942 -1.503 . . . . 1.0 106.942 177.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 29.5 p90 -143.12 164.23 30.71 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-N 116.123 -0.49 . . . . 1.0 110.073 -176.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 21.2 ttpp -127.31 114.84 18.12 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 123.423 0.452 . . . . 1.0 110.641 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -99.92 108.68 20.98 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 108.075 -1.083 . . . . 1.0 108.075 178.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 74.82 -114.28 4.31 Favored Glycine 0 CA--C 1.532 1.132 0 N-CA-C 111.128 -0.789 . . . . 1.0 111.128 -179.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -113.12 -10.91 13.38 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 122.674 0.39 . . . . 1.0 111.638 -179.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -99.23 133.77 43.04 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-O 120.706 0.289 . . . . 1.0 110.745 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 18.4 p30 -97.15 128.84 44.44 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.902 0.382 . . . . 1.0 110.133 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 74.1 mt-10 -132.94 155.01 49.89 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 115.738 -0.664 . . . . 1.0 109.854 -179.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -140.7 138.09 33.98 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.843 -0.617 . . . . 1.0 110.523 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -146.89 151.38 36.96 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.766 -0.652 . . . . 1.0 110.613 -179.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 50.5 m -102.67 134.02 46.72 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.353 -0.84 . . . . 1.0 109.166 179.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 7.6 mt -135.7 139.94 45.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 CA-C-O 121.298 0.57 . . . . 1.0 110.494 -177.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 52.0 pttt -82.47 141.51 32.64 Favored 'General case' 0 C--N 1.327 -0.376 0 O-C-N 121.905 -0.497 . . . . 1.0 110.192 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -68.62 143.38 54.84 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 120.97 0.414 . . . . 1.0 110.082 178.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 80.5 p -136.32 162.96 31.57 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 115.809 -0.632 . . . . 1.0 110.433 179.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -78.44 122.84 26.34 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.885 -0.598 . . . . 1.0 109.713 179.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.449 ' CG1' ' H ' ' A' ' 78' ' ' ASP . 3.6 pt -96.06 -53.44 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-N 116.795 -0.184 . . . . 1.0 110.587 179.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.449 ' H ' ' CG1' ' A' ' 77' ' ' ILE . 44.3 t0 -98.08 169.65 9.46 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 121.365 0.602 . . . . 1.0 111.579 -178.328 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 47.0 mmtm -61.82 -23.9 66.53 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 114.902 -1.044 . . . . 1.0 111.904 -178.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 35.6 pttt -77.53 -15.55 59.2 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 120.479 0.18 . . . . 1.0 110.626 -178.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 83.03 40.18 9.53 Favored Glycine 0 N--CA 1.467 0.753 0 C-N-CA 121.424 -0.417 . . . . 1.0 112.075 178.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 53.2 m -81.21 120.16 77.74 Favored Pre-proline 0 CA--C 1.545 0.753 0 N-CA-C 109.324 -0.621 . . . . 1.0 109.324 179.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -52.79 130.88 39.35 Favored 'Trans proline' 0 N--CA 1.497 1.717 0 C-N-CA 121.142 1.228 . . . . 1.0 112.909 178.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -169.14 155.03 25.03 Favored Glycine 0 N--CA 1.461 0.318 0 N-CA-C 110.666 -0.974 . . . . 1.0 110.666 178.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 3.3 mt -89.66 26.4 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 N-CA-C 109.501 -0.555 . . . . 1.0 109.501 -179.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 50.52 63.62 4.27 Favored Glycine 0 CA--C 1.531 1.056 0 N-CA-C 111.782 -0.527 . . . . 1.0 111.782 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 18.7 pt -146.62 164.6 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 N-CA-C 109.353 -0.61 . . . . 1.0 109.353 179.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 86.1 m -130.36 125.5 34.77 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 115.477 -0.783 . . . . 1.0 109.581 177.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 12.7 mt -111.01 134.7 52.4 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.282 0.633 . . . . 1.0 109.801 -179.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.412 ' O ' ' C ' ' A' ' 91' ' ' ASP . 16.0 m -154.81 137.39 6.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 108.367 -0.975 . . . . 1.0 108.367 179.156 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.412 ' C ' ' O ' ' A' ' 90' ' ' VAL . 83.8 m-20 -25.68 -86.87 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.342 0.657 . . . . 1.0 112.541 179.623 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -169.67 41.03 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.013 0.435 . . . . 1.0 110.585 178.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 49.7 mt 55.56 71.5 0.54 Allowed 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.857 -0.611 . . . . 1.0 110.49 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -132.94 108.13 8.72 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 115.779 -0.646 . . . . 1.0 110.178 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -88.45 -18.64 27.86 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 116.455 -0.339 . . . . 1.0 110.539 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 73.9 m80 -71.58 128.82 37.06 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.284 -0.416 . . . . 1.0 109.954 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 78.7 t60 -168.6 29.23 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.823 0.344 . . . . 1.0 110.219 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 77.3 m80 -64.45 -40.68 96.19 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.402 -0.363 . . . . 1.0 110.056 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 59.9 t-80 -163.74 143.4 8.24 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.81 0.338 . . . . 1.0 110.594 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 55.7 t-80 . . . . . 0 C--O 1.221 -0.417 0 CA-C-O 117.976 -1.012 . . . . 1.0 111.028 179.992 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.2 mtm . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.17 -0.678 . . . . 1.0 109.17 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 27.9 m -66.1 146.13 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 N-CA-C 109.802 -0.444 . . . . 1.0 109.802 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 18.5 tptp -59.98 116.06 3.88 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.292 -179.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.3 t -90.41 98.35 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 N-CA-C 110.092 -0.336 . . . . 1.0 110.092 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 81.6 p -67.29 -81.04 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.586 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -71.18 150.05 45.73 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.828 0.347 . . . . 1.0 110.115 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -133.53 91.82 2.9 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 115.765 -0.652 . . . . 1.0 109.747 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -171.23 -159.34 17.11 Favored Glycine 0 CA--C 1.521 0.461 0 N-CA-C 109.948 -1.261 . . . . 1.0 109.948 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 16.6 m -117.96 128.81 75.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 CA-C-O 121.297 0.57 . . . . 1.0 109.731 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -86.7 146.17 26.4 Favored 'General case' 0 C--O 1.221 -0.396 0 N-CA-C 108.639 -0.874 . . . . 1.0 108.639 -178.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 57.0 t -107.96 132.06 56.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 108.951 -0.759 . . . . 1.0 108.951 179.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.61 -50.83 7.33 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 116.287 -0.415 . . . . 1.0 111.245 -179.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 99.7 p -167.79 163.73 14.14 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 121.173 0.511 . . . . 1.0 111.301 -179.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 39.8 t -107.09 128.74 61.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 CA-C-N 115.128 -0.942 . . . . 1.0 108.497 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.413 ' O ' ' CB ' ' A' ' 16' ' ' GLU . 63.6 mttp -59.91 -36.75 77.64 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-N 116.099 -0.501 . . . . 1.0 110.55 -178.584 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.461 ' C ' ' H ' ' A' ' 18' ' ' VAL . 59.5 tt0 93.84 163.93 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.338 0 O-C-N 124.742 1.277 . . . . 1.0 111.129 178.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 70.59 -4.97 1.51 Allowed 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.496 -0.775 . . . . 1.0 109.567 -179.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.461 ' H ' ' C ' ' A' ' 16' ' ' GLU . 11.4 m -96.3 155.61 37.86 Favored Pre-proline 0 CA--C 1.541 0.604 0 CA-C-N 115.727 -0.669 . . . . 1.0 110.44 -178.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -55.92 -23.03 40.82 Favored 'Trans proline' 0 N--CA 1.503 2.058 0 C-N-CA 121.953 1.769 . . . . 1.0 112.226 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.44 -23.73 67.38 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.649 0.261 . . . . 1.0 110.852 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.5 136.0 44.1 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.306 -0.406 . . . . 1.0 110.887 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 91.28 -23.64 23.45 Favored Glycine 0 N--CA 1.469 0.89 0 N-CA-C 111.243 -0.743 . . . . 1.0 111.243 179.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 67.9 mt -102.12 -50.21 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 122.32 0.248 . . . . 1.0 110.489 -179.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 23.5 mt -109.89 157.15 19.53 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-O 121.077 0.465 . . . . 1.0 109.895 -179.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 50.3 t-80 -139.0 153.5 48.15 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.44 -0.8 . . . . 1.0 110.591 -179.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.42 144.39 31.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.369 -0.832 . . . . 1.0 110.812 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 89.01 -11.2 70.03 Favored Glycine 0 CA--C 1.528 0.898 0 N-CA-C 111.06 -0.816 . . . . 1.0 111.06 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -68.27 144.17 54.97 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 110.249 -0.278 . . . . 1.0 110.249 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.5 mp -117.75 121.45 40.87 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 110.127 -0.323 . . . . 1.0 110.127 -179.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 25.4 mm -80.36 125.88 39.29 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 N-CA-C 109.177 -0.675 . . . . 1.0 109.177 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 73.8 p -88.13 -47.36 8.54 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.169 -0.468 . . . . 1.0 110.449 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 71.9 tt0 -155.96 146.54 21.89 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.974 0.416 . . . . 1.0 111.222 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 12.6 tt -141.96 131.76 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 109.404 -0.591 . . . . 1.0 109.404 179.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.412 ' OD2' ' CE1' ' A' ' 47' ' ' TYR . 57.8 m-20 56.82 20.84 5.5 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.112 -0.494 . . . . 1.0 111.581 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.86 2.54 86.36 Favored Glycine 0 N--CA 1.472 1.063 0 CA-C-N 116.483 -0.326 . . . . 1.0 112.384 178.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -149.94 143.65 25.38 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 117.361 0.58 . . . . 1.0 111.008 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.458 ' OG ' ' N ' ' A' ' 38' ' ' PHE . 95.9 p -169.44 -66.18 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.204 0.526 . . . . 1.0 110.015 179.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.458 ' N ' ' OG ' ' A' ' 37' ' ' SER . 0.5 OUTLIER -54.48 179.29 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.262 -0.881 . . . . 1.0 110.137 179.736 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.439 ' O ' ' CB ' ' A' ' 40' ' ' SER . 3.4 tmtp? 66.49 64.83 0.49 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.215 -0.902 . . . . 1.0 110.816 179.645 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.439 ' CB ' ' O ' ' A' ' 39' ' ' LYS . 1.5 m 92.78 111.31 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.293 0.637 . . . . 1.0 110.757 179.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 50.3 m -52.52 -31.6 36.28 Favored 'General case' 0 N--CA 1.457 -0.089 0 N-CA-C 109.389 -0.597 . . . . 1.0 109.389 178.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.5 tm0? -55.38 -35.18 65.0 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 115.452 -0.795 . . . . 1.0 110.144 179.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -57.98 -27.86 63.85 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 115.963 -0.562 . . . . 1.0 109.779 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -72.59 -47.47 47.66 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.978 -0.555 . . . . 1.0 109.722 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 27.4 mm -63.55 -28.86 45.87 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 CA-C-N 115.797 -0.638 . . . . 1.0 109.833 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -62.62 -37.52 86.62 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.611 -0.722 . . . . 1.0 109.975 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.412 ' CE1' ' OD2' ' A' ' 34' ' ' ASP . 0.0 OUTLIER -66.62 -45.66 78.38 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.059 -0.519 . . . . 1.0 110.681 179.182 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 49.5 mt -60.61 -45.35 97.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 116.518 -0.31 . . . . 1.0 111.016 -176.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -74.16 -22.56 59.38 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.457 -0.338 . . . . 1.0 111.187 -178.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 46.6 t -85.81 -6.76 59.05 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-O 120.566 0.222 . . . . 1.0 111.217 -177.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.4 tptm -99.26 164.91 11.94 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-N 116.188 -0.46 . . . . 1.0 109.869 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -121.58 170.42 9.71 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 123.964 0.79 . . . . 1.0 109.893 -179.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 22.0 t -70.91 132.57 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-N 115.448 -0.797 . . . . 1.0 111.125 -178.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.37 -5.18 80.73 Favored Glycine 0 N--CA 1.469 0.854 0 N-CA-C 111.054 -0.818 . . . . 1.0 111.054 179.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -67.98 144.39 55.19 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.763 0.316 . . . . 1.0 110.751 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 36.3 m -90.19 153.72 20.29 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 108.988 -0.745 . . . . 1.0 108.988 178.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -140.13 161.27 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 CA-C-O 121.402 0.62 . . . . 1.0 110.599 -179.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.576 ' HZ2' ' HZ2' ' A' ' 60' ' ' LYS . 64.1 tttm -117.15 115.68 25.81 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 107.647 -1.242 . . . . 1.0 107.647 177.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.9 tp -103.18 143.13 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 122.332 0.253 . . . . 1.0 111.018 -178.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.576 ' HZ2' ' HZ2' ' A' ' 58' ' ' LYS . 6.9 tppt? -133.1 112.75 12.03 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 108.383 -0.969 . . . . 1.0 108.383 178.041 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 33.8 p90 -149.15 149.2 30.64 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.906 -0.405 . . . . 1.0 109.906 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -110.18 114.12 27.35 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 110.239 -0.282 . . . . 1.0 110.239 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 51.3 t-80 -91.91 112.0 23.76 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 108.013 -1.106 . . . . 1.0 108.013 178.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 62.17 -114.45 6.8 Favored Glycine 0 CA--C 1.532 1.152 0 N-CA-C 110.7 -0.96 . . . . 1.0 110.7 -179.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 23.0 p-10 -112.99 -0.5 14.75 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 122.476 0.31 . . . . 1.0 111.365 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.438 ' NZ ' ' OE2' ' A' ' 68' ' ' GLU . 10.8 ptmm? -110.73 123.42 50.0 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 121.421 0.629 . . . . 1.0 110.75 -179.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 46.4 p-10 -81.93 128.24 33.85 Favored 'General case' 0 C--N 1.339 0.13 0 CA-C-O 121.363 0.601 . . . . 1.0 110.353 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.438 ' OE2' ' NZ ' ' A' ' 66' ' ' LYS . 81.0 mm-40 -126.11 148.83 49.28 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 115.23 -0.895 . . . . 1.0 109.523 -179.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.413 ' OE2' ' NZ ' ' A' ' 58' ' ' LYS . 36.8 tt0 -140.86 135.2 31.11 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 109.186 -0.672 . . . . 1.0 109.186 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -148.1 142.22 26.04 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-O 121.537 0.684 . . . . 1.0 111.222 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 91.5 p -85.7 135.03 33.93 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 108.781 -0.822 . . . . 1.0 108.781 178.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 67.2 mt -129.28 122.37 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 CA-C-O 121.289 0.566 . . . . 1.0 109.963 -178.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 22.3 ttpp -82.29 138.3 34.61 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 109.64 -0.504 . . . . 1.0 109.64 179.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -69.68 143.97 53.0 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.373 0.606 . . . . 1.0 110.304 -178.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 69.7 p -143.28 172.25 13.0 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.064 -0.971 . . . . 1.0 110.435 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -89.3 140.83 29.1 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.343 -0.844 . . . . 1.0 109.583 179.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.427 ' CD1' ' N ' ' A' ' 77' ' ' ILE . 0.1 OUTLIER -131.92 -41.98 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 122.672 0.389 . . . . 1.0 110.839 -179.625 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.409 ' H ' HD11 ' A' ' 77' ' ' ILE . 73.7 m-20 -98.62 157.84 15.99 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 121.521 0.677 . . . . 1.0 110.729 -179.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -52.37 -27.09 14.25 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.845 -1.07 . . . . 1.0 112.046 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.504 ' HZ1' ' CB ' ' A' ' 82' ' ' THR . 18.1 pttp -81.4 13.24 3.07 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 116.303 -0.408 . . . . 1.0 111.039 -179.379 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 47.85 39.59 17.92 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 121.343 -0.456 . . . . 1.0 112.046 178.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.504 ' CB ' ' HZ1' ' A' ' 80' ' ' LYS . 86.8 m -80.17 122.09 82.55 Favored Pre-proline 0 CA--C 1.545 0.779 0 CA-C-N 117.101 0.451 . . . . 1.0 110.215 -179.159 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -57.03 114.86 2.11 Favored 'Trans proline' 0 N--CA 1.505 2.168 0 C-N-CA 121.401 1.4 . . . . 1.0 111.332 177.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -179.8 179.64 48.82 Favored Glycine 0 N--CA 1.463 0.449 0 N-CA-C 111.081 -0.808 . . . . 1.0 111.081 179.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.7 pt -105.69 177.5 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 N-CA-C 109.665 -0.495 . . . . 1.0 109.665 179.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -108.31 84.45 0.37 Allowed Glycine 0 N--CA 1.472 1.079 0 N-CA-C 111.05 -0.82 . . . . 1.0 111.05 -178.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.2 pp -146.77 168.3 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-O 121.272 0.558 . . . . 1.0 109.645 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 62.3 m -132.23 131.39 42.06 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 115.424 -0.807 . . . . 1.0 109.557 179.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 29.2 mt -110.52 147.51 33.99 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.711 -0.677 . . . . 1.0 109.267 -179.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 30.8 m -111.96 171.02 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-N 115.773 -0.649 . . . . 1.0 110.395 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 29.8 t70 62.26 33.39 16.65 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.266 -0.879 . . . . 1.0 110.535 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 21.7 p-10 -156.02 10.0 0.26 Allowed 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 116.171 -0.468 . . . . 1.0 111.051 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.43 ' O ' ' N ' ' A' ' 95' ' ' HIS . 1.8 pp -90.51 -27.5 19.16 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 116.094 -0.503 . . . . 1.0 110.358 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 78.6 tt0 -63.81 76.19 0.03 OUTLIER 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.548 -0.297 . . . . 1.0 110.222 -179.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . 0.43 ' N ' ' O ' ' A' ' 93' ' ' LEU . 57.2 t-80 -113.88 -0.21 14.23 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 122.471 0.309 . . . . 1.0 110.55 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 44.3 p-80 -157.9 -162.76 1.2 Allowed 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.776 0.322 . . . . 1.0 110.523 -179.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 77.4 t60 54.28 82.15 0.09 Allowed 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.084 -0.507 . . . . 1.0 111.093 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 34.6 p-80 -68.27 152.99 44.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.176 -0.466 . . . . 1.0 110.034 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . 0.433 ' CG ' ' N ' ' A' ' 100' ' ' HIS . 78.3 t60 56.99 162.83 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.929 -0.578 . . . . 1.0 111.833 179.518 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . 0.433 ' N ' ' CG ' ' A' ' 99' ' ' HIS . 31.6 p-80 . . . . . 0 C--O 1.22 -0.479 0 CA-C-N 115.031 -0.986 . . . . 1.0 109.354 179.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.433 ' H2 ' ' H ' ' A' ' 2' ' ' VAL . 22.1 ptt? . . . . . 0 N--CA 1.489 1.481 0 N-CA-C 109.364 -0.606 . . . . 1.0 109.364 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.433 ' H ' ' H2 ' ' A' ' 1' ' ' MET . 12.1 p -63.03 -32.84 57.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-N 116.416 -0.357 . . . . 1.0 110.433 -179.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -64.09 -10.49 22.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.991 -178.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 28.6 m -135.38 157.92 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 CA-C-O 121.189 0.519 . . . . 1.0 110.303 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.433 ' OG1' ' N ' ' A' ' 6' ' ' TYR . 2.8 t -82.26 179.42 7.81 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 115.404 -0.816 . . . . 1.0 110.58 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.433 ' N ' ' OG1' ' A' ' 5' ' ' THR . 59.4 t80 -67.86 121.91 17.03 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.966 -0.561 . . . . 1.0 110.25 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 36.3 p-10 -169.41 79.91 0.12 Allowed 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.905 -0.588 . . . . 1.0 110.049 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 153.67 -175.38 32.03 Favored Glycine 0 N--CA 1.467 0.75 0 N-CA-C 109.858 -1.297 . . . . 1.0 109.858 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 38.9 t -111.64 127.42 68.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 N-CA-C 109.18 -0.674 . . . . 1.0 109.18 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -86.85 143.36 27.49 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 115.962 -0.563 . . . . 1.0 109.634 -178.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 39.0 t -107.93 132.95 54.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 115.405 -0.816 . . . . 1.0 109.208 179.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.67 -44.39 17.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.814 -0.63 . . . . 1.0 111.971 -179.547 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 99.9 p -165.8 162.39 18.47 Favored 'General case' 0 CA--C 1.506 -0.727 0 CA-C-N 116.061 -0.518 . . . . 1.0 110.953 -179.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.44 ' O ' ' O ' ' A' ' 15' ' ' LYS . 40.3 t -120.42 137.62 53.62 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 114.728 -1.124 . . . . 1.0 108.732 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.44 ' O ' ' O ' ' A' ' 14' ' ' VAL . 3.9 mmmm -54.43 -116.6 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.477 0 O-C-N 123.815 0.697 . . . . 1.0 110.294 179.129 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 78.1 tt0 -162.32 -70.13 0.05 Allowed 'General case' 0 C--N 1.33 -0.269 0 O-C-N 121.755 -0.591 . . . . 1.0 111.445 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 29.2 p-10 -89.97 51.7 2.12 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.346 -0.388 . . . . 1.0 110.569 -178.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 32.8 m -124.99 156.71 68.81 Favored Pre-proline 0 N--CA 1.471 0.616 0 CA-C-N 115.841 -0.618 . . . . 1.0 110.151 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -58.86 -13.18 17.3 Favored 'Trans proline' 0 N--CA 1.499 1.827 0 C-N-CA 121.751 1.634 . . . . 1.0 112.054 178.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -81.99 -27.46 33.15 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.068 0.461 . . . . 1.0 110.381 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.91 130.5 41.17 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 115.694 -0.685 . . . . 1.0 110.134 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 98.57 -15.03 61.55 Favored Glycine 0 N--CA 1.472 1.054 0 N-CA-C 111.197 -0.761 . . . . 1.0 111.197 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 71.1 mt -115.23 -52.24 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 CA-C-N 116.616 0.208 . . . . 1.0 110.459 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 12.7 mt -102.0 149.77 23.9 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 109.816 -0.439 . . . . 1.0 109.816 -179.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.626 ' HE2' ' CD2' ' A' ' 63' ' ' HIS . 42.5 p-80 -141.11 154.89 46.13 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.389 0.614 . . . . 1.0 110.433 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.05 134.43 55.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.18 -0.918 . . . . 1.0 110.617 -179.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.27 -4.09 62.16 Favored Glycine 0 N--CA 1.471 0.983 0 N-CA-C 111.197 -0.761 . . . . 1.0 111.197 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -77.85 130.17 36.31 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 117.274 0.537 . . . . 1.0 110.264 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 14.3 mt -99.91 120.05 39.17 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 109.508 -0.552 . . . . 1.0 109.508 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 75.8 mt -92.34 137.51 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 N-CA-C 108.975 -0.75 . . . . 1.0 108.975 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.613 ' HG1' ' N ' ' A' ' 32' ' ' GLU . 51.9 p -102.41 -43.93 5.52 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 116.13 -0.486 . . . . 1.0 111.216 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.613 ' N ' ' HG1' ' A' ' 31' ' ' THR . 73.0 tt0 -153.72 163.09 40.59 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.337 0.589 . . . . 1.0 111.176 -178.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 16.9 tt -149.61 142.56 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-N 115.906 -0.588 . . . . 1.0 110.028 179.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 28.3 t70 50.19 19.99 0.58 Allowed 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 120.994 0.426 . . . . 1.0 111.74 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.95 19.64 77.21 Favored Glycine 0 N--CA 1.47 0.955 0 N-CA-C 111.919 -0.472 . . . . 1.0 111.919 178.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -149.65 168.96 22.13 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 122.473 -0.427 . . . . 1.0 110.329 -179.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 81.52 112.44 0.06 Allowed 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.388 -0.823 . . . . 1.0 109.819 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.443 ' CD1' ' N ' ' A' ' 38' ' ' PHE . 0.5 OUTLIER -86.95 -152.99 0.2 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.901 0.382 . . . . 1.0 110.118 -179.068 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.414 ' O ' ' C ' ' A' ' 40' ' ' SER . 31.6 ttmt -59.63 -59.24 5.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.029 -0.532 . . . . 1.0 111.779 -178.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.459 ' HG ' ' H ' ' A' ' 43' ' ' GLU . 30.6 t -27.28 117.07 0.08 Allowed 'General case' 0 N--CA 1.481 1.089 0 O-C-N 124.304 1.002 . . . . 1.0 111.128 -178.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 78.0 p -61.93 -48.65 79.47 Favored 'General case' 0 CA--C 1.513 -0.468 0 N-CA-C 109.404 -0.591 . . . . 1.0 109.404 -178.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 69.3 tp60 -51.43 -38.52 54.03 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.046 -0.525 . . . . 1.0 110.345 -178.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.459 ' H ' ' HG ' ' A' ' 40' ' ' SER . 50.8 tp10 -65.31 -32.64 74.39 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.347 -0.612 . . . . 1.0 109.347 179.044 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 27.8 t80 -72.11 -50.23 29.74 Favored 'General case' 0 C--O 1.219 -0.523 0 CA-C-N 116.337 -0.392 . . . . 1.0 110.204 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.7 mp -59.92 -37.18 70.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 109.247 -0.649 . . . . 1.0 109.247 179.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -60.49 -35.69 76.52 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.652 -0.704 . . . . 1.0 110.408 -178.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 44.4 t80 -68.08 -48.89 64.29 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.213 -0.449 . . . . 1.0 111.621 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 33.6 mt -52.78 -34.28 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-O 120.906 0.384 . . . . 1.0 110.427 -176.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 45.3 m170 -85.9 -22.54 27.43 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.036 -0.529 . . . . 1.0 111.121 -179.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 71.7 p -70.87 -17.98 62.71 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.645 -0.252 . . . . 1.0 111.269 -178.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 18.4 mmmt -90.48 -171.61 3.13 Favored 'General case' 0 CA--C 1.512 -0.492 0 N-CA-C 110.054 -0.35 . . . . 1.0 110.054 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -128.37 168.58 15.36 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 123.618 0.574 . . . . 1.0 110.148 -178.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 25.9 t -70.86 134.99 29.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.448 -0.796 . . . . 1.0 110.946 -178.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 90.31 -4.52 82.68 Favored Glycine 0 N--CA 1.47 0.938 0 N-CA-C 110.637 -0.985 . . . . 1.0 110.637 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -70.34 147.09 50.02 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 110.09 -0.337 . . . . 1.0 110.09 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 23.1 m -105.1 139.29 40.0 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 109.363 -0.606 . . . . 1.0 109.363 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 34.5 m -138.27 164.45 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 CA-C-N 116.12 -0.491 . . . . 1.0 111.535 -179.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.83 117.88 27.6 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 115.065 -0.971 . . . . 1.0 108.972 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.9 tt -97.72 141.79 15.39 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.201 0 O-C-N 123.314 0.384 . . . . 1.0 111.343 -178.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -121.43 119.91 33.43 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 107.721 -1.214 . . . . 1.0 107.721 178.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 18.7 p90 -147.75 161.26 41.59 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 110.065 -0.346 . . . . 1.0 110.065 -179.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 26.1 mtmm -128.27 117.84 22.22 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 123.464 0.477 . . . . 1.0 110.677 179.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.626 ' CD2' ' HE2' ' A' ' 25' ' ' HIS . 17.2 t-80 -107.64 112.15 24.73 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 108.37 -0.974 . . . . 1.0 108.37 178.105 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 73.19 -118.34 6.27 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.944 -0.862 . . . . 1.0 110.944 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 68.0 m-80 -115.95 14.04 16.07 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 122.704 0.401 . . . . 1.0 111.802 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -126.28 119.79 28.29 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 120.82 0.343 . . . . 1.0 110.938 -179.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 61.3 t-20 -84.74 133.16 34.37 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-N 116.116 -0.493 . . . . 1.0 109.845 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -128.67 161.34 29.9 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 115.228 -0.897 . . . . 1.0 110.015 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -141.08 139.79 34.1 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 115.454 -0.794 . . . . 1.0 110.149 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -150.65 161.48 42.51 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 115.664 -0.698 . . . . 1.0 110.493 -178.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 91.0 p -128.27 138.28 52.35 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 109.096 -0.705 . . . . 1.0 109.096 179.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.482 ' CD1' ' N ' ' A' ' 72' ' ' ILE . 0.1 OUTLIER -138.22 147.27 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-O 121.491 0.662 . . . . 1.0 110.535 -178.189 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 7.8 ttpm? -86.57 135.21 33.52 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.387 -0.824 . . . . 1.0 109.846 179.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -68.98 147.58 51.4 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.151 0.5 . . . . 1.0 110.498 179.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 18.6 p -141.17 168.61 19.36 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 115.187 -0.915 . . . . 1.0 110.659 -179.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -80.25 148.34 30.83 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.192 -0.913 . . . . 1.0 109.887 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.461 HG13 ' H ' ' A' ' 78' ' ' ASP . 1.6 pt -128.89 -55.92 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 CA-C-N 115.996 -0.547 . . . . 1.0 110.782 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.461 ' H ' HG13 ' A' ' 77' ' ' ILE . 68.5 m-20 -96.33 165.81 12.02 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 121.466 0.65 . . . . 1.0 110.987 -178.077 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 24.1 pttm -57.03 -18.5 14.2 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.685 -1.143 . . . . 1.0 111.502 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -81.54 -13.95 57.46 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 116.834 -0.166 . . . . 1.0 111.351 -179.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 77.72 30.75 51.84 Favored Glycine 0 N--CA 1.469 0.897 0 N-CA-C 111.366 -0.694 . . . . 1.0 111.366 179.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 85.8 m -79.26 125.51 83.16 Favored Pre-proline 0 CA--C 1.546 0.797 0 C-N-CA 120.455 -0.498 . . . . 1.0 109.761 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_exo -50.73 128.97 25.73 Favored 'Trans proline' 0 N--CA 1.501 1.914 0 C-N-CA 121.595 1.53 . . . . 1.0 112.553 178.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -152.14 130.07 2.98 Favored Glycine 0 N--CA 1.468 0.809 0 N-CA-C 111.078 -0.809 . . . . 1.0 111.078 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 96.1 mt -59.68 -25.52 32.15 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 N-CA-C 110.47 -0.196 . . . . 1.0 110.47 179.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 100.01 46.69 1.86 Allowed Glycine 0 N--CA 1.481 1.659 0 N-CA-C 111.211 -0.755 . . . . 1.0 111.211 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.1 pp -146.93 164.98 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 N-CA-C 109.67 -0.492 . . . . 1.0 109.67 -178.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 15.9 m -128.76 121.94 29.5 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 115.408 -0.814 . . . . 1.0 110.584 178.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.524 ' CD2' ' N ' ' A' ' 89' ' ' LEU . 0.4 OUTLIER -99.73 139.37 35.49 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.389 0.676 . . . . 1.0 109.759 -179.861 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 9.1 m -107.38 177.41 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 114.884 -1.053 . . . . 1.0 109.424 -179.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 64.75 42.05 4.8 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 124.433 1.083 . . . . 1.0 110.325 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 48.0 p30 -92.5 175.7 6.73 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 115.942 -0.572 . . . . 1.0 110.539 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 60.1 mt -64.38 -39.41 93.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.561 -0.745 . . . . 1.0 110.944 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -64.25 149.23 48.42 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.079 -0.509 . . . . 1.0 109.653 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -88.16 -6.83 57.65 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.464 -0.335 . . . . 1.0 110.815 -179.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 55.0 t-80 57.11 115.14 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.352 0 O-C-N 123.519 0.512 . . . . 1.0 110.924 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 85.1 t60 53.3 87.52 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.303 -0.408 . . . . 1.0 111.124 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 40.5 p-80 -68.87 165.29 20.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.19 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 39.9 p-80 -156.78 160.07 38.89 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.238 0.542 . . . . 1.0 111.303 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 83.8 t60 . . . . . 0 C--O 1.22 -0.474 0 CA-C-O 117.961 -1.019 . . . . 1.0 109.104 178.924 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.491 ' SD ' ' N ' ' A' ' 1' ' ' MET . 2.0 mpt? . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 108.902 -0.777 . . . . 1.0 108.902 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 18.8 t 55.42 74.44 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-N 116.259 -0.428 . . . . 1.0 110.565 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -65.2 -35.55 81.42 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.325 -0.398 . . . . 1.0 110.842 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 35.7 m -62.52 145.32 13.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.934 -0.575 . . . . 1.0 110.727 -179.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 23.9 m -61.96 -50.28 72.74 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.229 -0.441 . . . . 1.0 111.324 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 71.1 t80 55.4 104.2 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 120.829 0.347 . . . . 1.0 110.638 -179.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 34.0 t0 -169.4 111.25 0.48 Allowed 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.544 -0.539 . . . . 1.0 109.544 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -77.53 -161.33 14.76 Favored Glycine 0 N--CA 1.464 0.521 0 N-CA-C 110.243 -1.143 . . . . 1.0 110.243 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.6 t -111.93 129.65 67.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 N-CA-C 109.722 -0.473 . . . . 1.0 109.722 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -85.87 141.65 29.44 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.385 -0.598 . . . . 1.0 109.385 -178.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.6 t -100.45 136.0 33.84 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.31 0 CA-C-N 115.121 -0.945 . . . . 1.0 109.521 179.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 42.3 tp -89.72 -51.84 5.31 Favored 'General case' 0 N--CA 1.458 -0.071 0 CA-C-N 116.052 -0.522 . . . . 1.0 110.778 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 44.4 m -158.6 151.86 22.8 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.285 0.564 . . . . 1.0 110.845 -178.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.4 p -137.42 135.2 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-N 114.821 -1.081 . . . . 1.0 109.623 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -71.28 152.92 42.8 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.93 -0.767 . . . . 1.0 108.93 178.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -96.14 15.3 21.22 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 116.778 -0.192 . . . . 1.0 111.377 -178.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -133.77 41.62 3.01 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 109.132 -0.692 . . . . 1.0 109.132 179.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 8.7 m -141.31 153.13 65.87 Favored Pre-proline 0 CA--C 1.542 0.66 0 CA-C-N 115.786 -0.643 . . . . 1.0 110.0 -179.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -45.1 -30.85 5.17 Favored 'Trans proline' 0 N--CA 1.496 1.633 0 C-N-CA 122.178 1.919 . . . . 1.0 113.109 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.79 -23.82 67.43 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.059 0.457 . . . . 1.0 110.314 -178.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.0 107.44 1.25 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.81 -0.632 . . . . 1.0 110.144 179.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 108.05 -4.62 33.84 Favored Glycine 0 N--CA 1.476 1.304 0 N-CA-C 111.317 -0.713 . . . . 1.0 111.317 -179.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.3 mp -117.19 -50.15 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 122.461 0.304 . . . . 1.0 110.787 179.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 12.1 mt -112.03 150.46 30.6 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 121.242 0.544 . . . . 1.0 110.314 -179.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 -145.46 158.55 43.82 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.293 -0.867 . . . . 1.0 110.852 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.41 124.64 20.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.46 -0.791 . . . . 1.0 110.276 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 99.64 -4.44 58.02 Favored Glycine 0 N--CA 1.471 1.028 0 N-CA-C 111.129 -0.788 . . . . 1.0 111.129 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -74.96 141.94 43.98 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.979 0.39 . . . . 1.0 110.038 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 25.6 mt -115.96 121.13 41.36 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 109.958 -0.386 . . . . 1.0 109.958 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 62.4 mt -91.69 135.94 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 N-CA-C 107.883 -1.154 . . . . 1.0 107.883 178.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 3.0 p -123.72 -23.3 4.74 Favored 'General case' 0 N--CA 1.479 0.978 0 O-C-N 123.416 0.447 . . . . 1.0 111.408 -178.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 59.1 tt0 -152.27 147.21 26.09 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 120.924 -0.311 . . . . 1.0 110.536 -178.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.467 ' O ' ' N ' ' A' ' 35' ' ' GLY . 4.1 mp -135.89 137.11 49.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 N-CA-C 108.742 -0.836 . . . . 1.0 108.742 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 42.73 17.29 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 122.893 0.477 . . . . 1.0 112.118 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 33' ' ' ILE . . . 64.29 17.89 62.28 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 111.493 -0.643 . . . . 1.0 111.493 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.445 ' OE1' ' CE1' ' A' ' 47' ' ' TYR . 12.0 pt20 -82.96 166.48 18.81 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 122.532 -0.393 . . . . 1.0 111.81 -178.545 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 49.4 m -83.75 161.7 20.91 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.848 -0.615 . . . . 1.0 109.842 178.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.437 ' CE2' ' O ' ' A' ' 36' ' ' GLN . 1.3 p90 -172.59 -174.63 1.19 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.457 -0.792 . . . . 1.0 109.437 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -141.75 -68.76 0.38 Allowed 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.869 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 44.2 m -98.29 165.63 11.78 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.176 0.512 . . . . 1.0 110.486 -179.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 78.4 p -60.58 -29.82 69.42 Favored 'General case' 0 C--O 1.215 -0.717 0 N-CA-C 109.312 -0.625 . . . . 1.0 109.312 178.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -64.17 -30.71 71.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.925 -0.579 . . . . 1.0 110.741 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -60.33 -26.94 66.96 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.775 0.322 . . . . 1.0 110.444 -178.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -72.28 -51.13 22.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.997 0.427 . . . . 1.0 110.233 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.7 mp -57.39 -28.77 31.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 108.979 -0.749 . . . . 1.0 108.979 -179.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -70.64 -33.77 71.35 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.487 -0.779 . . . . 1.0 110.808 -178.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.445 ' CE1' ' OE1' ' A' ' 36' ' ' GLN . 84.0 t80 -69.48 -52.21 28.7 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 120.69 -0.404 . . . . 1.0 111.888 -178.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -67.08 -39.62 83.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-N 116.257 -0.428 . . . . 1.0 109.996 -178.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 81.0 t60 -59.59 -13.73 10.55 Favored 'General case' 0 CA--C 1.503 -0.838 0 CA-C-N 116.25 -0.432 . . . . 1.0 111.088 -178.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.47 ' HG ' ' H ' ' A' ' 51' ' ' LYS . 21.6 t -96.74 -142.68 0.28 Allowed 'General case' 0 N--CA 1.434 -1.251 0 CA-C-O 122.008 0.909 . . . . 1.0 109.042 178.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.47 ' H ' ' HG ' ' A' ' 50' ' ' SER . 30.1 mmtp 48.2 -169.84 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 114.26 -1.336 . . . . 1.0 110.049 -177.353 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -131.58 154.89 48.38 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.121 0.486 . . . . 1.0 110.319 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.6 t -59.88 142.57 15.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.578 -0.737 . . . . 1.0 111.03 -179.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 102.17 -20.45 45.15 Favored Glycine 0 N--CA 1.474 1.189 0 N-CA-C 110.596 -1.002 . . . . 1.0 110.596 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 -62.0 -174.13 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.794 0.331 . . . . 1.0 110.525 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.9 t -148.9 145.51 27.46 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 109.623 -0.51 . . . . 1.0 109.623 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 23.0 m -140.66 165.82 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 CA-C-O 121.116 0.484 . . . . 1.0 111.442 -178.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -119.68 120.03 35.44 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 114.877 -1.056 . . . . 1.0 108.385 178.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.5 tt -103.82 147.3 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 123.026 0.53 . . . . 1.0 110.907 -178.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 33.3 ttmt -131.02 117.27 18.93 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 108.207 -1.034 . . . . 1.0 108.207 177.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 26.1 p90 -136.49 165.33 26.1 Favored 'General case' 0 C--N 1.34 0.195 0 CA-C-N 115.92 -0.582 . . . . 1.0 110.581 -177.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.566 ' HZ1' ' ND2' ' A' ' 67' ' ' ASN . 67.5 mttm -121.17 139.25 53.61 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.308 -0.86 . . . . 1.0 110.466 -179.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 80.2 t60 -130.64 101.23 5.6 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.756 -0.656 . . . . 1.0 109.336 178.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 60.98 -110.41 3.03 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 110.702 -0.959 . . . . 1.0 110.702 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -112.82 13.72 19.76 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 122.578 0.351 . . . . 1.0 111.396 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 7.6 ttpm? -130.39 116.18 17.91 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 116.636 -0.256 . . . . 1.0 110.546 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.566 ' ND2' ' HZ1' ' A' ' 62' ' ' LYS . 41.5 m-20 -100.85 135.77 41.76 Favored 'General case' 0 C--N 1.341 0.236 0 N-CA-C 109.722 -0.473 . . . . 1.0 109.722 179.465 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -135.47 166.56 22.9 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 109.303 -0.628 . . . . 1.0 109.303 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.418 ' N ' ' CD ' ' A' ' 69' ' ' GLU . 3.0 pm0 -141.24 140.45 33.93 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.706 -0.679 . . . . 1.0 110.574 -179.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.92 154.63 38.61 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.794 -0.639 . . . . 1.0 110.681 -178.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 29.6 m -115.86 139.76 49.89 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 115.181 -0.918 . . . . 1.0 109.352 179.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -136.59 146.86 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-O 121.384 0.612 . . . . 1.0 110.469 -178.089 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -82.39 138.74 34.37 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.201 -0.908 . . . . 1.0 109.576 179.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.417 ' N ' ' CD2' ' A' ' 74' ' ' LEU . 4.1 mm? -67.24 146.45 54.16 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.442 0.639 . . . . 1.0 110.874 -179.356 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 45.4 p -140.91 160.1 40.8 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.052 -0.976 . . . . 1.0 110.796 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -80.32 131.71 35.69 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.346 -0.843 . . . . 1.0 109.537 179.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 10.7 pt -122.68 -44.98 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 122.677 0.391 . . . . 1.0 111.05 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.401 ' OD2' ' NZ ' ' A' ' 80' ' ' LYS . 30.6 t70 -99.81 156.98 16.82 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 121.636 0.732 . . . . 1.0 110.908 -179.118 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 10.3 mmpt? -48.44 -32.3 7.52 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.647 -1.161 . . . . 1.0 111.759 -179.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.401 ' NZ ' ' OD2' ' A' ' 78' ' ' ASP . 29.2 mtmm -82.72 12.42 4.76 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.415 -0.357 . . . . 1.0 111.375 -178.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 56.12 47.32 81.8 Favored Glycine 0 C--N 1.334 0.422 0 N-CA-C 111.635 -0.586 . . . . 1.0 111.635 178.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 86.5 m -79.87 120.37 79.71 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 120.491 -0.484 . . . . 1.0 110.471 -179.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -56.03 132.36 51.51 Favored 'Trans proline' 0 N--CA 1.498 1.787 0 C-N-CA 121.703 1.602 . . . . 1.0 111.738 177.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 154.98 179.41 30.14 Favored Glycine 0 N--CA 1.468 0.774 0 N-CA-C 110.62 -0.992 . . . . 1.0 110.62 178.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -103.92 -177.57 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 N-CA-C 109.037 -0.727 . . . . 1.0 109.037 -179.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -103.84 78.61 0.29 Allowed Glycine 0 C--N 1.339 0.699 0 N-CA-C 110.667 -0.973 . . . . 1.0 110.667 -179.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 49.7 pt -138.08 163.4 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 C-N-CA 122.796 0.438 . . . . 1.0 109.988 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 84.8 m -130.13 128.04 41.0 Favored 'General case' 0 N--CA 1.478 0.948 0 O-C-N 123.72 0.637 . . . . 1.0 109.777 177.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 54.1 mt -110.42 146.16 36.34 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 123.183 0.593 . . . . 1.0 110.153 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 33.7 m -107.05 171.57 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-N 115.606 -0.724 . . . . 1.0 110.176 -179.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -163.19 32.98 0.09 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.733 -0.667 . . . . 1.0 110.452 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.49 ' C ' ' H ' ' A' ' 94' ' ' GLU . 29.6 t0 58.09 164.4 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.752 -0.658 . . . . 1.0 110.814 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 37.6 mt 57.77 4.18 0.25 Allowed 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.281 -0.418 . . . . 1.0 111.049 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.49 ' H ' ' C ' ' A' ' 92' ' ' ASP . 48.3 tp10 -78.09 -36.57 47.99 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 116.308 -0.405 . . . . 1.0 110.378 -179.341 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 61.7 t-80 -87.78 -19.95 26.81 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.576 0.227 . . . . 1.0 110.712 -178.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 34.5 m-70 -70.18 -71.1 0.25 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.77 0.319 . . . . 1.0 110.44 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -78.66 161.37 26.97 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.275 -0.42 . . . . 1.0 110.671 -179.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 80.8 t60 -162.27 52.66 0.21 Allowed 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.139 -0.482 . . . . 1.0 110.053 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 41.2 m170 -66.18 -40.21 90.31 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.917 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 41.7 p-80 . . . . . 0 C--O 1.218 -0.557 0 CA-C-O 117.795 -1.097 . . . . 1.0 109.443 179.767 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.2 ptt? . . . . . 0 N--CA 1.492 1.66 0 N-CA-C 108.958 -0.756 . . . . 1.0 108.958 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.6 p -61.9 -29.62 46.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.956 -0.565 . . . . 1.0 110.387 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 50.3 mtmt -61.19 109.96 1.26 Allowed 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.258 -0.428 . . . . 1.0 110.47 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 10.2 p -64.38 147.23 12.55 Favored 'Isoleucine or valine' 0 C--O 1.232 0.158 0 CA-C-N 116.45 -0.341 . . . . 1.0 110.233 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 33.4 m -152.27 -50.54 0.11 Allowed 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 116.274 -0.421 . . . . 1.0 109.961 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -66.72 145.19 55.81 Favored 'General case' 0 N--CA 1.463 0.184 0 N-CA-C 109.957 -0.386 . . . . 1.0 109.957 179.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -135.48 -33.41 0.88 Allowed 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 116.247 -0.433 . . . . 1.0 110.054 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 42.73 -146.38 0.82 Allowed Glycine 0 N--CA 1.473 1.132 0 N-CA-C 111.294 -0.722 . . . . 1.0 111.294 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.9 t -135.23 127.53 47.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 N-CA-C 108.628 -0.879 . . . . 1.0 108.628 178.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -102.08 132.69 47.79 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 121.256 0.55 . . . . 1.0 110.255 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 61.2 t -76.87 132.1 33.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 N-CA-C 108.152 -1.055 . . . . 1.0 108.152 179.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.7 tt -76.14 -51.66 11.71 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-O 121.558 0.694 . . . . 1.0 110.71 -178.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 92.4 p -155.75 153.05 29.29 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.641 -0.709 . . . . 1.0 111.253 -179.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 51.7 t -136.84 113.77 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 108.706 -0.85 . . . . 1.0 108.706 178.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 34.3 mtmm -70.87 163.62 27.0 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 109.662 -0.496 . . . . 1.0 109.662 179.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 28.8 mp0 -98.83 46.36 0.99 Allowed 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 116.402 -0.363 . . . . 1.0 111.199 -179.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -158.36 35.15 0.24 Allowed 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 109.96 -0.385 . . . . 1.0 109.96 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 15.8 m -142.49 157.45 62.46 Favored Pre-proline 0 N--CA 1.481 1.09 0 N-CA-C 108.847 -0.797 . . . . 1.0 108.847 -179.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -45.8 -37.96 17.09 Favored 'Trans proline' 0 N--CA 1.507 2.31 0 CA-C-N 121.049 1.41 . . . . 1.0 112.807 179.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.26 -15.63 60.48 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.159 -0.473 . . . . 1.0 111.589 -179.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.95 139.41 46.74 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-O 121.195 0.521 . . . . 1.0 111.499 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 79.69 -11.13 34.82 Favored Glycine 0 N--CA 1.463 0.469 0 CA-C-N 115.352 -0.84 . . . . 1.0 111.94 176.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 67.2 mt -115.2 -50.85 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 N-CA-C 109.88 -0.415 . . . . 1.0 109.88 -178.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 15.0 mt -107.36 134.36 50.53 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 115.756 -0.656 . . . . 1.0 110.032 -179.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -110.84 132.7 53.98 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.784 -0.644 . . . . 1.0 109.525 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -47.64 137.14 9.56 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 120.751 0.31 . . . . 1.0 111.606 -178.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 94.93 -3.3 67.16 Favored Glycine 0 N--CA 1.471 0.969 0 N-CA-C 111.039 -0.824 . . . . 1.0 111.039 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -65.18 123.72 20.27 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 120.912 0.387 . . . . 1.0 110.545 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 37.8 tp -88.16 131.5 34.7 Favored 'General case' 0 C--O 1.208 -1.087 0 CA-C-O 118.085 -0.959 . . . . 1.0 109.024 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 18.3 mm -87.96 125.4 41.45 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 119.485 1.039 . . . . 1.0 108.988 178.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 82.0 p -97.03 -36.26 10.57 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 122.449 0.3 . . . . 1.0 111.223 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -153.5 149.5 27.77 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 109.867 -0.42 . . . . 1.0 109.867 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -147.17 139.67 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 N-CA-C 107.84 -1.17 . . . . 1.0 107.84 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 36.1 t70 47.79 22.05 0.32 Allowed 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 112.139 0.422 . . . . 1.0 112.139 178.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.34 -8.0 54.9 Favored Glycine 0 CA--C 1.529 0.92 0 N-CA-C 111.411 -0.675 . . . . 1.0 111.411 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -87.84 159.39 18.42 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 110.016 -0.364 . . . . 1.0 110.016 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.523 ' HG ' ' H ' ' A' ' 38' ' ' PHE . 81.2 p -97.92 -93.6 0.23 Allowed 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 116.308 -0.406 . . . . 1.0 111.42 -179.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.523 ' H ' ' HG ' ' A' ' 37' ' ' SER . 73.9 m-85 59.2 139.95 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 122.822 0.449 . . . . 1.0 110.863 -178.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -132.46 85.35 2.22 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-O 121.085 0.469 . . . . 1.0 110.26 -179.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.1 p 176.52 156.07 0.25 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.622 -1.172 . . . . 1.0 109.368 178.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 79.8 p -77.72 -51.78 10.01 Favored 'General case' 0 C--O 1.223 -0.293 0 CA-C-N 116.4 -0.364 . . . . 1.0 110.189 179.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -52.16 -42.38 63.36 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 122.099 -0.376 . . . . 1.0 111.27 -177.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -66.57 -31.34 71.98 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.218 -0.66 . . . . 1.0 109.218 178.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -73.98 -48.97 26.62 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.773 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.8 mp -55.6 -33.94 34.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 N-CA-C 108.319 -0.993 . . . . 1.0 108.319 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -64.4 -38.57 91.48 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.809 -0.632 . . . . 1.0 111.471 -179.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 77.3 t80 -67.57 -52.1 42.63 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 120.748 -0.381 . . . . 1.0 111.653 -178.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -67.78 -44.35 85.7 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 CA-C-O 120.553 0.216 . . . . 1.0 110.714 -179.321 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 63.8 t-80 -65.0 -16.94 64.0 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.668 -0.242 . . . . 1.0 111.365 -178.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 90.2 p -104.97 -4.2 22.36 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 122.319 0.248 . . . . 1.0 111.329 -178.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 14.3 tptp -87.54 135.67 33.25 Favored 'General case' 0 C--O 1.211 -0.95 0 N-CA-C 108.711 -0.848 . . . . 1.0 108.711 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -69.03 153.55 43.59 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 111.884 0.327 . . . . 1.0 111.884 -178.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.6 t -64.74 141.12 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-N 116.388 -0.369 . . . . 1.0 110.931 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 89.95 -23.74 19.05 Favored Glycine 0 N--CA 1.469 0.865 0 CA-C-N 116.011 -0.54 . . . . 1.0 111.963 177.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -53.7 151.9 5.76 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-N 117.354 0.577 . . . . 1.0 111.377 -178.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.0 m -104.96 128.63 53.32 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 121.376 0.607 . . . . 1.0 110.075 179.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 30.7 m -117.61 171.62 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 124.383 1.073 . . . . 1.0 109.829 -178.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 18.1 ttmm -125.43 113.9 18.13 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 107.376 -1.342 . . . . 1.0 107.376 178.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.6 tp -97.55 141.9 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 122.643 0.377 . . . . 1.0 110.53 -178.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.11 112.24 10.99 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 107.379 -1.341 . . . . 1.0 107.379 177.218 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 24.5 p90 -144.77 160.89 40.52 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 110.36 -0.237 . . . . 1.0 110.36 -178.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -134.76 136.9 42.97 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 109.154 -0.684 . . . . 1.0 109.154 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 61.6 t-80 -128.42 126.43 40.56 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 107.835 -1.172 . . . . 1.0 107.835 178.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 62.82 -117.18 10.66 Favored Glycine 0 CA--C 1.531 1.041 0 N-CA-C 110.65 -0.98 . . . . 1.0 110.65 -179.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -113.47 -21.58 10.78 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 122.845 0.458 . . . . 1.0 110.856 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -90.89 123.31 34.31 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 121.593 0.711 . . . . 1.0 111.598 -178.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 57.4 m-20 -92.96 135.94 33.71 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 109.446 -0.575 . . . . 1.0 109.446 -179.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 64.7 mt-10 -137.76 142.1 40.93 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 109.98 -0.378 . . . . 1.0 109.98 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -140.66 138.23 34.15 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 110.067 -0.346 . . . . 1.0 110.067 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -151.16 147.43 27.03 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-O 121.547 0.689 . . . . 1.0 112.778 -177.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 90.6 p -90.97 127.87 36.58 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 109.485 -0.561 . . . . 1.0 109.485 177.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.4 mp -130.44 129.06 64.48 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 N-CA-C 108.772 -0.825 . . . . 1.0 108.772 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 5.4 ptpt -81.38 142.92 32.56 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 122.023 -0.423 . . . . 1.0 110.517 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -61.32 145.14 52.46 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 109.936 -0.394 . . . . 1.0 109.936 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 72.3 p -134.82 155.1 51.22 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 115.972 -0.558 . . . . 1.0 110.259 178.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -79.93 122.28 26.5 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 108.752 -0.833 . . . . 1.0 108.752 178.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.497 ' CD1' ' H ' ' A' ' 77' ' ' ILE . 0.1 OUTLIER -118.07 -14.19 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 C-N-CA 122.597 0.359 . . . . 1.0 111.689 -178.714 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -120.02 145.72 46.56 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.052 0.453 . . . . 1.0 110.347 -179.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 24.0 pttm -47.72 -27.16 1.84 Allowed 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 115.658 -0.701 . . . . 1.0 112.343 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 14.4 pttm -81.29 -16.3 52.91 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-O 120.751 0.31 . . . . 1.0 110.343 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 81.81 50.56 4.89 Favored Glycine 0 N--CA 1.468 0.826 0 N-CA-C 111.891 -0.483 . . . . 1.0 111.891 179.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 32.4 m -81.68 119.42 75.37 Favored Pre-proline 0 CA--C 1.549 0.917 0 CA-C-O 118.915 -0.564 . . . . 1.0 110.062 179.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_exo -53.09 118.32 4.69 Favored 'Trans proline' 0 N--CA 1.505 2.165 0 CA-C-N 120.744 1.301 . . . . 1.0 111.369 177.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 173.1 -174.74 46.0 Favored Glycine 0 N--CA 1.469 0.866 0 C-N-CA 120.581 -0.818 . . . . 1.0 112.676 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -116.48 170.79 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 N-CA-C 107.258 -1.386 . . . . 1.0 107.258 178.491 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -90.91 42.67 2.87 Favored Glycine 0 N--CA 1.475 1.262 0 CA-C-N 118.1 0.409 . . . . 1.0 112.479 -177.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 48.8 pt -111.68 176.09 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 122.405 0.282 . . . . 1.0 110.341 -178.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 62.9 m -132.33 130.18 40.44 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 115.805 -0.634 . . . . 1.0 109.844 178.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 69.1 mt -104.65 143.54 32.94 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.022 0.529 . . . . 1.0 109.927 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.1 m -103.88 178.24 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 C-N-CA 123.379 0.672 . . . . 1.0 111.333 -177.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.3 t70 88.56 -27.16 0.06 Allowed 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 114.336 -1.302 . . . . 1.0 109.428 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 42.4 p30 -54.45 176.21 0.04 OUTLIER 'General case' 0 CA--C 1.529 0.164 0 CA-C-O 121.054 0.454 . . . . 1.0 111.388 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 46.4 mt -67.5 -40.41 85.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.606 -0.725 . . . . 1.0 110.336 179.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -65.83 100.86 0.59 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.318 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 20.5 p80 -88.87 -18.74 26.97 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.484 -0.325 . . . . 1.0 110.621 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 21.1 p80 -68.62 147.17 52.3 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.315 -0.402 . . . . 1.0 110.522 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -161.0 9.95 0.09 Allowed 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.412 -0.358 . . . . 1.0 110.555 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 84.8 t60 53.69 89.39 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.308 -0.406 . . . . 1.0 111.127 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 61.4 m80 54.33 -179.5 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.097 -0.502 . . . . 1.0 111.192 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 60.3 t-80 . . . . . 0 C--O 1.221 -0.435 0 CA-C-O 117.975 -1.012 . . . . 1.0 110.397 179.949 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.451 ' H1 ' ' H ' ' A' ' 2' ' ' VAL . 24.1 mmt . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.306 -0.628 . . . . 1.0 109.306 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.451 ' H ' ' H1 ' ' A' ' 1' ' ' MET . 8.2 p -168.47 -27.97 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 CA-C-N 116.351 -0.386 . . . . 1.0 110.443 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -70.27 4.86 1.97 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.616 0.246 . . . . 1.0 110.613 -179.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.414 ' H ' ' C ' ' A' ' 2' ' ' VAL . 25.2 t 55.16 83.58 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-N 116.491 -0.322 . . . . 1.0 110.38 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 25.6 m -61.76 -48.24 81.55 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.53 -0.304 . . . . 1.0 111.098 -179.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -119.19 -92.58 0.53 Allowed 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 122.866 0.466 . . . . 1.0 110.428 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.474 ' CG ' ' H ' ' A' ' 8' ' ' GLY . 9.6 p30 -177.03 -99.24 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 109.798 -0.445 . . . . 1.0 109.798 -179.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.474 ' H ' ' CG ' ' A' ' 7' ' ' ASP . . . 178.61 -159.31 24.41 Favored Glycine 0 CA--C 1.519 0.332 0 N-CA-C 109.86 -1.296 . . . . 1.0 109.86 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.7 m -111.54 128.39 68.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 N-CA-C 109.125 -0.695 . . . . 1.0 109.125 179.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.471 ' N ' ' O ' ' A' ' 90' ' ' VAL . 11.5 m-85 -88.45 132.23 34.56 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 121.329 0.585 . . . . 1.0 109.527 -178.015 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 83.7 t -76.46 134.54 28.69 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.227 0 N-CA-C 107.337 -1.357 . . . . 1.0 107.337 179.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.52 -51.57 6.1 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.578 0.227 . . . . 1.0 110.707 -178.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 40.2 t -154.03 150.68 28.5 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.004 0.431 . . . . 1.0 111.003 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 46.7 t -110.56 113.22 43.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-N 115.191 -0.913 . . . . 1.0 108.952 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.407 ' O ' ' O ' ' A' ' 16' ' ' GLU . 62.5 mttp -86.37 92.19 8.74 Favored 'General case' 0 C--O 1.221 -0.411 0 N-CA-C 108.384 -0.969 . . . . 1.0 108.384 179.327 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.409 ' N ' ' CD ' ' A' ' 16' ' ' GLU . 3.3 pm0 -44.77 -179.24 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.489 0 O-C-N 124.073 0.858 . . . . 1.0 112.689 -178.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 26.7 t70 62.73 30.0 16.78 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.683 -0.69 . . . . 1.0 109.763 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 28.3 m -133.6 157.13 78.72 Favored Pre-proline 0 N--CA 1.484 1.247 0 CA-C-N 115.954 -0.566 . . . . 1.0 110.558 -179.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -49.5 -38.57 44.48 Favored 'Trans proline' 0 N--CA 1.503 2.049 0 C-N-CA 121.253 1.302 . . . . 1.0 112.874 178.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.44 -17.33 62.57 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.505 -0.316 . . . . 1.0 110.929 -178.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.06 118.14 9.4 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 110.352 -0.24 . . . . 1.0 110.352 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 98.83 -3.76 59.0 Favored Glycine 0 N--CA 1.473 1.123 0 N-CA-C 111.604 -0.598 . . . . 1.0 111.604 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 65.1 mt -114.29 -50.48 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 CA-C-N 116.973 0.386 . . . . 1.0 110.247 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 48.1 mt -110.43 151.43 27.5 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.099 0.56 . . . . 1.0 110.114 -179.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.628 ' HE2' ' ND1' ' A' ' 63' ' ' HIS . 18.4 p-80 -143.5 155.1 44.24 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.403 -0.817 . . . . 1.0 110.105 -179.193 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.74 139.14 40.3 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 115.373 -0.831 . . . . 1.0 111.101 -179.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 91.82 -3.48 77.8 Favored Glycine 0 CA--C 1.528 0.889 0 N-CA-C 111.179 -0.769 . . . . 1.0 111.179 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -79.68 126.53 31.05 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 117.148 0.474 . . . . 1.0 110.501 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 17.5 mt -102.54 129.86 49.21 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 109.069 -0.715 . . . . 1.0 109.069 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 30.8 mm -85.17 127.39 39.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 N-CA-C 109.417 -0.586 . . . . 1.0 109.417 179.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 66.4 p -93.12 -42.13 9.56 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 116.599 -0.273 . . . . 1.0 110.708 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 73.1 tt0 -153.71 152.58 30.94 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.694 0.283 . . . . 1.0 110.379 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -137.87 138.53 43.9 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 N-CA-C 108.951 -0.759 . . . . 1.0 108.951 -179.218 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 37.6 t70 46.46 25.85 0.43 Allowed 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.211 0.529 . . . . 1.0 111.732 179.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.94 4.62 49.09 Favored Glycine 0 CA--C 1.527 0.815 0 CA-C-N 115.812 -0.631 . . . . 1.0 111.579 179.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -81.88 130.91 35.22 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 120.999 0.428 . . . . 1.0 110.635 -179.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 98.5 p -61.19 -117.61 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.752 -0.658 . . . . 1.0 111.081 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 56.88 171.55 0.04 OUTLIER 'General case' 0 CA--C 1.52 -0.176 0 CA-C-O 120.768 0.318 . . . . 1.0 110.309 -179.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 32.9 tptt -153.6 -69.43 0.14 Allowed 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 120.918 -0.313 . . . . 1.0 110.266 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 96.0 p -30.47 137.74 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.051 0 O-C-N 123.98 0.8 . . . . 1.0 111.635 -178.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 81.2 p -58.71 -50.8 72.55 Favored 'General case' 0 C--O 1.22 -0.45 0 C-N-CA 120.464 -0.494 . . . . 1.0 110.039 -178.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -48.88 -42.65 37.46 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.462 0.172 . . . . 1.0 111.244 -178.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.1 tp10 -69.79 -32.04 70.29 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.315 -0.624 . . . . 1.0 109.315 178.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -71.29 -49.77 39.42 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.9 0.381 . . . . 1.0 110.75 -179.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 38.4 mm -58.53 -29.07 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 115.516 -0.765 . . . . 1.0 109.639 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -66.92 -35.56 80.27 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.703 -0.681 . . . . 1.0 110.702 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -68.68 -46.91 67.82 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-O 121.223 0.535 . . . . 1.0 111.248 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 42.7 mt -52.66 -41.5 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-N 115.687 -0.688 . . . . 1.0 110.267 -175.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 32.3 m-70 -83.91 -18.97 35.6 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.074 -0.512 . . . . 1.0 111.275 -179.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 24.8 t -63.64 -24.94 68.0 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 111.646 0.239 . . . . 1.0 111.646 -178.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 48.7 mttm -94.23 -174.81 3.48 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 120.961 0.41 . . . . 1.0 110.107 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -130.63 161.58 31.27 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 115.46 -0.791 . . . . 1.0 110.536 -178.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 26.2 t -65.81 138.55 22.85 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-N 115.462 -0.79 . . . . 1.0 111.226 -178.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 99.76 -2.36 57.06 Favored Glycine 0 N--CA 1.477 1.421 0 N-CA-C 110.897 -0.881 . . . . 1.0 110.897 179.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -76.65 -172.8 2.35 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.695 -0.483 . . . . 1.0 109.695 179.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.8 t -148.05 141.13 24.96 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 109.479 -0.563 . . . . 1.0 109.479 179.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 27.7 m -142.3 165.88 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 CA-C-N 116.002 -0.545 . . . . 1.0 111.597 -178.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -118.32 121.94 41.63 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 108.003 -1.11 . . . . 1.0 108.003 178.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 13.2 tt -101.8 143.26 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 122.648 0.379 . . . . 1.0 110.887 -178.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -134.04 118.47 17.82 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 107.549 -1.278 . . . . 1.0 107.549 178.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 49.3 p90 -139.35 161.96 36.17 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-N 116.16 -0.473 . . . . 1.0 109.775 -178.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 7.8 ttpm? -118.77 112.83 20.23 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 123.342 0.401 . . . . 1.0 110.346 179.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.628 ' ND1' ' HE2' ' A' ' 25' ' ' HIS . 34.5 t60 -106.78 107.63 18.73 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 108.012 -1.107 . . . . 1.0 108.012 178.302 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 72.27 -115.99 5.65 Favored Glycine 0 CA--C 1.53 1.015 0 N-CA-C 111.054 -0.818 . . . . 1.0 111.054 -178.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -113.51 1.66 15.1 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 122.983 0.513 . . . . 1.0 111.407 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -124.02 124.29 42.23 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-O 121.48 0.657 . . . . 1.0 111.009 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 38.6 p-10 -101.86 143.19 32.06 Favored 'General case' 0 C--N 1.343 0.324 0 N-CA-C 109.33 -0.618 . . . . 1.0 109.33 179.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 68.5 mt-10 -130.5 167.14 19.13 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 115.542 -0.753 . . . . 1.0 109.285 -179.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 78.6 tt0 -136.0 137.68 41.46 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 109.466 -0.568 . . . . 1.0 109.466 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.11 157.32 43.29 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.56 -0.745 . . . . 1.0 110.394 -178.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 94.9 p -122.14 137.54 54.79 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 108.425 -0.954 . . . . 1.0 108.425 179.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.2 mp -135.93 140.32 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 CA-C-N 116.501 -0.318 . . . . 1.0 110.243 -177.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -80.39 137.51 36.54 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 109.061 -0.718 . . . . 1.0 109.061 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.401 ' N ' ' CD2' ' A' ' 74' ' ' LEU . 3.8 mm? -68.26 144.85 54.72 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.935 -0.575 . . . . 1.0 109.978 -179.329 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 79.8 p -139.08 166.16 25.23 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 115.335 -0.848 . . . . 1.0 109.787 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -94.37 146.46 24.04 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.331 -0.85 . . . . 1.0 109.734 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.431 HD11 ' H ' ' A' ' 78' ' ' ASP . 0.1 OUTLIER -144.92 -30.12 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-N 116.323 -0.399 . . . . 1.0 110.914 179.508 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.431 ' H ' HD11 ' A' ' 77' ' ' ILE . 81.8 m-20 -99.44 151.76 20.75 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 121.238 0.542 . . . . 1.0 110.243 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 10.1 ptpp? -48.72 -27.31 2.83 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.268 -0.878 . . . . 1.0 112.628 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -93.08 11.57 27.18 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 120.634 0.254 . . . . 1.0 111.376 -178.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 56.41 41.51 88.07 Favored Glycine 0 CA--C 1.525 0.665 0 C-N-CA 121.068 -0.587 . . . . 1.0 111.856 178.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 16.8 m -80.54 122.88 82.91 Favored Pre-proline 0 CA--C 1.551 0.998 0 CA-C-O 118.882 -0.58 . . . . 1.0 109.975 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_exo -51.63 126.75 20.52 Favored 'Trans proline' 0 N--CA 1.503 2.032 0 C-N-CA 121.363 1.375 . . . . 1.0 111.226 177.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.575 ' C ' ' H ' ' A' ' 86' ' ' GLY . . . -150.7 -13.59 0.09 OUTLIER Glycine 0 N--CA 1.478 1.473 0 C-N-CA 121.334 -0.46 . . . . 1.0 111.956 -179.024 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 41.4 mt 66.07 -30.05 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 O-C-N 123.782 0.342 . . . . 1.0 111.146 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.575 ' H ' ' C ' ' A' ' 84' ' ' GLY . . . 115.18 37.86 1.08 Allowed Glycine 0 N--CA 1.477 1.369 0 N-CA-C 110.473 -1.051 . . . . 1.0 110.473 -179.393 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 48.4 pt -140.87 163.94 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 122.599 0.36 . . . . 1.0 110.288 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 8.9 t -134.3 129.94 36.29 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.663 -0.699 . . . . 1.0 109.511 178.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.453 ' CD2' ' N ' ' A' ' 89' ' ' LEU . 1.3 mm? -106.36 135.31 48.07 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 108.253 -1.018 . . . . 1.0 108.253 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.471 ' O ' ' N ' ' A' ' 10' ' ' TYR . 52.3 t -154.87 132.67 2.51 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.608 0 N-CA-C 108.395 -0.965 . . . . 1.0 108.395 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -99.27 90.61 4.62 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 109.162 -0.681 . . . . 1.0 109.162 177.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -79.08 106.83 11.4 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 109.577 -0.527 . . . . 1.0 109.577 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 54.6 mt -71.3 70.3 0.58 Allowed 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 116.194 -0.457 . . . . 1.0 111.0 -178.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -154.41 25.64 0.46 Allowed 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 116.356 -0.384 . . . . 1.0 110.697 -179.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . 0.423 ' CD2' ' OH ' ' A' ' 10' ' ' TYR . 57.2 t-80 -87.93 -8.8 55.22 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 110.435 -0.209 . . . . 1.0 110.435 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 33.2 m80 54.35 -170.95 0.05 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.401 -0.363 . . . . 1.0 111.208 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 78.8 m80 -60.13 -41.63 93.08 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.833 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 18.9 t-80 -166.53 -68.98 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.813 0.339 . . . . 1.0 110.115 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 53.15 86.14 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.083 -0.508 . . . . 1.0 110.832 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 81.5 t60 . . . . . 0 C--O 1.219 -0.52 0 CA-C-O 118.046 -0.978 . . . . 1.0 110.927 -179.746 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.1 ttt . . . . . 0 N--CA 1.492 1.662 0 N-CA-C 109.059 -0.719 . . . . 1.0 109.059 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 28.7 t 54.89 100.91 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 CA-C-N 116.339 -0.392 . . . . 1.0 110.485 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -136.3 161.16 36.57 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 109.743 -0.466 . . . . 1.0 109.743 -179.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.1 p -60.26 -36.29 67.61 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-N 115.815 -0.63 . . . . 1.0 110.706 -179.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.5 m -68.93 156.25 38.87 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.193 0.52 . . . . 1.0 109.903 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -76.06 -91.43 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.685 -0.689 . . . . 1.0 109.633 179.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -137.79 -111.56 0.17 Allowed 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 122.684 0.394 . . . . 1.0 110.053 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 154.38 -159.67 29.02 Favored Glycine 0 N--CA 1.466 0.634 0 N-CA-C 109.191 -1.563 . . . . 1.0 109.191 -179.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 12.4 m -129.43 127.42 64.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 N-CA-C 108.789 -0.819 . . . . 1.0 108.789 178.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -91.08 127.85 36.67 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 110.028 -0.36 . . . . 1.0 110.028 -177.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 60.4 t -76.41 135.27 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 N-CA-C 107.142 -1.429 . . . . 1.0 107.142 178.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.8 tt -78.8 -51.11 10.22 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 121.119 0.485 . . . . 1.0 110.139 -178.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 95.3 p -157.37 153.3 27.08 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.036 0.446 . . . . 1.0 110.996 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 58.4 t -111.57 136.26 48.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 CA-C-N 115.419 -0.81 . . . . 1.0 108.972 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -96.41 121.74 38.54 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 108.845 -0.798 . . . . 1.0 108.845 178.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.435 ' N ' ' OE1' ' A' ' 16' ' ' GLU . 14.4 pm0 -85.66 63.28 7.97 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 120.85 0.357 . . . . 1.0 111.399 -178.226 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -163.45 27.18 0.09 Allowed 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.335 0.588 . . . . 1.0 109.568 179.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -143.64 160.61 50.16 Favored Pre-proline 0 N--CA 1.479 0.991 0 N-CA-C 108.85 -0.796 . . . . 1.0 108.85 -177.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -53.87 -25.76 36.72 Favored 'Trans proline' 0 N--CA 1.498 1.757 0 C-N-CA 121.358 1.372 . . . . 1.0 112.463 179.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.23 -12.96 62.13 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 120.724 0.297 . . . . 1.0 110.95 179.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.57 135.08 45.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 1.0 111.775 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.34 -4.36 85.75 Favored Glycine 0 N--CA 1.468 0.783 0 CA-C-N 115.908 -0.587 . . . . 1.0 111.951 178.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 67.6 mt -112.76 -50.48 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 CA-C-N 117.028 0.414 . . . . 1.0 109.957 -179.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 21.4 mt -105.78 150.34 25.64 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 115.834 -0.621 . . . . 1.0 109.981 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 63.7 t-80 -127.98 140.24 52.1 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 115.825 -0.625 . . . . 1.0 110.302 -179.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -49.98 140.73 11.8 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.896 0.379 . . . . 1.0 111.428 -179.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 86.7 -7.11 80.98 Favored Glycine 0 N--CA 1.471 0.986 0 N-CA-C 111.116 -0.794 . . . . 1.0 111.116 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.41 ' OD2' ' CD1' ' A' ' 61' ' ' TYR . 23.3 t0 -65.03 134.06 53.03 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 109.937 -0.394 . . . . 1.0 109.937 179.101 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 5.0 mp -95.65 135.42 37.36 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 108.875 -0.787 . . . . 1.0 108.875 179.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 38.6 mm -93.19 131.07 41.23 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 N-CA-C 108.955 -0.757 . . . . 1.0 108.955 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 54.1 p -85.95 -54.43 4.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.863 -0.608 . . . . 1.0 110.181 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 74.7 tt0 -154.92 160.13 40.93 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 120.851 0.357 . . . . 1.0 110.941 -179.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 20.6 tt -143.54 143.96 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 N-CA-C 108.699 -0.852 . . . . 1.0 108.699 178.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 35.0 t70 46.06 17.59 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 112.24 0.459 . . . . 1.0 112.24 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.52 5.35 49.8 Favored Glycine 0 CA--C 1.529 0.961 0 N-CA-C 111.164 -0.774 . . . . 1.0 111.164 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 21.4 mm100 -142.57 164.55 29.81 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-O 120.826 0.346 . . . . 1.0 110.614 -179.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 10.3 t 61.47 102.82 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.664 -0.698 . . . . 1.0 111.623 179.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -174.56 -17.55 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.71 -0.677 . . . . 1.0 111.79 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -54.39 -55.66 26.46 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.12 0.486 . . . . 1.0 111.141 -178.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 10.7 t -105.14 164.62 11.68 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 115.165 -0.925 . . . . 1.0 110.12 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 11.9 t -73.67 -51.13 17.73 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.106 -0.497 . . . . 1.0 110.718 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -63.44 -39.11 93.61 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.37 -0.377 . . . . 1.0 111.134 -178.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -56.16 -24.2 39.77 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.649 0.262 . . . . 1.0 110.657 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 38.6 t80 -72.36 -46.68 54.35 Favored 'General case' 0 C--O 1.225 -0.236 0 CA-C-O 120.926 0.393 . . . . 1.0 110.305 178.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.7 mp -59.78 -31.37 47.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 N-CA-C 108.788 -0.819 . . . . 1.0 108.788 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -63.58 -37.98 89.38 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 116.104 -0.498 . . . . 1.0 110.613 -179.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -64.49 -43.78 93.06 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.716 0.293 . . . . 1.0 111.297 178.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 38.2 mt -55.43 -42.92 69.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 120.213 -0.595 . . . . 1.0 109.996 -174.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 38.8 m170 -78.29 -22.3 48.44 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.368 -0.378 . . . . 1.0 111.432 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 37.7 m -66.6 -14.75 62.8 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.236 0.458 . . . . 1.0 112.236 -178.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -111.57 147.71 34.84 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 108.754 -0.832 . . . . 1.0 108.754 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -91.39 171.12 9.43 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.182 0.593 . . . . 1.0 111.274 -178.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 14.6 t -67.06 137.72 24.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.218 -179.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 100.82 -27.3 21.17 Favored Glycine 0 N--CA 1.468 0.82 0 N-CA-C 111.369 -0.693 . . . . 1.0 111.369 178.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -55.73 149.64 14.08 Favored 'General case' 0 C--O 1.226 -0.166 0 CA-C-N 117.728 0.764 . . . . 1.0 111.568 -178.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 70.0 p -87.55 136.38 32.97 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 108.557 -0.905 . . . . 1.0 108.557 178.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -121.06 163.17 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 O-C-N 123.529 0.518 . . . . 1.0 110.641 -177.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -129.79 110.85 12.07 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 107.307 -1.368 . . . . 1.0 107.307 178.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 40.6 mm -100.52 137.84 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 109.743 -0.465 . . . . 1.0 109.743 -178.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 6.8 tppt? -128.27 113.87 16.2 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 106.776 -1.564 . . . . 1.0 106.776 177.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.41 ' CD1' ' OD2' ' A' ' 28' ' ' ASP . 27.2 p90 -145.5 157.85 43.93 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.929 0.395 . . . . 1.0 109.939 -178.497 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 25.5 pttm -130.07 135.62 48.44 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 115.757 -0.656 . . . . 1.0 109.733 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 59.4 t-80 -129.31 120.47 25.7 Favored 'General case' 0 C--N 1.347 0.464 0 N-CA-C 107.005 -1.479 . . . . 1.0 107.005 178.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 71.23 -117.18 6.63 Favored Glycine 0 CA--C 1.535 1.338 0 N-CA-C 110.777 -0.929 . . . . 1.0 110.777 -179.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -113.68 -19.93 11.38 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 122.86 0.464 . . . . 1.0 111.557 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 59.5 pttt -99.43 132.43 44.77 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-O 121.015 0.436 . . . . 1.0 111.236 -179.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -102.27 144.37 30.87 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 109.473 -0.565 . . . . 1.0 109.473 179.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -134.29 141.04 46.81 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 109.057 -0.72 . . . . 1.0 109.057 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -124.36 131.22 53.5 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 109.468 -0.567 . . . . 1.0 109.468 179.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -146.31 144.93 30.13 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.965 -0.561 . . . . 1.0 110.278 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 48.7 m -99.12 133.56 43.23 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 108.514 -0.921 . . . . 1.0 108.514 178.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 5.6 mt -138.57 138.97 42.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 CA-C-O 120.77 0.319 . . . . 1.0 111.33 -177.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 47.3 mttm -82.97 141.32 32.2 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 121.78 -0.575 . . . . 1.0 109.897 178.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -62.04 148.32 44.42 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 109.262 -0.644 . . . . 1.0 109.262 179.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 66.9 p -135.93 162.14 33.68 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.15 0.58 . . . . 1.0 109.549 178.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -82.1 116.09 21.52 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 109.302 -0.629 . . . . 1.0 109.302 178.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.5 ' CD1' ' H ' ' A' ' 77' ' ' ILE . 0.1 OUTLIER -102.0 -18.53 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 C-N-CA 122.415 0.286 . . . . 1.0 111.273 -179.753 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -123.08 145.55 48.45 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-O 121.159 0.504 . . . . 1.0 110.915 -179.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 24.6 pttm -49.41 -18.8 0.43 Allowed 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.633 -0.712 . . . . 1.0 112.345 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 30.7 mtmm -80.44 -16.62 53.96 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 120.825 0.345 . . . . 1.0 110.908 -178.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 83.15 39.98 9.6 Favored Glycine 0 N--CA 1.468 0.818 0 N-CA-C 111.778 -0.529 . . . . 1.0 111.778 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 88.7 m -81.98 123.64 79.72 Favored Pre-proline 0 CA--C 1.553 1.058 0 CA-C-O 118.696 -0.668 . . . . 1.0 109.573 179.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -50.54 131.79 33.73 Favored 'Trans proline' 0 N--CA 1.506 2.24 0 C-N-CA 121.357 1.371 . . . . 1.0 111.986 177.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -172.4 163.74 35.92 Favored Glycine 0 CA--C 1.529 0.963 0 N-CA-C 111.136 -0.786 . . . . 1.0 111.136 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -111.87 35.51 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 CA-C-O 121.482 0.658 . . . . 1.0 109.432 -179.263 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 53.17 58.9 10.42 Favored Glycine 0 N--CA 1.468 0.805 0 N-CA-C 111.083 -0.807 . . . . 1.0 111.083 179.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 21.6 pt -143.27 162.8 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-N 114.628 -0.786 . . . . 1.0 109.984 179.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 93.3 m -135.05 116.17 14.3 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-N 114.825 -1.08 . . . . 1.0 111.127 178.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 9.6 mp -97.74 135.99 38.73 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 122.925 0.49 . . . . 1.0 110.226 179.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 12.9 m -153.04 136.31 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 N-CA-C 108.918 -0.771 . . . . 1.0 108.918 178.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -74.38 -57.38 3.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.024 0.44 . . . . 1.0 110.049 179.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 34.3 p-10 -169.61 -178.75 3.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.9 -0.591 . . . . 1.0 110.196 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 53.1 mt 44.26 29.87 0.4 Allowed 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 116.073 -0.512 . . . . 1.0 111.34 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 53.87 -122.14 1.94 Allowed 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 116.042 -0.526 . . . . 1.0 110.626 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -91.63 -0.86 57.61 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 110.112 -0.329 . . . . 1.0 110.112 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 50.1 t-80 53.51 80.36 0.11 Allowed 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.99 0.424 . . . . 1.0 110.799 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -73.12 161.76 30.24 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.997 -0.547 . . . . 1.0 110.537 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 71.2 m80 -61.95 169.05 2.81 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.063 -0.517 . . . . 1.0 110.453 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 56.27 95.1 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.934 -0.576 . . . . 1.0 111.507 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 86.0 t60 . . . . . 0 C--O 1.221 -0.407 0 CA-C-O 117.965 -1.017 . . . . 1.0 109.865 179.334 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 37.2 t70 . . . . . 0 N--CA 1.47 0.562 0 CA-C-O 120.885 0.374 . . . . 1.0 110.031 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -84.18 -148.71 9.23 Favored Glycine 0 C--N 1.339 0.709 0 N-CA-C 110.003 -1.239 . . . . 1.0 110.003 179.242 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.7 p -127.85 134.59 65.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 N-CA-C 109.014 -0.736 . . . . 1.0 109.014 178.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -89.52 149.41 22.91 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 109.484 -0.562 . . . . 1.0 109.484 -178.857 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 49.1 t -98.31 128.71 49.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 N-CA-C 108.793 -0.817 . . . . 1.0 108.793 179.223 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 8.2 tp -75.83 -39.89 55.88 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.986 0.422 . . . . 1.0 110.8 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.2 t -167.55 161.04 13.5 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.9 -0.591 . . . . 1.0 111.859 -178.81 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 44.0 t -132.87 115.7 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 CA-C-N 115.367 -0.833 . . . . 1.0 109.239 179.018 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.402 ' O ' ' N ' ' A' ' 17' ' ' ASP . 74.1 mmtt -73.26 105.21 4.57 Favored 'General case' 0 C--O 1.221 -0.404 0 N-CA-C 108.906 -0.776 . . . . 1.0 108.906 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -64.94 64.29 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 120.875 0.369 . . . . 1.0 111.698 -178.301 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.402 ' N ' ' O ' ' A' ' 15' ' ' LYS . 37.0 t70 -175.97 45.68 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 108.136 -1.061 . . . . 1.0 108.136 179.54 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 23.0 m -150.19 160.88 32.45 Favored Pre-proline 0 N--CA 1.483 1.19 0 CA-C-O 118.995 -0.526 . . . . 1.0 109.731 -178.42 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -47.3 -33.32 16.18 Favored 'Trans proline' 0 N--CA 1.506 2.242 0 C-N-CA 121.252 1.301 . . . . 1.0 112.543 177.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.06 -22.77 67.07 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 116.761 -0.2 . . . . 1.0 111.39 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.59 124.61 21.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.016 0.436 . . . . 1.0 111.008 -178.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.85 -9.71 70.61 Favored Glycine 0 N--CA 1.473 1.138 0 CA-C-N 115.663 -0.699 . . . . 1.0 111.633 179.528 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 71.0 mt -114.31 -50.9 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 C-N-CA 122.633 0.373 . . . . 1.0 110.289 -179.427 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 42.7 mt -113.18 148.38 35.54 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 108.777 -0.823 . . . . 1.0 108.777 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -139.92 154.33 47.2 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 115.745 -0.661 . . . . 1.0 110.023 -179.159 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.44 139.66 52.57 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.858 -0.61 . . . . 1.0 110.918 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 94.55 -6.84 71.14 Favored Glycine 0 N--CA 1.473 1.107 0 N-CA-C 111.083 -0.807 . . . . 1.0 111.083 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -74.49 150.89 39.65 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 109.637 -0.505 . . . . 1.0 109.637 179.043 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 5.0 mp -120.91 120.66 36.13 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 109.696 -0.483 . . . . 1.0 109.696 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 61.4 mt -89.39 134.63 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 N-CA-C 107.959 -1.126 . . . . 1.0 107.959 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 65.1 p -97.2 -49.2 5.06 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 116.741 -0.208 . . . . 1.0 111.279 -178.221 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.8 tp10 -154.05 159.83 41.73 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 121.256 0.55 . . . . 1.0 111.3 -178.242 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.424 ' O ' ' N ' ' A' ' 35' ' ' GLY . 4.7 mp -135.85 129.59 48.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 N-CA-C 107.611 -1.255 . . . . 1.0 107.611 179.192 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 41.57 20.14 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 113.077 0.769 . . . . 1.0 113.077 179.365 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 33' ' ' ILE . . . 69.22 6.56 54.16 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 111.101 -0.8 . . . . 1.0 111.101 179.521 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 . . . . . 0 N--CA 1.472 0.628 0 CA-C-O 120.82 0.343 . . . . 1.0 110.233 -179.708 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 15.0 m . . . . . 0 N--CA 1.479 0.991 0 N-CA-C 110.084 -0.339 . . . . 1.0 110.084 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 11.7 t -56.21 -40.7 74.43 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.507 0.194 . . . . 1.0 110.543 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -53.8 -28.68 36.69 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.367 -0.379 . . . . 1.0 110.719 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -58.86 -35.31 72.75 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.887 0.375 . . . . 1.0 110.393 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -68.85 -47.53 65.73 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 116.255 -0.43 . . . . 1.0 110.436 -179.487 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.513 ' N ' HD12 ' A' ' 45' ' ' ILE . 1.7 mp -52.69 -31.87 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 N-CA-C 108.998 -0.742 . . . . 1.0 108.998 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 47.3 m-20 -70.98 -37.87 72.74 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.797 -0.638 . . . . 1.0 111.431 -179.404 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 80.1 t80 -66.79 -52.68 41.19 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 120.8 0.333 . . . . 1.0 111.607 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -62.46 -26.05 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 N-CA-C 109.362 -0.607 . . . . 1.0 109.362 -178.449 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -90.66 -21.96 21.41 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 116.342 -0.39 . . . . 1.0 111.392 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 47.4 m -81.77 -13.62 57.49 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 122.422 -0.174 . . . . 1.0 111.295 -178.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 43.7 mmtm -95.27 -168.97 1.89 Allowed 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 109.992 -0.373 . . . . 1.0 109.992 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 3.6 mmpt? -131.23 159.26 38.31 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.184 0.594 . . . . 1.0 110.526 -178.057 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.5 t -64.59 140.43 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-N 115.764 -0.653 . . . . 1.0 110.33 -179.358 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 94.27 -12.9 68.34 Favored Glycine 0 N--CA 1.476 1.305 0 N-CA-C 110.843 -0.903 . . . . 1.0 110.843 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -67.85 -165.25 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 109.618 -0.512 . . . . 1.0 109.618 179.478 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 77.3 p -140.75 153.97 46.1 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 108.932 -0.766 . . . . 1.0 108.932 178.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 3.2 p -140.55 154.72 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 CA-C-O 121.102 0.477 . . . . 1.0 110.716 -179.017 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 49.4 mtmt -121.74 112.39 18.34 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 107.954 -1.128 . . . . 1.0 107.954 177.301 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.431 HD13 HD11 ' A' ' 72' ' ' ILE . 4.4 mp -99.2 138.65 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 N-CA-C 109.05 -0.722 . . . . 1.0 109.05 -178.793 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -111.19 113.31 25.72 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 105.607 -1.997 . . . . 1.0 105.607 177.445 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 17.8 p90 -149.84 156.87 42.53 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 109.611 -0.514 . . . . 1.0 109.611 -178.748 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 22.7 pttm -125.96 118.2 24.88 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 121.261 0.553 . . . . 1.0 110.053 -179.451 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -89.63 101.82 14.5 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 107.642 -1.244 . . . . 1.0 107.642 179.262 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 83.76 -111.94 3.5 Favored Glycine 0 CA--C 1.535 1.296 0 N-CA-C 111.475 -0.65 . . . . 1.0 111.475 -178.681 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -114.52 -2.43 13.16 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 122.826 0.45 . . . . 1.0 111.821 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 58.0 pttt -105.55 134.28 48.93 Favored 'General case' 0 N--CA 1.484 1.269 0 CA-C-O 121.162 0.506 . . . . 1.0 111.052 -179.187 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -84.08 119.58 25.13 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 109.747 -0.464 . . . . 1.0 109.747 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 69.7 mt-10 -119.9 152.79 36.84 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-N 115.51 -0.768 . . . . 1.0 110.021 -179.686 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -139.82 133.52 30.47 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 109.253 -0.647 . . . . 1.0 109.253 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -147.03 152.32 38.39 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.946 -0.57 . . . . 1.0 109.952 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.754 ' C ' HD13 ' A' ' 72' ' ' ILE . 17.7 t -125.41 136.53 53.51 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.005 -0.998 . . . . 1.0 108.576 179.024 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.754 HD13 ' C ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -128.68 149.07 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 O-C-N 123.418 0.449 . . . . 1.0 109.965 -178.907 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -78.42 136.34 37.62 Favored 'General case' 0 C--O 1.231 0.084 0 N-CA-C 108.186 -1.042 . . . . 1.0 108.186 178.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.446 HD22 ' N ' ' A' ' 74' ' ' LEU . 3.8 mm? -66.74 147.28 53.47 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.119 0.485 . . . . 1.0 110.598 -178.501 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 30.6 p -140.87 160.73 39.43 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.648 -0.705 . . . . 1.0 109.747 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -80.23 131.15 35.64 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 108.975 -0.75 . . . . 1.0 108.975 178.392 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -114.0 -52.66 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 123.127 0.571 . . . . 1.0 110.544 -179.287 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 57.4 p30 -99.61 162.55 12.95 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.327 0.584 . . . . 1.0 110.872 -178.105 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 59.5 pttt -51.15 -31.92 21.33 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.096 -0.956 . . . . 1.0 112.326 -178.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 26.2 ttmt -80.23 12.06 3.14 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 120.672 0.272 . . . . 1.0 110.762 -179.028 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 52.72 49.09 55.0 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 120.967 -0.635 . . . . 1.0 111.833 179.544 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 58.6 m -80.3 120.41 79.39 Favored Pre-proline 0 CA--C 1.54 0.573 0 CA-C-O 118.619 -0.705 . . . . 1.0 109.698 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -58.7 134.84 63.27 Favored 'Trans proline' 0 N--CA 1.497 1.693 0 CA-C-N 120.819 1.328 . . . . 1.0 112.122 177.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 148.81 152.53 5.74 Favored Glycine 0 N--CA 1.473 1.123 0 N-CA-C 112.003 -0.439 . . . . 1.0 112.003 178.612 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 6.5 pt -72.44 176.95 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 N-CA-C 108.369 -0.974 . . . . 1.0 108.369 177.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -103.27 86.92 0.55 Allowed Glycine 0 N--CA 1.473 1.12 0 N-CA-C 111.817 -0.513 . . . . 1.0 111.817 -179.068 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 48.8 pt -143.7 166.91 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 CA-C-N 115.504 -0.348 . . . . 1.0 110.17 178.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 95.4 m -128.44 128.99 45.47 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 109.182 -0.673 . . . . 1.0 109.182 177.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 12.9 mt -97.89 163.2 12.89 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.057 0.943 . . . . 1.0 109.853 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 24.2 t . . . . . 0 N--CA 1.479 1.024 0 CA-C-N 116.087 -0.506 . . . . 1.0 109.777 -178.735 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 33.7 p-10 . . . . . 0 N--CA 1.471 0.584 0 N-CA-C 109.651 -0.5 . . . . 1.0 109.651 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 161.14 -166.09 35.59 Favored Glycine 0 N--CA 1.461 0.318 0 N-CA-C 108.963 -1.655 . . . . 1.0 108.963 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.1 p -125.72 130.78 72.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 N-CA-C 109.222 -0.659 . . . . 1.0 109.222 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.465 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 0.2 OUTLIER -91.12 151.81 20.85 Favored 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 109.303 -0.628 . . . . 1.0 109.303 -178.863 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 56.1 t -106.0 127.48 61.06 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 N-CA-C 108.5 -0.926 . . . . 1.0 108.5 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 41.2 tp -79.97 -49.56 11.67 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-O 121.169 0.509 . . . . 1.0 111.063 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 97.2 p -167.21 163.19 15.44 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.571 -0.741 . . . . 1.0 111.403 -179.18 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.444 ' O ' ' O ' ' A' ' 15' ' ' LYS . 39.2 t -119.92 138.37 50.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 CA-C-N 114.952 -1.022 . . . . 1.0 109.659 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.444 ' O ' ' O ' ' A' ' 14' ' ' VAL . 36.3 tptt -39.49 -108.75 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 O-C-N 123.981 0.8 . . . . 1.0 111.778 179.468 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -159.61 20.01 0.17 Allowed 'General case' 0 N--CA 1.482 1.156 0 O-C-N 121.096 -1.002 . . . . 1.0 112.363 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.752 ' O ' ' O ' ' A' ' 18' ' ' VAL . 4.2 p-10 -169.02 -68.06 0.02 OUTLIER 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 107.109 -1.441 . . . . 1.0 107.109 178.035 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.752 ' O ' ' O ' ' A' ' 17' ' ' ASP . 29.3 m 4.46 148.2 0.0 OUTLIER Pre-proline 0 N--CA 1.504 2.237 0 O-C-N 125.874 1.984 . . . . 1.0 114.091 -177.181 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -56.7 9.18 0.04 OUTLIER 'Trans proline' 0 N--CA 1.496 1.673 0 CA-C-N 120.346 1.159 . . . . 1.0 113.206 -178.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.529 ' H ' ' C ' ' A' ' 18' ' ' VAL . . . -106.48 -24.15 12.29 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 109.435 -0.58 . . . . 1.0 109.435 177.07 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.691 ' HB3' ' O ' ' A' ' 17' ' ' ASP . . . -75.36 134.53 40.96 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-O 121.278 0.561 . . . . 1.0 110.247 179.374 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 90.75 -22.03 30.23 Favored Glycine 0 N--CA 1.471 0.977 0 CA-C-N 115.422 -0.808 . . . . 1.0 111.387 179.485 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 84.9 mt -105.36 -51.32 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 N-CA-C 109.945 -0.391 . . . . 1.0 109.945 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 18.8 mt -99.59 134.42 42.51 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 109.283 -0.636 . . . . 1.0 109.283 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -118.42 144.59 45.84 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 115.919 -0.582 . . . . 1.0 109.659 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -52.48 132.51 35.11 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 116.473 -0.331 . . . . 1.0 110.703 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 101.39 -4.38 54.62 Favored Glycine 0 N--CA 1.474 1.179 0 N-CA-C 111.601 -0.6 . . . . 1.0 111.601 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -72.82 152.38 41.57 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 117.506 0.653 . . . . 1.0 109.599 178.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.4 mp -124.15 122.31 37.48 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 122.753 0.421 . . . . 1.0 110.364 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 31.9 mm -74.78 122.44 28.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 N-CA-C 109.253 -0.647 . . . . 1.0 109.253 179.257 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 47.8 p -89.85 -43.77 10.4 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 116.4 -0.363 . . . . 1.0 111.023 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 72.9 tt0 -154.69 151.61 28.95 Favored 'General case' 0 N--CA 1.482 1.136 0 CA-C-O 120.991 0.424 . . . . 1.0 111.414 -178.643 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.41 HD13 ' CE1' ' A' ' 44' ' ' PHE . 1.6 mt -145.49 133.87 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 CA-C-O 120.977 0.417 . . . . 1.0 110.246 178.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 37.7 t70 54.5 34.94 22.19 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.808 -0.633 . . . . 1.0 111.256 178.321 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.18 -9.15 13.64 Favored Glycine 0 CA--C 1.531 1.058 0 N-CA-C 111.412 -0.675 . . . . 1.0 111.412 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 . . . . . 0 N--CA 1.478 0.956 0 CA-C-N 116.802 0.301 . . . . 1.0 110.264 -179.998 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 49.0 m . . . . . 0 N--CA 1.481 1.091 0 N-CA-C 110.214 -0.291 . . . . 1.0 110.214 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 46.6 t -64.26 -51.61 62.74 Favored 'General case' 0 C--O 1.219 -0.533 0 CA-C-N 116.417 -0.356 . . . . 1.0 110.575 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -53.88 -34.41 59.36 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 122.277 -0.265 . . . . 1.0 111.226 -179.121 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.0 tp10 -64.44 -36.81 85.39 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 109.299 -0.63 . . . . 1.0 109.299 179.134 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.41 ' CE1' HD13 ' A' ' 33' ' ' ILE . 5.0 t80 -66.69 -48.28 69.76 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.419 0.628 . . . . 1.0 109.537 178.568 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 26.3 mm -53.62 -27.96 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-N 115.542 -0.754 . . . . 1.0 110.313 -178.475 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -70.78 -35.23 72.49 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 116.359 -0.382 . . . . 1.0 110.119 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 28.7 t80 -67.18 -46.16 74.76 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.822 0.344 . . . . 1.0 110.997 178.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 25.7 mt -53.74 -38.55 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 115.954 -0.566 . . . . 1.0 109.945 -175.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 52.0 m-70 -80.89 -20.88 41.24 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 116.052 -0.522 . . . . 1.0 110.966 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 11.2 t -78.06 37.14 0.24 Allowed 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 120.748 0.308 . . . . 1.0 111.483 -178.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -146.55 -169.6 3.31 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 109.024 -0.732 . . . . 1.0 109.024 179.605 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -131.55 166.51 21.24 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 122.955 0.502 . . . . 1.0 109.759 -178.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 22.7 t -68.46 137.76 23.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 115.95 -0.568 . . . . 1.0 110.939 -178.674 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.75 -2.43 85.93 Favored Glycine 0 N--CA 1.478 1.484 0 N-CA-C 111.217 -0.753 . . . . 1.0 111.217 179.173 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -62.08 -168.91 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.832 -0.433 . . . . 1.0 109.832 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 23.4 m -146.55 139.88 25.72 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 108.972 -0.751 . . . . 1.0 108.972 179.632 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.459 HG22 ' N ' ' A' ' 58' ' ' LYS . 6.0 p -141.46 160.79 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 CA-C-N 116.305 -0.407 . . . . 1.0 110.172 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.459 ' N ' HG22 ' A' ' 57' ' ' VAL . 21.8 ttpp -112.71 123.28 49.94 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 108.111 -1.07 . . . . 1.0 108.111 177.587 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.497 HG22 ' O ' ' A' ' 70' ' ' ALA . 11.5 tt -101.02 143.03 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 C-N-CA 122.776 0.43 . . . . 1.0 111.003 -178.61 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 17.6 tptp -133.58 113.56 12.56 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 107.661 -1.237 . . . . 1.0 107.661 177.588 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 25.1 p90 -144.45 157.93 44.0 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 109.226 -0.657 . . . . 1.0 109.226 -179.727 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -116.24 115.79 26.62 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 117.912 0.324 . . . . 1.0 110.206 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -118.66 115.76 25.18 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 108.108 -1.071 . . . . 1.0 108.108 177.796 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 73.25 -133.63 18.48 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 110.716 -0.953 . . . . 1.0 110.716 -178.688 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -107.26 2.1 24.38 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 122.82 0.448 . . . . 1.0 111.072 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 20.8 pttp -122.37 119.5 31.23 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-O 121.593 0.711 . . . . 1.0 111.145 -179.437 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -82.97 123.92 29.89 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 109.386 -0.598 . . . . 1.0 109.386 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -114.51 142.03 46.94 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.062 0.545 . . . . 1.0 109.943 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -124.87 136.69 54.02 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 109.135 -0.691 . . . . 1.0 109.135 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.497 ' O ' HG22 ' A' ' 59' ' ' ILE . . . -148.69 128.42 13.32 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.301 0.572 . . . . 1.0 111.388 -179.168 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 12.2 m -87.03 139.53 30.48 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 109.146 -0.687 . . . . 1.0 109.146 178.436 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 11.1 pt -140.11 149.86 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-N 116.086 -0.506 . . . . 1.0 110.534 -178.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 18.4 pttp -93.19 139.03 31.04 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.541 -0.754 . . . . 1.0 109.235 178.77 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.45 HD22 ' N ' ' A' ' 74' ' ' LEU . 3.6 mm? -64.04 150.8 44.59 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 109.665 -0.494 . . . . 1.0 109.665 179.44 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 72.9 p -137.39 159.36 42.15 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 115.894 -0.594 . . . . 1.0 110.188 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -81.44 135.14 35.62 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 109.313 -0.625 . . . . 1.0 109.313 178.609 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.681 HD13 ' H ' ' A' ' 77' ' ' ILE . 0.1 OUTLIER -134.63 -8.53 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 C-N-CA 122.475 0.31 . . . . 1.0 111.313 -179.363 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -127.66 148.27 50.38 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 122.937 0.495 . . . . 1.0 110.173 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -48.72 -33.26 9.85 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.238 -0.437 . . . . 1.0 111.805 -179.355 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -79.04 7.45 7.35 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 120.756 0.313 . . . . 1.0 110.846 -179.364 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 57.4 46.29 92.02 Favored Glycine 0 CA--C 1.529 0.954 0 CA-C-N 116.215 -0.448 . . . . 1.0 112.519 178.851 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 4.5 m -79.6 119.15 75.9 Favored Pre-proline 0 CA--C 1.551 0.982 0 CA-C-O 118.875 -0.584 . . . . 1.0 109.771 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -52.93 125.98 19.95 Favored 'Trans proline' 0 N--CA 1.504 2.112 0 C-N-CA 121.285 1.323 . . . . 1.0 111.077 177.599 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 173.74 172.6 39.24 Favored Glycine 0 N--CA 1.469 0.854 0 C-N-CA 120.801 -0.714 . . . . 1.0 112.254 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.19 173.4 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 N-CA-C 106.976 -1.49 . . . . 1.0 106.976 177.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -104.55 83.6 0.4 Allowed Glycine 0 N--CA 1.475 1.264 0 N-CA-C 110.549 -1.02 . . . . 1.0 110.549 -179.06 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.505 HD13 ' H ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -143.62 168.15 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-O 121.373 0.606 . . . . 1.0 110.746 179.607 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 26.4 m -128.14 132.72 48.91 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 115.099 -0.955 . . . . 1.0 109.344 178.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.665 HD22 ' N ' ' A' ' 89' ' ' LEU . 0.9 OUTLIER -99.61 159.52 14.98 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 123.194 0.598 . . . . 1.0 109.41 -179.99 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.2 m . . . . . 0 N--CA 1.488 1.431 0 CA-C-N 115.672 -0.695 . . . . 1.0 110.018 -178.368 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 . . . . . 0 N--CA 1.463 0.212 0 CA-C-O 120.861 0.363 . . . . 1.0 110.686 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 166.39 -175.36 41.83 Favored Glycine 0 N--CA 1.462 0.418 0 N-CA-C 109.968 -1.253 . . . . 1.0 109.968 -179.532 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 18.7 m -112.61 130.99 65.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 N-CA-C 108.859 -0.793 . . . . 1.0 108.859 179.283 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.449 ' CD1' HD22 ' A' ' 29' ' ' LEU . 10.0 m-85 -88.13 137.42 32.34 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 109.828 -0.434 . . . . 1.0 109.828 -177.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 62.1 t -90.28 127.51 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 N-CA-C 108.861 -0.792 . . . . 1.0 108.861 179.176 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 48.6 tp -81.05 -44.27 18.28 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 120.87 0.366 . . . . 1.0 111.144 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.2 t -163.31 156.87 19.48 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 121.317 0.58 . . . . 1.0 111.187 -178.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.4 p -137.12 134.9 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 CA-C-N 114.969 -1.014 . . . . 1.0 109.314 179.457 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -76.37 160.22 29.77 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 109.15 -0.685 . . . . 1.0 109.15 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -99.35 -5.63 29.29 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 111.673 0.249 . . . . 1.0 111.673 -178.221 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 25.0 p-10 -106.68 29.02 7.32 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 122.611 0.364 . . . . 1.0 110.908 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.6 m -130.75 156.13 80.34 Favored Pre-proline 0 N--CA 1.483 1.175 0 C-N-CA 123.137 0.575 . . . . 1.0 109.545 -179.378 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -56.57 -22.06 41.46 Favored 'Trans proline' 0 N--CA 1.505 2.2 0 C-N-CA 121.688 1.592 . . . . 1.0 112.141 -179.542 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.415 ' HB2' HG22 ' A' ' 85' ' ' ILE . . . -62.4 -26.96 68.76 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.147 0.499 . . . . 1.0 110.536 -179.494 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.67 125.36 25.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.572 -0.74 . . . . 1.0 110.935 -178.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 95.5 -15.71 62.68 Favored Glycine 0 N--CA 1.475 1.237 0 N-CA-C 111.478 -0.649 . . . . 1.0 111.478 179.224 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 81.2 mt -113.55 -49.9 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 N-CA-C 110.039 -0.356 . . . . 1.0 110.039 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 16.2 mt -110.75 147.55 34.19 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 109.613 -0.514 . . . . 1.0 109.613 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.4 ' CD2' ' OD1' ' A' ' 28' ' ' ASP . 13.6 p-80 -143.64 156.61 44.61 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.559 -0.746 . . . . 1.0 110.051 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.07 143.41 32.81 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 115.739 -0.664 . . . . 1.0 111.435 -179.189 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 95.06 -4.6 67.9 Favored Glycine 0 N--CA 1.474 1.168 0 N-CA-C 111.696 -0.562 . . . . 1.0 111.696 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.4 ' OD1' ' CD2' ' A' ' 25' ' ' HIS . 9.7 m-20 -82.8 123.04 28.97 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 117.145 0.473 . . . . 1.0 110.276 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.449 HD22 ' CD1' ' A' ' 10' ' ' TYR . 20.0 mt -97.92 121.07 39.39 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 109.711 -0.477 . . . . 1.0 109.711 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 16.0 mm -77.43 127.64 38.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 N-CA-C 108.948 -0.76 . . . . 1.0 108.948 -179.235 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 75.8 p -77.75 -51.95 9.72 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.291 -0.413 . . . . 1.0 110.678 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -155.14 166.28 34.07 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.032 0.444 . . . . 1.0 109.945 -179.153 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.444 HD11 ' CD1' ' A' ' 59' ' ' ILE . 1.0 OUTLIER -134.04 126.59 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-N 115.064 -0.971 . . . . 1.0 109.931 179.319 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 37.5 t70 48.97 16.91 0.13 Allowed 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.699 -0.682 . . . . 1.0 111.624 179.022 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.82 14.86 78.15 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 111.331 -0.708 . . . . 1.0 111.331 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 . . . . . 0 N--CA 1.476 0.868 0 CA-C-O 120.899 0.381 . . . . 1.0 110.297 -179.614 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 21.2 t . . . . . 0 N--CA 1.465 0.325 0 CA-C-O 120.834 0.349 . . . . 1.0 110.49 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 50.3 m -65.78 -42.23 91.06 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.042 -0.526 . . . . 1.0 109.846 178.53 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -64.86 -37.88 89.11 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.069 -0.514 . . . . 1.0 111.067 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -54.82 -25.37 27.98 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.027 0.441 . . . . 1.0 110.037 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -70.29 -45.65 65.92 Favored 'General case' 0 C--O 1.221 -0.429 0 N-CA-C 109.154 -0.684 . . . . 1.0 109.154 179.305 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.508 ' N ' HD12 ' A' ' 45' ' ' ILE . 1.6 mp -64.28 -30.13 49.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 N-CA-C 108.896 -0.779 . . . . 1.0 108.896 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -63.13 -34.1 76.88 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.237 -179.067 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 32.2 t80 -69.14 -44.21 72.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.243 -0.435 . . . . 1.0 111.519 179.212 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 44.0 mt -57.44 -42.5 80.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.319 -0.401 . . . . 1.0 110.275 -175.387 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 54.2 m-70 -76.52 -18.76 58.55 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.309 -0.405 . . . . 1.0 111.117 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 13.0 t -92.33 46.48 1.26 Allowed 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 111.564 0.209 . . . . 1.0 111.564 -178.819 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 13.8 mmtm -149.31 175.74 11.16 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 109.242 -0.651 . . . . 1.0 109.242 179.26 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -130.1 154.1 47.81 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-O 121.067 0.46 . . . . 1.0 109.787 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 28.5 t -60.83 135.43 25.58 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 115.933 -0.576 . . . . 1.0 110.864 -178.306 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 97.55 -19.59 54.08 Favored Glycine 0 N--CA 1.477 1.422 0 N-CA-C 110.951 -0.86 . . . . 1.0 110.951 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -65.54 143.41 57.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.594 0.235 . . . . 1.0 110.497 -179.549 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 68.0 p -96.22 152.56 18.45 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 109.153 -0.684 . . . . 1.0 109.153 179.146 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 6.6 p -140.49 155.42 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 CA-C-O 121.232 0.539 . . . . 1.0 110.757 -179.376 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 31.6 mtmm -101.18 123.08 44.75 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.319 -0.855 . . . . 1.0 109.486 178.508 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.506 HG13 HD11 ' A' ' 72' ' ' ILE . 1.0 OUTLIER -117.71 136.06 56.08 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 C-N-CA 122.84 0.456 . . . . 1.0 110.109 179.693 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 12.8 ptpt -135.72 120.51 18.48 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 107.745 -1.206 . . . . 1.0 107.745 178.13 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 34.7 p90 -146.21 149.28 33.64 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 110.146 -0.316 . . . . 1.0 110.146 -179.627 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 20.9 pttm -111.57 114.49 27.59 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.355 0.598 . . . . 1.0 110.552 -179.544 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 70.5 t60 -98.69 120.87 39.85 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 108.045 -1.094 . . . . 1.0 108.045 178.4 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 61.6 -118.04 13.49 Favored Glycine 0 CA--C 1.531 1.034 0 N-CA-C 111.121 -0.791 . . . . 1.0 111.121 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 -114.16 14.55 18.23 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 122.942 0.497 . . . . 1.0 111.544 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 17.1 ptmt -122.75 121.16 35.66 Favored 'General case' 0 N--CA 1.485 1.309 0 CA-C-O 121.38 0.61 . . . . 1.0 111.157 -179.616 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -77.01 124.38 27.71 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 116.079 -0.51 . . . . 1.0 109.889 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -127.81 140.56 51.96 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 115.863 -0.608 . . . . 1.0 110.052 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.4 ' CD ' ' N ' ' A' ' 69' ' ' GLU . 1.9 pm0 -142.18 136.09 29.62 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 115.813 -0.63 . . . . 1.0 110.58 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -161.28 129.44 4.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.788 -0.642 . . . . 1.0 111.188 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 9.4 t -85.54 146.18 27.03 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 108.915 -0.772 . . . . 1.0 108.915 178.735 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.723 ' N ' HD13 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -134.55 149.83 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 CA-C-O 121.425 0.631 . . . . 1.0 110.329 -178.981 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.6 ttmp? -81.2 139.47 35.51 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 115.11 -0.95 . . . . 1.0 109.268 179.451 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -73.64 149.73 41.81 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.193 0.521 . . . . 1.0 110.0 179.611 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 27.3 p -140.73 164.17 30.91 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.398 -0.819 . . . . 1.0 110.123 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -79.97 131.95 35.92 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 109.271 -0.641 . . . . 1.0 109.271 178.654 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.3 pt -109.63 -55.88 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 CA-C-N 115.946 -0.57 . . . . 1.0 109.794 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.416 ' OD2' ' NZ ' ' A' ' 80' ' ' LYS . 40.9 t0 -98.41 171.53 8.11 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 121.507 0.67 . . . . 1.0 111.48 -178.095 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -60.16 -28.56 68.02 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.811 -1.086 . . . . 1.0 112.045 -179.339 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.416 ' NZ ' ' OD2' ' A' ' 78' ' ' ASP . 19.6 pttm -80.09 14.58 1.8 Allowed 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 120.619 0.247 . . . . 1.0 110.517 -179.374 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 49.24 41.15 30.77 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 112.169 -0.372 . . . . 1.0 112.169 178.532 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 15.9 m -80.02 120.51 80.0 Favored Pre-proline 0 CA--C 1.547 0.834 0 N-CA-C 109.544 -0.539 . . . . 1.0 109.544 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -52.95 131.8 44.23 Favored 'Trans proline' 0 N--CA 1.501 1.927 0 C-N-CA 121.463 1.442 . . . . 1.0 112.277 178.508 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -158.58 146.14 12.72 Favored Glycine 0 N--CA 1.468 0.788 0 N-CA-C 111.474 -0.65 . . . . 1.0 111.474 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.415 HG22 ' HB2' ' A' ' 20' ' ' ALA . 40.7 mm -67.6 -26.05 34.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.455 -0.373 . . . . 1.0 110.418 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 99.47 45.6 2.12 Favored Glycine 0 N--CA 1.475 1.255 0 N-CA-C 110.684 -0.966 . . . . 1.0 110.684 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 38.4 pt -145.15 166.89 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 N-CA-C 109.863 -0.421 . . . . 1.0 109.863 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 77.0 m -127.25 127.07 43.82 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 109.253 -0.647 . . . . 1.0 109.253 177.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.1 mp -99.39 146.69 26.03 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 120.797 0.332 . . . . 1.0 110.525 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.7 p . . . . . 0 N--CA 1.477 0.917 0 CA-C-N 115.777 -0.647 . . . . 1.0 109.744 -179.042 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 48.7 p-10 . . . . . 0 N--CA 1.453 -0.308 0 N-CA-C 109.366 -0.605 . . . . 1.0 109.366 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -69.66 -160.17 2.52 Favored Glycine 0 CA--C 1.52 0.376 0 N-CA-C 110.122 -1.191 . . . . 1.0 110.122 179.289 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.9 m -112.82 132.41 61.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 N-CA-C 109.362 -0.607 . . . . 1.0 109.362 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -92.27 132.37 36.74 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 115.791 -0.64 . . . . 1.0 110.588 -178.244 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 57.3 t -77.56 134.55 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.126 0 N-CA-C 107.335 -1.357 . . . . 1.0 107.335 177.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.3 tt -81.03 -51.19 8.77 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.056 0.455 . . . . 1.0 111.163 -178.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.0 m -163.61 159.79 22.19 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.151 0.5 . . . . 1.0 111.343 -179.129 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 26.4 t -109.24 134.75 50.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-N 114.992 -1.004 . . . . 1.0 109.134 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -63.86 -36.55 84.29 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 116.4 -0.364 . . . . 1.0 110.675 -179.579 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 73.38 25.91 2.1 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.5 1.12 . . . . 1.0 111.835 -179.687 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -145.75 35.23 1.04 Allowed 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 108.709 -0.848 . . . . 1.0 108.709 178.715 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.446 HG23 ' HB3' ' A' ' 20' ' ' ALA . 6.5 m -145.08 158.06 52.74 Favored Pre-proline 0 N--CA 1.476 0.851 0 CA-C-N 115.903 -0.589 . . . . 1.0 110.238 -178.306 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -50.88 -15.08 1.57 Allowed 'Trans proline' 0 N--CA 1.505 2.171 0 C-N-CA 121.781 1.654 . . . . 1.0 112.17 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.525 ' HB2' HG22 ' A' ' 85' ' ' ILE . . . -64.55 -35.17 80.12 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.966 0.412 . . . . 1.0 110.591 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.56 129.71 41.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.924 -0.58 . . . . 1.0 111.313 -178.665 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.44 -7.52 75.06 Favored Glycine 0 N--CA 1.47 0.942 0 N-CA-C 111.109 -0.796 . . . . 1.0 111.109 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 52.9 mt -115.54 -50.61 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 CA-C-O 120.769 0.318 . . . . 1.0 110.498 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 28.4 mt -113.53 153.54 28.59 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.091 0.556 . . . . 1.0 110.101 -179.348 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 67.6 m80 -144.12 157.03 44.55 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.86 -0.609 . . . . 1.0 111.001 -179.015 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.05 140.3 38.4 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.924 -0.58 . . . . 1.0 111.134 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 91.81 -4.38 78.74 Favored Glycine 0 N--CA 1.471 0.972 0 N-CA-C 111.283 -0.727 . . . . 1.0 111.283 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -67.63 124.85 24.4 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 109.425 -0.583 . . . . 1.0 109.425 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 10.6 mt -96.61 122.28 39.36 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 109.095 -0.706 . . . . 1.0 109.095 179.207 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 33.7 mm -83.62 116.48 27.68 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 109.124 -0.695 . . . . 1.0 109.124 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 71.7 p -90.56 -39.78 12.34 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 116.278 -0.419 . . . . 1.0 111.436 -179.403 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -146.32 148.78 32.75 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 109.826 -0.435 . . . . 1.0 109.826 -179.083 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.418 ' O ' ' N ' ' A' ' 35' ' ' GLY . 3.6 mt -129.59 128.86 66.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 108.709 -0.848 . . . . 1.0 108.709 179.211 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 26.5 t0 45.8 14.47 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 112.131 0.419 . . . . 1.0 112.131 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 33' ' ' ILE . . . 65.73 17.9 65.48 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.937 -0.865 . . . . 1.0 110.937 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 . . . . . 0 N--CA 1.477 0.884 0 CA-C-O 120.932 0.396 . . . . 1.0 110.625 -179.002 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.5 t . . . . . 0 C--O 1.233 0.189 0 CA-C-O 121.227 0.537 . . . . 1.0 110.122 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 73.1 m -75.93 -33.01 59.84 Favored 'General case' 0 C--O 1.218 -0.566 0 CA-C-N 115.702 -0.681 . . . . 1.0 109.917 179.064 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.407 ' NE2' ' OD2' ' A' ' 46' ' ' ASP . 0.0 OUTLIER -74.05 -45.4 49.74 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 120.948 0.404 . . . . 1.0 111.187 -178.897 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -56.56 -20.86 22.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.123 -0.489 . . . . 1.0 110.49 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -72.1 -52.18 17.99 Favored 'General case' 0 N--CA 1.461 0.097 0 C-N-CA 120.542 -0.463 . . . . 1.0 110.406 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.7 mp -54.05 -31.8 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 N-CA-C 108.651 -0.87 . . . . 1.0 108.651 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.407 ' OD2' ' NE2' ' A' ' 42' ' ' GLN . 61.8 m-20 -72.0 -32.57 67.32 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.018 -0.992 . . . . 1.0 111.227 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 77.3 t80 -69.23 -52.57 26.4 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 120.875 0.369 . . . . 1.0 111.479 -179.4 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -54.92 -25.63 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 N-CA-C 109.53 -0.545 . . . . 1.0 109.53 -177.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 42.5 m170 -94.15 -18.12 22.07 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.58 -0.737 . . . . 1.0 110.558 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 27.6 t -66.75 -22.43 66.04 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.712 0.291 . . . . 1.0 111.448 -178.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -90.48 -169.06 2.27 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 109.649 -0.5 . . . . 1.0 109.649 179.462 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.9 mptp? -122.46 168.29 12.29 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 122.958 0.503 . . . . 1.0 110.658 -179.015 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 22.1 t -65.2 135.1 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-N 115.738 -0.665 . . . . 1.0 110.732 -178.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.97 -0.88 86.54 Favored Glycine 0 N--CA 1.474 1.172 0 N-CA-C 110.968 -0.853 . . . . 1.0 110.968 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -73.54 147.18 44.2 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 110.235 -0.283 . . . . 1.0 110.235 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 80.7 p -86.51 150.33 24.33 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 109.574 -0.528 . . . . 1.0 109.574 178.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.409 HG12 ' O ' ' A' ' 72' ' ' ILE . 0.3 OUTLIER -141.93 161.58 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 CA-C-O 120.933 0.397 . . . . 1.0 111.244 -179.367 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 49.9 mtmt -123.4 114.52 20.26 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.011 -0.995 . . . . 1.0 108.734 177.692 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 35.3 mm -106.87 140.14 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 CA-C-O 121.004 0.431 . . . . 1.0 110.378 -179.412 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -131.99 115.77 16.26 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 106.942 -1.503 . . . . 1.0 106.942 177.413 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 29.5 p90 -143.12 164.23 30.71 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-N 116.123 -0.49 . . . . 1.0 110.073 -176.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 21.2 ttpp -127.31 114.84 18.12 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 123.423 0.452 . . . . 1.0 110.641 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -99.92 108.68 20.98 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 108.075 -1.083 . . . . 1.0 108.075 178.388 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 74.82 -114.28 4.31 Favored Glycine 0 CA--C 1.532 1.132 0 N-CA-C 111.128 -0.789 . . . . 1.0 111.128 -179.179 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 14.5 p30 -113.12 -10.91 13.38 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 122.674 0.39 . . . . 1.0 111.638 -179.661 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -99.23 133.77 43.04 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-O 120.706 0.289 . . . . 1.0 110.745 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 18.4 p30 -97.15 128.84 44.44 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.902 0.382 . . . . 1.0 110.133 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 74.1 mt-10 -132.94 155.01 49.89 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 115.738 -0.664 . . . . 1.0 109.854 -179.445 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -140.7 138.09 33.98 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.843 -0.617 . . . . 1.0 110.523 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -146.89 151.38 36.96 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.766 -0.652 . . . . 1.0 110.613 -179.047 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 50.5 m -102.67 134.02 46.72 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.353 -0.84 . . . . 1.0 109.166 179.133 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.409 ' O ' HG12 ' A' ' 57' ' ' VAL . 7.6 mt -135.7 139.94 45.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 CA-C-O 121.298 0.57 . . . . 1.0 110.494 -177.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 52.0 pttt -82.47 141.51 32.64 Favored 'General case' 0 C--N 1.327 -0.376 0 O-C-N 121.905 -0.497 . . . . 1.0 110.192 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -68.62 143.38 54.84 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 120.97 0.414 . . . . 1.0 110.082 178.702 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 80.5 p -136.32 162.96 31.57 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 115.809 -0.632 . . . . 1.0 110.433 179.109 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -78.44 122.84 26.34 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.885 -0.598 . . . . 1.0 109.713 179.023 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.433 ' CG1' ' N ' ' A' ' 78' ' ' ASP . 3.6 pt -96.06 -53.44 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-N 116.795 -0.184 . . . . 1.0 110.587 179.605 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.433 ' N ' ' CG1' ' A' ' 77' ' ' ILE . 44.3 t0 -98.08 169.65 9.46 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 121.365 0.602 . . . . 1.0 111.579 -178.328 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 47.0 mmtm -61.82 -23.9 66.53 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 114.902 -1.044 . . . . 1.0 111.904 -178.507 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 35.6 pttt -77.53 -15.55 59.2 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 120.479 0.18 . . . . 1.0 110.626 -178.716 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 83.03 40.18 9.53 Favored Glycine 0 N--CA 1.467 0.753 0 C-N-CA 121.424 -0.417 . . . . 1.0 112.075 178.797 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 53.2 m -81.21 120.16 77.74 Favored Pre-proline 0 CA--C 1.545 0.753 0 N-CA-C 109.324 -0.621 . . . . 1.0 109.324 179.109 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -52.79 130.88 39.35 Favored 'Trans proline' 0 N--CA 1.497 1.717 0 C-N-CA 121.142 1.228 . . . . 1.0 112.909 178.69 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -169.14 155.03 25.03 Favored Glycine 0 N--CA 1.461 0.318 0 N-CA-C 110.666 -0.974 . . . . 1.0 110.666 178.483 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.525 HG22 ' HB2' ' A' ' 20' ' ' ALA . 3.3 mt -89.66 26.4 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 N-CA-C 109.501 -0.555 . . . . 1.0 109.501 -179.414 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 50.52 63.62 4.27 Favored Glycine 0 CA--C 1.531 1.056 0 N-CA-C 111.782 -0.527 . . . . 1.0 111.782 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 18.7 pt -146.62 164.6 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 N-CA-C 109.353 -0.61 . . . . 1.0 109.353 179.273 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 86.1 m -130.36 125.5 34.77 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 115.477 -0.783 . . . . 1.0 109.581 177.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 12.7 mt -111.01 134.7 52.4 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.282 0.633 . . . . 1.0 109.801 -179.288 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 16.0 m . . . . . 0 C--N 1.327 -0.385 0 N-CA-C 108.367 -0.975 . . . . 1.0 108.367 179.156 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 41.5 t0 . . . . . 0 N--CA 1.472 0.648 0 N-CA-C 109.747 -0.464 . . . . 1.0 109.747 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -171.23 -159.34 17.11 Favored Glycine 0 CA--C 1.521 0.461 0 N-CA-C 109.948 -1.261 . . . . 1.0 109.948 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 16.6 m -117.96 128.81 75.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 CA-C-O 121.297 0.57 . . . . 1.0 109.731 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -86.7 146.17 26.4 Favored 'General case' 0 C--O 1.221 -0.396 0 N-CA-C 108.639 -0.874 . . . . 1.0 108.639 -178.053 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 57.0 t -107.96 132.06 56.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 108.951 -0.759 . . . . 1.0 108.951 179.232 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.513 HD23 HG11 ' A' ' 90' ' ' VAL . 0.2 OUTLIER -84.61 -50.83 7.33 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 116.287 -0.415 . . . . 1.0 111.245 -179.571 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 99.7 p -167.79 163.73 14.14 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 121.173 0.511 . . . . 1.0 111.301 -179.309 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 39.8 t -107.09 128.74 61.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 CA-C-N 115.128 -0.942 . . . . 1.0 108.497 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.413 ' O ' ' CB ' ' A' ' 16' ' ' GLU . 63.6 mttp -59.91 -36.75 77.64 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-N 116.099 -0.501 . . . . 1.0 110.55 -178.584 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.435 ' C ' ' H ' ' A' ' 18' ' ' VAL . 59.5 tt0 93.84 163.93 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.338 0 O-C-N 124.742 1.277 . . . . 1.0 111.129 178.572 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 70.59 -4.97 1.51 Allowed 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.496 -0.775 . . . . 1.0 109.567 -179.649 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.435 ' H ' ' C ' ' A' ' 16' ' ' GLU . 11.4 m -96.3 155.61 37.86 Favored Pre-proline 0 CA--C 1.541 0.604 0 CA-C-N 115.727 -0.669 . . . . 1.0 110.44 -178.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -55.92 -23.03 40.82 Favored 'Trans proline' 0 N--CA 1.503 2.058 0 C-N-CA 121.953 1.769 . . . . 1.0 112.226 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.44 -23.73 67.38 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.649 0.261 . . . . 1.0 110.852 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.5 136.0 44.1 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.306 -0.406 . . . . 1.0 110.887 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 91.28 -23.64 23.45 Favored Glycine 0 N--CA 1.469 0.89 0 N-CA-C 111.243 -0.743 . . . . 1.0 111.243 179.381 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 67.9 mt -102.12 -50.21 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 122.32 0.248 . . . . 1.0 110.489 -179.475 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 23.5 mt -109.89 157.15 19.53 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-O 121.077 0.465 . . . . 1.0 109.895 -179.343 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 50.3 t-80 -139.0 153.5 48.15 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.44 -0.8 . . . . 1.0 110.591 -179.094 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.42 144.39 31.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.369 -0.832 . . . . 1.0 110.812 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 89.01 -11.2 70.03 Favored Glycine 0 CA--C 1.528 0.898 0 N-CA-C 111.06 -0.816 . . . . 1.0 111.06 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -68.27 144.17 54.97 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 110.249 -0.278 . . . . 1.0 110.249 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.5 mp -117.75 121.45 40.87 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 110.127 -0.323 . . . . 1.0 110.127 -179.522 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 25.4 mm -80.36 125.88 39.29 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 N-CA-C 109.177 -0.675 . . . . 1.0 109.177 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 73.8 p -88.13 -47.36 8.54 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.169 -0.468 . . . . 1.0 110.449 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 71.9 tt0 -155.96 146.54 21.89 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.974 0.416 . . . . 1.0 111.222 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 12.6 tt -141.96 131.76 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 109.404 -0.591 . . . . 1.0 109.404 179.144 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.412 ' OD2' ' CE1' ' A' ' 47' ' ' TYR . 57.8 m-20 56.82 20.84 5.5 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.112 -0.494 . . . . 1.0 111.581 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.86 2.54 86.36 Favored Glycine 0 N--CA 1.472 1.063 0 CA-C-N 116.483 -0.326 . . . . 1.0 112.384 178.627 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 . . . . . 0 N--CA 1.474 0.769 0 CA-C-N 117.361 0.58 . . . . 1.0 111.008 -179.917 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.5 m . . . . . 0 N--CA 1.477 0.907 0 CA-C-O 120.798 0.332 . . . . 1.0 110.757 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 50.3 m -52.52 -31.6 36.28 Favored 'General case' 0 N--CA 1.457 -0.089 0 N-CA-C 109.389 -0.597 . . . . 1.0 109.389 178.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.5 tm0? -55.38 -35.18 65.0 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 115.452 -0.795 . . . . 1.0 110.144 179.592 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -57.98 -27.86 63.85 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 115.963 -0.562 . . . . 1.0 109.779 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -72.59 -47.47 47.66 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.978 -0.555 . . . . 1.0 109.722 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 27.4 mm -63.55 -28.86 45.87 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 CA-C-N 115.797 -0.638 . . . . 1.0 109.833 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -62.62 -37.52 86.62 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.611 -0.722 . . . . 1.0 109.975 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.412 ' CE1' ' OD2' ' A' ' 34' ' ' ASP . 0.0 OUTLIER -66.62 -45.66 78.38 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.059 -0.519 . . . . 1.0 110.681 179.182 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 49.5 mt -60.61 -45.35 97.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 116.518 -0.31 . . . . 1.0 111.016 -176.761 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -74.16 -22.56 59.38 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.457 -0.338 . . . . 1.0 111.187 -178.717 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 46.6 t -85.81 -6.76 59.05 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-O 120.566 0.222 . . . . 1.0 111.217 -177.733 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.4 tptm -99.26 164.91 11.94 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-N 116.188 -0.46 . . . . 1.0 109.869 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -121.58 170.42 9.71 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 123.964 0.79 . . . . 1.0 109.893 -179.614 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 22.0 t -70.91 132.57 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-N 115.448 -0.797 . . . . 1.0 111.125 -178.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.37 -5.18 80.73 Favored Glycine 0 N--CA 1.469 0.854 0 N-CA-C 111.054 -0.818 . . . . 1.0 111.054 179.072 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -67.98 144.39 55.19 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.763 0.316 . . . . 1.0 110.751 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 36.3 m -90.19 153.72 20.29 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 108.988 -0.745 . . . . 1.0 108.988 178.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.469 HG12 ' O ' ' A' ' 72' ' ' ILE . 0.5 OUTLIER -140.13 161.27 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 CA-C-O 121.402 0.62 . . . . 1.0 110.599 -179.568 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -117.15 115.68 25.81 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 107.647 -1.242 . . . . 1.0 107.647 177.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.565 HG22 ' O ' ' A' ' 70' ' ' ALA . 2.9 tp -103.18 143.13 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 122.332 0.253 . . . . 1.0 111.018 -178.455 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 6.9 tppt? -133.1 112.75 12.03 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 108.383 -0.969 . . . . 1.0 108.383 178.041 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 33.8 p90 -149.15 149.2 30.64 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.906 -0.405 . . . . 1.0 109.906 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -110.18 114.12 27.35 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 110.239 -0.282 . . . . 1.0 110.239 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 51.3 t-80 -91.91 112.0 23.76 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 108.013 -1.106 . . . . 1.0 108.013 178.427 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 62.17 -114.45 6.8 Favored Glycine 0 CA--C 1.532 1.152 0 N-CA-C 110.7 -0.96 . . . . 1.0 110.7 -179.12 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 23.0 p-10 -112.99 -0.5 14.75 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 122.476 0.31 . . . . 1.0 111.365 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.437 ' NZ ' ' OE2' ' A' ' 68' ' ' GLU . 10.8 ptmm? -110.73 123.42 50.0 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 121.421 0.629 . . . . 1.0 110.75 -179.606 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 46.4 p-10 -81.93 128.24 33.85 Favored 'General case' 0 C--N 1.339 0.13 0 CA-C-O 121.363 0.601 . . . . 1.0 110.353 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.437 ' OE2' ' NZ ' ' A' ' 66' ' ' LYS . 81.0 mm-40 -126.11 148.83 49.28 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 115.23 -0.895 . . . . 1.0 109.523 -179.647 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -140.86 135.2 31.11 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 109.186 -0.672 . . . . 1.0 109.186 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.565 ' O ' HG22 ' A' ' 59' ' ' ILE . . . -148.1 142.22 26.04 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-O 121.537 0.684 . . . . 1.0 111.222 -179.398 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 91.5 p -85.7 135.03 33.93 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 108.781 -0.822 . . . . 1.0 108.781 178.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.469 ' O ' HG12 ' A' ' 57' ' ' VAL . 67.2 mt -129.28 122.37 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 CA-C-O 121.289 0.566 . . . . 1.0 109.963 -178.717 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 22.3 ttpp -82.29 138.3 34.61 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 109.64 -0.504 . . . . 1.0 109.64 179.197 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -69.68 143.97 53.0 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.373 0.606 . . . . 1.0 110.304 -178.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 69.7 p -143.28 172.25 13.0 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.064 -0.971 . . . . 1.0 110.435 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -89.3 140.83 29.1 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.343 -0.844 . . . . 1.0 109.583 179.408 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.822 HD13 ' H ' ' A' ' 77' ' ' ILE . 0.1 OUTLIER -131.92 -41.98 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 122.672 0.389 . . . . 1.0 110.839 -179.625 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -98.62 157.84 15.99 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 121.521 0.677 . . . . 1.0 110.729 -179.568 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -52.37 -27.09 14.25 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.845 -1.07 . . . . 1.0 112.046 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.544 ' HZ2' ' CB ' ' A' ' 82' ' ' THR . 18.1 pttp -81.4 13.24 3.07 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 116.303 -0.408 . . . . 1.0 111.039 -179.379 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 47.85 39.59 17.92 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 121.343 -0.456 . . . . 1.0 112.046 178.633 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.544 ' CB ' ' HZ2' ' A' ' 80' ' ' LYS . 86.8 m -80.17 122.09 82.55 Favored Pre-proline 0 CA--C 1.545 0.779 0 CA-C-N 117.101 0.451 . . . . 1.0 110.215 -179.159 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -57.03 114.86 2.11 Favored 'Trans proline' 0 N--CA 1.505 2.168 0 C-N-CA 121.401 1.4 . . . . 1.0 111.332 177.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -179.8 179.64 48.82 Favored Glycine 0 N--CA 1.463 0.449 0 N-CA-C 111.081 -0.808 . . . . 1.0 111.081 179.573 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.7 pt -105.69 177.5 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 N-CA-C 109.665 -0.495 . . . . 1.0 109.665 179.11 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -108.31 84.45 0.37 Allowed Glycine 0 N--CA 1.472 1.079 0 N-CA-C 111.05 -0.82 . . . . 1.0 111.05 -178.694 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.467 HD12 ' O ' ' A' ' 87' ' ' ILE . 1.2 pp -146.77 168.3 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-O 121.272 0.558 . . . . 1.0 109.645 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 62.3 m -132.23 131.39 42.06 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 115.424 -0.807 . . . . 1.0 109.557 179.265 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 29.2 mt -110.52 147.51 33.99 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.711 -0.677 . . . . 1.0 109.267 -179.366 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.513 HG11 HD23 ' A' ' 12' ' ' LEU . 30.8 m . . . . . 0 N--CA 1.476 0.872 0 CA-C-N 115.773 -0.649 . . . . 1.0 110.395 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 36.3 p-10 . . . . . 0 N--CA 1.463 0.193 0 CA-C-O 121.004 0.43 . . . . 1.0 110.049 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 153.67 -175.38 32.03 Favored Glycine 0 N--CA 1.467 0.75 0 N-CA-C 109.858 -1.297 . . . . 1.0 109.858 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 38.9 t -111.64 127.42 68.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 N-CA-C 109.18 -0.674 . . . . 1.0 109.18 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -86.85 143.36 27.49 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 115.962 -0.563 . . . . 1.0 109.634 -178.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 39.0 t -107.93 132.95 54.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 115.405 -0.816 . . . . 1.0 109.208 179.383 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.584 HD23 HG11 ' A' ' 90' ' ' VAL . 0.2 OUTLIER -81.67 -44.39 17.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.814 -0.63 . . . . 1.0 111.971 -179.547 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 99.9 p -165.8 162.39 18.47 Favored 'General case' 0 CA--C 1.506 -0.727 0 CA-C-N 116.061 -0.518 . . . . 1.0 110.953 -179.214 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.44 ' O ' ' O ' ' A' ' 15' ' ' LYS . 40.3 t -120.42 137.62 53.62 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 114.728 -1.124 . . . . 1.0 108.732 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.44 ' O ' ' O ' ' A' ' 14' ' ' VAL . 3.9 mmmm -54.43 -116.6 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.477 0 O-C-N 123.815 0.697 . . . . 1.0 110.294 179.129 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 78.1 tt0 -162.32 -70.13 0.05 Allowed 'General case' 0 C--N 1.33 -0.269 0 O-C-N 121.755 -0.591 . . . . 1.0 111.445 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 29.2 p-10 -89.97 51.7 2.12 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.346 -0.388 . . . . 1.0 110.569 -178.336 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 32.8 m -124.99 156.71 68.81 Favored Pre-proline 0 N--CA 1.471 0.616 0 CA-C-N 115.841 -0.618 . . . . 1.0 110.151 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -58.86 -13.18 17.3 Favored 'Trans proline' 0 N--CA 1.499 1.827 0 C-N-CA 121.751 1.634 . . . . 1.0 112.054 178.794 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.402 ' HB2' HG22 ' A' ' 85' ' ' ILE . . . -81.99 -27.46 33.15 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.068 0.461 . . . . 1.0 110.381 -179.404 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.91 130.5 41.17 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 115.694 -0.685 . . . . 1.0 110.134 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 98.57 -15.03 61.55 Favored Glycine 0 N--CA 1.472 1.054 0 N-CA-C 111.197 -0.761 . . . . 1.0 111.197 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 71.1 mt -115.23 -52.24 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 CA-C-N 116.616 0.208 . . . . 1.0 110.459 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.423 HD21 HD13 ' A' ' 59' ' ' ILE . 12.7 mt -102.0 149.77 23.9 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 109.816 -0.439 . . . . 1.0 109.816 -179.245 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 42.5 p-80 -141.11 154.89 46.13 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.389 0.614 . . . . 1.0 110.433 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.05 134.43 55.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.18 -0.918 . . . . 1.0 110.617 -179.664 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.27 -4.09 62.16 Favored Glycine 0 N--CA 1.471 0.983 0 N-CA-C 111.197 -0.761 . . . . 1.0 111.197 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -77.85 130.17 36.31 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 117.274 0.537 . . . . 1.0 110.264 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 14.3 mt -99.91 120.05 39.17 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 109.508 -0.552 . . . . 1.0 109.508 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.61 HD13 HD11 ' A' ' 59' ' ' ILE . 75.8 mt -92.34 137.51 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 N-CA-C 108.975 -0.75 . . . . 1.0 108.975 179.643 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 51.9 p -102.41 -43.93 5.52 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 116.13 -0.486 . . . . 1.0 111.216 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 73.0 tt0 -153.72 163.09 40.59 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.337 0.589 . . . . 1.0 111.176 -178.706 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 16.9 tt -149.61 142.56 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-N 115.906 -0.588 . . . . 1.0 110.028 179.447 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 28.3 t70 50.19 19.99 0.58 Allowed 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 120.994 0.426 . . . . 1.0 111.74 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.95 19.64 77.21 Favored Glycine 0 N--CA 1.47 0.955 0 N-CA-C 111.919 -0.472 . . . . 1.0 111.919 178.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 . . . . . 0 N--CA 1.47 0.552 0 O-C-N 122.473 -0.427 . . . . 1.0 110.329 -179.034 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 30.6 t . . . . . 0 N--CA 1.481 1.089 0 CA-C-O 120.576 0.227 . . . . 1.0 111.128 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 78.0 p -61.93 -48.65 79.47 Favored 'General case' 0 CA--C 1.513 -0.468 0 N-CA-C 109.404 -0.591 . . . . 1.0 109.404 -178.339 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 69.3 tp60 -51.43 -38.52 54.03 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.046 -0.525 . . . . 1.0 110.345 -178.5 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.8 tp10 -65.31 -32.64 74.39 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.347 -0.612 . . . . 1.0 109.347 179.044 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 27.8 t80 -72.11 -50.23 29.74 Favored 'General case' 0 C--O 1.219 -0.523 0 CA-C-N 116.337 -0.392 . . . . 1.0 110.204 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.7 mp -59.92 -37.18 70.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 109.247 -0.649 . . . . 1.0 109.247 179.456 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -60.49 -35.69 76.52 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.652 -0.704 . . . . 1.0 110.408 -178.428 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 44.4 t80 -68.08 -48.89 64.29 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.213 -0.449 . . . . 1.0 111.621 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 33.6 mt -52.78 -34.28 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-O 120.906 0.384 . . . . 1.0 110.427 -176.494 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 45.3 m170 -85.9 -22.54 27.43 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.036 -0.529 . . . . 1.0 111.121 -179.576 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 71.7 p -70.87 -17.98 62.71 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.645 -0.252 . . . . 1.0 111.269 -178.57 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 18.4 mmmt -90.48 -171.61 3.13 Favored 'General case' 0 CA--C 1.512 -0.492 0 N-CA-C 110.054 -0.35 . . . . 1.0 110.054 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -128.37 168.58 15.36 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 123.618 0.574 . . . . 1.0 110.148 -178.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 25.9 t -70.86 134.99 29.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.448 -0.796 . . . . 1.0 110.946 -178.712 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 90.31 -4.52 82.68 Favored Glycine 0 N--CA 1.47 0.938 0 N-CA-C 110.637 -0.985 . . . . 1.0 110.637 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -70.34 147.09 50.02 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 110.09 -0.337 . . . . 1.0 110.09 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 23.1 m -105.1 139.29 40.0 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 109.363 -0.606 . . . . 1.0 109.363 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 34.5 m -138.27 164.45 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 CA-C-N 116.12 -0.491 . . . . 1.0 111.535 -179.514 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.83 117.88 27.6 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 115.065 -0.971 . . . . 1.0 108.972 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.61 HD11 HD13 ' A' ' 30' ' ' ILE . 18.9 tt -97.72 141.79 15.39 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.201 0 O-C-N 123.314 0.384 . . . . 1.0 111.343 -178.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -121.43 119.91 33.43 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 107.721 -1.214 . . . . 1.0 107.721 178.303 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 18.7 p90 -147.75 161.26 41.59 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 110.065 -0.346 . . . . 1.0 110.065 -179.241 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 26.1 mtmm -128.27 117.84 22.22 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 123.464 0.477 . . . . 1.0 110.677 179.423 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 55.1 t60 -107.64 112.15 24.73 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 108.37 -0.974 . . . . 1.0 108.37 178.105 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 73.19 -118.34 6.27 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.944 -0.862 . . . . 1.0 110.944 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 68.0 m-80 -115.95 14.04 16.07 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 122.704 0.401 . . . . 1.0 111.802 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -126.28 119.79 28.29 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 120.82 0.343 . . . . 1.0 110.938 -179.392 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 61.3 t-20 -84.74 133.16 34.37 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-N 116.116 -0.493 . . . . 1.0 109.845 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -128.67 161.34 29.9 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 115.228 -0.897 . . . . 1.0 110.015 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -141.08 139.79 34.1 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 115.454 -0.794 . . . . 1.0 110.149 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -150.65 161.48 42.51 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 115.664 -0.698 . . . . 1.0 110.493 -178.043 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 91.0 p -128.27 138.28 52.35 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 109.096 -0.705 . . . . 1.0 109.096 179.313 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.721 ' N ' HD13 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -138.22 147.27 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-O 121.491 0.662 . . . . 1.0 110.535 -178.189 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 7.8 ttpm? -86.57 135.21 33.52 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.387 -0.824 . . . . 1.0 109.846 179.384 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -68.98 147.58 51.4 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.151 0.5 . . . . 1.0 110.498 179.593 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 18.6 p -141.17 168.61 19.36 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 115.187 -0.915 . . . . 1.0 110.659 -179.235 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -80.25 148.34 30.83 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.192 -0.913 . . . . 1.0 109.887 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.446 HG13 ' H ' ' A' ' 78' ' ' ASP . 1.6 pt -128.89 -55.92 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 CA-C-N 115.996 -0.547 . . . . 1.0 110.782 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.446 ' H ' HG13 ' A' ' 77' ' ' ILE . 68.5 m-20 -96.33 165.81 12.02 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 121.466 0.65 . . . . 1.0 110.987 -178.077 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 24.1 pttm -57.03 -18.5 14.2 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.685 -1.143 . . . . 1.0 111.502 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -81.54 -13.95 57.46 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 116.834 -0.166 . . . . 1.0 111.351 -179.073 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 77.72 30.75 51.84 Favored Glycine 0 N--CA 1.469 0.897 0 N-CA-C 111.366 -0.694 . . . . 1.0 111.366 179.414 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 85.8 m -79.26 125.51 83.16 Favored Pre-proline 0 CA--C 1.546 0.797 0 C-N-CA 120.455 -0.498 . . . . 1.0 109.761 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_exo -50.73 128.97 25.73 Favored 'Trans proline' 0 N--CA 1.501 1.914 0 C-N-CA 121.595 1.53 . . . . 1.0 112.553 178.183 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -152.14 130.07 2.98 Favored Glycine 0 N--CA 1.468 0.809 0 N-CA-C 111.078 -0.809 . . . . 1.0 111.078 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.402 HG22 ' HB2' ' A' ' 20' ' ' ALA . 96.1 mt -59.68 -25.52 32.15 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 N-CA-C 110.47 -0.196 . . . . 1.0 110.47 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 100.01 46.69 1.86 Allowed Glycine 0 N--CA 1.481 1.659 0 N-CA-C 111.211 -0.755 . . . . 1.0 111.211 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.471 HD13 HD21 ' A' ' 89' ' ' LEU . 1.1 pp -146.93 164.98 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 N-CA-C 109.67 -0.492 . . . . 1.0 109.67 -178.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 15.9 m -128.76 121.94 29.5 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 115.408 -0.814 . . . . 1.0 110.584 178.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.775 HD22 ' N ' ' A' ' 89' ' ' LEU . 0.4 OUTLIER -99.73 139.37 35.49 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.389 0.676 . . . . 1.0 109.759 -179.861 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.584 HG11 HD23 ' A' ' 12' ' ' LEU . 9.1 m . . . . . 0 C--N 1.324 -0.539 0 CA-C-N 114.884 -1.053 . . . . 1.0 109.424 -179.325 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 34.0 t0 . . . . . 0 CA--C 1.528 0.124 0 N-CA-C 109.544 -0.539 . . . . 1.0 109.544 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -77.53 -161.33 14.76 Favored Glycine 0 N--CA 1.464 0.521 0 N-CA-C 110.243 -1.143 . . . . 1.0 110.243 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.6 t -111.93 129.65 67.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 N-CA-C 109.722 -0.473 . . . . 1.0 109.722 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -85.87 141.65 29.44 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.385 -0.598 . . . . 1.0 109.385 -178.441 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.6 t -100.45 136.0 33.84 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.31 0 CA-C-N 115.121 -0.945 . . . . 1.0 109.521 179.61 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 42.3 tp -89.72 -51.84 5.31 Favored 'General case' 0 N--CA 1.458 -0.071 0 CA-C-N 116.052 -0.522 . . . . 1.0 110.778 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 44.4 m -158.6 151.86 22.8 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.285 0.564 . . . . 1.0 110.845 -178.644 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.4 p -137.42 135.2 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-N 114.821 -1.081 . . . . 1.0 109.623 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -71.28 152.92 42.8 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.93 -0.767 . . . . 1.0 108.93 178.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -96.14 15.3 21.22 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 116.778 -0.192 . . . . 1.0 111.377 -178.026 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -133.77 41.62 3.01 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 109.132 -0.692 . . . . 1.0 109.132 179.308 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 8.7 m -141.31 153.13 65.87 Favored Pre-proline 0 CA--C 1.542 0.66 0 CA-C-N 115.786 -0.643 . . . . 1.0 110.0 -179.654 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.718 ' O ' HD13 ' A' ' 23' ' ' ILE . 80.9 Cg_exo -45.1 -30.85 5.17 Favored 'Trans proline' 0 N--CA 1.496 1.633 0 C-N-CA 122.178 1.919 . . . . 1.0 113.109 179.307 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.79 -23.82 67.43 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.059 0.457 . . . . 1.0 110.314 -178.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.0 107.44 1.25 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.81 -0.632 . . . . 1.0 110.144 179.298 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.542 ' C ' HD12 ' A' ' 23' ' ' ILE . . . 108.05 -4.62 33.84 Favored Glycine 0 N--CA 1.476 1.304 0 N-CA-C 111.317 -0.713 . . . . 1.0 111.317 -179.611 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.718 HD13 ' O ' ' A' ' 19' ' ' PRO . 3.3 mp -117.19 -50.15 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 122.461 0.304 . . . . 1.0 110.787 179.485 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 12.1 mt -112.03 150.46 30.6 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 121.242 0.544 . . . . 1.0 110.314 -179.175 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 -145.46 158.55 43.82 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.293 -0.867 . . . . 1.0 110.852 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.41 124.64 20.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.46 -0.791 . . . . 1.0 110.276 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 99.64 -4.44 58.02 Favored Glycine 0 N--CA 1.471 1.028 0 N-CA-C 111.129 -0.788 . . . . 1.0 111.129 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -74.96 141.94 43.98 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.979 0.39 . . . . 1.0 110.038 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 25.6 mt -115.96 121.13 41.36 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 109.958 -0.386 . . . . 1.0 109.958 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 62.4 mt -91.69 135.94 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 N-CA-C 107.883 -1.154 . . . . 1.0 107.883 178.758 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 3.0 p -123.72 -23.3 4.74 Favored 'General case' 0 N--CA 1.479 0.978 0 O-C-N 123.416 0.447 . . . . 1.0 111.408 -178.764 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 59.1 tt0 -152.27 147.21 26.09 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 120.924 -0.311 . . . . 1.0 110.536 -178.666 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.467 ' O ' ' N ' ' A' ' 35' ' ' GLY . 4.1 mp -135.89 137.11 49.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 N-CA-C 108.742 -0.836 . . . . 1.0 108.742 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 42.73 17.29 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 122.893 0.477 . . . . 1.0 112.118 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 33' ' ' ILE . . . 64.29 17.89 62.28 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 111.493 -0.643 . . . . 1.0 111.493 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.445 ' OE1' ' CE1' ' A' ' 47' ' ' TYR . 12.0 pt20 . . . . . 0 N--CA 1.469 0.491 0 O-C-N 122.532 -0.393 . . . . 1.0 111.81 -178.545 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 44.2 m . . . . . 0 N--CA 1.473 0.693 0 CA-C-O 121.176 0.512 . . . . 1.0 110.486 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 78.4 p -60.58 -29.82 69.42 Favored 'General case' 0 C--O 1.215 -0.717 0 N-CA-C 109.312 -0.625 . . . . 1.0 109.312 178.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -64.17 -30.71 71.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.925 -0.579 . . . . 1.0 110.741 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -60.33 -26.94 66.96 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.775 0.322 . . . . 1.0 110.444 -178.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -72.28 -51.13 22.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.997 0.427 . . . . 1.0 110.233 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.551 ' N ' HD12 ' A' ' 45' ' ' ILE . 1.7 mp -57.39 -28.77 31.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 108.979 -0.749 . . . . 1.0 108.979 -179.042 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -70.64 -33.77 71.35 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.487 -0.779 . . . . 1.0 110.808 -178.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.445 ' CE1' ' OE1' ' A' ' 36' ' ' GLN . 84.0 t80 -69.48 -52.21 28.7 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 120.69 -0.404 . . . . 1.0 111.888 -178.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -67.08 -39.62 83.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-N 116.257 -0.428 . . . . 1.0 109.996 -178.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 81.0 t60 -59.59 -13.73 10.55 Favored 'General case' 0 CA--C 1.503 -0.838 0 CA-C-N 116.25 -0.432 . . . . 1.0 111.088 -178.76 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 21.6 t -96.74 -142.68 0.28 Allowed 'General case' 0 N--CA 1.434 -1.251 0 CA-C-O 122.008 0.909 . . . . 1.0 109.042 178.746 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 30.1 mmtp 48.2 -169.84 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 114.26 -1.336 . . . . 1.0 110.049 -177.353 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -131.58 154.89 48.38 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.121 0.486 . . . . 1.0 110.319 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.6 t -59.88 142.57 15.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.578 -0.737 . . . . 1.0 111.03 -179.109 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 102.17 -20.45 45.15 Favored Glycine 0 N--CA 1.474 1.189 0 N-CA-C 110.596 -1.002 . . . . 1.0 110.596 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 -62.0 -174.13 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.794 0.331 . . . . 1.0 110.525 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.9 t -148.9 145.51 27.46 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 109.623 -0.51 . . . . 1.0 109.623 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 23.0 m -140.66 165.82 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 CA-C-O 121.116 0.484 . . . . 1.0 111.442 -178.727 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -119.68 120.03 35.44 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 114.877 -1.056 . . . . 1.0 108.385 178.517 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.5 tt -103.82 147.3 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 123.026 0.53 . . . . 1.0 110.907 -178.737 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 33.3 ttmt -131.02 117.27 18.93 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 108.207 -1.034 . . . . 1.0 108.207 177.468 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 26.1 p90 -136.49 165.33 26.1 Favored 'General case' 0 C--N 1.34 0.195 0 CA-C-N 115.92 -0.582 . . . . 1.0 110.581 -177.539 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -121.17 139.25 53.61 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.308 -0.86 . . . . 1.0 110.466 -179.708 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 80.2 t60 -130.64 101.23 5.6 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.756 -0.656 . . . . 1.0 109.336 178.331 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 60.98 -110.41 3.03 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 110.702 -0.959 . . . . 1.0 110.702 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -112.82 13.72 19.76 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 122.578 0.351 . . . . 1.0 111.396 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 7.6 ttpm? -130.39 116.18 17.91 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 116.636 -0.256 . . . . 1.0 110.546 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -100.85 135.77 41.76 Favored 'General case' 0 C--N 1.341 0.236 0 N-CA-C 109.722 -0.473 . . . . 1.0 109.722 179.465 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -135.47 166.56 22.9 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 109.303 -0.628 . . . . 1.0 109.303 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.418 ' CD ' ' N ' ' A' ' 69' ' ' GLU . 3.0 pm0 -141.24 140.45 33.93 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.706 -0.679 . . . . 1.0 110.574 -179.73 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.4 ' HB3' HG23 ' A' ' 23' ' ' ILE . . . -149.92 154.63 38.61 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.794 -0.639 . . . . 1.0 110.681 -178.822 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 29.6 m -115.86 139.76 49.89 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 115.181 -0.918 . . . . 1.0 109.352 179.143 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -136.59 146.86 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-O 121.384 0.612 . . . . 1.0 110.469 -178.089 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -82.39 138.74 34.37 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.201 -0.908 . . . . 1.0 109.576 179.181 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.491 HD22 ' N ' ' A' ' 74' ' ' LEU . 4.1 mm? -67.24 146.45 54.16 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.442 0.639 . . . . 1.0 110.874 -179.356 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 45.4 p -140.91 160.1 40.8 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.052 -0.976 . . . . 1.0 110.796 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -80.32 131.71 35.69 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.346 -0.843 . . . . 1.0 109.537 179.554 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 10.7 pt -122.68 -44.98 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 122.677 0.391 . . . . 1.0 111.05 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.401 ' OD2' ' NZ ' ' A' ' 80' ' ' LYS . 30.6 t70 -99.81 156.98 16.82 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 121.636 0.732 . . . . 1.0 110.908 -179.118 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 10.3 mmpt? -48.44 -32.3 7.52 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.647 -1.161 . . . . 1.0 111.759 -179.594 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.401 ' NZ ' ' OD2' ' A' ' 78' ' ' ASP . 29.2 mtmm -82.72 12.42 4.76 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.415 -0.357 . . . . 1.0 111.375 -178.746 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 56.12 47.32 81.8 Favored Glycine 0 C--N 1.334 0.422 0 N-CA-C 111.635 -0.586 . . . . 1.0 111.635 178.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 86.5 m -79.87 120.37 79.71 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 120.491 -0.484 . . . . 1.0 110.471 -179.432 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -56.03 132.36 51.51 Favored 'Trans proline' 0 N--CA 1.498 1.787 0 C-N-CA 121.703 1.602 . . . . 1.0 111.738 177.637 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 154.98 179.41 30.14 Favored Glycine 0 N--CA 1.468 0.774 0 N-CA-C 110.62 -0.992 . . . . 1.0 110.62 178.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.417 ' N ' HD13 ' A' ' 85' ' ' ILE . 0.0 OUTLIER -103.92 -177.57 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 N-CA-C 109.037 -0.727 . . . . 1.0 109.037 -179.566 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -103.84 78.61 0.29 Allowed Glycine 0 C--N 1.339 0.699 0 N-CA-C 110.667 -0.973 . . . . 1.0 110.667 -179.214 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 49.7 pt -138.08 163.4 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 C-N-CA 122.796 0.438 . . . . 1.0 109.988 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 84.8 m -130.13 128.04 41.0 Favored 'General case' 0 N--CA 1.478 0.948 0 O-C-N 123.72 0.637 . . . . 1.0 109.777 177.761 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 54.1 mt -110.42 146.16 36.34 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 123.183 0.593 . . . . 1.0 110.153 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 33.7 m . . . . . 0 N--CA 1.473 0.685 0 CA-C-N 115.606 -0.724 . . . . 1.0 110.176 -179.128 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 . . . . . 0 N--CA 1.473 0.722 0 N-CA-C 110.054 -0.35 . . . . 1.0 110.054 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 42.73 -146.38 0.82 Allowed Glycine 0 N--CA 1.473 1.132 0 N-CA-C 111.294 -0.722 . . . . 1.0 111.294 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.9 t -135.23 127.53 47.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 N-CA-C 108.628 -0.879 . . . . 1.0 108.628 178.218 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.46 ' CZ ' HD13 ' A' ' 29' ' ' LEU . 97.1 m-85 -102.08 132.69 47.79 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 121.256 0.55 . . . . 1.0 110.255 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 61.2 t -76.87 132.1 33.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 N-CA-C 108.152 -1.055 . . . . 1.0 108.152 179.149 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.432 ' O ' HD23 ' A' ' 12' ' ' LEU . 1.7 tt -76.14 -51.66 11.71 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-O 121.558 0.694 . . . . 1.0 110.71 -178.753 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 92.4 p -155.75 153.05 29.29 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.641 -0.709 . . . . 1.0 111.253 -179.11 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 51.7 t -136.84 113.77 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 108.706 -0.85 . . . . 1.0 108.706 178.581 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 34.3 mtmm -70.87 163.62 27.0 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 109.662 -0.496 . . . . 1.0 109.662 179.071 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 28.8 mp0 -98.83 46.36 0.99 Allowed 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 116.402 -0.363 . . . . 1.0 111.199 -179.175 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -158.36 35.15 0.24 Allowed 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 109.96 -0.385 . . . . 1.0 109.96 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 15.8 m -142.49 157.45 62.46 Favored Pre-proline 0 N--CA 1.481 1.09 0 N-CA-C 108.847 -0.797 . . . . 1.0 108.847 -179.043 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -45.8 -37.96 17.09 Favored 'Trans proline' 0 N--CA 1.507 2.31 0 CA-C-N 121.049 1.41 . . . . 1.0 112.807 179.235 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.26 -15.63 60.48 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.159 -0.473 . . . . 1.0 111.589 -179.239 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.95 139.41 46.74 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-O 121.195 0.521 . . . . 1.0 111.499 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 79.69 -11.13 34.82 Favored Glycine 0 N--CA 1.463 0.469 0 CA-C-N 115.352 -0.84 . . . . 1.0 111.94 176.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 67.2 mt -115.2 -50.85 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 N-CA-C 109.88 -0.415 . . . . 1.0 109.88 -178.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 15.0 mt -107.36 134.36 50.53 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 115.756 -0.656 . . . . 1.0 110.032 -179.147 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -110.84 132.7 53.98 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.784 -0.644 . . . . 1.0 109.525 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -47.64 137.14 9.56 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 120.751 0.31 . . . . 1.0 111.606 -178.598 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 94.93 -3.3 67.16 Favored Glycine 0 N--CA 1.471 0.969 0 N-CA-C 111.039 -0.824 . . . . 1.0 111.039 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -65.18 123.72 20.27 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 120.912 0.387 . . . . 1.0 110.545 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.46 HD13 ' CZ ' ' A' ' 10' ' ' TYR . 37.8 tp -88.16 131.5 34.7 Favored 'General case' 0 C--O 1.208 -1.087 0 CA-C-O 118.085 -0.959 . . . . 1.0 109.024 179.689 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 18.3 mm -87.96 125.4 41.45 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 119.485 1.039 . . . . 1.0 108.988 178.196 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 82.0 p -97.03 -36.26 10.57 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 122.449 0.3 . . . . 1.0 111.223 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -153.5 149.5 27.77 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 109.867 -0.42 . . . . 1.0 109.867 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.504 HD13 ' H ' ' A' ' 34' ' ' ASP . 0.3 OUTLIER -147.17 139.67 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 N-CA-C 107.84 -1.17 . . . . 1.0 107.84 -179.998 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.504 ' H ' HD13 ' A' ' 33' ' ' ILE . 36.1 t70 47.79 22.05 0.32 Allowed 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 112.139 0.422 . . . . 1.0 112.139 178.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.34 -8.0 54.9 Favored Glycine 0 CA--C 1.529 0.92 0 N-CA-C 111.411 -0.675 . . . . 1.0 111.411 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 . . . . . 0 N--CA 1.473 0.691 0 N-CA-C 110.016 -0.364 . . . . 1.0 110.016 179.809 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.1 p . . . . . 0 N--CA 1.469 0.482 0 N-CA-C 109.368 -0.604 . . . . 1.0 109.368 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 79.8 p -77.72 -51.78 10.01 Favored 'General case' 0 C--O 1.223 -0.293 0 CA-C-N 116.4 -0.364 . . . . 1.0 110.189 179.308 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -52.16 -42.38 63.36 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 122.099 -0.376 . . . . 1.0 111.27 -177.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -66.57 -31.34 71.98 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.218 -0.66 . . . . 1.0 109.218 178.681 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -73.98 -48.97 26.62 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.773 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.8 mp -55.6 -33.94 34.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 N-CA-C 108.319 -0.993 . . . . 1.0 108.319 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -64.4 -38.57 91.48 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.809 -0.632 . . . . 1.0 111.471 -179.226 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 77.3 t80 -67.57 -52.1 42.63 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 120.748 -0.381 . . . . 1.0 111.653 -178.743 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -67.78 -44.35 85.7 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 CA-C-O 120.553 0.216 . . . . 1.0 110.714 -179.321 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 63.8 t-80 -65.0 -16.94 64.0 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.668 -0.242 . . . . 1.0 111.365 -178.686 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 90.2 p -104.97 -4.2 22.36 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 122.319 0.248 . . . . 1.0 111.329 -178.549 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.449 ' HZ1' ' CG ' ' A' ' 55' ' ' ASP . 14.3 tptp -87.54 135.67 33.25 Favored 'General case' 0 C--O 1.211 -0.95 0 N-CA-C 108.711 -0.848 . . . . 1.0 108.711 179.609 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -69.03 153.55 43.59 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 111.884 0.327 . . . . 1.0 111.884 -178.417 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.6 t -64.74 141.12 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-N 116.388 -0.369 . . . . 1.0 110.931 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 89.95 -23.74 19.05 Favored Glycine 0 N--CA 1.469 0.865 0 CA-C-N 116.011 -0.54 . . . . 1.0 111.963 177.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.449 ' CG ' ' HZ1' ' A' ' 51' ' ' LYS . 11.7 t70 -53.7 151.9 5.76 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-N 117.354 0.577 . . . . 1.0 111.377 -178.4 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.0 m -104.96 128.63 53.32 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 121.376 0.607 . . . . 1.0 110.075 179.621 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 30.7 m -117.61 171.62 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 124.383 1.073 . . . . 1.0 109.829 -178.426 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 18.1 ttmm -125.43 113.9 18.13 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 107.376 -1.342 . . . . 1.0 107.376 178.329 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.566 HG22 ' O ' ' A' ' 70' ' ' ALA . 1.6 tp -97.55 141.9 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 122.643 0.377 . . . . 1.0 110.53 -178.188 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.11 112.24 10.99 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 107.379 -1.341 . . . . 1.0 107.379 177.218 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 24.5 p90 -144.77 160.89 40.52 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 110.36 -0.237 . . . . 1.0 110.36 -178.587 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -134.76 136.9 42.97 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 109.154 -0.684 . . . . 1.0 109.154 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 61.6 t-80 -128.42 126.43 40.56 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 107.835 -1.172 . . . . 1.0 107.835 178.764 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 62.82 -117.18 10.66 Favored Glycine 0 CA--C 1.531 1.041 0 N-CA-C 110.65 -0.98 . . . . 1.0 110.65 -179.468 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -113.47 -21.58 10.78 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 122.845 0.458 . . . . 1.0 110.856 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -90.89 123.31 34.31 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 121.593 0.711 . . . . 1.0 111.598 -178.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 57.4 m-20 -92.96 135.94 33.71 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 109.446 -0.575 . . . . 1.0 109.446 -179.332 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 64.7 mt-10 -137.76 142.1 40.93 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 109.98 -0.378 . . . . 1.0 109.98 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -140.66 138.23 34.15 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 110.067 -0.346 . . . . 1.0 110.067 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.566 ' O ' HG22 ' A' ' 59' ' ' ILE . . . -151.16 147.43 27.03 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-O 121.547 0.689 . . . . 1.0 112.778 -177.304 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 90.6 p -90.97 127.87 36.58 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 109.485 -0.561 . . . . 1.0 109.485 177.404 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.4 mp -130.44 129.06 64.48 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 N-CA-C 108.772 -0.825 . . . . 1.0 108.772 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 5.4 ptpt -81.38 142.92 32.56 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 122.023 -0.423 . . . . 1.0 110.517 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.419 HD22 ' N ' ' A' ' 74' ' ' LEU . 3.5 mm? -61.32 145.14 52.46 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 109.936 -0.394 . . . . 1.0 109.936 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 72.3 p -134.82 155.1 51.22 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 115.972 -0.558 . . . . 1.0 110.259 178.705 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -79.93 122.28 26.5 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 108.752 -0.833 . . . . 1.0 108.752 178.679 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.789 HD13 ' H ' ' A' ' 77' ' ' ILE . 0.1 OUTLIER -118.07 -14.19 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 C-N-CA 122.597 0.359 . . . . 1.0 111.689 -178.714 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -120.02 145.72 46.56 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.052 0.453 . . . . 1.0 110.347 -179.285 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 24.0 pttm -47.72 -27.16 1.84 Allowed 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 115.658 -0.701 . . . . 1.0 112.343 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 14.4 pttm -81.29 -16.3 52.91 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-O 120.751 0.31 . . . . 1.0 110.343 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 81.81 50.56 4.89 Favored Glycine 0 N--CA 1.468 0.826 0 N-CA-C 111.891 -0.483 . . . . 1.0 111.891 179.088 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 32.4 m -81.68 119.42 75.37 Favored Pre-proline 0 CA--C 1.549 0.917 0 CA-C-O 118.915 -0.564 . . . . 1.0 110.062 179.395 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_exo -53.09 118.32 4.69 Favored 'Trans proline' 0 N--CA 1.505 2.165 0 CA-C-N 120.744 1.301 . . . . 1.0 111.369 177.487 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 173.1 -174.74 46.0 Favored Glycine 0 N--CA 1.469 0.866 0 C-N-CA 120.581 -0.818 . . . . 1.0 112.676 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -116.48 170.79 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 N-CA-C 107.258 -1.386 . . . . 1.0 107.258 178.491 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -90.91 42.67 2.87 Favored Glycine 0 N--CA 1.475 1.262 0 CA-C-N 118.1 0.409 . . . . 1.0 112.479 -177.809 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 48.8 pt -111.68 176.09 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 122.405 0.282 . . . . 1.0 110.341 -178.416 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 62.9 m -132.33 130.18 40.44 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 115.805 -0.634 . . . . 1.0 109.844 178.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 69.1 mt -104.65 143.54 32.94 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.022 0.529 . . . . 1.0 109.927 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.1 m . . . . . 0 N--CA 1.483 1.195 0 C-N-CA 123.379 0.672 . . . . 1.0 111.333 -177.475 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.456 ' CG ' ' H ' ' A' ' 8' ' ' GLY . 9.6 p30 . . . . . 0 CA--C 1.54 0.566 0 N-CA-C 109.798 -0.445 . . . . 1.0 109.798 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.456 ' H ' ' CG ' ' A' ' 7' ' ' ASP . . . 178.61 -159.31 24.41 Favored Glycine 0 CA--C 1.519 0.332 0 N-CA-C 109.86 -1.296 . . . . 1.0 109.86 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.7 m -111.54 128.39 68.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 N-CA-C 109.125 -0.695 . . . . 1.0 109.125 179.185 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.463 ' N ' ' O ' ' A' ' 90' ' ' VAL . 11.5 m-85 -88.45 132.23 34.56 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 121.329 0.585 . . . . 1.0 109.527 -178.015 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 83.7 t -76.46 134.54 28.69 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.227 0 N-CA-C 107.337 -1.357 . . . . 1.0 107.337 179.083 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.52 -51.57 6.1 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.578 0.227 . . . . 1.0 110.707 -178.844 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 40.2 t -154.03 150.68 28.5 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.004 0.431 . . . . 1.0 111.003 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 46.7 t -110.56 113.22 43.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-N 115.191 -0.913 . . . . 1.0 108.952 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.407 ' O ' ' O ' ' A' ' 16' ' ' GLU . 62.5 mttp -86.37 92.19 8.74 Favored 'General case' 0 C--O 1.221 -0.411 0 N-CA-C 108.384 -0.969 . . . . 1.0 108.384 179.327 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.47 ' H ' ' CD ' ' A' ' 16' ' ' GLU . 3.3 pm0 -44.77 -179.24 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.489 0 O-C-N 124.073 0.858 . . . . 1.0 112.689 -178.766 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 26.7 t70 62.73 30.0 16.78 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.683 -0.69 . . . . 1.0 109.763 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 28.3 m -133.6 157.13 78.72 Favored Pre-proline 0 N--CA 1.484 1.247 0 CA-C-N 115.954 -0.566 . . . . 1.0 110.558 -179.339 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -49.5 -38.57 44.48 Favored 'Trans proline' 0 N--CA 1.503 2.049 0 C-N-CA 121.253 1.302 . . . . 1.0 112.874 178.685 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.44 -17.33 62.57 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.505 -0.316 . . . . 1.0 110.929 -178.51 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.06 118.14 9.4 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 110.352 -0.24 . . . . 1.0 110.352 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 98.83 -3.76 59.0 Favored Glycine 0 N--CA 1.473 1.123 0 N-CA-C 111.604 -0.598 . . . . 1.0 111.604 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 65.1 mt -114.29 -50.48 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 CA-C-N 116.973 0.386 . . . . 1.0 110.247 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 48.1 mt -110.43 151.43 27.5 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.099 0.56 . . . . 1.0 110.114 -179.493 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.407 ' HE2' ' CE1' ' A' ' 63' ' ' HIS . 18.4 p-80 -143.5 155.1 44.24 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.403 -0.817 . . . . 1.0 110.105 -179.193 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.74 139.14 40.3 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 115.373 -0.831 . . . . 1.0 111.101 -179.217 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 91.82 -3.48 77.8 Favored Glycine 0 CA--C 1.528 0.889 0 N-CA-C 111.179 -0.769 . . . . 1.0 111.179 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -79.68 126.53 31.05 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 117.148 0.474 . . . . 1.0 110.501 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 17.5 mt -102.54 129.86 49.21 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 109.069 -0.715 . . . . 1.0 109.069 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 30.8 mm -85.17 127.39 39.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 N-CA-C 109.417 -0.586 . . . . 1.0 109.417 179.614 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 66.4 p -93.12 -42.13 9.56 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 116.599 -0.273 . . . . 1.0 110.708 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 73.1 tt0 -153.71 152.58 30.94 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.694 0.283 . . . . 1.0 110.379 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.534 HD13 ' H ' ' A' ' 34' ' ' ASP . 0.3 OUTLIER -137.87 138.53 43.9 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 N-CA-C 108.951 -0.759 . . . . 1.0 108.951 -179.218 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.534 ' H ' HD13 ' A' ' 33' ' ' ILE . 37.6 t70 46.46 25.85 0.43 Allowed 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.211 0.529 . . . . 1.0 111.732 179.329 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.94 4.62 49.09 Favored Glycine 0 CA--C 1.527 0.815 0 CA-C-N 115.812 -0.631 . . . . 1.0 111.579 179.364 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 . . . . . 0 N--CA 1.47 0.54 0 CA-C-O 120.999 0.428 . . . . 1.0 110.635 -179.458 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 96.0 p . . . . . 0 N--CA 1.48 1.051 0 N-CA-C 111.635 0.235 . . . . 1.0 111.635 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 81.2 p -58.71 -50.8 72.55 Favored 'General case' 0 C--O 1.22 -0.45 0 C-N-CA 120.464 -0.494 . . . . 1.0 110.039 -178.64 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -48.88 -42.65 37.46 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.462 0.172 . . . . 1.0 111.244 -178.439 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.1 tp10 -69.79 -32.04 70.29 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.315 -0.624 . . . . 1.0 109.315 178.451 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -71.29 -49.77 39.42 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.9 0.381 . . . . 1.0 110.75 -179.43 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 38.4 mm -58.53 -29.07 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 115.516 -0.765 . . . . 1.0 109.639 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -66.92 -35.56 80.27 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.703 -0.681 . . . . 1.0 110.702 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -68.68 -46.91 67.82 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-O 121.223 0.535 . . . . 1.0 111.248 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 42.7 mt -52.66 -41.5 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-N 115.687 -0.688 . . . . 1.0 110.267 -175.469 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 32.3 m-70 -83.91 -18.97 35.6 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.074 -0.512 . . . . 1.0 111.275 -179.676 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 24.8 t -63.64 -24.94 68.0 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 111.646 0.239 . . . . 1.0 111.646 -178.159 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 48.7 mttm -94.23 -174.81 3.48 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 120.961 0.41 . . . . 1.0 110.107 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -130.63 161.58 31.27 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 115.46 -0.791 . . . . 1.0 110.536 -178.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 26.2 t -65.81 138.55 22.85 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-N 115.462 -0.79 . . . . 1.0 111.226 -178.502 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 99.76 -2.36 57.06 Favored Glycine 0 N--CA 1.477 1.421 0 N-CA-C 110.897 -0.881 . . . . 1.0 110.897 179.354 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -76.65 -172.8 2.35 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.695 -0.483 . . . . 1.0 109.695 179.379 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.8 t -148.05 141.13 24.96 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 109.479 -0.563 . . . . 1.0 109.479 179.528 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 27.7 m -142.3 165.88 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 CA-C-N 116.002 -0.545 . . . . 1.0 111.597 -178.593 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -118.32 121.94 41.63 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 108.003 -1.11 . . . . 1.0 108.003 178.091 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 13.2 tt -101.8 143.26 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 122.648 0.379 . . . . 1.0 110.887 -178.372 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -134.04 118.47 17.82 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 107.549 -1.278 . . . . 1.0 107.549 178.52 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 49.3 p90 -139.35 161.96 36.17 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-N 116.16 -0.473 . . . . 1.0 109.775 -178.232 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 7.8 ttpm? -118.77 112.83 20.23 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 123.342 0.401 . . . . 1.0 110.346 179.351 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' HIS . . . . . 0.407 ' CE1' ' HE2' ' A' ' 25' ' ' HIS . 34.5 t60 -106.78 107.63 18.73 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 108.012 -1.107 . . . . 1.0 108.012 178.302 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 72.27 -115.99 5.65 Favored Glycine 0 CA--C 1.53 1.015 0 N-CA-C 111.054 -0.818 . . . . 1.0 111.054 -178.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -113.51 1.66 15.1 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 122.983 0.513 . . . . 1.0 111.407 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -124.02 124.29 42.23 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-O 121.48 0.657 . . . . 1.0 111.009 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 38.6 p-10 -101.86 143.19 32.06 Favored 'General case' 0 C--N 1.343 0.324 0 N-CA-C 109.33 -0.618 . . . . 1.0 109.33 179.442 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 68.5 mt-10 -130.5 167.14 19.13 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 115.542 -0.753 . . . . 1.0 109.285 -179.372 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 78.6 tt0 -136.0 137.68 41.46 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 109.466 -0.568 . . . . 1.0 109.466 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.11 157.32 43.29 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.56 -0.745 . . . . 1.0 110.394 -178.346 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 94.9 p -122.14 137.54 54.79 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 108.425 -0.954 . . . . 1.0 108.425 179.014 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.2 mp -135.93 140.32 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 CA-C-N 116.501 -0.318 . . . . 1.0 110.243 -177.549 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -80.39 137.51 36.54 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 109.061 -0.718 . . . . 1.0 109.061 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.465 HD22 ' N ' ' A' ' 74' ' ' LEU . 3.8 mm? -68.26 144.85 54.72 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.935 -0.575 . . . . 1.0 109.978 -179.329 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 79.8 p -139.08 166.16 25.23 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 115.335 -0.848 . . . . 1.0 109.787 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -94.37 146.46 24.04 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.331 -0.85 . . . . 1.0 109.734 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.647 HD13 ' H ' ' A' ' 77' ' ' ILE . 0.1 OUTLIER -144.92 -30.12 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-N 116.323 -0.399 . . . . 1.0 110.914 179.508 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.405 ' H ' HD13 ' A' ' 77' ' ' ILE . 81.8 m-20 -99.44 151.76 20.75 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 121.238 0.542 . . . . 1.0 110.243 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 10.1 ptpp? -48.72 -27.31 2.83 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.268 -0.878 . . . . 1.0 112.628 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -93.08 11.57 27.18 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 120.634 0.254 . . . . 1.0 111.376 -178.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 56.41 41.51 88.07 Favored Glycine 0 CA--C 1.525 0.665 0 C-N-CA 121.068 -0.587 . . . . 1.0 111.856 178.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 16.8 m -80.54 122.88 82.91 Favored Pre-proline 0 CA--C 1.551 0.998 0 CA-C-O 118.882 -0.58 . . . . 1.0 109.975 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.448 ' HB3' HD12 ' A' ' 74' ' ' LEU . 55.1 Cg_exo -51.63 126.75 20.52 Favored 'Trans proline' 0 N--CA 1.503 2.032 0 C-N-CA 121.363 1.375 . . . . 1.0 111.226 177.196 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.545 ' C ' ' H ' ' A' ' 86' ' ' GLY . . . -150.7 -13.59 0.09 OUTLIER Glycine 0 N--CA 1.478 1.473 0 C-N-CA 121.334 -0.46 . . . . 1.0 111.956 -179.024 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 41.4 mt 66.07 -30.05 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 O-C-N 123.782 0.342 . . . . 1.0 111.146 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.545 ' H ' ' C ' ' A' ' 84' ' ' GLY . . . 115.18 37.86 1.08 Allowed Glycine 0 N--CA 1.477 1.369 0 N-CA-C 110.473 -1.051 . . . . 1.0 110.473 -179.393 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 48.4 pt -140.87 163.94 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 122.599 0.36 . . . . 1.0 110.288 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 8.9 t -134.3 129.94 36.29 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.663 -0.699 . . . . 1.0 109.511 178.807 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.696 HD22 ' N ' ' A' ' 89' ' ' LEU . 1.3 mm? -106.36 135.31 48.07 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 108.253 -1.018 . . . . 1.0 108.253 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.463 ' O ' ' N ' ' A' ' 10' ' ' TYR . 52.3 t . . . . . 0 C--O 1.217 -0.608 0 N-CA-C 108.395 -0.965 . . . . 1.0 108.395 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 35.0 t0 . . . . . 0 N--CA 1.472 0.64 0 N-CA-C 110.053 -0.351 . . . . 1.0 110.053 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 154.38 -159.67 29.02 Favored Glycine 0 N--CA 1.466 0.634 0 N-CA-C 109.191 -1.563 . . . . 1.0 109.191 -179.428 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 12.4 m -129.43 127.42 64.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 N-CA-C 108.789 -0.819 . . . . 1.0 108.789 178.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -91.08 127.85 36.67 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 110.028 -0.36 . . . . 1.0 110.028 -177.758 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 60.4 t -76.41 135.27 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 N-CA-C 107.142 -1.429 . . . . 1.0 107.142 178.61 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.8 tt -78.8 -51.11 10.22 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 121.119 0.485 . . . . 1.0 110.139 -178.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 95.3 p -157.37 153.3 27.08 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.036 0.446 . . . . 1.0 110.996 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 58.4 t -111.57 136.26 48.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 CA-C-N 115.419 -0.81 . . . . 1.0 108.972 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -96.41 121.74 38.54 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 108.845 -0.798 . . . . 1.0 108.845 178.478 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.435 ' N ' ' OE1' ' A' ' 16' ' ' GLU . 14.4 pm0 -85.66 63.28 7.97 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 120.85 0.357 . . . . 1.0 111.399 -178.226 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -163.45 27.18 0.09 Allowed 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.335 0.588 . . . . 1.0 109.568 179.375 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -143.64 160.61 50.16 Favored Pre-proline 0 N--CA 1.479 0.991 0 N-CA-C 108.85 -0.796 . . . . 1.0 108.85 -177.802 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -53.87 -25.76 36.72 Favored 'Trans proline' 0 N--CA 1.498 1.757 0 C-N-CA 121.358 1.372 . . . . 1.0 112.463 179.134 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.23 -12.96 62.13 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 120.724 0.297 . . . . 1.0 110.95 179.228 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.57 135.08 45.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 1.0 111.775 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.34 -4.36 85.75 Favored Glycine 0 N--CA 1.468 0.783 0 CA-C-N 115.908 -0.587 . . . . 1.0 111.951 178.486 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 67.6 mt -112.76 -50.48 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 CA-C-N 117.028 0.414 . . . . 1.0 109.957 -179.167 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 21.4 mt -105.78 150.34 25.64 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 115.834 -0.621 . . . . 1.0 109.981 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 63.7 t-80 -127.98 140.24 52.1 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 115.825 -0.625 . . . . 1.0 110.302 -179.634 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -49.98 140.73 11.8 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.896 0.379 . . . . 1.0 111.428 -179.487 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 86.7 -7.11 80.98 Favored Glycine 0 N--CA 1.471 0.986 0 N-CA-C 111.116 -0.794 . . . . 1.0 111.116 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.41 ' OD2' ' CD1' ' A' ' 61' ' ' TYR . 23.3 t0 -65.03 134.06 53.03 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 109.937 -0.394 . . . . 1.0 109.937 179.101 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 5.0 mp -95.65 135.42 37.36 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 108.875 -0.787 . . . . 1.0 108.875 179.304 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 38.6 mm -93.19 131.07 41.23 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 N-CA-C 108.955 -0.757 . . . . 1.0 108.955 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 54.1 p -85.95 -54.43 4.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.863 -0.608 . . . . 1.0 110.181 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 74.7 tt0 -154.92 160.13 40.93 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 120.851 0.357 . . . . 1.0 110.941 -179.322 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 20.6 tt -143.54 143.96 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 N-CA-C 108.699 -0.852 . . . . 1.0 108.699 178.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 35.0 t70 46.06 17.59 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 112.24 0.459 . . . . 1.0 112.24 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.52 5.35 49.8 Favored Glycine 0 CA--C 1.529 0.961 0 N-CA-C 111.164 -0.774 . . . . 1.0 111.164 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 21.4 mm100 . . . . . 0 N--CA 1.481 1.078 0 CA-C-O 120.826 0.346 . . . . 1.0 110.614 -179.301 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 10.7 t . . . . . 0 N--CA 1.48 1.06 0 CA-C-O 120.886 0.374 . . . . 1.0 110.12 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 11.9 t -73.67 -51.13 17.73 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.106 -0.497 . . . . 1.0 110.718 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -63.44 -39.11 93.61 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.37 -0.377 . . . . 1.0 111.134 -178.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -56.16 -24.2 39.77 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.649 0.262 . . . . 1.0 110.657 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 38.6 t80 -72.36 -46.68 54.35 Favored 'General case' 0 C--O 1.225 -0.236 0 CA-C-O 120.926 0.393 . . . . 1.0 110.305 178.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.462 ' N ' HD12 ' A' ' 45' ' ' ILE . 1.7 mp -59.78 -31.37 47.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 N-CA-C 108.788 -0.819 . . . . 1.0 108.788 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -63.58 -37.98 89.38 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 116.104 -0.498 . . . . 1.0 110.613 -179.101 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -64.49 -43.78 93.06 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.716 0.293 . . . . 1.0 111.297 178.74 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 38.2 mt -55.43 -42.92 69.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 120.213 -0.595 . . . . 1.0 109.996 -174.383 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 38.8 m170 -78.29 -22.3 48.44 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.368 -0.378 . . . . 1.0 111.432 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 37.7 m -66.6 -14.75 62.8 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.236 0.458 . . . . 1.0 112.236 -178.097 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -111.57 147.71 34.84 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 108.754 -0.832 . . . . 1.0 108.754 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -91.39 171.12 9.43 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.182 0.593 . . . . 1.0 111.274 -178.407 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 14.6 t -67.06 137.72 24.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.218 -179.535 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 100.82 -27.3 21.17 Favored Glycine 0 N--CA 1.468 0.82 0 N-CA-C 111.369 -0.693 . . . . 1.0 111.369 178.319 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -55.73 149.64 14.08 Favored 'General case' 0 C--O 1.226 -0.166 0 CA-C-N 117.728 0.764 . . . . 1.0 111.568 -178.756 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 70.0 p -87.55 136.38 32.97 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 108.557 -0.905 . . . . 1.0 108.557 178.283 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -121.06 163.17 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 O-C-N 123.529 0.518 . . . . 1.0 110.641 -177.658 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -129.79 110.85 12.07 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 107.307 -1.368 . . . . 1.0 107.307 178.288 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 40.6 mm -100.52 137.84 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 109.743 -0.465 . . . . 1.0 109.743 -178.456 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 6.8 tppt? -128.27 113.87 16.2 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 106.776 -1.564 . . . . 1.0 106.776 177.329 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.41 ' CD1' ' OD2' ' A' ' 28' ' ' ASP . 27.2 p90 -145.5 157.85 43.93 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.929 0.395 . . . . 1.0 109.939 -178.497 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 25.5 pttm -130.07 135.62 48.44 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 115.757 -0.656 . . . . 1.0 109.733 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 59.4 t-80 -129.31 120.47 25.7 Favored 'General case' 0 C--N 1.347 0.464 0 N-CA-C 107.005 -1.479 . . . . 1.0 107.005 178.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 71.23 -117.18 6.63 Favored Glycine 0 CA--C 1.535 1.338 0 N-CA-C 110.777 -0.929 . . . . 1.0 110.777 -179.274 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -113.68 -19.93 11.38 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 122.86 0.464 . . . . 1.0 111.557 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 59.5 pttt -99.43 132.43 44.77 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-O 121.015 0.436 . . . . 1.0 111.236 -179.269 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -102.27 144.37 30.87 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 109.473 -0.565 . . . . 1.0 109.473 179.17 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -134.29 141.04 46.81 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 109.057 -0.72 . . . . 1.0 109.057 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -124.36 131.22 53.5 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 109.468 -0.567 . . . . 1.0 109.468 179.758 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -146.31 144.93 30.13 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.965 -0.561 . . . . 1.0 110.278 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 48.7 m -99.12 133.56 43.23 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 108.514 -0.921 . . . . 1.0 108.514 178.547 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 5.6 mt -138.57 138.97 42.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 CA-C-O 120.77 0.319 . . . . 1.0 111.33 -177.036 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 47.3 mttm -82.97 141.32 32.2 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 121.78 -0.575 . . . . 1.0 109.897 178.276 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.42 HD22 ' N ' ' A' ' 74' ' ' LEU . 3.5 mm? -62.04 148.32 44.42 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 109.262 -0.644 . . . . 1.0 109.262 179.119 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 66.9 p -135.93 162.14 33.68 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.15 0.58 . . . . 1.0 109.549 178.423 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -82.1 116.09 21.52 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 109.302 -0.629 . . . . 1.0 109.302 178.607 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.724 HD13 ' H ' ' A' ' 77' ' ' ILE . 0.1 OUTLIER -102.0 -18.53 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 C-N-CA 122.415 0.286 . . . . 1.0 111.273 -179.753 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -123.08 145.55 48.45 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-O 121.159 0.504 . . . . 1.0 110.915 -179.159 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 24.6 pttm -49.41 -18.8 0.43 Allowed 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.633 -0.712 . . . . 1.0 112.345 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 30.7 mtmm -80.44 -16.62 53.96 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 120.825 0.345 . . . . 1.0 110.908 -178.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 83.15 39.98 9.6 Favored Glycine 0 N--CA 1.468 0.818 0 N-CA-C 111.778 -0.529 . . . . 1.0 111.778 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 88.7 m -81.98 123.64 79.72 Favored Pre-proline 0 CA--C 1.553 1.058 0 CA-C-O 118.696 -0.668 . . . . 1.0 109.573 179.275 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -50.54 131.79 33.73 Favored 'Trans proline' 0 N--CA 1.506 2.24 0 C-N-CA 121.357 1.371 . . . . 1.0 111.986 177.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -172.4 163.74 35.92 Favored Glycine 0 CA--C 1.529 0.963 0 N-CA-C 111.136 -0.786 . . . . 1.0 111.136 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -111.87 35.51 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 CA-C-O 121.482 0.658 . . . . 1.0 109.432 -179.263 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.5 ' H ' HG21 ' A' ' 77' ' ' ILE . . . 53.17 58.9 10.42 Favored Glycine 0 N--CA 1.468 0.805 0 N-CA-C 111.083 -0.807 . . . . 1.0 111.083 179.168 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 21.6 pt -143.27 162.8 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-N 114.628 -0.786 . . . . 1.0 109.984 179.286 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 93.3 m -135.05 116.17 14.3 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-N 114.825 -1.08 . . . . 1.0 111.127 178.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 9.6 mp -97.74 135.99 38.73 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 122.925 0.49 . . . . 1.0 110.226 179.263 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 12.9 m . . . . . 0 N--CA 1.472 0.636 0 N-CA-C 108.918 -0.771 . . . . 1.0 108.918 178.031 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.0 ptt? . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 109.324 -0.621 . . . . 1.0 109.324 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.6 t -73.16 94.72 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-O 120.872 0.367 . . . . 1.0 110.03 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -87.31 63.1 7.58 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.148 -0.478 . . . . 1.0 109.887 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 12.0 p -67.01 137.38 24.93 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-N 116.2 -0.455 . . . . 1.0 109.781 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 70.1 p -99.27 160.7 14.09 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 109.65 -0.5 . . . . 1.0 109.65 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.402 ' CD2' ' O ' ' A' ' 6' ' ' TYR . 76.8 t80 -168.36 55.01 0.06 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.239 0.542 . . . . 1.0 109.714 179.58 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -150.25 81.35 1.36 Allowed 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.707 -0.679 . . . . 1.0 110.031 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -84.18 -148.71 9.23 Favored Glycine 0 C--N 1.339 0.709 0 N-CA-C 110.003 -1.239 . . . . 1.0 110.003 179.242 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.7 p -127.85 134.59 65.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 N-CA-C 109.014 -0.736 . . . . 1.0 109.014 178.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -89.52 149.41 22.91 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 109.484 -0.562 . . . . 1.0 109.484 -178.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 49.1 t -98.31 128.71 49.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 N-CA-C 108.793 -0.817 . . . . 1.0 108.793 179.223 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 8.2 tp -75.83 -39.89 55.88 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.986 0.422 . . . . 1.0 110.8 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.2 t -167.55 161.04 13.5 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.9 -0.591 . . . . 1.0 111.859 -178.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 44.0 t -132.87 115.7 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 CA-C-N 115.367 -0.833 . . . . 1.0 109.239 179.018 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.402 ' O ' ' N ' ' A' ' 17' ' ' ASP . 74.1 mmtt -73.26 105.21 4.57 Favored 'General case' 0 C--O 1.221 -0.404 0 N-CA-C 108.906 -0.776 . . . . 1.0 108.906 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -64.94 64.29 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 120.875 0.369 . . . . 1.0 111.698 -178.301 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.402 ' N ' ' O ' ' A' ' 15' ' ' LYS . 37.0 t70 -175.97 45.68 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 108.136 -1.061 . . . . 1.0 108.136 179.54 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 23.0 m -150.19 160.88 32.45 Favored Pre-proline 0 N--CA 1.483 1.19 0 CA-C-O 118.995 -0.526 . . . . 1.0 109.731 -178.42 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -47.3 -33.32 16.18 Favored 'Trans proline' 0 N--CA 1.506 2.242 0 C-N-CA 121.252 1.301 . . . . 1.0 112.543 177.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.06 -22.77 67.07 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 116.761 -0.2 . . . . 1.0 111.39 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.59 124.61 21.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.016 0.436 . . . . 1.0 111.008 -178.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.85 -9.71 70.61 Favored Glycine 0 N--CA 1.473 1.138 0 CA-C-N 115.663 -0.699 . . . . 1.0 111.633 179.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 71.0 mt -114.31 -50.9 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 C-N-CA 122.633 0.373 . . . . 1.0 110.289 -179.427 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 42.7 mt -113.18 148.38 35.54 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 108.777 -0.823 . . . . 1.0 108.777 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -139.92 154.33 47.2 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 115.745 -0.661 . . . . 1.0 110.023 -179.159 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.44 139.66 52.57 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.858 -0.61 . . . . 1.0 110.918 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 94.55 -6.84 71.14 Favored Glycine 0 N--CA 1.473 1.107 0 N-CA-C 111.083 -0.807 . . . . 1.0 111.083 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -74.49 150.89 39.65 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 109.637 -0.505 . . . . 1.0 109.637 179.043 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 5.0 mp -120.91 120.66 36.13 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 109.696 -0.483 . . . . 1.0 109.696 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 61.4 mt -89.39 134.63 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 N-CA-C 107.959 -1.126 . . . . 1.0 107.959 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 65.1 p -97.2 -49.2 5.06 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 116.741 -0.208 . . . . 1.0 111.279 -178.221 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.8 tp10 -154.05 159.83 41.73 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 121.256 0.55 . . . . 1.0 111.3 -178.242 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.424 ' O ' ' N ' ' A' ' 35' ' ' GLY . 4.7 mp -135.85 129.59 48.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 N-CA-C 107.611 -1.255 . . . . 1.0 107.611 179.192 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 41.57 20.14 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 113.077 0.769 . . . . 1.0 113.077 179.365 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 33' ' ' ILE . . . 69.22 6.56 54.16 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 111.101 -0.8 . . . . 1.0 111.101 179.521 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -86.85 134.49 33.54 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 120.82 0.343 . . . . 1.0 110.233 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 43.9 t -154.86 157.35 37.72 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 109.214 -0.661 . . . . 1.0 109.214 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -148.27 -26.14 0.33 Allowed 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.202 -0.454 . . . . 1.0 110.004 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -167.28 -108.37 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.898 0 CA-C-N 116.694 -0.23 . . . . 1.0 110.759 179.068 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 15.0 m -110.69 -141.8 0.38 Allowed 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.666 0.786 . . . . 1.0 110.084 -178.37 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 11.7 t -56.21 -40.7 74.43 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.507 0.194 . . . . 1.0 110.543 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -53.8 -28.68 36.69 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.367 -0.379 . . . . 1.0 110.719 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -58.86 -35.31 72.75 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.887 0.375 . . . . 1.0 110.393 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -68.85 -47.53 65.73 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 116.255 -0.43 . . . . 1.0 110.436 -179.487 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.513 ' N ' HD12 ' A' ' 45' ' ' ILE . 1.7 mp -52.69 -31.87 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 N-CA-C 108.998 -0.742 . . . . 1.0 108.998 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 47.3 m-20 -70.98 -37.87 72.74 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.797 -0.638 . . . . 1.0 111.431 -179.404 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 80.1 t80 -66.79 -52.68 41.19 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 120.8 0.333 . . . . 1.0 111.607 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -62.46 -26.05 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 N-CA-C 109.362 -0.607 . . . . 1.0 109.362 -178.449 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -90.66 -21.96 21.41 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 116.342 -0.39 . . . . 1.0 111.392 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 47.4 m -81.77 -13.62 57.49 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 122.422 -0.174 . . . . 1.0 111.295 -178.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 43.7 mmtm -95.27 -168.97 1.89 Allowed 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 109.992 -0.373 . . . . 1.0 109.992 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 3.6 mmpt? -131.23 159.26 38.31 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.184 0.594 . . . . 1.0 110.526 -178.057 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.5 t -64.59 140.43 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-N 115.764 -0.653 . . . . 1.0 110.33 -179.358 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 94.27 -12.9 68.34 Favored Glycine 0 N--CA 1.476 1.305 0 N-CA-C 110.843 -0.903 . . . . 1.0 110.843 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -67.85 -165.25 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 109.618 -0.512 . . . . 1.0 109.618 179.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 77.3 p -140.75 153.97 46.1 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 108.932 -0.766 . . . . 1.0 108.932 178.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 3.2 p -140.55 154.72 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 CA-C-O 121.102 0.477 . . . . 1.0 110.716 -179.017 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 49.4 mtmt -121.74 112.39 18.34 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 107.954 -1.128 . . . . 1.0 107.954 177.301 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.431 HD13 HD11 ' A' ' 72' ' ' ILE . 4.4 mp -99.2 138.65 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 N-CA-C 109.05 -0.722 . . . . 1.0 109.05 -178.793 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -111.19 113.31 25.72 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 105.607 -1.997 . . . . 1.0 105.607 177.445 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 17.8 p90 -149.84 156.87 42.53 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 109.611 -0.514 . . . . 1.0 109.611 -178.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 22.7 pttm -125.96 118.2 24.88 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 121.261 0.553 . . . . 1.0 110.053 -179.451 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -89.63 101.82 14.5 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 107.642 -1.244 . . . . 1.0 107.642 179.262 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 83.76 -111.94 3.5 Favored Glycine 0 CA--C 1.535 1.296 0 N-CA-C 111.475 -0.65 . . . . 1.0 111.475 -178.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -114.52 -2.43 13.16 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 122.826 0.45 . . . . 1.0 111.821 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 58.0 pttt -105.55 134.28 48.93 Favored 'General case' 0 N--CA 1.484 1.269 0 CA-C-O 121.162 0.506 . . . . 1.0 111.052 -179.187 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -84.08 119.58 25.13 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 109.747 -0.464 . . . . 1.0 109.747 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 69.7 mt-10 -119.9 152.79 36.84 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-N 115.51 -0.768 . . . . 1.0 110.021 -179.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -139.82 133.52 30.47 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 109.253 -0.647 . . . . 1.0 109.253 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -147.03 152.32 38.39 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.946 -0.57 . . . . 1.0 109.952 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.754 ' C ' HD13 ' A' ' 72' ' ' ILE . 17.7 t -125.41 136.53 53.51 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.005 -0.998 . . . . 1.0 108.576 179.024 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.754 HD13 ' C ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -128.68 149.07 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 O-C-N 123.418 0.449 . . . . 1.0 109.965 -178.907 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -78.42 136.34 37.62 Favored 'General case' 0 C--O 1.231 0.084 0 N-CA-C 108.186 -1.042 . . . . 1.0 108.186 178.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.446 HD22 ' N ' ' A' ' 74' ' ' LEU . 3.8 mm? -66.74 147.28 53.47 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.119 0.485 . . . . 1.0 110.598 -178.501 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 30.6 p -140.87 160.73 39.43 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.648 -0.705 . . . . 1.0 109.747 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -80.23 131.15 35.64 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 108.975 -0.75 . . . . 1.0 108.975 178.392 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -114.0 -52.66 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 123.127 0.571 . . . . 1.0 110.544 -179.287 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 57.4 p30 -99.61 162.55 12.95 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.327 0.584 . . . . 1.0 110.872 -178.105 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 59.5 pttt -51.15 -31.92 21.33 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.096 -0.956 . . . . 1.0 112.326 -178.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 26.2 ttmt -80.23 12.06 3.14 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 120.672 0.272 . . . . 1.0 110.762 -179.028 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 52.72 49.09 55.0 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 120.967 -0.635 . . . . 1.0 111.833 179.544 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 58.6 m -80.3 120.41 79.39 Favored Pre-proline 0 CA--C 1.54 0.573 0 CA-C-O 118.619 -0.705 . . . . 1.0 109.698 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -58.7 134.84 63.27 Favored 'Trans proline' 0 N--CA 1.497 1.693 0 CA-C-N 120.819 1.328 . . . . 1.0 112.122 177.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 148.81 152.53 5.74 Favored Glycine 0 N--CA 1.473 1.123 0 N-CA-C 112.003 -0.439 . . . . 1.0 112.003 178.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 6.5 pt -72.44 176.95 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 N-CA-C 108.369 -0.974 . . . . 1.0 108.369 177.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -103.27 86.92 0.55 Allowed Glycine 0 N--CA 1.473 1.12 0 N-CA-C 111.817 -0.513 . . . . 1.0 111.817 -179.068 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 48.8 pt -143.7 166.91 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 CA-C-N 115.504 -0.348 . . . . 1.0 110.17 178.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 95.4 m -128.44 128.99 45.47 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 109.182 -0.673 . . . . 1.0 109.182 177.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 12.9 mt -97.89 163.2 12.89 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.057 0.943 . . . . 1.0 109.853 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 24.2 t -103.05 141.46 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 CA-C-N 116.087 -0.506 . . . . 1.0 109.777 -178.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 22.0 p-10 -163.21 58.14 0.19 Allowed 'General case' 0 C--N 1.334 -0.104 0 CA-C-N 115.696 -0.684 . . . . 1.0 109.542 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 49.7 t0 57.99 107.64 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.213 -0.903 . . . . 1.0 110.592 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 75.6 mt -47.18 -83.24 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 111.858 0.318 . . . . 1.0 111.858 -178.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 49.9 -165.53 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 110.296 -0.261 . . . . 1.0 110.296 -179.393 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 44.1 m80 -88.19 -21.0 24.8 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 122.462 -0.149 . . . . 1.0 110.868 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 60.3 t-80 40.53 75.28 0.08 Allowed 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 122.577 0.351 . . . . 1.0 111.295 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 50.3 t-80 -166.7 90.71 0.4 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.859 0.362 . . . . 1.0 110.278 -178.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -66.1 -42.8 88.79 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.066 -0.516 . . . . 1.0 109.99 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -168.75 -55.12 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.332 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 56.4 t-80 . . . . . 0 C--O 1.219 -0.509 0 CA-C-O 118.034 -0.984 . . . . 1.0 110.937 -179.607 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.1 mtm . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 108.912 -0.773 . . . . 1.0 108.912 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 23.0 t -74.12 95.0 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 N-CA-C 109.697 -0.483 . . . . 1.0 109.697 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -138.72 -35.91 0.57 Allowed 'General case' 0 N--CA 1.48 1.036 0 CA-C-O 120.946 0.403 . . . . 1.0 110.261 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 12.3 p -65.03 -38.38 82.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.926 -0.579 . . . . 1.0 110.416 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 68.4 p -63.27 137.0 58.05 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.101 -0.499 . . . . 1.0 110.494 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 50.3 70.29 0.53 Allowed 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.362 -0.381 . . . . 1.0 111.259 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 33.7 p-10 -123.52 -130.16 0.26 Allowed 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 122.988 0.515 . . . . 1.0 109.651 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 161.14 -166.09 35.59 Favored Glycine 0 N--CA 1.461 0.318 0 N-CA-C 108.963 -1.655 . . . . 1.0 108.963 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.1 p -125.72 130.78 72.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 N-CA-C 109.222 -0.659 . . . . 1.0 109.222 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.465 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 0.2 OUTLIER -91.12 151.81 20.85 Favored 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 109.303 -0.628 . . . . 1.0 109.303 -178.863 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 56.1 t -106.0 127.48 61.06 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 N-CA-C 108.5 -0.926 . . . . 1.0 108.5 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 41.2 tp -79.97 -49.56 11.67 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-O 121.169 0.509 . . . . 1.0 111.063 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 97.2 p -167.21 163.19 15.44 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.571 -0.741 . . . . 1.0 111.403 -179.18 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.444 ' O ' ' O ' ' A' ' 15' ' ' LYS . 39.2 t -119.92 138.37 50.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 CA-C-N 114.952 -1.022 . . . . 1.0 109.659 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.444 ' O ' ' O ' ' A' ' 14' ' ' VAL . 36.3 tptt -39.49 -108.75 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 O-C-N 123.981 0.8 . . . . 1.0 111.778 179.468 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -159.61 20.01 0.17 Allowed 'General case' 0 N--CA 1.482 1.156 0 O-C-N 121.096 -1.002 . . . . 1.0 112.363 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.752 ' O ' ' O ' ' A' ' 18' ' ' VAL . 4.2 p-10 -169.02 -68.06 0.02 OUTLIER 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 107.109 -1.441 . . . . 1.0 107.109 178.035 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.752 ' O ' ' O ' ' A' ' 17' ' ' ASP . 29.3 m 4.46 148.2 0.0 OUTLIER Pre-proline 0 N--CA 1.504 2.237 0 O-C-N 125.874 1.984 . . . . 1.0 114.091 -177.181 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -56.7 9.18 0.04 OUTLIER 'Trans proline' 0 N--CA 1.496 1.673 0 CA-C-N 120.346 1.159 . . . . 1.0 113.206 -178.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.529 ' H ' ' C ' ' A' ' 18' ' ' VAL . . . -106.48 -24.15 12.29 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 109.435 -0.58 . . . . 1.0 109.435 177.07 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.691 ' HB3' ' O ' ' A' ' 17' ' ' ASP . . . -75.36 134.53 40.96 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-O 121.278 0.561 . . . . 1.0 110.247 179.374 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 90.75 -22.03 30.23 Favored Glycine 0 N--CA 1.471 0.977 0 CA-C-N 115.422 -0.808 . . . . 1.0 111.387 179.485 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 84.9 mt -105.36 -51.32 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 N-CA-C 109.945 -0.391 . . . . 1.0 109.945 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 18.8 mt -99.59 134.42 42.51 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 109.283 -0.636 . . . . 1.0 109.283 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -118.42 144.59 45.84 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 115.919 -0.582 . . . . 1.0 109.659 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -52.48 132.51 35.11 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 116.473 -0.331 . . . . 1.0 110.703 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 101.39 -4.38 54.62 Favored Glycine 0 N--CA 1.474 1.179 0 N-CA-C 111.601 -0.6 . . . . 1.0 111.601 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -72.82 152.38 41.57 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 117.506 0.653 . . . . 1.0 109.599 178.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.4 mp -124.15 122.31 37.48 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 122.753 0.421 . . . . 1.0 110.364 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 31.9 mm -74.78 122.44 28.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 N-CA-C 109.253 -0.647 . . . . 1.0 109.253 179.257 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 47.8 p -89.85 -43.77 10.4 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 116.4 -0.363 . . . . 1.0 111.023 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 72.9 tt0 -154.69 151.61 28.95 Favored 'General case' 0 N--CA 1.482 1.136 0 CA-C-O 120.991 0.424 . . . . 1.0 111.414 -178.643 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.41 HD13 ' CE1' ' A' ' 44' ' ' PHE . 1.6 mt -145.49 133.87 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 CA-C-O 120.977 0.417 . . . . 1.0 110.246 178.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 37.7 t70 54.5 34.94 22.19 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.808 -0.633 . . . . 1.0 111.256 178.321 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.18 -9.15 13.64 Favored Glycine 0 CA--C 1.531 1.058 0 N-CA-C 111.412 -0.675 . . . . 1.0 111.412 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -99.82 130.32 46.01 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 116.802 0.301 . . . . 1.0 110.264 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 90.6 p -103.52 102.71 12.61 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 122.583 0.353 . . . . 1.0 110.068 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -77.14 139.07 39.85 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 110.167 -0.309 . . . . 1.0 110.167 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 30.3 mtmm -94.79 -15.39 23.83 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 116.587 -0.279 . . . . 1.0 111.137 -179.465 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 49.0 m -129.57 150.46 50.9 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 122.678 0.391 . . . . 1.0 110.214 -179.386 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 46.6 t -64.26 -51.61 62.74 Favored 'General case' 0 C--O 1.219 -0.533 0 CA-C-N 116.417 -0.356 . . . . 1.0 110.575 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -53.88 -34.41 59.36 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 122.277 -0.265 . . . . 1.0 111.226 -179.121 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.0 tp10 -64.44 -36.81 85.39 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 109.299 -0.63 . . . . 1.0 109.299 179.134 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.41 ' CE1' HD13 ' A' ' 33' ' ' ILE . 5.0 t80 -66.69 -48.28 69.76 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.419 0.628 . . . . 1.0 109.537 178.568 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 26.3 mm -53.62 -27.96 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-N 115.542 -0.754 . . . . 1.0 110.313 -178.475 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -70.78 -35.23 72.49 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 116.359 -0.382 . . . . 1.0 110.119 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 28.7 t80 -67.18 -46.16 74.76 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.822 0.344 . . . . 1.0 110.997 178.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 25.7 mt -53.74 -38.55 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 115.954 -0.566 . . . . 1.0 109.945 -175.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 52.0 m-70 -80.89 -20.88 41.24 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 116.052 -0.522 . . . . 1.0 110.966 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 11.2 t -78.06 37.14 0.24 Allowed 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 120.748 0.308 . . . . 1.0 111.483 -178.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -146.55 -169.6 3.31 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 109.024 -0.732 . . . . 1.0 109.024 179.605 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -131.55 166.51 21.24 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 122.955 0.502 . . . . 1.0 109.759 -178.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 22.7 t -68.46 137.76 23.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 115.95 -0.568 . . . . 1.0 110.939 -178.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.75 -2.43 85.93 Favored Glycine 0 N--CA 1.478 1.484 0 N-CA-C 111.217 -0.753 . . . . 1.0 111.217 179.173 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -62.08 -168.91 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.832 -0.433 . . . . 1.0 109.832 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 23.4 m -146.55 139.88 25.72 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 108.972 -0.751 . . . . 1.0 108.972 179.632 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.459 HG22 ' N ' ' A' ' 58' ' ' LYS . 6.0 p -141.46 160.79 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 CA-C-N 116.305 -0.407 . . . . 1.0 110.172 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.459 ' N ' HG22 ' A' ' 57' ' ' VAL . 21.8 ttpp -112.71 123.28 49.94 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 108.111 -1.07 . . . . 1.0 108.111 177.587 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.497 HG22 ' O ' ' A' ' 70' ' ' ALA . 11.5 tt -101.02 143.03 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 C-N-CA 122.776 0.43 . . . . 1.0 111.003 -178.61 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 17.6 tptp -133.58 113.56 12.56 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 107.661 -1.237 . . . . 1.0 107.661 177.588 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 25.1 p90 -144.45 157.93 44.0 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 109.226 -0.657 . . . . 1.0 109.226 -179.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -116.24 115.79 26.62 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 117.912 0.324 . . . . 1.0 110.206 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -118.66 115.76 25.18 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 108.108 -1.071 . . . . 1.0 108.108 177.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 73.25 -133.63 18.48 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 110.716 -0.953 . . . . 1.0 110.716 -178.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -107.26 2.1 24.38 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 122.82 0.448 . . . . 1.0 111.072 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 20.8 pttp -122.37 119.5 31.23 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-O 121.593 0.711 . . . . 1.0 111.145 -179.437 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -82.97 123.92 29.89 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 109.386 -0.598 . . . . 1.0 109.386 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -114.51 142.03 46.94 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.062 0.545 . . . . 1.0 109.943 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -124.87 136.69 54.02 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 109.135 -0.691 . . . . 1.0 109.135 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.497 ' O ' HG22 ' A' ' 59' ' ' ILE . . . -148.69 128.42 13.32 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.301 0.572 . . . . 1.0 111.388 -179.168 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 12.2 m -87.03 139.53 30.48 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 109.146 -0.687 . . . . 1.0 109.146 178.436 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 11.1 pt -140.11 149.86 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-N 116.086 -0.506 . . . . 1.0 110.534 -178.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 18.4 pttp -93.19 139.03 31.04 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.541 -0.754 . . . . 1.0 109.235 178.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.45 HD22 ' N ' ' A' ' 74' ' ' LEU . 3.6 mm? -64.04 150.8 44.59 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 109.665 -0.494 . . . . 1.0 109.665 179.44 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 72.9 p -137.39 159.36 42.15 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 115.894 -0.594 . . . . 1.0 110.188 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -81.44 135.14 35.62 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 109.313 -0.625 . . . . 1.0 109.313 178.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.681 HD13 ' H ' ' A' ' 77' ' ' ILE . 0.1 OUTLIER -134.63 -8.53 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 C-N-CA 122.475 0.31 . . . . 1.0 111.313 -179.363 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -127.66 148.27 50.38 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 122.937 0.495 . . . . 1.0 110.173 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -48.72 -33.26 9.85 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.238 -0.437 . . . . 1.0 111.805 -179.355 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -79.04 7.45 7.35 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 120.756 0.313 . . . . 1.0 110.846 -179.364 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 57.4 46.29 92.02 Favored Glycine 0 CA--C 1.529 0.954 0 CA-C-N 116.215 -0.448 . . . . 1.0 112.519 178.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 4.5 m -79.6 119.15 75.9 Favored Pre-proline 0 CA--C 1.551 0.982 0 CA-C-O 118.875 -0.584 . . . . 1.0 109.771 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -52.93 125.98 19.95 Favored 'Trans proline' 0 N--CA 1.504 2.112 0 C-N-CA 121.285 1.323 . . . . 1.0 111.077 177.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 173.74 172.6 39.24 Favored Glycine 0 N--CA 1.469 0.854 0 C-N-CA 120.801 -0.714 . . . . 1.0 112.254 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.19 173.4 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 N-CA-C 106.976 -1.49 . . . . 1.0 106.976 177.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -104.55 83.6 0.4 Allowed Glycine 0 N--CA 1.475 1.264 0 N-CA-C 110.549 -1.02 . . . . 1.0 110.549 -179.06 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.505 HD13 ' H ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -143.62 168.15 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-O 121.373 0.606 . . . . 1.0 110.746 179.607 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 26.4 m -128.14 132.72 48.91 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 115.099 -0.955 . . . . 1.0 109.344 178.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.665 HD22 ' N ' ' A' ' 89' ' ' LEU . 0.9 OUTLIER -99.61 159.52 14.98 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 123.194 0.598 . . . . 1.0 109.41 -179.99 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.2 m -106.51 150.16 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 CA-C-N 115.672 -0.695 . . . . 1.0 110.018 -178.368 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 28.9 p-10 -163.38 68.23 0.2 Allowed 'General case' 0 C--O 1.232 0.16 0 CA-C-N 115.726 -0.67 . . . . 1.0 110.305 179.425 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.479 ' CG ' ' H ' ' A' ' 93' ' ' LEU . 17.8 p-10 -44.45 -79.62 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 115.806 -0.634 . . . . 1.0 111.062 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.479 ' H ' ' CG ' ' A' ' 92' ' ' ASP . 48.0 mt 52.36 64.09 1.99 Allowed 'General case' 0 CA--C 1.54 0.573 0 O-C-N 122.378 -0.201 . . . . 1.0 111.134 178.759 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 57.04 116.31 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.002 0.43 . . . . 1.0 110.656 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 92.0 m-70 -86.63 -5.38 59.15 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 122.245 -0.284 . . . . 1.0 110.433 -179.29 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.401 ' O ' ' CD2' ' A' ' 98' ' ' HIS . 96.6 m-70 51.85 39.42 25.71 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.011 0.434 . . . . 1.0 111.102 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 17.9 p80 -64.43 150.06 47.22 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.911 -0.586 . . . . 1.0 110.68 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.401 ' CD2' ' O ' ' A' ' 96' ' ' HIS . 93.4 m-70 -148.25 -34.3 0.23 Allowed 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 116.222 -0.445 . . . . 1.0 110.157 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 85.3 t60 -63.74 -45.61 89.08 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.22 -0.445 . . . . 1.0 110.887 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 63.6 t-80 . . . . . 0 C--O 1.219 -0.515 0 CA-C-O 118.014 -0.993 . . . . 1.0 110.772 -179.2 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.8 mtm . . . . . 0 N--CA 1.491 1.609 0 N-CA-C 109.021 -0.733 . . . . 1.0 109.021 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 27.1 m -67.05 146.21 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-N 116.303 -0.408 . . . . 1.0 110.164 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -153.39 -77.64 0.11 Allowed 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.955 0.407 . . . . 1.0 110.687 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 46.4 t -69.2 131.88 33.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.002 -0.545 . . . . 1.0 109.957 -179.368 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 57.9 p -68.16 -107.29 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 116.351 -0.386 . . . . 1.0 110.641 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -74.72 124.55 26.96 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.836 0.351 . . . . 1.0 110.074 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -70.12 -78.33 0.07 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.686 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 166.39 -175.36 41.83 Favored Glycine 0 N--CA 1.462 0.418 0 N-CA-C 109.968 -1.253 . . . . 1.0 109.968 -179.532 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 18.7 m -112.61 130.99 65.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 N-CA-C 108.859 -0.793 . . . . 1.0 108.859 179.283 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.449 ' CD1' HD22 ' A' ' 29' ' ' LEU . 10.0 m-85 -88.13 137.42 32.34 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 109.828 -0.434 . . . . 1.0 109.828 -177.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 62.1 t -90.28 127.51 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 N-CA-C 108.861 -0.792 . . . . 1.0 108.861 179.176 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 48.6 tp -81.05 -44.27 18.28 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 120.87 0.366 . . . . 1.0 111.144 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.2 t -163.31 156.87 19.48 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 121.317 0.58 . . . . 1.0 111.187 -178.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.4 p -137.12 134.9 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 CA-C-N 114.969 -1.014 . . . . 1.0 109.314 179.457 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -76.37 160.22 29.77 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 109.15 -0.685 . . . . 1.0 109.15 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -99.35 -5.63 29.29 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 111.673 0.249 . . . . 1.0 111.673 -178.221 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 25.0 p-10 -106.68 29.02 7.32 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 122.611 0.364 . . . . 1.0 110.908 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.6 m -130.75 156.13 80.34 Favored Pre-proline 0 N--CA 1.483 1.175 0 C-N-CA 123.137 0.575 . . . . 1.0 109.545 -179.378 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -56.57 -22.06 41.46 Favored 'Trans proline' 0 N--CA 1.505 2.2 0 C-N-CA 121.688 1.592 . . . . 1.0 112.141 -179.542 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.415 ' HB2' HG22 ' A' ' 85' ' ' ILE . . . -62.4 -26.96 68.76 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.147 0.499 . . . . 1.0 110.536 -179.494 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.67 125.36 25.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.572 -0.74 . . . . 1.0 110.935 -178.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 95.5 -15.71 62.68 Favored Glycine 0 N--CA 1.475 1.237 0 N-CA-C 111.478 -0.649 . . . . 1.0 111.478 179.224 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 81.2 mt -113.55 -49.9 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 N-CA-C 110.039 -0.356 . . . . 1.0 110.039 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 16.2 mt -110.75 147.55 34.19 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 109.613 -0.514 . . . . 1.0 109.613 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.4 ' CD2' ' OD1' ' A' ' 28' ' ' ASP . 13.6 p-80 -143.64 156.61 44.61 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.559 -0.746 . . . . 1.0 110.051 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.07 143.41 32.81 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 115.739 -0.664 . . . . 1.0 111.435 -179.189 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 95.06 -4.6 67.9 Favored Glycine 0 N--CA 1.474 1.168 0 N-CA-C 111.696 -0.562 . . . . 1.0 111.696 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.4 ' OD1' ' CD2' ' A' ' 25' ' ' HIS . 9.7 m-20 -82.8 123.04 28.97 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 117.145 0.473 . . . . 1.0 110.276 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.449 HD22 ' CD1' ' A' ' 10' ' ' TYR . 20.0 mt -97.92 121.07 39.39 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 109.711 -0.477 . . . . 1.0 109.711 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 16.0 mm -77.43 127.64 38.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 N-CA-C 108.948 -0.76 . . . . 1.0 108.948 -179.235 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 75.8 p -77.75 -51.95 9.72 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.291 -0.413 . . . . 1.0 110.678 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -155.14 166.28 34.07 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.032 0.444 . . . . 1.0 109.945 -179.153 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.444 HD11 ' CD1' ' A' ' 59' ' ' ILE . 1.0 OUTLIER -134.04 126.59 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-N 115.064 -0.971 . . . . 1.0 109.931 179.319 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 37.5 t70 48.97 16.91 0.13 Allowed 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.699 -0.682 . . . . 1.0 111.624 179.022 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.82 14.86 78.15 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 111.331 -0.708 . . . . 1.0 111.331 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -138.91 163.29 32.68 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-O 120.899 0.381 . . . . 1.0 110.297 -179.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 24.3 p 58.09 106.37 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.703 -0.68 . . . . 1.0 111.519 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.415 ' H ' ' H ' ' A' ' 39' ' ' LYS . 27.2 p90 -174.18 -1.05 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.202 -0.454 . . . . 1.0 110.851 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.415 ' H ' ' H ' ' A' ' 38' ' ' PHE . 32.6 mtmm -80.34 9.01 6.35 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.602 -0.272 . . . . 1.0 110.846 -179.199 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 21.2 t -174.29 156.63 2.61 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.49 179.387 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 50.3 m -65.78 -42.23 91.06 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.042 -0.526 . . . . 1.0 109.846 178.53 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -64.86 -37.88 89.11 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.069 -0.514 . . . . 1.0 111.067 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -54.82 -25.37 27.98 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.027 0.441 . . . . 1.0 110.037 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -70.29 -45.65 65.92 Favored 'General case' 0 C--O 1.221 -0.429 0 N-CA-C 109.154 -0.684 . . . . 1.0 109.154 179.305 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.508 ' N ' HD12 ' A' ' 45' ' ' ILE . 1.6 mp -64.28 -30.13 49.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 N-CA-C 108.896 -0.779 . . . . 1.0 108.896 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -63.13 -34.1 76.88 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.237 -179.067 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 32.2 t80 -69.14 -44.21 72.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.243 -0.435 . . . . 1.0 111.519 179.212 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 44.0 mt -57.44 -42.5 80.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.319 -0.401 . . . . 1.0 110.275 -175.387 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 54.2 m-70 -76.52 -18.76 58.55 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.309 -0.405 . . . . 1.0 111.117 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 13.0 t -92.33 46.48 1.26 Allowed 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 111.564 0.209 . . . . 1.0 111.564 -178.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 13.8 mmtm -149.31 175.74 11.16 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 109.242 -0.651 . . . . 1.0 109.242 179.26 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -130.1 154.1 47.81 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-O 121.067 0.46 . . . . 1.0 109.787 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 28.5 t -60.83 135.43 25.58 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 115.933 -0.576 . . . . 1.0 110.864 -178.306 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 97.55 -19.59 54.08 Favored Glycine 0 N--CA 1.477 1.422 0 N-CA-C 110.951 -0.86 . . . . 1.0 110.951 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -65.54 143.41 57.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.594 0.235 . . . . 1.0 110.497 -179.549 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 68.0 p -96.22 152.56 18.45 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 109.153 -0.684 . . . . 1.0 109.153 179.146 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 6.6 p -140.49 155.42 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 CA-C-O 121.232 0.539 . . . . 1.0 110.757 -179.376 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 31.6 mtmm -101.18 123.08 44.75 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.319 -0.855 . . . . 1.0 109.486 178.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.506 HG13 HD11 ' A' ' 72' ' ' ILE . 1.0 OUTLIER -117.71 136.06 56.08 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 C-N-CA 122.84 0.456 . . . . 1.0 110.109 179.693 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 12.8 ptpt -135.72 120.51 18.48 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 107.745 -1.206 . . . . 1.0 107.745 178.13 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 34.7 p90 -146.21 149.28 33.64 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 110.146 -0.316 . . . . 1.0 110.146 -179.627 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 20.9 pttm -111.57 114.49 27.59 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.355 0.598 . . . . 1.0 110.552 -179.544 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 70.5 t60 -98.69 120.87 39.85 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 108.045 -1.094 . . . . 1.0 108.045 178.4 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 61.6 -118.04 13.49 Favored Glycine 0 CA--C 1.531 1.034 0 N-CA-C 111.121 -0.791 . . . . 1.0 111.121 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 -114.16 14.55 18.23 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 122.942 0.497 . . . . 1.0 111.544 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 17.1 ptmt -122.75 121.16 35.66 Favored 'General case' 0 N--CA 1.485 1.309 0 CA-C-O 121.38 0.61 . . . . 1.0 111.157 -179.616 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -77.01 124.38 27.71 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 116.079 -0.51 . . . . 1.0 109.889 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -127.81 140.56 51.96 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 115.863 -0.608 . . . . 1.0 110.052 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.4 ' CD ' ' N ' ' A' ' 69' ' ' GLU . 1.9 pm0 -142.18 136.09 29.62 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 115.813 -0.63 . . . . 1.0 110.58 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -161.28 129.44 4.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.788 -0.642 . . . . 1.0 111.188 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 9.4 t -85.54 146.18 27.03 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 108.915 -0.772 . . . . 1.0 108.915 178.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.723 ' N ' HD13 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -134.55 149.83 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 CA-C-O 121.425 0.631 . . . . 1.0 110.329 -178.981 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.6 ttmp? -81.2 139.47 35.51 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 115.11 -0.95 . . . . 1.0 109.268 179.451 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -73.64 149.73 41.81 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.193 0.521 . . . . 1.0 110.0 179.611 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 27.3 p -140.73 164.17 30.91 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.398 -0.819 . . . . 1.0 110.123 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -79.97 131.95 35.92 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 109.271 -0.641 . . . . 1.0 109.271 178.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.3 pt -109.63 -55.88 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 CA-C-N 115.946 -0.57 . . . . 1.0 109.794 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.416 ' OD2' ' NZ ' ' A' ' 80' ' ' LYS . 40.9 t0 -98.41 171.53 8.11 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 121.507 0.67 . . . . 1.0 111.48 -178.095 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -60.16 -28.56 68.02 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.811 -1.086 . . . . 1.0 112.045 -179.339 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.416 ' NZ ' ' OD2' ' A' ' 78' ' ' ASP . 19.6 pttm -80.09 14.58 1.8 Allowed 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 120.619 0.247 . . . . 1.0 110.517 -179.374 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 49.24 41.15 30.77 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 112.169 -0.372 . . . . 1.0 112.169 178.532 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 15.9 m -80.02 120.51 80.0 Favored Pre-proline 0 CA--C 1.547 0.834 0 N-CA-C 109.544 -0.539 . . . . 1.0 109.544 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -52.95 131.8 44.23 Favored 'Trans proline' 0 N--CA 1.501 1.927 0 C-N-CA 121.463 1.442 . . . . 1.0 112.277 178.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -158.58 146.14 12.72 Favored Glycine 0 N--CA 1.468 0.788 0 N-CA-C 111.474 -0.65 . . . . 1.0 111.474 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.415 HG22 ' HB2' ' A' ' 20' ' ' ALA . 40.7 mm -67.6 -26.05 34.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.455 -0.373 . . . . 1.0 110.418 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 99.47 45.6 2.12 Favored Glycine 0 N--CA 1.475 1.255 0 N-CA-C 110.684 -0.966 . . . . 1.0 110.684 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 38.4 pt -145.15 166.89 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 N-CA-C 109.863 -0.421 . . . . 1.0 109.863 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 77.0 m -127.25 127.07 43.82 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 109.253 -0.647 . . . . 1.0 109.253 177.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.1 mp -99.39 146.69 26.03 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 120.797 0.332 . . . . 1.0 110.525 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.484 HG22 ' H ' ' A' ' 92' ' ' ASP . 7.7 p -104.99 164.11 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 CA-C-N 115.777 -0.647 . . . . 1.0 109.744 -179.042 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.463 ' N ' HG22 ' A' ' 90' ' ' VAL . 28.7 t70 -155.94 38.73 0.36 Allowed 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.043 0.449 . . . . 1.0 110.131 -179.154 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.484 ' H ' HG22 ' A' ' 90' ' ' VAL . 73.9 m-20 54.93 44.5 28.2 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.84 -0.618 . . . . 1.0 110.838 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 60.6 mt -59.29 -67.05 0.41 Allowed 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.1 -0.5 . . . . 1.0 110.356 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 69.5 mt-10 53.85 21.13 2.62 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.124 -0.489 . . . . 1.0 111.278 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' HIS . . . . . 0.419 ' O ' ' N ' ' A' ' 97' ' ' HIS . 65.4 m80 -88.83 -17.81 28.96 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 116.36 -0.382 . . . . 1.0 110.315 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.408 ' O ' ' N ' ' A' ' 98' ' ' HIS . 83.1 t60 54.08 -86.58 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.501 -0.318 . . . . 1.0 111.297 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' HIS . . . . . 0.419 ' N ' ' O ' ' A' ' 95' ' ' HIS . 83.1 t60 -65.96 72.87 0.07 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.952 0.406 . . . . 1.0 110.586 -179.497 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.537 ' CG ' ' H ' ' A' ' 99' ' ' HIS . 17.1 t-80 51.48 -122.9 2.05 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 116.322 -0.399 . . . . 1.0 110.977 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' HIS . . . . . 0.537 ' H ' ' CG ' ' A' ' 98' ' ' HIS . 8.7 t60 -68.99 -44.84 72.02 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 120.65 0.262 . . . . 1.0 111.077 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' HIS . . . . . 0.401 ' O ' ' CG ' ' A' ' 100' ' ' HIS . 82.2 t60 . . . . . 0 N--CA 1.469 0.483 0 CA-C-O 117.985 -1.007 . . . . 1.0 110.445 -178.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.3 ptt? . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.015 -0.735 . . . . 1.0 109.015 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 56.9 t -61.74 -44.14 98.3 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 N-CA-C 110.265 -0.272 . . . . 1.0 110.265 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -71.02 137.76 49.3 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.382 -0.372 . . . . 1.0 110.103 -179.484 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 41.1 t -141.88 83.09 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 N-CA-C 110.059 -0.348 . . . . 1.0 110.059 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 22.9 m -65.24 -51.69 59.24 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.443 -0.344 . . . . 1.0 111.483 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 52.3 p90 -69.29 146.6 52.11 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 120.77 0.319 . . . . 1.0 110.578 -179.442 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 48.7 p-10 -162.56 148.26 12.53 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.366 -0.605 . . . . 1.0 109.366 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -69.66 -160.17 2.52 Favored Glycine 0 CA--C 1.52 0.376 0 N-CA-C 110.122 -1.191 . . . . 1.0 110.122 179.289 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.9 m -112.82 132.41 61.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 N-CA-C 109.362 -0.607 . . . . 1.0 109.362 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -92.27 132.37 36.74 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 115.791 -0.64 . . . . 1.0 110.588 -178.244 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 57.3 t -77.56 134.55 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.126 0 N-CA-C 107.335 -1.357 . . . . 1.0 107.335 177.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.3 tt -81.03 -51.19 8.77 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.056 0.455 . . . . 1.0 111.163 -178.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.0 m -163.61 159.79 22.19 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.151 0.5 . . . . 1.0 111.343 -179.129 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 26.4 t -109.24 134.75 50.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-N 114.992 -1.004 . . . . 1.0 109.134 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -63.86 -36.55 84.29 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 116.4 -0.364 . . . . 1.0 110.675 -179.579 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 73.38 25.91 2.1 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.5 1.12 . . . . 1.0 111.835 -179.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -145.75 35.23 1.04 Allowed 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 108.709 -0.848 . . . . 1.0 108.709 178.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.446 HG23 ' HB3' ' A' ' 20' ' ' ALA . 6.5 m -145.08 158.06 52.74 Favored Pre-proline 0 N--CA 1.476 0.851 0 CA-C-N 115.903 -0.589 . . . . 1.0 110.238 -178.306 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -50.88 -15.08 1.57 Allowed 'Trans proline' 0 N--CA 1.505 2.171 0 C-N-CA 121.781 1.654 . . . . 1.0 112.17 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.525 ' HB2' HG22 ' A' ' 85' ' ' ILE . . . -64.55 -35.17 80.12 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.966 0.412 . . . . 1.0 110.591 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.56 129.71 41.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.924 -0.58 . . . . 1.0 111.313 -178.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.44 -7.52 75.06 Favored Glycine 0 N--CA 1.47 0.942 0 N-CA-C 111.109 -0.796 . . . . 1.0 111.109 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 52.9 mt -115.54 -50.61 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 CA-C-O 120.769 0.318 . . . . 1.0 110.498 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 28.4 mt -113.53 153.54 28.59 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.091 0.556 . . . . 1.0 110.101 -179.348 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 67.6 m80 -144.12 157.03 44.55 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.86 -0.609 . . . . 1.0 111.001 -179.015 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.05 140.3 38.4 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.924 -0.58 . . . . 1.0 111.134 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 91.81 -4.38 78.74 Favored Glycine 0 N--CA 1.471 0.972 0 N-CA-C 111.283 -0.727 . . . . 1.0 111.283 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -67.63 124.85 24.4 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 109.425 -0.583 . . . . 1.0 109.425 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 10.6 mt -96.61 122.28 39.36 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 109.095 -0.706 . . . . 1.0 109.095 179.207 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 33.7 mm -83.62 116.48 27.68 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 109.124 -0.695 . . . . 1.0 109.124 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 71.7 p -90.56 -39.78 12.34 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 116.278 -0.419 . . . . 1.0 111.436 -179.403 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.433 ' OE2' ' CD2' ' A' ' 38' ' ' PHE . 4.4 tp10 -146.32 148.78 32.75 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 109.826 -0.435 . . . . 1.0 109.826 -179.083 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.418 ' O ' ' N ' ' A' ' 35' ' ' GLY . 3.6 mt -129.59 128.86 66.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 108.709 -0.848 . . . . 1.0 108.709 179.211 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 26.5 t0 45.8 14.47 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 112.131 0.419 . . . . 1.0 112.131 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 33' ' ' ILE . . . 65.73 17.9 65.48 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.937 -0.865 . . . . 1.0 110.937 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -139.59 163.3 32.92 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-O 120.932 0.396 . . . . 1.0 110.625 -179.002 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.467 ' O ' ' CG ' ' A' ' 38' ' ' PHE . 46.7 t 63.44 -99.99 0.08 Allowed 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.189 -0.914 . . . . 1.0 110.862 -179.246 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.467 ' CG ' ' O ' ' A' ' 37' ' ' SER . 33.3 p90 44.59 13.32 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 112.27 0.47 . . . . 1.0 112.27 -178.827 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.462 ' N ' ' O ' ' A' ' 37' ' ' SER . 22.5 pttp -92.11 5.32 50.76 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.026 0.53 . . . . 1.0 111.289 -179.291 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.5 t -169.43 151.41 4.47 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.227 0.537 . . . . 1.0 110.122 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 73.1 m -75.93 -33.01 59.84 Favored 'General case' 0 C--O 1.218 -0.566 0 CA-C-N 115.702 -0.681 . . . . 1.0 109.917 179.064 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.407 ' NE2' ' OD2' ' A' ' 46' ' ' ASP . 0.0 OUTLIER -74.05 -45.4 49.74 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 120.948 0.404 . . . . 1.0 111.187 -178.897 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -56.56 -20.86 22.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.123 -0.489 . . . . 1.0 110.49 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -72.1 -52.18 17.99 Favored 'General case' 0 N--CA 1.461 0.097 0 C-N-CA 120.542 -0.463 . . . . 1.0 110.406 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.7 mp -54.05 -31.8 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 N-CA-C 108.651 -0.87 . . . . 1.0 108.651 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.407 ' OD2' ' NE2' ' A' ' 42' ' ' GLN . 61.8 m-20 -72.0 -32.57 67.32 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.018 -0.992 . . . . 1.0 111.227 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 77.3 t80 -69.23 -52.57 26.4 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 120.875 0.369 . . . . 1.0 111.479 -179.4 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -54.92 -25.63 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 N-CA-C 109.53 -0.545 . . . . 1.0 109.53 -177.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 42.5 m170 -94.15 -18.12 22.07 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.58 -0.737 . . . . 1.0 110.558 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 27.6 t -66.75 -22.43 66.04 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.712 0.291 . . . . 1.0 111.448 -178.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -90.48 -169.06 2.27 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 109.649 -0.5 . . . . 1.0 109.649 179.462 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.9 mptp? -122.46 168.29 12.29 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 122.958 0.503 . . . . 1.0 110.658 -179.015 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 22.1 t -65.2 135.1 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-N 115.738 -0.665 . . . . 1.0 110.732 -178.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.97 -0.88 86.54 Favored Glycine 0 N--CA 1.474 1.172 0 N-CA-C 110.968 -0.853 . . . . 1.0 110.968 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -73.54 147.18 44.2 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 110.235 -0.283 . . . . 1.0 110.235 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 80.7 p -86.51 150.33 24.33 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 109.574 -0.528 . . . . 1.0 109.574 178.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.409 HG12 ' O ' ' A' ' 72' ' ' ILE . 0.3 OUTLIER -141.93 161.58 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 CA-C-O 120.933 0.397 . . . . 1.0 111.244 -179.367 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 49.9 mtmt -123.4 114.52 20.26 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.011 -0.995 . . . . 1.0 108.734 177.692 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 35.3 mm -106.87 140.14 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 CA-C-O 121.004 0.431 . . . . 1.0 110.378 -179.412 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -131.99 115.77 16.26 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 106.942 -1.503 . . . . 1.0 106.942 177.413 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 29.5 p90 -143.12 164.23 30.71 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-N 116.123 -0.49 . . . . 1.0 110.073 -176.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 21.2 ttpp -127.31 114.84 18.12 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 123.423 0.452 . . . . 1.0 110.641 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -99.92 108.68 20.98 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 108.075 -1.083 . . . . 1.0 108.075 178.388 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 74.82 -114.28 4.31 Favored Glycine 0 CA--C 1.532 1.132 0 N-CA-C 111.128 -0.789 . . . . 1.0 111.128 -179.179 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 14.5 p30 -113.12 -10.91 13.38 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 122.674 0.39 . . . . 1.0 111.638 -179.661 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -99.23 133.77 43.04 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-O 120.706 0.289 . . . . 1.0 110.745 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 18.4 p30 -97.15 128.84 44.44 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.902 0.382 . . . . 1.0 110.133 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 74.1 mt-10 -132.94 155.01 49.89 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 115.738 -0.664 . . . . 1.0 109.854 -179.445 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -140.7 138.09 33.98 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.843 -0.617 . . . . 1.0 110.523 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -146.89 151.38 36.96 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.766 -0.652 . . . . 1.0 110.613 -179.047 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 50.5 m -102.67 134.02 46.72 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.353 -0.84 . . . . 1.0 109.166 179.133 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.409 ' O ' HG12 ' A' ' 57' ' ' VAL . 7.6 mt -135.7 139.94 45.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 CA-C-O 121.298 0.57 . . . . 1.0 110.494 -177.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 52.0 pttt -82.47 141.51 32.64 Favored 'General case' 0 C--N 1.327 -0.376 0 O-C-N 121.905 -0.497 . . . . 1.0 110.192 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -68.62 143.38 54.84 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 120.97 0.414 . . . . 1.0 110.082 178.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 80.5 p -136.32 162.96 31.57 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 115.809 -0.632 . . . . 1.0 110.433 179.109 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -78.44 122.84 26.34 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.885 -0.598 . . . . 1.0 109.713 179.023 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.433 ' CG1' ' N ' ' A' ' 78' ' ' ASP . 3.6 pt -96.06 -53.44 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-N 116.795 -0.184 . . . . 1.0 110.587 179.605 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.433 ' N ' ' CG1' ' A' ' 77' ' ' ILE . 44.3 t0 -98.08 169.65 9.46 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 121.365 0.602 . . . . 1.0 111.579 -178.328 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 47.0 mmtm -61.82 -23.9 66.53 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 114.902 -1.044 . . . . 1.0 111.904 -178.507 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 35.6 pttt -77.53 -15.55 59.2 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 120.479 0.18 . . . . 1.0 110.626 -178.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 83.03 40.18 9.53 Favored Glycine 0 N--CA 1.467 0.753 0 C-N-CA 121.424 -0.417 . . . . 1.0 112.075 178.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 53.2 m -81.21 120.16 77.74 Favored Pre-proline 0 CA--C 1.545 0.753 0 N-CA-C 109.324 -0.621 . . . . 1.0 109.324 179.109 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -52.79 130.88 39.35 Favored 'Trans proline' 0 N--CA 1.497 1.717 0 C-N-CA 121.142 1.228 . . . . 1.0 112.909 178.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -169.14 155.03 25.03 Favored Glycine 0 N--CA 1.461 0.318 0 N-CA-C 110.666 -0.974 . . . . 1.0 110.666 178.483 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.525 HG22 ' HB2' ' A' ' 20' ' ' ALA . 3.3 mt -89.66 26.4 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 N-CA-C 109.501 -0.555 . . . . 1.0 109.501 -179.414 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 50.52 63.62 4.27 Favored Glycine 0 CA--C 1.531 1.056 0 N-CA-C 111.782 -0.527 . . . . 1.0 111.782 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 18.7 pt -146.62 164.6 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 N-CA-C 109.353 -0.61 . . . . 1.0 109.353 179.273 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 86.1 m -130.36 125.5 34.77 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 115.477 -0.783 . . . . 1.0 109.581 177.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 12.7 mt -111.01 134.7 52.4 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.282 0.633 . . . . 1.0 109.801 -179.288 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.412 ' O ' ' C ' ' A' ' 91' ' ' ASP . 16.0 m -154.81 137.39 6.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 108.367 -0.975 . . . . 1.0 108.367 179.156 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.412 ' C ' ' O ' ' A' ' 90' ' ' VAL . 83.8 m-20 -25.68 -86.87 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.342 0.657 . . . . 1.0 112.541 179.623 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -169.67 41.03 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.013 0.435 . . . . 1.0 110.585 178.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 49.7 mt 55.56 71.5 0.54 Allowed 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.857 -0.611 . . . . 1.0 110.49 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -132.94 108.13 8.72 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 115.779 -0.646 . . . . 1.0 110.178 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -88.45 -18.64 27.86 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 116.455 -0.339 . . . . 1.0 110.539 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 73.9 m80 -71.58 128.82 37.06 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.284 -0.416 . . . . 1.0 109.954 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 78.7 t60 -168.6 29.23 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.823 0.344 . . . . 1.0 110.219 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 77.3 m80 -64.45 -40.68 96.19 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.402 -0.363 . . . . 1.0 110.056 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 59.9 t-80 -163.74 143.4 8.24 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.81 0.338 . . . . 1.0 110.594 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 55.7 t-80 . . . . . 0 C--O 1.221 -0.417 0 CA-C-O 117.976 -1.012 . . . . 1.0 111.028 179.992 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.2 mtm . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.17 -0.678 . . . . 1.0 109.17 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 27.9 m -66.1 146.13 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 N-CA-C 109.802 -0.444 . . . . 1.0 109.802 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 18.5 tptp -59.98 116.06 3.88 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.292 -179.49 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.3 t -90.41 98.35 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 N-CA-C 110.092 -0.336 . . . . 1.0 110.092 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 81.6 p -67.29 -81.04 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.586 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -71.18 150.05 45.73 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.828 0.347 . . . . 1.0 110.115 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -133.53 91.82 2.9 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 115.765 -0.652 . . . . 1.0 109.747 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -171.23 -159.34 17.11 Favored Glycine 0 CA--C 1.521 0.461 0 N-CA-C 109.948 -1.261 . . . . 1.0 109.948 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 16.6 m -117.96 128.81 75.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 CA-C-O 121.297 0.57 . . . . 1.0 109.731 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -86.7 146.17 26.4 Favored 'General case' 0 C--O 1.221 -0.396 0 N-CA-C 108.639 -0.874 . . . . 1.0 108.639 -178.053 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 57.0 t -107.96 132.06 56.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 108.951 -0.759 . . . . 1.0 108.951 179.232 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.513 HD23 HG11 ' A' ' 90' ' ' VAL . 0.2 OUTLIER -84.61 -50.83 7.33 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 116.287 -0.415 . . . . 1.0 111.245 -179.571 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 99.7 p -167.79 163.73 14.14 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 121.173 0.511 . . . . 1.0 111.301 -179.309 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 39.8 t -107.09 128.74 61.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 CA-C-N 115.128 -0.942 . . . . 1.0 108.497 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.413 ' O ' ' CB ' ' A' ' 16' ' ' GLU . 63.6 mttp -59.91 -36.75 77.64 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-N 116.099 -0.501 . . . . 1.0 110.55 -178.584 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.435 ' C ' ' H ' ' A' ' 18' ' ' VAL . 59.5 tt0 93.84 163.93 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.338 0 O-C-N 124.742 1.277 . . . . 1.0 111.129 178.572 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 70.59 -4.97 1.51 Allowed 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.496 -0.775 . . . . 1.0 109.567 -179.649 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.435 ' H ' ' C ' ' A' ' 16' ' ' GLU . 11.4 m -96.3 155.61 37.86 Favored Pre-proline 0 CA--C 1.541 0.604 0 CA-C-N 115.727 -0.669 . . . . 1.0 110.44 -178.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -55.92 -23.03 40.82 Favored 'Trans proline' 0 N--CA 1.503 2.058 0 C-N-CA 121.953 1.769 . . . . 1.0 112.226 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.44 -23.73 67.38 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.649 0.261 . . . . 1.0 110.852 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.5 136.0 44.1 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.306 -0.406 . . . . 1.0 110.887 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 91.28 -23.64 23.45 Favored Glycine 0 N--CA 1.469 0.89 0 N-CA-C 111.243 -0.743 . . . . 1.0 111.243 179.381 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 67.9 mt -102.12 -50.21 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 122.32 0.248 . . . . 1.0 110.489 -179.475 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 23.5 mt -109.89 157.15 19.53 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-O 121.077 0.465 . . . . 1.0 109.895 -179.343 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 50.3 t-80 -139.0 153.5 48.15 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.44 -0.8 . . . . 1.0 110.591 -179.094 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.42 144.39 31.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.369 -0.832 . . . . 1.0 110.812 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 89.01 -11.2 70.03 Favored Glycine 0 CA--C 1.528 0.898 0 N-CA-C 111.06 -0.816 . . . . 1.0 111.06 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -68.27 144.17 54.97 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 110.249 -0.278 . . . . 1.0 110.249 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.5 mp -117.75 121.45 40.87 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 110.127 -0.323 . . . . 1.0 110.127 -179.522 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 25.4 mm -80.36 125.88 39.29 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 N-CA-C 109.177 -0.675 . . . . 1.0 109.177 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 73.8 p -88.13 -47.36 8.54 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.169 -0.468 . . . . 1.0 110.449 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 71.9 tt0 -155.96 146.54 21.89 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.974 0.416 . . . . 1.0 111.222 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 12.6 tt -141.96 131.76 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 109.404 -0.591 . . . . 1.0 109.404 179.144 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.412 ' OD2' ' CE1' ' A' ' 47' ' ' TYR . 57.8 m-20 56.82 20.84 5.5 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.112 -0.494 . . . . 1.0 111.581 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.86 2.54 86.36 Favored Glycine 0 N--CA 1.472 1.063 0 CA-C-N 116.483 -0.326 . . . . 1.0 112.384 178.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -149.94 143.65 25.38 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 117.361 0.58 . . . . 1.0 111.008 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.458 ' OG ' ' N ' ' A' ' 38' ' ' PHE . 95.9 p -169.44 -66.18 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.204 0.526 . . . . 1.0 110.015 179.562 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.458 ' N ' ' OG ' ' A' ' 37' ' ' SER . 0.5 OUTLIER -54.48 179.29 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.262 -0.881 . . . . 1.0 110.137 179.736 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.439 ' O ' ' CB ' ' A' ' 40' ' ' SER . 3.4 tmtp? 66.49 64.83 0.49 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.215 -0.902 . . . . 1.0 110.816 179.645 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.439 ' CB ' ' O ' ' A' ' 39' ' ' LYS . 1.5 m 92.78 111.31 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.293 0.637 . . . . 1.0 110.757 179.684 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 50.3 m -52.52 -31.6 36.28 Favored 'General case' 0 N--CA 1.457 -0.089 0 N-CA-C 109.389 -0.597 . . . . 1.0 109.389 178.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.5 tm0? -55.38 -35.18 65.0 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 115.452 -0.795 . . . . 1.0 110.144 179.592 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -57.98 -27.86 63.85 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 115.963 -0.562 . . . . 1.0 109.779 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -72.59 -47.47 47.66 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.978 -0.555 . . . . 1.0 109.722 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 27.4 mm -63.55 -28.86 45.87 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 CA-C-N 115.797 -0.638 . . . . 1.0 109.833 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -62.62 -37.52 86.62 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.611 -0.722 . . . . 1.0 109.975 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.412 ' CE1' ' OD2' ' A' ' 34' ' ' ASP . 0.0 OUTLIER -66.62 -45.66 78.38 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.059 -0.519 . . . . 1.0 110.681 179.182 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 49.5 mt -60.61 -45.35 97.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 116.518 -0.31 . . . . 1.0 111.016 -176.761 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -74.16 -22.56 59.38 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.457 -0.338 . . . . 1.0 111.187 -178.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 46.6 t -85.81 -6.76 59.05 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-O 120.566 0.222 . . . . 1.0 111.217 -177.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.4 tptm -99.26 164.91 11.94 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-N 116.188 -0.46 . . . . 1.0 109.869 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -121.58 170.42 9.71 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 123.964 0.79 . . . . 1.0 109.893 -179.614 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 22.0 t -70.91 132.57 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-N 115.448 -0.797 . . . . 1.0 111.125 -178.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.37 -5.18 80.73 Favored Glycine 0 N--CA 1.469 0.854 0 N-CA-C 111.054 -0.818 . . . . 1.0 111.054 179.072 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -67.98 144.39 55.19 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.763 0.316 . . . . 1.0 110.751 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 36.3 m -90.19 153.72 20.29 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 108.988 -0.745 . . . . 1.0 108.988 178.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.469 HG12 ' O ' ' A' ' 72' ' ' ILE . 0.5 OUTLIER -140.13 161.27 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 CA-C-O 121.402 0.62 . . . . 1.0 110.599 -179.568 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -117.15 115.68 25.81 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 107.647 -1.242 . . . . 1.0 107.647 177.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.565 HG22 ' O ' ' A' ' 70' ' ' ALA . 2.9 tp -103.18 143.13 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 122.332 0.253 . . . . 1.0 111.018 -178.455 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 6.9 tppt? -133.1 112.75 12.03 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 108.383 -0.969 . . . . 1.0 108.383 178.041 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 33.8 p90 -149.15 149.2 30.64 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.906 -0.405 . . . . 1.0 109.906 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -110.18 114.12 27.35 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 110.239 -0.282 . . . . 1.0 110.239 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 51.3 t-80 -91.91 112.0 23.76 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 108.013 -1.106 . . . . 1.0 108.013 178.427 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 62.17 -114.45 6.8 Favored Glycine 0 CA--C 1.532 1.152 0 N-CA-C 110.7 -0.96 . . . . 1.0 110.7 -179.12 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 23.0 p-10 -112.99 -0.5 14.75 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 122.476 0.31 . . . . 1.0 111.365 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.437 ' NZ ' ' OE2' ' A' ' 68' ' ' GLU . 10.8 ptmm? -110.73 123.42 50.0 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 121.421 0.629 . . . . 1.0 110.75 -179.606 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 46.4 p-10 -81.93 128.24 33.85 Favored 'General case' 0 C--N 1.339 0.13 0 CA-C-O 121.363 0.601 . . . . 1.0 110.353 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.437 ' OE2' ' NZ ' ' A' ' 66' ' ' LYS . 81.0 mm-40 -126.11 148.83 49.28 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 115.23 -0.895 . . . . 1.0 109.523 -179.647 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -140.86 135.2 31.11 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 109.186 -0.672 . . . . 1.0 109.186 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.565 ' O ' HG22 ' A' ' 59' ' ' ILE . . . -148.1 142.22 26.04 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-O 121.537 0.684 . . . . 1.0 111.222 -179.398 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 91.5 p -85.7 135.03 33.93 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 108.781 -0.822 . . . . 1.0 108.781 178.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.469 ' O ' HG12 ' A' ' 57' ' ' VAL . 67.2 mt -129.28 122.37 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 CA-C-O 121.289 0.566 . . . . 1.0 109.963 -178.717 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 22.3 ttpp -82.29 138.3 34.61 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 109.64 -0.504 . . . . 1.0 109.64 179.197 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -69.68 143.97 53.0 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.373 0.606 . . . . 1.0 110.304 -178.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 69.7 p -143.28 172.25 13.0 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.064 -0.971 . . . . 1.0 110.435 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -89.3 140.83 29.1 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.343 -0.844 . . . . 1.0 109.583 179.408 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.822 HD13 ' H ' ' A' ' 77' ' ' ILE . 0.1 OUTLIER -131.92 -41.98 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 122.672 0.389 . . . . 1.0 110.839 -179.625 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -98.62 157.84 15.99 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 121.521 0.677 . . . . 1.0 110.729 -179.568 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -52.37 -27.09 14.25 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.845 -1.07 . . . . 1.0 112.046 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.544 ' HZ2' ' CB ' ' A' ' 82' ' ' THR . 18.1 pttp -81.4 13.24 3.07 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 116.303 -0.408 . . . . 1.0 111.039 -179.379 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 47.85 39.59 17.92 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 121.343 -0.456 . . . . 1.0 112.046 178.633 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.544 ' CB ' ' HZ2' ' A' ' 80' ' ' LYS . 86.8 m -80.17 122.09 82.55 Favored Pre-proline 0 CA--C 1.545 0.779 0 CA-C-N 117.101 0.451 . . . . 1.0 110.215 -179.159 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -57.03 114.86 2.11 Favored 'Trans proline' 0 N--CA 1.505 2.168 0 C-N-CA 121.401 1.4 . . . . 1.0 111.332 177.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -179.8 179.64 48.82 Favored Glycine 0 N--CA 1.463 0.449 0 N-CA-C 111.081 -0.808 . . . . 1.0 111.081 179.573 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.7 pt -105.69 177.5 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 N-CA-C 109.665 -0.495 . . . . 1.0 109.665 179.11 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -108.31 84.45 0.37 Allowed Glycine 0 N--CA 1.472 1.079 0 N-CA-C 111.05 -0.82 . . . . 1.0 111.05 -178.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.467 HD12 ' O ' ' A' ' 87' ' ' ILE . 1.2 pp -146.77 168.3 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-O 121.272 0.558 . . . . 1.0 109.645 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 62.3 m -132.23 131.39 42.06 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 115.424 -0.807 . . . . 1.0 109.557 179.265 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 29.2 mt -110.52 147.51 33.99 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.711 -0.677 . . . . 1.0 109.267 -179.366 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.513 HG11 HD23 ' A' ' 12' ' ' LEU . 30.8 m -111.96 171.02 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-N 115.773 -0.649 . . . . 1.0 110.395 -179.749 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 29.8 t70 62.26 33.39 16.65 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.266 -0.879 . . . . 1.0 110.535 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 21.7 p-10 -156.02 10.0 0.26 Allowed 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 116.171 -0.468 . . . . 1.0 111.051 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.43 ' O ' ' N ' ' A' ' 95' ' ' HIS . 1.8 pp -90.51 -27.5 19.16 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 116.094 -0.503 . . . . 1.0 110.358 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 78.6 tt0 -63.81 76.19 0.03 OUTLIER 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.548 -0.297 . . . . 1.0 110.222 -179.613 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' HIS . . . . . 0.43 ' N ' ' O ' ' A' ' 93' ' ' LEU . 57.2 t-80 -113.88 -0.21 14.23 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 122.471 0.309 . . . . 1.0 110.55 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 44.3 p-80 -157.9 -162.76 1.2 Allowed 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.776 0.322 . . . . 1.0 110.523 -179.534 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 77.4 t60 54.28 82.15 0.09 Allowed 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.084 -0.507 . . . . 1.0 111.093 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 34.6 p-80 -68.27 152.99 44.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.176 -0.466 . . . . 1.0 110.034 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' HIS . . . . . 0.433 ' CG ' ' N ' ' A' ' 100' ' ' HIS . 78.3 t60 56.99 162.83 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.929 -0.578 . . . . 1.0 111.833 179.518 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' HIS . . . . . 0.433 ' N ' ' CG ' ' A' ' 99' ' ' HIS . 31.6 p-80 . . . . . 0 C--O 1.22 -0.479 0 CA-C-N 115.031 -0.986 . . . . 1.0 109.354 179.184 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.1 ptt? . . . . . 0 N--CA 1.489 1.481 0 N-CA-C 109.364 -0.606 . . . . 1.0 109.364 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.1 p -63.03 -32.84 57.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-N 116.416 -0.357 . . . . 1.0 110.433 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -64.09 -10.49 22.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.991 -178.487 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 28.6 m -135.38 157.92 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 CA-C-O 121.189 0.519 . . . . 1.0 110.303 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.433 ' OG1' ' N ' ' A' ' 6' ' ' TYR . 2.8 t -82.26 179.42 7.81 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 115.404 -0.816 . . . . 1.0 110.58 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.433 ' N ' ' OG1' ' A' ' 5' ' ' THR . 59.4 t80 -67.86 121.91 17.03 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.966 -0.561 . . . . 1.0 110.25 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 36.3 p-10 -169.41 79.91 0.12 Allowed 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.905 -0.588 . . . . 1.0 110.049 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 153.67 -175.38 32.03 Favored Glycine 0 N--CA 1.467 0.75 0 N-CA-C 109.858 -1.297 . . . . 1.0 109.858 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 38.9 t -111.64 127.42 68.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 N-CA-C 109.18 -0.674 . . . . 1.0 109.18 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -86.85 143.36 27.49 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 115.962 -0.563 . . . . 1.0 109.634 -178.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 39.0 t -107.93 132.95 54.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 115.405 -0.816 . . . . 1.0 109.208 179.383 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.584 HD23 HG11 ' A' ' 90' ' ' VAL . 0.2 OUTLIER -81.67 -44.39 17.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.814 -0.63 . . . . 1.0 111.971 -179.547 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 99.9 p -165.8 162.39 18.47 Favored 'General case' 0 CA--C 1.506 -0.727 0 CA-C-N 116.061 -0.518 . . . . 1.0 110.953 -179.214 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.44 ' O ' ' O ' ' A' ' 15' ' ' LYS . 40.3 t -120.42 137.62 53.62 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 114.728 -1.124 . . . . 1.0 108.732 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.44 ' O ' ' O ' ' A' ' 14' ' ' VAL . 3.9 mmmm -54.43 -116.6 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.477 0 O-C-N 123.815 0.697 . . . . 1.0 110.294 179.129 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 78.1 tt0 -162.32 -70.13 0.05 Allowed 'General case' 0 C--N 1.33 -0.269 0 O-C-N 121.755 -0.591 . . . . 1.0 111.445 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 29.2 p-10 -89.97 51.7 2.12 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.346 -0.388 . . . . 1.0 110.569 -178.336 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 32.8 m -124.99 156.71 68.81 Favored Pre-proline 0 N--CA 1.471 0.616 0 CA-C-N 115.841 -0.618 . . . . 1.0 110.151 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -58.86 -13.18 17.3 Favored 'Trans proline' 0 N--CA 1.499 1.827 0 C-N-CA 121.751 1.634 . . . . 1.0 112.054 178.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.402 ' HB2' HG22 ' A' ' 85' ' ' ILE . . . -81.99 -27.46 33.15 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.068 0.461 . . . . 1.0 110.381 -179.404 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.91 130.5 41.17 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 115.694 -0.685 . . . . 1.0 110.134 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 98.57 -15.03 61.55 Favored Glycine 0 N--CA 1.472 1.054 0 N-CA-C 111.197 -0.761 . . . . 1.0 111.197 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 71.1 mt -115.23 -52.24 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 CA-C-N 116.616 0.208 . . . . 1.0 110.459 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.423 HD21 HD13 ' A' ' 59' ' ' ILE . 12.7 mt -102.0 149.77 23.9 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 109.816 -0.439 . . . . 1.0 109.816 -179.245 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 42.5 p-80 -141.11 154.89 46.13 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.389 0.614 . . . . 1.0 110.433 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.05 134.43 55.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.18 -0.918 . . . . 1.0 110.617 -179.664 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.27 -4.09 62.16 Favored Glycine 0 N--CA 1.471 0.983 0 N-CA-C 111.197 -0.761 . . . . 1.0 111.197 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -77.85 130.17 36.31 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 117.274 0.537 . . . . 1.0 110.264 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 14.3 mt -99.91 120.05 39.17 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 109.508 -0.552 . . . . 1.0 109.508 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.61 HD13 HD11 ' A' ' 59' ' ' ILE . 75.8 mt -92.34 137.51 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 N-CA-C 108.975 -0.75 . . . . 1.0 108.975 179.643 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 51.9 p -102.41 -43.93 5.52 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 116.13 -0.486 . . . . 1.0 111.216 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 73.0 tt0 -153.72 163.09 40.59 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.337 0.589 . . . . 1.0 111.176 -178.706 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 16.9 tt -149.61 142.56 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-N 115.906 -0.588 . . . . 1.0 110.028 179.447 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 28.3 t70 50.19 19.99 0.58 Allowed 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 120.994 0.426 . . . . 1.0 111.74 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.95 19.64 77.21 Favored Glycine 0 N--CA 1.47 0.955 0 N-CA-C 111.919 -0.472 . . . . 1.0 111.919 178.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -149.65 168.96 22.13 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 122.473 -0.427 . . . . 1.0 110.329 -179.034 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 81.52 112.44 0.06 Allowed 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.388 -0.823 . . . . 1.0 109.819 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.443 ' CD1' ' N ' ' A' ' 38' ' ' PHE . 0.5 OUTLIER -86.95 -152.99 0.2 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.901 0.382 . . . . 1.0 110.118 -179.068 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.414 ' O ' ' C ' ' A' ' 40' ' ' SER . 31.6 ttmt -59.63 -59.24 5.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.029 -0.532 . . . . 1.0 111.779 -178.491 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.414 ' C ' ' O ' ' A' ' 39' ' ' LYS . 30.6 t -27.28 117.07 0.08 Allowed 'General case' 0 N--CA 1.481 1.089 0 O-C-N 124.304 1.002 . . . . 1.0 111.128 -178.585 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 78.0 p -61.93 -48.65 79.47 Favored 'General case' 0 CA--C 1.513 -0.468 0 N-CA-C 109.404 -0.591 . . . . 1.0 109.404 -178.339 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 69.3 tp60 -51.43 -38.52 54.03 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.046 -0.525 . . . . 1.0 110.345 -178.5 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.8 tp10 -65.31 -32.64 74.39 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.347 -0.612 . . . . 1.0 109.347 179.044 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 27.8 t80 -72.11 -50.23 29.74 Favored 'General case' 0 C--O 1.219 -0.523 0 CA-C-N 116.337 -0.392 . . . . 1.0 110.204 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.7 mp -59.92 -37.18 70.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 109.247 -0.649 . . . . 1.0 109.247 179.456 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -60.49 -35.69 76.52 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.652 -0.704 . . . . 1.0 110.408 -178.428 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 44.4 t80 -68.08 -48.89 64.29 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.213 -0.449 . . . . 1.0 111.621 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 33.6 mt -52.78 -34.28 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-O 120.906 0.384 . . . . 1.0 110.427 -176.494 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 45.3 m170 -85.9 -22.54 27.43 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.036 -0.529 . . . . 1.0 111.121 -179.576 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 71.7 p -70.87 -17.98 62.71 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.645 -0.252 . . . . 1.0 111.269 -178.57 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 18.4 mmmt -90.48 -171.61 3.13 Favored 'General case' 0 CA--C 1.512 -0.492 0 N-CA-C 110.054 -0.35 . . . . 1.0 110.054 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -128.37 168.58 15.36 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 123.618 0.574 . . . . 1.0 110.148 -178.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 25.9 t -70.86 134.99 29.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.448 -0.796 . . . . 1.0 110.946 -178.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 90.31 -4.52 82.68 Favored Glycine 0 N--CA 1.47 0.938 0 N-CA-C 110.637 -0.985 . . . . 1.0 110.637 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -70.34 147.09 50.02 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 110.09 -0.337 . . . . 1.0 110.09 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 23.1 m -105.1 139.29 40.0 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 109.363 -0.606 . . . . 1.0 109.363 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 34.5 m -138.27 164.45 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 CA-C-N 116.12 -0.491 . . . . 1.0 111.535 -179.514 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.83 117.88 27.6 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 115.065 -0.971 . . . . 1.0 108.972 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.61 HD11 HD13 ' A' ' 30' ' ' ILE . 18.9 tt -97.72 141.79 15.39 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.201 0 O-C-N 123.314 0.384 . . . . 1.0 111.343 -178.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -121.43 119.91 33.43 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 107.721 -1.214 . . . . 1.0 107.721 178.303 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 18.7 p90 -147.75 161.26 41.59 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 110.065 -0.346 . . . . 1.0 110.065 -179.241 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 26.1 mtmm -128.27 117.84 22.22 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 123.464 0.477 . . . . 1.0 110.677 179.423 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 55.1 t60 -107.64 112.15 24.73 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 108.37 -0.974 . . . . 1.0 108.37 178.105 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 73.19 -118.34 6.27 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.944 -0.862 . . . . 1.0 110.944 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 68.0 m-80 -115.95 14.04 16.07 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 122.704 0.401 . . . . 1.0 111.802 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -126.28 119.79 28.29 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 120.82 0.343 . . . . 1.0 110.938 -179.392 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 61.3 t-20 -84.74 133.16 34.37 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-N 116.116 -0.493 . . . . 1.0 109.845 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -128.67 161.34 29.9 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 115.228 -0.897 . . . . 1.0 110.015 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -141.08 139.79 34.1 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 115.454 -0.794 . . . . 1.0 110.149 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -150.65 161.48 42.51 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 115.664 -0.698 . . . . 1.0 110.493 -178.043 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 91.0 p -128.27 138.28 52.35 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 109.096 -0.705 . . . . 1.0 109.096 179.313 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.721 ' N ' HD13 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -138.22 147.27 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-O 121.491 0.662 . . . . 1.0 110.535 -178.189 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 7.8 ttpm? -86.57 135.21 33.52 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.387 -0.824 . . . . 1.0 109.846 179.384 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -68.98 147.58 51.4 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.151 0.5 . . . . 1.0 110.498 179.593 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 18.6 p -141.17 168.61 19.36 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 115.187 -0.915 . . . . 1.0 110.659 -179.235 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -80.25 148.34 30.83 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.192 -0.913 . . . . 1.0 109.887 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.446 HG13 ' H ' ' A' ' 78' ' ' ASP . 1.6 pt -128.89 -55.92 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 CA-C-N 115.996 -0.547 . . . . 1.0 110.782 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.446 ' H ' HG13 ' A' ' 77' ' ' ILE . 68.5 m-20 -96.33 165.81 12.02 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 121.466 0.65 . . . . 1.0 110.987 -178.077 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 24.1 pttm -57.03 -18.5 14.2 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.685 -1.143 . . . . 1.0 111.502 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -81.54 -13.95 57.46 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 116.834 -0.166 . . . . 1.0 111.351 -179.073 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 77.72 30.75 51.84 Favored Glycine 0 N--CA 1.469 0.897 0 N-CA-C 111.366 -0.694 . . . . 1.0 111.366 179.414 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 85.8 m -79.26 125.51 83.16 Favored Pre-proline 0 CA--C 1.546 0.797 0 C-N-CA 120.455 -0.498 . . . . 1.0 109.761 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_exo -50.73 128.97 25.73 Favored 'Trans proline' 0 N--CA 1.501 1.914 0 C-N-CA 121.595 1.53 . . . . 1.0 112.553 178.183 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -152.14 130.07 2.98 Favored Glycine 0 N--CA 1.468 0.809 0 N-CA-C 111.078 -0.809 . . . . 1.0 111.078 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.402 HG22 ' HB2' ' A' ' 20' ' ' ALA . 96.1 mt -59.68 -25.52 32.15 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 N-CA-C 110.47 -0.196 . . . . 1.0 110.47 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 100.01 46.69 1.86 Allowed Glycine 0 N--CA 1.481 1.659 0 N-CA-C 111.211 -0.755 . . . . 1.0 111.211 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.471 HD13 HD21 ' A' ' 89' ' ' LEU . 1.1 pp -146.93 164.98 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 N-CA-C 109.67 -0.492 . . . . 1.0 109.67 -178.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 15.9 m -128.76 121.94 29.5 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 115.408 -0.814 . . . . 1.0 110.584 178.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.775 HD22 ' N ' ' A' ' 89' ' ' LEU . 0.4 OUTLIER -99.73 139.37 35.49 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.389 0.676 . . . . 1.0 109.759 -179.861 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.584 HG11 HD23 ' A' ' 12' ' ' LEU . 9.1 m -107.38 177.41 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 114.884 -1.053 . . . . 1.0 109.424 -179.325 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 64.75 42.05 4.8 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 124.433 1.083 . . . . 1.0 110.325 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 48.0 p30 -92.5 175.7 6.73 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 115.942 -0.572 . . . . 1.0 110.539 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 60.1 mt -64.38 -39.41 93.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.561 -0.745 . . . . 1.0 110.944 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -64.25 149.23 48.42 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.079 -0.509 . . . . 1.0 109.653 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -88.16 -6.83 57.65 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.464 -0.335 . . . . 1.0 110.815 -179.172 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 55.0 t-80 57.11 115.14 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.352 0 O-C-N 123.519 0.512 . . . . 1.0 110.924 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 85.1 t60 53.3 87.52 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.303 -0.408 . . . . 1.0 111.124 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 40.5 p-80 -68.87 165.29 20.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.19 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 39.9 p-80 -156.78 160.07 38.89 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.238 0.542 . . . . 1.0 111.303 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 83.8 t60 . . . . . 0 C--O 1.22 -0.474 0 CA-C-O 117.961 -1.019 . . . . 1.0 109.104 178.924 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mpt? . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 108.902 -0.777 . . . . 1.0 108.902 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 18.8 t 55.42 74.44 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-N 116.259 -0.428 . . . . 1.0 110.565 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -65.2 -35.55 81.42 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.325 -0.398 . . . . 1.0 110.842 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 35.7 m -62.52 145.32 13.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.934 -0.575 . . . . 1.0 110.727 -179.298 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 23.9 m -61.96 -50.28 72.74 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.229 -0.441 . . . . 1.0 111.324 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 71.1 t80 55.4 104.2 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 120.829 0.347 . . . . 1.0 110.638 -179.043 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 34.0 t0 -169.4 111.25 0.48 Allowed 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.544 -0.539 . . . . 1.0 109.544 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -77.53 -161.33 14.76 Favored Glycine 0 N--CA 1.464 0.521 0 N-CA-C 110.243 -1.143 . . . . 1.0 110.243 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.6 t -111.93 129.65 67.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 N-CA-C 109.722 -0.473 . . . . 1.0 109.722 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -85.87 141.65 29.44 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.385 -0.598 . . . . 1.0 109.385 -178.441 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.6 t -100.45 136.0 33.84 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.31 0 CA-C-N 115.121 -0.945 . . . . 1.0 109.521 179.61 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 42.3 tp -89.72 -51.84 5.31 Favored 'General case' 0 N--CA 1.458 -0.071 0 CA-C-N 116.052 -0.522 . . . . 1.0 110.778 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 44.4 m -158.6 151.86 22.8 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.285 0.564 . . . . 1.0 110.845 -178.644 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.4 p -137.42 135.2 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-N 114.821 -1.081 . . . . 1.0 109.623 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -71.28 152.92 42.8 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.93 -0.767 . . . . 1.0 108.93 178.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -96.14 15.3 21.22 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 116.778 -0.192 . . . . 1.0 111.377 -178.026 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -133.77 41.62 3.01 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 109.132 -0.692 . . . . 1.0 109.132 179.308 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 8.7 m -141.31 153.13 65.87 Favored Pre-proline 0 CA--C 1.542 0.66 0 CA-C-N 115.786 -0.643 . . . . 1.0 110.0 -179.654 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.718 ' O ' HD13 ' A' ' 23' ' ' ILE . 80.9 Cg_exo -45.1 -30.85 5.17 Favored 'Trans proline' 0 N--CA 1.496 1.633 0 C-N-CA 122.178 1.919 . . . . 1.0 113.109 179.307 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.79 -23.82 67.43 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.059 0.457 . . . . 1.0 110.314 -178.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.0 107.44 1.25 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.81 -0.632 . . . . 1.0 110.144 179.298 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.542 ' C ' HD12 ' A' ' 23' ' ' ILE . . . 108.05 -4.62 33.84 Favored Glycine 0 N--CA 1.476 1.304 0 N-CA-C 111.317 -0.713 . . . . 1.0 111.317 -179.611 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.718 HD13 ' O ' ' A' ' 19' ' ' PRO . 3.3 mp -117.19 -50.15 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 122.461 0.304 . . . . 1.0 110.787 179.485 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 12.1 mt -112.03 150.46 30.6 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 121.242 0.544 . . . . 1.0 110.314 -179.175 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 -145.46 158.55 43.82 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.293 -0.867 . . . . 1.0 110.852 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.41 124.64 20.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.46 -0.791 . . . . 1.0 110.276 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 99.64 -4.44 58.02 Favored Glycine 0 N--CA 1.471 1.028 0 N-CA-C 111.129 -0.788 . . . . 1.0 111.129 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -74.96 141.94 43.98 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.979 0.39 . . . . 1.0 110.038 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 25.6 mt -115.96 121.13 41.36 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 109.958 -0.386 . . . . 1.0 109.958 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 62.4 mt -91.69 135.94 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 N-CA-C 107.883 -1.154 . . . . 1.0 107.883 178.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 3.0 p -123.72 -23.3 4.74 Favored 'General case' 0 N--CA 1.479 0.978 0 O-C-N 123.416 0.447 . . . . 1.0 111.408 -178.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 59.1 tt0 -152.27 147.21 26.09 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 120.924 -0.311 . . . . 1.0 110.536 -178.666 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.467 ' O ' ' N ' ' A' ' 35' ' ' GLY . 4.1 mp -135.89 137.11 49.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 N-CA-C 108.742 -0.836 . . . . 1.0 108.742 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 42.73 17.29 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 122.893 0.477 . . . . 1.0 112.118 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 33' ' ' ILE . . . 64.29 17.89 62.28 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 111.493 -0.643 . . . . 1.0 111.493 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.445 ' OE1' ' CE1' ' A' ' 47' ' ' TYR . 12.0 pt20 -82.96 166.48 18.81 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 122.532 -0.393 . . . . 1.0 111.81 -178.545 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 49.4 m -83.75 161.7 20.91 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.848 -0.615 . . . . 1.0 109.842 178.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.437 ' CE2' ' O ' ' A' ' 36' ' ' GLN . 1.3 p90 -172.59 -174.63 1.19 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.457 -0.792 . . . . 1.0 109.437 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -141.75 -68.76 0.38 Allowed 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.869 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 44.2 m -98.29 165.63 11.78 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.176 0.512 . . . . 1.0 110.486 -179.281 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 78.4 p -60.58 -29.82 69.42 Favored 'General case' 0 C--O 1.215 -0.717 0 N-CA-C 109.312 -0.625 . . . . 1.0 109.312 178.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -64.17 -30.71 71.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.925 -0.579 . . . . 1.0 110.741 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -60.33 -26.94 66.96 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.775 0.322 . . . . 1.0 110.444 -178.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -72.28 -51.13 22.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.997 0.427 . . . . 1.0 110.233 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.551 ' N ' HD12 ' A' ' 45' ' ' ILE . 1.7 mp -57.39 -28.77 31.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 108.979 -0.749 . . . . 1.0 108.979 -179.042 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -70.64 -33.77 71.35 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.487 -0.779 . . . . 1.0 110.808 -178.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.445 ' CE1' ' OE1' ' A' ' 36' ' ' GLN . 84.0 t80 -69.48 -52.21 28.7 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 120.69 -0.404 . . . . 1.0 111.888 -178.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -67.08 -39.62 83.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-N 116.257 -0.428 . . . . 1.0 109.996 -178.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 81.0 t60 -59.59 -13.73 10.55 Favored 'General case' 0 CA--C 1.503 -0.838 0 CA-C-N 116.25 -0.432 . . . . 1.0 111.088 -178.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 21.6 t -96.74 -142.68 0.28 Allowed 'General case' 0 N--CA 1.434 -1.251 0 CA-C-O 122.008 0.909 . . . . 1.0 109.042 178.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 30.1 mmtp 48.2 -169.84 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 114.26 -1.336 . . . . 1.0 110.049 -177.353 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -131.58 154.89 48.38 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.121 0.486 . . . . 1.0 110.319 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.6 t -59.88 142.57 15.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.578 -0.737 . . . . 1.0 111.03 -179.109 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 102.17 -20.45 45.15 Favored Glycine 0 N--CA 1.474 1.189 0 N-CA-C 110.596 -1.002 . . . . 1.0 110.596 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 -62.0 -174.13 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.794 0.331 . . . . 1.0 110.525 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.9 t -148.9 145.51 27.46 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 109.623 -0.51 . . . . 1.0 109.623 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 23.0 m -140.66 165.82 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 CA-C-O 121.116 0.484 . . . . 1.0 111.442 -178.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -119.68 120.03 35.44 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 114.877 -1.056 . . . . 1.0 108.385 178.517 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.5 tt -103.82 147.3 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 123.026 0.53 . . . . 1.0 110.907 -178.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 33.3 ttmt -131.02 117.27 18.93 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 108.207 -1.034 . . . . 1.0 108.207 177.468 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 26.1 p90 -136.49 165.33 26.1 Favored 'General case' 0 C--N 1.34 0.195 0 CA-C-N 115.92 -0.582 . . . . 1.0 110.581 -177.539 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -121.17 139.25 53.61 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.308 -0.86 . . . . 1.0 110.466 -179.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 80.2 t60 -130.64 101.23 5.6 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.756 -0.656 . . . . 1.0 109.336 178.331 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 60.98 -110.41 3.03 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 110.702 -0.959 . . . . 1.0 110.702 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -112.82 13.72 19.76 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 122.578 0.351 . . . . 1.0 111.396 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 7.6 ttpm? -130.39 116.18 17.91 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 116.636 -0.256 . . . . 1.0 110.546 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -100.85 135.77 41.76 Favored 'General case' 0 C--N 1.341 0.236 0 N-CA-C 109.722 -0.473 . . . . 1.0 109.722 179.465 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -135.47 166.56 22.9 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 109.303 -0.628 . . . . 1.0 109.303 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.418 ' CD ' ' N ' ' A' ' 69' ' ' GLU . 3.0 pm0 -141.24 140.45 33.93 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.706 -0.679 . . . . 1.0 110.574 -179.73 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.4 ' HB3' HG23 ' A' ' 23' ' ' ILE . . . -149.92 154.63 38.61 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.794 -0.639 . . . . 1.0 110.681 -178.822 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 29.6 m -115.86 139.76 49.89 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 115.181 -0.918 . . . . 1.0 109.352 179.143 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -136.59 146.86 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-O 121.384 0.612 . . . . 1.0 110.469 -178.089 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -82.39 138.74 34.37 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.201 -0.908 . . . . 1.0 109.576 179.181 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.491 HD22 ' N ' ' A' ' 74' ' ' LEU . 4.1 mm? -67.24 146.45 54.16 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.442 0.639 . . . . 1.0 110.874 -179.356 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 45.4 p -140.91 160.1 40.8 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.052 -0.976 . . . . 1.0 110.796 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -80.32 131.71 35.69 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.346 -0.843 . . . . 1.0 109.537 179.554 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 10.7 pt -122.68 -44.98 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 122.677 0.391 . . . . 1.0 111.05 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.401 ' OD2' ' NZ ' ' A' ' 80' ' ' LYS . 30.6 t70 -99.81 156.98 16.82 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 121.636 0.732 . . . . 1.0 110.908 -179.118 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 10.3 mmpt? -48.44 -32.3 7.52 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.647 -1.161 . . . . 1.0 111.759 -179.594 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.401 ' NZ ' ' OD2' ' A' ' 78' ' ' ASP . 29.2 mtmm -82.72 12.42 4.76 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.415 -0.357 . . . . 1.0 111.375 -178.746 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 56.12 47.32 81.8 Favored Glycine 0 C--N 1.334 0.422 0 N-CA-C 111.635 -0.586 . . . . 1.0 111.635 178.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 86.5 m -79.87 120.37 79.71 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 120.491 -0.484 . . . . 1.0 110.471 -179.432 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -56.03 132.36 51.51 Favored 'Trans proline' 0 N--CA 1.498 1.787 0 C-N-CA 121.703 1.602 . . . . 1.0 111.738 177.637 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 154.98 179.41 30.14 Favored Glycine 0 N--CA 1.468 0.774 0 N-CA-C 110.62 -0.992 . . . . 1.0 110.62 178.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.417 ' N ' HD13 ' A' ' 85' ' ' ILE . 0.0 OUTLIER -103.92 -177.57 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 N-CA-C 109.037 -0.727 . . . . 1.0 109.037 -179.566 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -103.84 78.61 0.29 Allowed Glycine 0 C--N 1.339 0.699 0 N-CA-C 110.667 -0.973 . . . . 1.0 110.667 -179.214 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 49.7 pt -138.08 163.4 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 C-N-CA 122.796 0.438 . . . . 1.0 109.988 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 84.8 m -130.13 128.04 41.0 Favored 'General case' 0 N--CA 1.478 0.948 0 O-C-N 123.72 0.637 . . . . 1.0 109.777 177.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 54.1 mt -110.42 146.16 36.34 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 123.183 0.593 . . . . 1.0 110.153 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 33.7 m -107.05 171.57 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-N 115.606 -0.724 . . . . 1.0 110.176 -179.128 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -163.19 32.98 0.09 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.733 -0.667 . . . . 1.0 110.452 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.442 ' C ' ' H ' ' A' ' 94' ' ' GLU . 29.6 t0 58.09 164.4 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.752 -0.658 . . . . 1.0 110.814 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 37.6 mt 57.77 4.18 0.25 Allowed 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.281 -0.418 . . . . 1.0 111.049 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.442 ' H ' ' C ' ' A' ' 92' ' ' ASP . 48.3 tp10 -78.09 -36.57 47.99 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 116.308 -0.405 . . . . 1.0 110.378 -179.341 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 61.7 t-80 -87.78 -19.95 26.81 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.576 0.227 . . . . 1.0 110.712 -178.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 45.1 m80 -70.18 -71.1 0.25 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.77 0.319 . . . . 1.0 110.44 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -78.66 161.37 26.97 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.275 -0.42 . . . . 1.0 110.671 -179.672 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -162.27 52.66 0.21 Allowed 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.139 -0.482 . . . . 1.0 110.053 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 41.2 m170 -66.18 -40.21 90.31 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.917 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 41.7 p-80 . . . . . 0 C--O 1.218 -0.557 0 CA-C-O 117.795 -1.097 . . . . 1.0 109.443 179.767 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.2 ptt? . . . . . 0 N--CA 1.492 1.66 0 N-CA-C 108.958 -0.756 . . . . 1.0 108.958 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.6 p -61.9 -29.62 46.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.956 -0.565 . . . . 1.0 110.387 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 50.3 mtmt -61.19 109.96 1.26 Allowed 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.258 -0.428 . . . . 1.0 110.47 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 10.2 p -64.38 147.23 12.55 Favored 'Isoleucine or valine' 0 C--O 1.232 0.158 0 CA-C-N 116.45 -0.341 . . . . 1.0 110.233 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 33.4 m -152.27 -50.54 0.11 Allowed 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 116.274 -0.421 . . . . 1.0 109.961 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -66.72 145.19 55.81 Favored 'General case' 0 N--CA 1.463 0.184 0 N-CA-C 109.957 -0.386 . . . . 1.0 109.957 179.561 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -135.48 -33.41 0.88 Allowed 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 116.247 -0.433 . . . . 1.0 110.054 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 42.73 -146.38 0.82 Allowed Glycine 0 N--CA 1.473 1.132 0 N-CA-C 111.294 -0.722 . . . . 1.0 111.294 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.9 t -135.23 127.53 47.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 N-CA-C 108.628 -0.879 . . . . 1.0 108.628 178.218 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.46 ' CZ ' HD13 ' A' ' 29' ' ' LEU . 97.1 m-85 -102.08 132.69 47.79 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 121.256 0.55 . . . . 1.0 110.255 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 61.2 t -76.87 132.1 33.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 N-CA-C 108.152 -1.055 . . . . 1.0 108.152 179.149 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.432 ' O ' HD23 ' A' ' 12' ' ' LEU . 1.7 tt -76.14 -51.66 11.71 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-O 121.558 0.694 . . . . 1.0 110.71 -178.753 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 92.4 p -155.75 153.05 29.29 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.641 -0.709 . . . . 1.0 111.253 -179.11 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 51.7 t -136.84 113.77 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 108.706 -0.85 . . . . 1.0 108.706 178.581 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 34.3 mtmm -70.87 163.62 27.0 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 109.662 -0.496 . . . . 1.0 109.662 179.071 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 28.8 mp0 -98.83 46.36 0.99 Allowed 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 116.402 -0.363 . . . . 1.0 111.199 -179.175 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -158.36 35.15 0.24 Allowed 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 109.96 -0.385 . . . . 1.0 109.96 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 15.8 m -142.49 157.45 62.46 Favored Pre-proline 0 N--CA 1.481 1.09 0 N-CA-C 108.847 -0.797 . . . . 1.0 108.847 -179.043 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -45.8 -37.96 17.09 Favored 'Trans proline' 0 N--CA 1.507 2.31 0 CA-C-N 121.049 1.41 . . . . 1.0 112.807 179.235 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.26 -15.63 60.48 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.159 -0.473 . . . . 1.0 111.589 -179.239 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.95 139.41 46.74 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-O 121.195 0.521 . . . . 1.0 111.499 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 79.69 -11.13 34.82 Favored Glycine 0 N--CA 1.463 0.469 0 CA-C-N 115.352 -0.84 . . . . 1.0 111.94 176.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 67.2 mt -115.2 -50.85 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 N-CA-C 109.88 -0.415 . . . . 1.0 109.88 -178.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 15.0 mt -107.36 134.36 50.53 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 115.756 -0.656 . . . . 1.0 110.032 -179.147 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -110.84 132.7 53.98 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.784 -0.644 . . . . 1.0 109.525 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -47.64 137.14 9.56 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 120.751 0.31 . . . . 1.0 111.606 -178.598 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 94.93 -3.3 67.16 Favored Glycine 0 N--CA 1.471 0.969 0 N-CA-C 111.039 -0.824 . . . . 1.0 111.039 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -65.18 123.72 20.27 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 120.912 0.387 . . . . 1.0 110.545 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.46 HD13 ' CZ ' ' A' ' 10' ' ' TYR . 37.8 tp -88.16 131.5 34.7 Favored 'General case' 0 C--O 1.208 -1.087 0 CA-C-O 118.085 -0.959 . . . . 1.0 109.024 179.689 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 18.3 mm -87.96 125.4 41.45 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 119.485 1.039 . . . . 1.0 108.988 178.196 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 82.0 p -97.03 -36.26 10.57 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 122.449 0.3 . . . . 1.0 111.223 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -153.5 149.5 27.77 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 109.867 -0.42 . . . . 1.0 109.867 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.504 HD13 ' H ' ' A' ' 34' ' ' ASP . 0.3 OUTLIER -147.17 139.67 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 N-CA-C 107.84 -1.17 . . . . 1.0 107.84 -179.998 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.504 ' H ' HD13 ' A' ' 33' ' ' ILE . 36.1 t70 47.79 22.05 0.32 Allowed 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 112.139 0.422 . . . . 1.0 112.139 178.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.34 -8.0 54.9 Favored Glycine 0 CA--C 1.529 0.92 0 N-CA-C 111.411 -0.675 . . . . 1.0 111.411 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -87.84 159.39 18.42 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 110.016 -0.364 . . . . 1.0 110.016 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 81.2 p -97.92 -93.6 0.23 Allowed 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 116.308 -0.406 . . . . 1.0 111.42 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 59.2 139.95 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 122.822 0.449 . . . . 1.0 110.863 -178.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -132.46 85.35 2.22 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-O 121.085 0.469 . . . . 1.0 110.26 -179.313 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.1 p 176.52 156.07 0.25 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.622 -1.172 . . . . 1.0 109.368 178.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 79.8 p -77.72 -51.78 10.01 Favored 'General case' 0 C--O 1.223 -0.293 0 CA-C-N 116.4 -0.364 . . . . 1.0 110.189 179.308 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -52.16 -42.38 63.36 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 122.099 -0.376 . . . . 1.0 111.27 -177.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -66.57 -31.34 71.98 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.218 -0.66 . . . . 1.0 109.218 178.681 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -73.98 -48.97 26.62 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.773 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.8 mp -55.6 -33.94 34.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 N-CA-C 108.319 -0.993 . . . . 1.0 108.319 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -64.4 -38.57 91.48 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.809 -0.632 . . . . 1.0 111.471 -179.226 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 77.3 t80 -67.57 -52.1 42.63 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 120.748 -0.381 . . . . 1.0 111.653 -178.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -67.78 -44.35 85.7 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 CA-C-O 120.553 0.216 . . . . 1.0 110.714 -179.321 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 63.8 t-80 -65.0 -16.94 64.0 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.668 -0.242 . . . . 1.0 111.365 -178.686 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 90.2 p -104.97 -4.2 22.36 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 122.319 0.248 . . . . 1.0 111.329 -178.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.449 ' HZ1' ' CG ' ' A' ' 55' ' ' ASP . 14.3 tptp -87.54 135.67 33.25 Favored 'General case' 0 C--O 1.211 -0.95 0 N-CA-C 108.711 -0.848 . . . . 1.0 108.711 179.609 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -69.03 153.55 43.59 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 111.884 0.327 . . . . 1.0 111.884 -178.417 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.6 t -64.74 141.12 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-N 116.388 -0.369 . . . . 1.0 110.931 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 89.95 -23.74 19.05 Favored Glycine 0 N--CA 1.469 0.865 0 CA-C-N 116.011 -0.54 . . . . 1.0 111.963 177.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.449 ' CG ' ' HZ1' ' A' ' 51' ' ' LYS . 11.7 t70 -53.7 151.9 5.76 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-N 117.354 0.577 . . . . 1.0 111.377 -178.4 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.0 m -104.96 128.63 53.32 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 121.376 0.607 . . . . 1.0 110.075 179.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 30.7 m -117.61 171.62 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 124.383 1.073 . . . . 1.0 109.829 -178.426 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 18.1 ttmm -125.43 113.9 18.13 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 107.376 -1.342 . . . . 1.0 107.376 178.329 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.566 HG22 ' O ' ' A' ' 70' ' ' ALA . 1.6 tp -97.55 141.9 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 122.643 0.377 . . . . 1.0 110.53 -178.188 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.11 112.24 10.99 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 107.379 -1.341 . . . . 1.0 107.379 177.218 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 24.5 p90 -144.77 160.89 40.52 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 110.36 -0.237 . . . . 1.0 110.36 -178.587 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -134.76 136.9 42.97 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 109.154 -0.684 . . . . 1.0 109.154 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 61.6 t-80 -128.42 126.43 40.56 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 107.835 -1.172 . . . . 1.0 107.835 178.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 62.82 -117.18 10.66 Favored Glycine 0 CA--C 1.531 1.041 0 N-CA-C 110.65 -0.98 . . . . 1.0 110.65 -179.468 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -113.47 -21.58 10.78 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 122.845 0.458 . . . . 1.0 110.856 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -90.89 123.31 34.31 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 121.593 0.711 . . . . 1.0 111.598 -178.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 57.4 m-20 -92.96 135.94 33.71 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 109.446 -0.575 . . . . 1.0 109.446 -179.332 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 64.7 mt-10 -137.76 142.1 40.93 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 109.98 -0.378 . . . . 1.0 109.98 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -140.66 138.23 34.15 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 110.067 -0.346 . . . . 1.0 110.067 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.566 ' O ' HG22 ' A' ' 59' ' ' ILE . . . -151.16 147.43 27.03 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-O 121.547 0.689 . . . . 1.0 112.778 -177.304 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 90.6 p -90.97 127.87 36.58 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 109.485 -0.561 . . . . 1.0 109.485 177.404 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.4 mp -130.44 129.06 64.48 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 N-CA-C 108.772 -0.825 . . . . 1.0 108.772 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 5.4 ptpt -81.38 142.92 32.56 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 122.023 -0.423 . . . . 1.0 110.517 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.419 HD22 ' N ' ' A' ' 74' ' ' LEU . 3.5 mm? -61.32 145.14 52.46 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 109.936 -0.394 . . . . 1.0 109.936 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 72.3 p -134.82 155.1 51.22 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 115.972 -0.558 . . . . 1.0 110.259 178.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -79.93 122.28 26.5 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 108.752 -0.833 . . . . 1.0 108.752 178.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.789 HD13 ' H ' ' A' ' 77' ' ' ILE . 0.1 OUTLIER -118.07 -14.19 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 C-N-CA 122.597 0.359 . . . . 1.0 111.689 -178.714 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -120.02 145.72 46.56 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.052 0.453 . . . . 1.0 110.347 -179.285 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 24.0 pttm -47.72 -27.16 1.84 Allowed 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 115.658 -0.701 . . . . 1.0 112.343 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 14.4 pttm -81.29 -16.3 52.91 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-O 120.751 0.31 . . . . 1.0 110.343 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 81.81 50.56 4.89 Favored Glycine 0 N--CA 1.468 0.826 0 N-CA-C 111.891 -0.483 . . . . 1.0 111.891 179.088 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 32.4 m -81.68 119.42 75.37 Favored Pre-proline 0 CA--C 1.549 0.917 0 CA-C-O 118.915 -0.564 . . . . 1.0 110.062 179.395 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_exo -53.09 118.32 4.69 Favored 'Trans proline' 0 N--CA 1.505 2.165 0 CA-C-N 120.744 1.301 . . . . 1.0 111.369 177.487 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 173.1 -174.74 46.0 Favored Glycine 0 N--CA 1.469 0.866 0 C-N-CA 120.581 -0.818 . . . . 1.0 112.676 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -116.48 170.79 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 N-CA-C 107.258 -1.386 . . . . 1.0 107.258 178.491 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -90.91 42.67 2.87 Favored Glycine 0 N--CA 1.475 1.262 0 CA-C-N 118.1 0.409 . . . . 1.0 112.479 -177.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 48.8 pt -111.68 176.09 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 122.405 0.282 . . . . 1.0 110.341 -178.416 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 62.9 m -132.33 130.18 40.44 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 115.805 -0.634 . . . . 1.0 109.844 178.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 69.1 mt -104.65 143.54 32.94 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.022 0.529 . . . . 1.0 109.927 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.1 m -103.88 178.24 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 C-N-CA 123.379 0.672 . . . . 1.0 111.333 -177.475 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.3 t70 88.56 -27.16 0.06 Allowed 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 114.336 -1.302 . . . . 1.0 109.428 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 42.4 p30 -54.45 176.21 0.04 OUTLIER 'General case' 0 CA--C 1.529 0.164 0 CA-C-O 121.054 0.454 . . . . 1.0 111.388 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 46.4 mt -67.5 -40.41 85.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.606 -0.725 . . . . 1.0 110.336 179.625 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -65.83 100.86 0.59 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.318 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 45.4 p-80 -88.87 -18.74 26.97 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.484 -0.325 . . . . 1.0 110.621 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 21.1 p80 -68.62 147.17 52.3 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.315 -0.402 . . . . 1.0 110.522 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -161.0 9.95 0.09 Allowed 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.412 -0.358 . . . . 1.0 110.555 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 84.8 t60 53.69 89.39 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.308 -0.406 . . . . 1.0 111.127 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 61.4 m80 54.33 -179.5 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.097 -0.502 . . . . 1.0 111.192 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 60.3 t-80 . . . . . 0 C--O 1.221 -0.435 0 CA-C-O 117.975 -1.012 . . . . 1.0 110.397 179.949 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.1 mmt . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.306 -0.628 . . . . 1.0 109.306 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 8.2 p -168.47 -27.97 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 CA-C-N 116.351 -0.386 . . . . 1.0 110.443 179.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -70.27 4.86 1.97 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.616 0.246 . . . . 1.0 110.613 -179.306 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 25.2 t 55.16 83.58 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-N 116.491 -0.322 . . . . 1.0 110.38 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 25.6 m -61.76 -48.24 81.55 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.53 -0.304 . . . . 1.0 111.098 -179.282 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -119.19 -92.58 0.53 Allowed 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 122.866 0.466 . . . . 1.0 110.428 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.456 ' CG ' ' H ' ' A' ' 8' ' ' GLY . 9.6 p30 -177.03 -99.24 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 109.798 -0.445 . . . . 1.0 109.798 -179.498 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.456 ' H ' ' CG ' ' A' ' 7' ' ' ASP . . . 178.61 -159.31 24.41 Favored Glycine 0 CA--C 1.519 0.332 0 N-CA-C 109.86 -1.296 . . . . 1.0 109.86 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.7 m -111.54 128.39 68.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 N-CA-C 109.125 -0.695 . . . . 1.0 109.125 179.185 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.463 ' N ' ' O ' ' A' ' 90' ' ' VAL . 11.5 m-85 -88.45 132.23 34.56 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 121.329 0.585 . . . . 1.0 109.527 -178.015 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 83.7 t -76.46 134.54 28.69 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.227 0 N-CA-C 107.337 -1.357 . . . . 1.0 107.337 179.083 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.52 -51.57 6.1 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.578 0.227 . . . . 1.0 110.707 -178.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 40.2 t -154.03 150.68 28.5 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.004 0.431 . . . . 1.0 111.003 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 46.7 t -110.56 113.22 43.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-N 115.191 -0.913 . . . . 1.0 108.952 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.407 ' O ' ' O ' ' A' ' 16' ' ' GLU . 62.5 mttp -86.37 92.19 8.74 Favored 'General case' 0 C--O 1.221 -0.411 0 N-CA-C 108.384 -0.969 . . . . 1.0 108.384 179.327 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.47 ' H ' ' CD ' ' A' ' 16' ' ' GLU . 3.3 pm0 -44.77 -179.24 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.489 0 O-C-N 124.073 0.858 . . . . 1.0 112.689 -178.766 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 26.7 t70 62.73 30.0 16.78 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.683 -0.69 . . . . 1.0 109.763 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 28.3 m -133.6 157.13 78.72 Favored Pre-proline 0 N--CA 1.484 1.247 0 CA-C-N 115.954 -0.566 . . . . 1.0 110.558 -179.339 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -49.5 -38.57 44.48 Favored 'Trans proline' 0 N--CA 1.503 2.049 0 C-N-CA 121.253 1.302 . . . . 1.0 112.874 178.685 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.44 -17.33 62.57 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.505 -0.316 . . . . 1.0 110.929 -178.51 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.06 118.14 9.4 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 110.352 -0.24 . . . . 1.0 110.352 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 98.83 -3.76 59.0 Favored Glycine 0 N--CA 1.473 1.123 0 N-CA-C 111.604 -0.598 . . . . 1.0 111.604 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 65.1 mt -114.29 -50.48 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 CA-C-N 116.973 0.386 . . . . 1.0 110.247 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 48.1 mt -110.43 151.43 27.5 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.099 0.56 . . . . 1.0 110.114 -179.493 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.407 ' HE2' ' CE1' ' A' ' 63' ' ' HIS . 18.4 p-80 -143.5 155.1 44.24 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.403 -0.817 . . . . 1.0 110.105 -179.193 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.74 139.14 40.3 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 115.373 -0.831 . . . . 1.0 111.101 -179.217 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 91.82 -3.48 77.8 Favored Glycine 0 CA--C 1.528 0.889 0 N-CA-C 111.179 -0.769 . . . . 1.0 111.179 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -79.68 126.53 31.05 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 117.148 0.474 . . . . 1.0 110.501 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 17.5 mt -102.54 129.86 49.21 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 109.069 -0.715 . . . . 1.0 109.069 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 30.8 mm -85.17 127.39 39.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 N-CA-C 109.417 -0.586 . . . . 1.0 109.417 179.614 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 66.4 p -93.12 -42.13 9.56 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 116.599 -0.273 . . . . 1.0 110.708 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 73.1 tt0 -153.71 152.58 30.94 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.694 0.283 . . . . 1.0 110.379 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.534 HD13 ' H ' ' A' ' 34' ' ' ASP . 0.3 OUTLIER -137.87 138.53 43.9 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 N-CA-C 108.951 -0.759 . . . . 1.0 108.951 -179.218 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.534 ' H ' HD13 ' A' ' 33' ' ' ILE . 37.6 t70 46.46 25.85 0.43 Allowed 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.211 0.529 . . . . 1.0 111.732 179.329 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.94 4.62 49.09 Favored Glycine 0 CA--C 1.527 0.815 0 CA-C-N 115.812 -0.631 . . . . 1.0 111.579 179.364 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -81.88 130.91 35.22 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 120.999 0.428 . . . . 1.0 110.635 -179.458 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 98.5 p -61.19 -117.61 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.752 -0.658 . . . . 1.0 111.081 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 56.88 171.55 0.04 OUTLIER 'General case' 0 CA--C 1.52 -0.176 0 CA-C-O 120.768 0.318 . . . . 1.0 110.309 -179.191 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 32.9 tptt -153.6 -69.43 0.14 Allowed 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 120.918 -0.313 . . . . 1.0 110.266 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 96.0 p -30.47 137.74 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.051 0 O-C-N 123.98 0.8 . . . . 1.0 111.635 -178.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 81.2 p -58.71 -50.8 72.55 Favored 'General case' 0 C--O 1.22 -0.45 0 C-N-CA 120.464 -0.494 . . . . 1.0 110.039 -178.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -48.88 -42.65 37.46 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.462 0.172 . . . . 1.0 111.244 -178.439 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.1 tp10 -69.79 -32.04 70.29 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.315 -0.624 . . . . 1.0 109.315 178.451 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -71.29 -49.77 39.42 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.9 0.381 . . . . 1.0 110.75 -179.43 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 38.4 mm -58.53 -29.07 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 115.516 -0.765 . . . . 1.0 109.639 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -66.92 -35.56 80.27 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.703 -0.681 . . . . 1.0 110.702 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -68.68 -46.91 67.82 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-O 121.223 0.535 . . . . 1.0 111.248 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 42.7 mt -52.66 -41.5 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-N 115.687 -0.688 . . . . 1.0 110.267 -175.469 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 32.3 m-70 -83.91 -18.97 35.6 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.074 -0.512 . . . . 1.0 111.275 -179.676 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 24.8 t -63.64 -24.94 68.0 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 111.646 0.239 . . . . 1.0 111.646 -178.159 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 48.7 mttm -94.23 -174.81 3.48 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 120.961 0.41 . . . . 1.0 110.107 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -130.63 161.58 31.27 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 115.46 -0.791 . . . . 1.0 110.536 -178.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 26.2 t -65.81 138.55 22.85 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-N 115.462 -0.79 . . . . 1.0 111.226 -178.502 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 99.76 -2.36 57.06 Favored Glycine 0 N--CA 1.477 1.421 0 N-CA-C 110.897 -0.881 . . . . 1.0 110.897 179.354 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -76.65 -172.8 2.35 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.695 -0.483 . . . . 1.0 109.695 179.379 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.8 t -148.05 141.13 24.96 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 109.479 -0.563 . . . . 1.0 109.479 179.528 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 27.7 m -142.3 165.88 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 CA-C-N 116.002 -0.545 . . . . 1.0 111.597 -178.593 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -118.32 121.94 41.63 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 108.003 -1.11 . . . . 1.0 108.003 178.091 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 13.2 tt -101.8 143.26 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 122.648 0.379 . . . . 1.0 110.887 -178.372 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -134.04 118.47 17.82 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 107.549 -1.278 . . . . 1.0 107.549 178.52 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 49.3 p90 -139.35 161.96 36.17 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-N 116.16 -0.473 . . . . 1.0 109.775 -178.232 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 7.8 ttpm? -118.77 112.83 20.23 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 123.342 0.401 . . . . 1.0 110.346 179.351 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.407 ' CE1' ' HE2' ' A' ' 25' ' ' HIS . 34.5 t60 -106.78 107.63 18.73 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 108.012 -1.107 . . . . 1.0 108.012 178.302 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 72.27 -115.99 5.65 Favored Glycine 0 CA--C 1.53 1.015 0 N-CA-C 111.054 -0.818 . . . . 1.0 111.054 -178.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -113.51 1.66 15.1 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 122.983 0.513 . . . . 1.0 111.407 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -124.02 124.29 42.23 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-O 121.48 0.657 . . . . 1.0 111.009 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 38.6 p-10 -101.86 143.19 32.06 Favored 'General case' 0 C--N 1.343 0.324 0 N-CA-C 109.33 -0.618 . . . . 1.0 109.33 179.442 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 68.5 mt-10 -130.5 167.14 19.13 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 115.542 -0.753 . . . . 1.0 109.285 -179.372 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 78.6 tt0 -136.0 137.68 41.46 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 109.466 -0.568 . . . . 1.0 109.466 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.11 157.32 43.29 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.56 -0.745 . . . . 1.0 110.394 -178.346 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 94.9 p -122.14 137.54 54.79 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 108.425 -0.954 . . . . 1.0 108.425 179.014 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.2 mp -135.93 140.32 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 CA-C-N 116.501 -0.318 . . . . 1.0 110.243 -177.549 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -80.39 137.51 36.54 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 109.061 -0.718 . . . . 1.0 109.061 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.465 HD22 ' N ' ' A' ' 74' ' ' LEU . 3.8 mm? -68.26 144.85 54.72 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.935 -0.575 . . . . 1.0 109.978 -179.329 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 79.8 p -139.08 166.16 25.23 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 115.335 -0.848 . . . . 1.0 109.787 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -94.37 146.46 24.04 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.331 -0.85 . . . . 1.0 109.734 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.647 HD13 ' H ' ' A' ' 77' ' ' ILE . 0.1 OUTLIER -144.92 -30.12 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-N 116.323 -0.399 . . . . 1.0 110.914 179.508 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.405 ' H ' HD13 ' A' ' 77' ' ' ILE . 81.8 m-20 -99.44 151.76 20.75 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 121.238 0.542 . . . . 1.0 110.243 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 10.1 ptpp? -48.72 -27.31 2.83 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.268 -0.878 . . . . 1.0 112.628 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -93.08 11.57 27.18 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 120.634 0.254 . . . . 1.0 111.376 -178.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 56.41 41.51 88.07 Favored Glycine 0 CA--C 1.525 0.665 0 C-N-CA 121.068 -0.587 . . . . 1.0 111.856 178.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 16.8 m -80.54 122.88 82.91 Favored Pre-proline 0 CA--C 1.551 0.998 0 CA-C-O 118.882 -0.58 . . . . 1.0 109.975 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.448 ' HB3' HD12 ' A' ' 74' ' ' LEU . 55.1 Cg_exo -51.63 126.75 20.52 Favored 'Trans proline' 0 N--CA 1.503 2.032 0 C-N-CA 121.363 1.375 . . . . 1.0 111.226 177.196 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.545 ' C ' ' H ' ' A' ' 86' ' ' GLY . . . -150.7 -13.59 0.09 OUTLIER Glycine 0 N--CA 1.478 1.473 0 C-N-CA 121.334 -0.46 . . . . 1.0 111.956 -179.024 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 41.4 mt 66.07 -30.05 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 O-C-N 123.782 0.342 . . . . 1.0 111.146 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.545 ' H ' ' C ' ' A' ' 84' ' ' GLY . . . 115.18 37.86 1.08 Allowed Glycine 0 N--CA 1.477 1.369 0 N-CA-C 110.473 -1.051 . . . . 1.0 110.473 -179.393 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 48.4 pt -140.87 163.94 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 122.599 0.36 . . . . 1.0 110.288 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 8.9 t -134.3 129.94 36.29 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.663 -0.699 . . . . 1.0 109.511 178.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.696 HD22 ' N ' ' A' ' 89' ' ' LEU . 1.3 mm? -106.36 135.31 48.07 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 108.253 -1.018 . . . . 1.0 108.253 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.463 ' O ' ' N ' ' A' ' 10' ' ' TYR . 52.3 t -154.87 132.67 2.51 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.608 0 N-CA-C 108.395 -0.965 . . . . 1.0 108.395 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -99.27 90.61 4.62 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 109.162 -0.681 . . . . 1.0 109.162 177.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -79.08 106.83 11.4 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 109.577 -0.527 . . . . 1.0 109.577 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 54.6 mt -71.3 70.3 0.58 Allowed 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 116.194 -0.457 . . . . 1.0 111.0 -178.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -154.41 25.64 0.46 Allowed 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 116.356 -0.384 . . . . 1.0 110.697 -179.433 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 64.5 t60 -87.93 -8.8 55.22 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 110.435 -0.209 . . . . 1.0 110.435 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 33.2 m80 54.35 -170.95 0.05 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.401 -0.363 . . . . 1.0 111.208 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 78.8 m80 -60.13 -41.63 93.08 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.833 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 66.5 t60 -166.53 -68.98 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.813 0.339 . . . . 1.0 110.115 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 53.15 86.14 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.083 -0.508 . . . . 1.0 110.832 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 81.5 t60 . . . . . 0 C--O 1.219 -0.52 0 CA-C-O 118.046 -0.978 . . . . 1.0 110.927 -179.746 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.1 ttt . . . . . 0 N--CA 1.492 1.662 0 N-CA-C 109.059 -0.719 . . . . 1.0 109.059 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 28.7 t 54.89 100.91 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 CA-C-N 116.339 -0.392 . . . . 1.0 110.485 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -136.3 161.16 36.57 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 109.743 -0.466 . . . . 1.0 109.743 -179.608 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.1 p -60.26 -36.29 67.61 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-N 115.815 -0.63 . . . . 1.0 110.706 -179.454 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.5 m -68.93 156.25 38.87 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.193 0.52 . . . . 1.0 109.903 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -76.06 -91.43 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.685 -0.689 . . . . 1.0 109.633 179.554 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -137.79 -111.56 0.17 Allowed 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 122.684 0.394 . . . . 1.0 110.053 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 154.38 -159.67 29.02 Favored Glycine 0 N--CA 1.466 0.634 0 N-CA-C 109.191 -1.563 . . . . 1.0 109.191 -179.428 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 12.4 m -129.43 127.42 64.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 N-CA-C 108.789 -0.819 . . . . 1.0 108.789 178.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -91.08 127.85 36.67 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 110.028 -0.36 . . . . 1.0 110.028 -177.758 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 60.4 t -76.41 135.27 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 N-CA-C 107.142 -1.429 . . . . 1.0 107.142 178.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.8 tt -78.8 -51.11 10.22 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 121.119 0.485 . . . . 1.0 110.139 -178.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 95.3 p -157.37 153.3 27.08 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.036 0.446 . . . . 1.0 110.996 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 58.4 t -111.57 136.26 48.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 CA-C-N 115.419 -0.81 . . . . 1.0 108.972 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -96.41 121.74 38.54 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 108.845 -0.798 . . . . 1.0 108.845 178.478 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.435 ' N ' ' OE1' ' A' ' 16' ' ' GLU . 14.4 pm0 -85.66 63.28 7.97 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 120.85 0.357 . . . . 1.0 111.399 -178.226 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -163.45 27.18 0.09 Allowed 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.335 0.588 . . . . 1.0 109.568 179.375 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -143.64 160.61 50.16 Favored Pre-proline 0 N--CA 1.479 0.991 0 N-CA-C 108.85 -0.796 . . . . 1.0 108.85 -177.802 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -53.87 -25.76 36.72 Favored 'Trans proline' 0 N--CA 1.498 1.757 0 C-N-CA 121.358 1.372 . . . . 1.0 112.463 179.134 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.23 -12.96 62.13 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 120.724 0.297 . . . . 1.0 110.95 179.228 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.57 135.08 45.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 1.0 111.775 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.34 -4.36 85.75 Favored Glycine 0 N--CA 1.468 0.783 0 CA-C-N 115.908 -0.587 . . . . 1.0 111.951 178.486 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 67.6 mt -112.76 -50.48 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 CA-C-N 117.028 0.414 . . . . 1.0 109.957 -179.167 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 21.4 mt -105.78 150.34 25.64 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 115.834 -0.621 . . . . 1.0 109.981 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 63.7 t-80 -127.98 140.24 52.1 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 115.825 -0.625 . . . . 1.0 110.302 -179.634 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -49.98 140.73 11.8 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.896 0.379 . . . . 1.0 111.428 -179.487 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 86.7 -7.11 80.98 Favored Glycine 0 N--CA 1.471 0.986 0 N-CA-C 111.116 -0.794 . . . . 1.0 111.116 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.41 ' OD2' ' CD1' ' A' ' 61' ' ' TYR . 23.3 t0 -65.03 134.06 53.03 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 109.937 -0.394 . . . . 1.0 109.937 179.101 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 5.0 mp -95.65 135.42 37.36 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 108.875 -0.787 . . . . 1.0 108.875 179.304 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 38.6 mm -93.19 131.07 41.23 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 N-CA-C 108.955 -0.757 . . . . 1.0 108.955 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 54.1 p -85.95 -54.43 4.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.863 -0.608 . . . . 1.0 110.181 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 74.7 tt0 -154.92 160.13 40.93 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 120.851 0.357 . . . . 1.0 110.941 -179.322 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 20.6 tt -143.54 143.96 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 N-CA-C 108.699 -0.852 . . . . 1.0 108.699 178.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 35.0 t70 46.06 17.59 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 112.24 0.459 . . . . 1.0 112.24 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.52 5.35 49.8 Favored Glycine 0 CA--C 1.529 0.961 0 N-CA-C 111.164 -0.774 . . . . 1.0 111.164 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 21.4 mm100 -142.57 164.55 29.81 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-O 120.826 0.346 . . . . 1.0 110.614 -179.301 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 10.3 t 61.47 102.82 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.664 -0.698 . . . . 1.0 111.623 179.539 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -174.56 -17.55 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.71 -0.677 . . . . 1.0 111.79 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -54.39 -55.66 26.46 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.12 0.486 . . . . 1.0 111.141 -178.085 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 10.7 t -105.14 164.62 11.68 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 115.165 -0.925 . . . . 1.0 110.12 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 11.9 t -73.67 -51.13 17.73 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.106 -0.497 . . . . 1.0 110.718 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -63.44 -39.11 93.61 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.37 -0.377 . . . . 1.0 111.134 -178.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -56.16 -24.2 39.77 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.649 0.262 . . . . 1.0 110.657 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 38.6 t80 -72.36 -46.68 54.35 Favored 'General case' 0 C--O 1.225 -0.236 0 CA-C-O 120.926 0.393 . . . . 1.0 110.305 178.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.462 ' N ' HD12 ' A' ' 45' ' ' ILE . 1.7 mp -59.78 -31.37 47.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 N-CA-C 108.788 -0.819 . . . . 1.0 108.788 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -63.58 -37.98 89.38 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 116.104 -0.498 . . . . 1.0 110.613 -179.101 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -64.49 -43.78 93.06 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.716 0.293 . . . . 1.0 111.297 178.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 38.2 mt -55.43 -42.92 69.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 120.213 -0.595 . . . . 1.0 109.996 -174.383 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 38.8 m170 -78.29 -22.3 48.44 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.368 -0.378 . . . . 1.0 111.432 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 37.7 m -66.6 -14.75 62.8 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.236 0.458 . . . . 1.0 112.236 -178.097 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -111.57 147.71 34.84 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 108.754 -0.832 . . . . 1.0 108.754 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -91.39 171.12 9.43 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.182 0.593 . . . . 1.0 111.274 -178.407 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 14.6 t -67.06 137.72 24.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.218 -179.535 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 100.82 -27.3 21.17 Favored Glycine 0 N--CA 1.468 0.82 0 N-CA-C 111.369 -0.693 . . . . 1.0 111.369 178.319 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -55.73 149.64 14.08 Favored 'General case' 0 C--O 1.226 -0.166 0 CA-C-N 117.728 0.764 . . . . 1.0 111.568 -178.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 70.0 p -87.55 136.38 32.97 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 108.557 -0.905 . . . . 1.0 108.557 178.283 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -121.06 163.17 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 O-C-N 123.529 0.518 . . . . 1.0 110.641 -177.658 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -129.79 110.85 12.07 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 107.307 -1.368 . . . . 1.0 107.307 178.288 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 40.6 mm -100.52 137.84 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 109.743 -0.465 . . . . 1.0 109.743 -178.456 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 6.8 tppt? -128.27 113.87 16.2 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 106.776 -1.564 . . . . 1.0 106.776 177.329 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.41 ' CD1' ' OD2' ' A' ' 28' ' ' ASP . 27.2 p90 -145.5 157.85 43.93 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.929 0.395 . . . . 1.0 109.939 -178.497 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 25.5 pttm -130.07 135.62 48.44 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 115.757 -0.656 . . . . 1.0 109.733 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 59.4 t-80 -129.31 120.47 25.7 Favored 'General case' 0 C--N 1.347 0.464 0 N-CA-C 107.005 -1.479 . . . . 1.0 107.005 178.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 71.23 -117.18 6.63 Favored Glycine 0 CA--C 1.535 1.338 0 N-CA-C 110.777 -0.929 . . . . 1.0 110.777 -179.274 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -113.68 -19.93 11.38 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 122.86 0.464 . . . . 1.0 111.557 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 59.5 pttt -99.43 132.43 44.77 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-O 121.015 0.436 . . . . 1.0 111.236 -179.269 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -102.27 144.37 30.87 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 109.473 -0.565 . . . . 1.0 109.473 179.17 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -134.29 141.04 46.81 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 109.057 -0.72 . . . . 1.0 109.057 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -124.36 131.22 53.5 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 109.468 -0.567 . . . . 1.0 109.468 179.758 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -146.31 144.93 30.13 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.965 -0.561 . . . . 1.0 110.278 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 48.7 m -99.12 133.56 43.23 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 108.514 -0.921 . . . . 1.0 108.514 178.547 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 5.6 mt -138.57 138.97 42.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 CA-C-O 120.77 0.319 . . . . 1.0 111.33 -177.036 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 47.3 mttm -82.97 141.32 32.2 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 121.78 -0.575 . . . . 1.0 109.897 178.276 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.42 HD22 ' N ' ' A' ' 74' ' ' LEU . 3.5 mm? -62.04 148.32 44.42 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 109.262 -0.644 . . . . 1.0 109.262 179.119 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 66.9 p -135.93 162.14 33.68 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.15 0.58 . . . . 1.0 109.549 178.423 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -82.1 116.09 21.52 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 109.302 -0.629 . . . . 1.0 109.302 178.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.724 HD13 ' H ' ' A' ' 77' ' ' ILE . 0.1 OUTLIER -102.0 -18.53 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 C-N-CA 122.415 0.286 . . . . 1.0 111.273 -179.753 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -123.08 145.55 48.45 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-O 121.159 0.504 . . . . 1.0 110.915 -179.159 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 24.6 pttm -49.41 -18.8 0.43 Allowed 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.633 -0.712 . . . . 1.0 112.345 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 30.7 mtmm -80.44 -16.62 53.96 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 120.825 0.345 . . . . 1.0 110.908 -178.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 83.15 39.98 9.6 Favored Glycine 0 N--CA 1.468 0.818 0 N-CA-C 111.778 -0.529 . . . . 1.0 111.778 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 88.7 m -81.98 123.64 79.72 Favored Pre-proline 0 CA--C 1.553 1.058 0 CA-C-O 118.696 -0.668 . . . . 1.0 109.573 179.275 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -50.54 131.79 33.73 Favored 'Trans proline' 0 N--CA 1.506 2.24 0 C-N-CA 121.357 1.371 . . . . 1.0 111.986 177.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -172.4 163.74 35.92 Favored Glycine 0 CA--C 1.529 0.963 0 N-CA-C 111.136 -0.786 . . . . 1.0 111.136 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -111.87 35.51 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 CA-C-O 121.482 0.658 . . . . 1.0 109.432 -179.263 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.5 ' H ' HG21 ' A' ' 77' ' ' ILE . . . 53.17 58.9 10.42 Favored Glycine 0 N--CA 1.468 0.805 0 N-CA-C 111.083 -0.807 . . . . 1.0 111.083 179.168 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 21.6 pt -143.27 162.8 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-N 114.628 -0.786 . . . . 1.0 109.984 179.286 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 93.3 m -135.05 116.17 14.3 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-N 114.825 -1.08 . . . . 1.0 111.127 178.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 9.6 mp -97.74 135.99 38.73 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 122.925 0.49 . . . . 1.0 110.226 179.263 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 12.9 m -153.04 136.31 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 N-CA-C 108.918 -0.771 . . . . 1.0 108.918 178.031 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -74.38 -57.38 3.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.024 0.44 . . . . 1.0 110.049 179.504 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 34.3 p-10 -169.61 -178.75 3.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.9 -0.591 . . . . 1.0 110.196 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 53.1 mt 44.26 29.87 0.4 Allowed 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 116.073 -0.512 . . . . 1.0 111.34 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 53.87 -122.14 1.94 Allowed 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 116.042 -0.526 . . . . 1.0 110.626 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -91.63 -0.86 57.61 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 110.112 -0.329 . . . . 1.0 110.112 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 50.1 t-80 53.51 80.36 0.11 Allowed 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.99 0.424 . . . . 1.0 110.799 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -73.12 161.76 30.24 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.997 -0.547 . . . . 1.0 110.537 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 71.2 m80 -61.95 169.05 2.81 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.063 -0.517 . . . . 1.0 110.453 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 56.27 95.1 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.934 -0.576 . . . . 1.0 111.507 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 86.0 t60 . . . . . 0 C--O 1.221 -0.407 0 CA-C-O 117.965 -1.017 . . . . 1.0 109.865 179.334 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 37.2 t70 . . . . . 0 N--CA 1.47 0.562 0 CA-C-O 120.885 0.374 . . . . 1.0 110.031 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -84.18 -148.71 9.23 Favored Glycine 0 C--N 1.339 0.709 0 N-CA-C 110.003 -1.239 . . . . 1.0 110.003 179.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.7 p -127.85 134.59 65.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 N-CA-C 109.014 -0.736 . . . . 1.0 109.014 178.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -89.52 149.41 22.91 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 109.484 -0.562 . . . . 1.0 109.484 -178.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 49.1 t -98.31 128.71 49.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 N-CA-C 108.793 -0.817 . . . . 1.0 108.793 179.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 8.2 tp -75.83 -39.89 55.88 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.986 0.422 . . . . 1.0 110.8 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.2 t -167.55 161.04 13.5 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.9 -0.591 . . . . 1.0 111.859 -178.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 44.0 t -132.87 115.7 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 CA-C-N 115.367 -0.833 . . . . 1.0 109.239 179.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.402 ' O ' ' N ' ' A' ' 17' ' ' ASP . 74.1 mmtt -73.26 105.21 4.57 Favored 'General case' 0 C--O 1.221 -0.404 0 N-CA-C 108.906 -0.776 . . . . 1.0 108.906 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -64.94 64.29 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 120.875 0.369 . . . . 1.0 111.698 -178.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.402 ' N ' ' O ' ' A' ' 15' ' ' LYS . 37.0 t70 -175.97 45.68 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 108.136 -1.061 . . . . 1.0 108.136 179.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 23.0 m -150.19 160.88 32.45 Favored Pre-proline 0 N--CA 1.483 1.19 0 CA-C-O 118.995 -0.526 . . . . 1.0 109.731 -178.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -47.3 -33.32 16.18 Favored 'Trans proline' 0 N--CA 1.506 2.242 0 C-N-CA 121.252 1.301 . . . . 1.0 112.543 177.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.06 -22.77 67.07 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 116.761 -0.2 . . . . 1.0 111.39 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.59 124.61 21.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.016 0.436 . . . . 1.0 111.008 -178.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.85 -9.71 70.61 Favored Glycine 0 N--CA 1.473 1.138 0 CA-C-N 115.663 -0.699 . . . . 1.0 111.633 179.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 71.0 mt -114.31 -50.9 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 C-N-CA 122.633 0.373 . . . . 1.0 110.289 -179.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 42.7 mt -113.18 148.38 35.54 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 108.777 -0.823 . . . . 1.0 108.777 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -139.92 154.33 47.2 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 115.745 -0.661 . . . . 1.0 110.023 -179.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.44 139.66 52.57 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.858 -0.61 . . . . 1.0 110.918 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 94.55 -6.84 71.14 Favored Glycine 0 N--CA 1.473 1.107 0 N-CA-C 111.083 -0.807 . . . . 1.0 111.083 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -74.49 150.89 39.65 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 109.637 -0.505 . . . . 1.0 109.637 179.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 5.0 mp -120.91 120.66 36.13 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 109.696 -0.483 . . . . 1.0 109.696 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 61.4 mt -89.39 134.63 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 N-CA-C 107.959 -1.126 . . . . 1.0 107.959 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 65.1 p -97.2 -49.2 5.06 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 116.741 -0.208 . . . . 1.0 111.279 -178.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.8 tp10 -154.05 159.83 41.73 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 121.256 0.55 . . . . 1.0 111.3 -178.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.424 ' O ' ' N ' ' A' ' 35' ' ' GLY . 4.7 mp -135.85 129.59 48.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 N-CA-C 107.611 -1.255 . . . . 1.0 107.611 179.192 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 41.57 20.14 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 113.077 0.769 . . . . 1.0 113.077 179.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 33' ' ' ILE . . . 69.22 6.56 54.16 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 111.101 -0.8 . . . . 1.0 111.101 179.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 . . . . . 0 N--CA 1.472 0.628 0 CA-C-O 120.82 0.343 . . . . 1.0 110.233 -179.708 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 15.0 m . . . . . 0 N--CA 1.479 0.991 0 N-CA-C 110.084 -0.339 . . . . 1.0 110.084 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 11.7 t -56.21 -40.7 74.43 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.507 0.194 . . . . 1.0 110.543 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -53.8 -28.68 36.69 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.367 -0.379 . . . . 1.0 110.719 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -58.86 -35.31 72.75 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.887 0.375 . . . . 1.0 110.393 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -68.85 -47.53 65.73 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 116.255 -0.43 . . . . 1.0 110.436 -179.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.513 HD12 ' N ' ' A' ' 45' ' ' ILE . 1.7 mp -52.69 -31.87 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 N-CA-C 108.998 -0.742 . . . . 1.0 108.998 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 47.3 m-20 -70.98 -37.87 72.74 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.797 -0.638 . . . . 1.0 111.431 -179.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 80.1 t80 -66.79 -52.68 41.19 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 120.8 0.333 . . . . 1.0 111.607 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -62.46 -26.05 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 N-CA-C 109.362 -0.607 . . . . 1.0 109.362 -178.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -90.66 -21.96 21.41 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 116.342 -0.39 . . . . 1.0 111.392 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 47.4 m -81.77 -13.62 57.49 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 122.422 -0.174 . . . . 1.0 111.295 -178.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 43.7 mmtm -95.27 -168.97 1.89 Allowed 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 109.992 -0.373 . . . . 1.0 109.992 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 3.6 mmpt? -131.23 159.26 38.31 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.184 0.594 . . . . 1.0 110.526 -178.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.5 t -64.59 140.43 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-N 115.764 -0.653 . . . . 1.0 110.33 -179.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 94.27 -12.9 68.34 Favored Glycine 0 N--CA 1.476 1.305 0 N-CA-C 110.843 -0.903 . . . . 1.0 110.843 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -67.85 -165.25 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 109.618 -0.512 . . . . 1.0 109.618 179.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 77.3 p -140.75 153.97 46.1 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 108.932 -0.766 . . . . 1.0 108.932 178.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 3.2 p -140.55 154.72 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 CA-C-O 121.102 0.477 . . . . 1.0 110.716 -179.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 49.4 mtmt -121.74 112.39 18.34 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 107.954 -1.128 . . . . 1.0 107.954 177.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.431 HD13 HD11 ' A' ' 72' ' ' ILE . 4.4 mp -99.2 138.65 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 N-CA-C 109.05 -0.722 . . . . 1.0 109.05 -178.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -111.19 113.31 25.72 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 105.607 -1.997 . . . . 1.0 105.607 177.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 17.8 p90 -149.84 156.87 42.53 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 109.611 -0.514 . . . . 1.0 109.611 -178.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 22.7 pttm -125.96 118.2 24.88 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 121.261 0.553 . . . . 1.0 110.053 -179.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -89.63 101.82 14.5 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 107.642 -1.244 . . . . 1.0 107.642 179.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 83.76 -111.94 3.5 Favored Glycine 0 CA--C 1.535 1.296 0 N-CA-C 111.475 -0.65 . . . . 1.0 111.475 -178.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -114.52 -2.43 13.16 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 122.826 0.45 . . . . 1.0 111.821 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 58.0 pttt -105.55 134.28 48.93 Favored 'General case' 0 N--CA 1.484 1.269 0 CA-C-O 121.162 0.506 . . . . 1.0 111.052 -179.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -84.08 119.58 25.13 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 109.747 -0.464 . . . . 1.0 109.747 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 69.7 mt-10 -119.9 152.79 36.84 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-N 115.51 -0.768 . . . . 1.0 110.021 -179.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -139.82 133.52 30.47 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 109.253 -0.647 . . . . 1.0 109.253 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -147.03 152.32 38.39 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.946 -0.57 . . . . 1.0 109.952 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.754 ' C ' HD13 ' A' ' 72' ' ' ILE . 17.7 t -125.41 136.53 53.51 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.005 -0.998 . . . . 1.0 108.576 179.024 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.754 HD13 ' C ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -128.68 149.07 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 O-C-N 123.418 0.449 . . . . 1.0 109.965 -178.907 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -78.42 136.34 37.62 Favored 'General case' 0 C--O 1.231 0.084 0 N-CA-C 108.186 -1.042 . . . . 1.0 108.186 178.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.446 HD22 ' N ' ' A' ' 74' ' ' LEU . 3.8 mm? -66.74 147.28 53.47 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.119 0.485 . . . . 1.0 110.598 -178.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 30.6 p -140.87 160.73 39.43 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.648 -0.705 . . . . 1.0 109.747 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -80.23 131.15 35.64 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 108.975 -0.75 . . . . 1.0 108.975 178.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -114.0 -52.66 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 123.127 0.571 . . . . 1.0 110.544 -179.287 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 57.4 p30 -99.61 162.55 12.95 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.327 0.584 . . . . 1.0 110.872 -178.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 59.5 pttt -51.15 -31.92 21.33 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.096 -0.956 . . . . 1.0 112.326 -178.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 26.2 ttmt -80.23 12.06 3.14 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 120.672 0.272 . . . . 1.0 110.762 -179.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 52.72 49.09 55.0 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 120.967 -0.635 . . . . 1.0 111.833 179.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 58.6 m -80.3 120.41 79.39 Favored Pre-proline 0 CA--C 1.54 0.573 0 CA-C-O 118.619 -0.705 . . . . 1.0 109.698 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -58.7 134.84 63.27 Favored 'Trans proline' 0 N--CA 1.497 1.693 0 CA-C-N 120.819 1.328 . . . . 1.0 112.122 177.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 148.81 152.53 5.74 Favored Glycine 0 N--CA 1.473 1.123 0 N-CA-C 112.003 -0.439 . . . . 1.0 112.003 178.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 6.5 pt -72.44 176.95 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 N-CA-C 108.369 -0.974 . . . . 1.0 108.369 177.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -103.27 86.92 0.55 Allowed Glycine 0 N--CA 1.473 1.12 0 N-CA-C 111.817 -0.513 . . . . 1.0 111.817 -179.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 48.8 pt -143.7 166.91 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 CA-C-N 115.504 -0.348 . . . . 1.0 110.17 178.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 95.4 m -128.44 128.99 45.47 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 109.182 -0.673 . . . . 1.0 109.182 177.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 12.9 mt -97.89 163.2 12.89 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.057 0.943 . . . . 1.0 109.853 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 24.2 t . . . . . 0 N--CA 1.479 1.024 0 CA-C-N 116.087 -0.506 . . . . 1.0 109.777 -178.735 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 33.7 p-10 . . . . . 0 N--CA 1.471 0.584 0 N-CA-C 109.651 -0.5 . . . . 1.0 109.651 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 161.14 -166.09 35.59 Favored Glycine 0 N--CA 1.461 0.318 0 N-CA-C 108.963 -1.655 . . . . 1.0 108.963 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.1 p -125.72 130.78 72.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 N-CA-C 109.222 -0.659 . . . . 1.0 109.222 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.465 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 0.2 OUTLIER -91.12 151.81 20.85 Favored 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 109.303 -0.628 . . . . 1.0 109.303 -178.863 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 56.1 t -106.0 127.48 61.06 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 N-CA-C 108.5 -0.926 . . . . 1.0 108.5 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 41.2 tp -79.97 -49.56 11.67 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-O 121.169 0.509 . . . . 1.0 111.063 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 97.2 p -167.21 163.19 15.44 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.571 -0.741 . . . . 1.0 111.403 -179.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.444 ' O ' ' O ' ' A' ' 15' ' ' LYS . 39.2 t -119.92 138.37 50.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 CA-C-N 114.952 -1.022 . . . . 1.0 109.659 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.444 ' O ' ' O ' ' A' ' 14' ' ' VAL . 36.3 tptt -39.49 -108.75 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 O-C-N 123.981 0.8 . . . . 1.0 111.778 179.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -159.61 20.01 0.17 Allowed 'General case' 0 N--CA 1.482 1.156 0 O-C-N 121.096 -1.002 . . . . 1.0 112.363 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.752 ' O ' ' O ' ' A' ' 18' ' ' VAL . 4.2 p-10 -169.02 -68.06 0.02 OUTLIER 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 107.109 -1.441 . . . . 1.0 107.109 178.035 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.752 ' O ' ' O ' ' A' ' 17' ' ' ASP . 29.3 m 4.46 148.2 0.0 OUTLIER Pre-proline 0 N--CA 1.504 2.237 0 O-C-N 125.874 1.984 . . . . 1.0 114.091 -177.181 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -56.7 9.18 0.04 OUTLIER 'Trans proline' 0 N--CA 1.496 1.673 0 CA-C-N 120.346 1.159 . . . . 1.0 113.206 -178.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.529 ' H ' ' C ' ' A' ' 18' ' ' VAL . . . -106.48 -24.15 12.29 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 109.435 -0.58 . . . . 1.0 109.435 177.07 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.691 ' HB3' ' O ' ' A' ' 17' ' ' ASP . . . -75.36 134.53 40.96 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-O 121.278 0.561 . . . . 1.0 110.247 179.374 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 90.75 -22.03 30.23 Favored Glycine 0 N--CA 1.471 0.977 0 CA-C-N 115.422 -0.808 . . . . 1.0 111.387 179.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 84.9 mt -105.36 -51.32 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 N-CA-C 109.945 -0.391 . . . . 1.0 109.945 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 18.8 mt -99.59 134.42 42.51 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 109.283 -0.636 . . . . 1.0 109.283 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -118.42 144.59 45.84 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 115.919 -0.582 . . . . 1.0 109.659 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -52.48 132.51 35.11 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 116.473 -0.331 . . . . 1.0 110.703 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 101.39 -4.38 54.62 Favored Glycine 0 N--CA 1.474 1.179 0 N-CA-C 111.601 -0.6 . . . . 1.0 111.601 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -72.82 152.38 41.57 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 117.506 0.653 . . . . 1.0 109.599 178.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.4 mp -124.15 122.31 37.48 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 122.753 0.421 . . . . 1.0 110.364 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 31.9 mm -74.78 122.44 28.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 N-CA-C 109.253 -0.647 . . . . 1.0 109.253 179.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 47.8 p -89.85 -43.77 10.4 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 116.4 -0.363 . . . . 1.0 111.023 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 72.9 tt0 -154.69 151.61 28.95 Favored 'General case' 0 N--CA 1.482 1.136 0 CA-C-O 120.991 0.424 . . . . 1.0 111.414 -178.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.41 HD13 ' CE1' ' A' ' 44' ' ' PHE . 1.6 mt -145.49 133.87 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 CA-C-O 120.977 0.417 . . . . 1.0 110.246 178.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 37.7 t70 54.5 34.94 22.19 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.808 -0.633 . . . . 1.0 111.256 178.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.18 -9.15 13.64 Favored Glycine 0 CA--C 1.531 1.058 0 N-CA-C 111.412 -0.675 . . . . 1.0 111.412 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 . . . . . 0 N--CA 1.478 0.956 0 CA-C-N 116.802 0.301 . . . . 1.0 110.264 -179.998 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 49.0 m . . . . . 0 N--CA 1.481 1.091 0 N-CA-C 110.214 -0.291 . . . . 1.0 110.214 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 46.6 t -64.26 -51.61 62.74 Favored 'General case' 0 C--O 1.219 -0.533 0 CA-C-N 116.417 -0.356 . . . . 1.0 110.575 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -53.88 -34.41 59.36 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 122.277 -0.265 . . . . 1.0 111.226 -179.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.0 tp10 -64.44 -36.81 85.39 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 109.299 -0.63 . . . . 1.0 109.299 179.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.41 ' CE1' HD13 ' A' ' 33' ' ' ILE . 5.0 t80 -66.69 -48.28 69.76 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.419 0.628 . . . . 1.0 109.537 178.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 26.3 mm -53.62 -27.96 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-N 115.542 -0.754 . . . . 1.0 110.313 -178.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -70.78 -35.23 72.49 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 116.359 -0.382 . . . . 1.0 110.119 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 28.7 t80 -67.18 -46.16 74.76 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.822 0.344 . . . . 1.0 110.997 178.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 25.7 mt -53.74 -38.55 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 115.954 -0.566 . . . . 1.0 109.945 -175.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 52.0 m-70 -80.89 -20.88 41.24 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 116.052 -0.522 . . . . 1.0 110.966 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 11.2 t -78.06 37.14 0.24 Allowed 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 120.748 0.308 . . . . 1.0 111.483 -178.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -146.55 -169.6 3.31 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 109.024 -0.732 . . . . 1.0 109.024 179.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -131.55 166.51 21.24 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 122.955 0.502 . . . . 1.0 109.759 -178.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 22.7 t -68.46 137.76 23.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 115.95 -0.568 . . . . 1.0 110.939 -178.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.75 -2.43 85.93 Favored Glycine 0 N--CA 1.478 1.484 0 N-CA-C 111.217 -0.753 . . . . 1.0 111.217 179.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -62.08 -168.91 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.832 -0.433 . . . . 1.0 109.832 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 23.4 m -146.55 139.88 25.72 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 108.972 -0.751 . . . . 1.0 108.972 179.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.459 HG22 ' N ' ' A' ' 58' ' ' LYS . 6.0 p -141.46 160.79 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 CA-C-N 116.305 -0.407 . . . . 1.0 110.172 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.459 ' N ' HG22 ' A' ' 57' ' ' VAL . 21.8 ttpp -112.71 123.28 49.94 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 108.111 -1.07 . . . . 1.0 108.111 177.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.497 HG22 ' O ' ' A' ' 70' ' ' ALA . 11.5 tt -101.02 143.03 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 C-N-CA 122.776 0.43 . . . . 1.0 111.003 -178.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 17.6 tptp -133.58 113.56 12.56 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 107.661 -1.237 . . . . 1.0 107.661 177.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 25.1 p90 -144.45 157.93 44.0 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 109.226 -0.657 . . . . 1.0 109.226 -179.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -116.24 115.79 26.62 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 117.912 0.324 . . . . 1.0 110.206 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -118.66 115.76 25.18 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 108.108 -1.071 . . . . 1.0 108.108 177.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 73.25 -133.63 18.48 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 110.716 -0.953 . . . . 1.0 110.716 -178.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -107.26 2.1 24.38 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 122.82 0.448 . . . . 1.0 111.072 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 20.8 pttp -122.37 119.5 31.23 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-O 121.593 0.711 . . . . 1.0 111.145 -179.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -82.97 123.92 29.89 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 109.386 -0.598 . . . . 1.0 109.386 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -114.51 142.03 46.94 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.062 0.545 . . . . 1.0 109.943 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -124.87 136.69 54.02 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 109.135 -0.691 . . . . 1.0 109.135 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.497 ' O ' HG22 ' A' ' 59' ' ' ILE . . . -148.69 128.42 13.32 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.301 0.572 . . . . 1.0 111.388 -179.168 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 12.2 m -87.03 139.53 30.48 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 109.146 -0.687 . . . . 1.0 109.146 178.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 11.1 pt -140.11 149.86 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-N 116.086 -0.506 . . . . 1.0 110.534 -178.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 18.4 pttp -93.19 139.03 31.04 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.541 -0.754 . . . . 1.0 109.235 178.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.45 HD22 ' N ' ' A' ' 74' ' ' LEU . 3.6 mm? -64.04 150.8 44.59 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 109.665 -0.494 . . . . 1.0 109.665 179.44 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 72.9 p -137.39 159.36 42.15 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 115.894 -0.594 . . . . 1.0 110.188 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -81.44 135.14 35.62 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 109.313 -0.625 . . . . 1.0 109.313 178.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.681 ' H ' HD13 ' A' ' 77' ' ' ILE . 0.1 OUTLIER -134.63 -8.53 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 C-N-CA 122.475 0.31 . . . . 1.0 111.313 -179.363 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -127.66 148.27 50.38 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 122.937 0.495 . . . . 1.0 110.173 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -48.72 -33.26 9.85 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.238 -0.437 . . . . 1.0 111.805 -179.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -79.04 7.45 7.35 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 120.756 0.313 . . . . 1.0 110.846 -179.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 57.4 46.29 92.02 Favored Glycine 0 CA--C 1.529 0.954 0 CA-C-N 116.215 -0.448 . . . . 1.0 112.519 178.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 4.5 m -79.6 119.15 75.9 Favored Pre-proline 0 CA--C 1.551 0.982 0 CA-C-O 118.875 -0.584 . . . . 1.0 109.771 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -52.93 125.98 19.95 Favored 'Trans proline' 0 N--CA 1.504 2.112 0 C-N-CA 121.285 1.323 . . . . 1.0 111.077 177.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 173.74 172.6 39.24 Favored Glycine 0 N--CA 1.469 0.854 0 C-N-CA 120.801 -0.714 . . . . 1.0 112.254 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.19 173.4 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 N-CA-C 106.976 -1.49 . . . . 1.0 106.976 177.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -104.55 83.6 0.4 Allowed Glycine 0 N--CA 1.475 1.264 0 N-CA-C 110.549 -1.02 . . . . 1.0 110.549 -179.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.505 HD13 ' H ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -143.62 168.15 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-O 121.373 0.606 . . . . 1.0 110.746 179.607 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 26.4 m -128.14 132.72 48.91 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 115.099 -0.955 . . . . 1.0 109.344 178.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.665 HD22 ' N ' ' A' ' 89' ' ' LEU . 0.9 OUTLIER -99.61 159.52 14.98 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 123.194 0.598 . . . . 1.0 109.41 -179.99 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.2 m . . . . . 0 N--CA 1.488 1.431 0 CA-C-N 115.672 -0.695 . . . . 1.0 110.018 -178.368 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 . . . . . 0 N--CA 1.463 0.212 0 CA-C-O 120.861 0.363 . . . . 1.0 110.686 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 166.39 -175.36 41.83 Favored Glycine 0 N--CA 1.462 0.418 0 N-CA-C 109.968 -1.253 . . . . 1.0 109.968 -179.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 18.7 m -112.61 130.99 65.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 N-CA-C 108.859 -0.793 . . . . 1.0 108.859 179.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.449 ' CD1' HD22 ' A' ' 29' ' ' LEU . 10.0 m-85 -88.13 137.42 32.34 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 109.828 -0.434 . . . . 1.0 109.828 -177.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 62.1 t -90.28 127.51 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 N-CA-C 108.861 -0.792 . . . . 1.0 108.861 179.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 48.6 tp -81.05 -44.27 18.28 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 120.87 0.366 . . . . 1.0 111.144 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.2 t -163.31 156.87 19.48 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 121.317 0.58 . . . . 1.0 111.187 -178.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.4 p -137.12 134.9 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 CA-C-N 114.969 -1.014 . . . . 1.0 109.314 179.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -76.37 160.22 29.77 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 109.15 -0.685 . . . . 1.0 109.15 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -99.35 -5.63 29.29 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 111.673 0.249 . . . . 1.0 111.673 -178.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 25.0 p-10 -106.68 29.02 7.32 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 122.611 0.364 . . . . 1.0 110.908 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.6 m -130.75 156.13 80.34 Favored Pre-proline 0 N--CA 1.483 1.175 0 C-N-CA 123.137 0.575 . . . . 1.0 109.545 -179.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -56.57 -22.06 41.46 Favored 'Trans proline' 0 N--CA 1.505 2.2 0 C-N-CA 121.688 1.592 . . . . 1.0 112.141 -179.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.415 ' HB2' HG22 ' A' ' 85' ' ' ILE . . . -62.4 -26.96 68.76 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.147 0.499 . . . . 1.0 110.536 -179.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.67 125.36 25.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.572 -0.74 . . . . 1.0 110.935 -178.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 95.5 -15.71 62.68 Favored Glycine 0 N--CA 1.475 1.237 0 N-CA-C 111.478 -0.649 . . . . 1.0 111.478 179.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 81.2 mt -113.55 -49.9 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 N-CA-C 110.039 -0.356 . . . . 1.0 110.039 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 16.2 mt -110.75 147.55 34.19 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 109.613 -0.514 . . . . 1.0 109.613 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.4 ' CD2' ' OD1' ' A' ' 28' ' ' ASP . 13.6 p-80 -143.64 156.61 44.61 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.559 -0.746 . . . . 1.0 110.051 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.07 143.41 32.81 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 115.739 -0.664 . . . . 1.0 111.435 -179.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 95.06 -4.6 67.9 Favored Glycine 0 N--CA 1.474 1.168 0 N-CA-C 111.696 -0.562 . . . . 1.0 111.696 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.4 ' OD1' ' CD2' ' A' ' 25' ' ' HIS . 9.7 m-20 -82.8 123.04 28.97 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 117.145 0.473 . . . . 1.0 110.276 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.449 HD22 ' CD1' ' A' ' 10' ' ' TYR . 20.0 mt -97.92 121.07 39.39 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 109.711 -0.477 . . . . 1.0 109.711 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 16.0 mm -77.43 127.64 38.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 N-CA-C 108.948 -0.76 . . . . 1.0 108.948 -179.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 75.8 p -77.75 -51.95 9.72 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.291 -0.413 . . . . 1.0 110.678 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -155.14 166.28 34.07 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.032 0.444 . . . . 1.0 109.945 -179.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.444 HD11 ' CD1' ' A' ' 59' ' ' ILE . 1.0 OUTLIER -134.04 126.59 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-N 115.064 -0.971 . . . . 1.0 109.931 179.319 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 37.5 t70 48.97 16.91 0.13 Allowed 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.699 -0.682 . . . . 1.0 111.624 179.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.82 14.86 78.15 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 111.331 -0.708 . . . . 1.0 111.331 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 . . . . . 0 N--CA 1.476 0.868 0 CA-C-O 120.899 0.381 . . . . 1.0 110.297 -179.614 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 21.2 t . . . . . 0 N--CA 1.465 0.325 0 CA-C-O 120.834 0.349 . . . . 1.0 110.49 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 50.3 m -65.78 -42.23 91.06 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.042 -0.526 . . . . 1.0 109.846 178.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -64.86 -37.88 89.11 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.069 -0.514 . . . . 1.0 111.067 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -54.82 -25.37 27.98 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.027 0.441 . . . . 1.0 110.037 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -70.29 -45.65 65.92 Favored 'General case' 0 C--O 1.221 -0.429 0 N-CA-C 109.154 -0.684 . . . . 1.0 109.154 179.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.508 HD12 ' N ' ' A' ' 45' ' ' ILE . 1.6 mp -64.28 -30.13 49.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 N-CA-C 108.896 -0.779 . . . . 1.0 108.896 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -63.13 -34.1 76.88 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.237 -179.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 32.2 t80 -69.14 -44.21 72.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.243 -0.435 . . . . 1.0 111.519 179.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 44.0 mt -57.44 -42.5 80.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.319 -0.401 . . . . 1.0 110.275 -175.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 54.2 m-70 -76.52 -18.76 58.55 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.309 -0.405 . . . . 1.0 111.117 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 13.0 t -92.33 46.48 1.26 Allowed 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 111.564 0.209 . . . . 1.0 111.564 -178.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 13.8 mmtm -149.31 175.74 11.16 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 109.242 -0.651 . . . . 1.0 109.242 179.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -130.1 154.1 47.81 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-O 121.067 0.46 . . . . 1.0 109.787 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 28.5 t -60.83 135.43 25.58 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 115.933 -0.576 . . . . 1.0 110.864 -178.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 97.55 -19.59 54.08 Favored Glycine 0 N--CA 1.477 1.422 0 N-CA-C 110.951 -0.86 . . . . 1.0 110.951 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -65.54 143.41 57.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.594 0.235 . . . . 1.0 110.497 -179.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 68.0 p -96.22 152.56 18.45 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 109.153 -0.684 . . . . 1.0 109.153 179.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 6.6 p -140.49 155.42 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 CA-C-O 121.232 0.539 . . . . 1.0 110.757 -179.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 31.6 mtmm -101.18 123.08 44.75 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.319 -0.855 . . . . 1.0 109.486 178.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.506 HG13 HD11 ' A' ' 72' ' ' ILE . 1.0 OUTLIER -117.71 136.06 56.08 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 C-N-CA 122.84 0.456 . . . . 1.0 110.109 179.693 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 12.8 ptpt -135.72 120.51 18.48 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 107.745 -1.206 . . . . 1.0 107.745 178.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 34.7 p90 -146.21 149.28 33.64 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 110.146 -0.316 . . . . 1.0 110.146 -179.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 20.9 pttm -111.57 114.49 27.59 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.355 0.598 . . . . 1.0 110.552 -179.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 70.5 t60 -98.69 120.87 39.85 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 108.045 -1.094 . . . . 1.0 108.045 178.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 61.6 -118.04 13.49 Favored Glycine 0 CA--C 1.531 1.034 0 N-CA-C 111.121 -0.791 . . . . 1.0 111.121 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -114.16 14.55 18.23 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 122.942 0.497 . . . . 1.0 111.544 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 17.1 ptmt -122.75 121.16 35.66 Favored 'General case' 0 N--CA 1.485 1.309 0 CA-C-O 121.38 0.61 . . . . 1.0 111.157 -179.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 30.6 m120 -77.01 124.38 27.71 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 116.079 -0.51 . . . . 1.0 109.889 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -127.81 140.56 51.96 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 115.863 -0.608 . . . . 1.0 110.052 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.4 ' CD ' ' N ' ' A' ' 69' ' ' GLU . 1.9 pm0 -142.18 136.09 29.62 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 115.813 -0.63 . . . . 1.0 110.58 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -161.28 129.44 4.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.788 -0.642 . . . . 1.0 111.188 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 9.4 t -85.54 146.18 27.03 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 108.915 -0.772 . . . . 1.0 108.915 178.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.723 ' N ' HD13 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -134.55 149.83 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 CA-C-O 121.425 0.631 . . . . 1.0 110.329 -178.981 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.6 ttmp? -81.2 139.47 35.51 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 115.11 -0.95 . . . . 1.0 109.268 179.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -73.64 149.73 41.81 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.193 0.521 . . . . 1.0 110.0 179.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 27.3 p -140.73 164.17 30.91 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.398 -0.819 . . . . 1.0 110.123 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -79.97 131.95 35.92 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 109.271 -0.641 . . . . 1.0 109.271 178.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.3 pt -109.63 -55.88 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 CA-C-N 115.946 -0.57 . . . . 1.0 109.794 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.416 ' OD2' ' NZ ' ' A' ' 80' ' ' LYS . 40.9 t0 -98.41 171.53 8.11 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 121.507 0.67 . . . . 1.0 111.48 -178.095 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -60.16 -28.56 68.02 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.811 -1.086 . . . . 1.0 112.045 -179.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.416 ' NZ ' ' OD2' ' A' ' 78' ' ' ASP . 19.6 pttm -80.09 14.58 1.8 Allowed 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 120.619 0.247 . . . . 1.0 110.517 -179.374 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 49.24 41.15 30.77 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 112.169 -0.372 . . . . 1.0 112.169 178.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 15.9 m -80.02 120.51 80.0 Favored Pre-proline 0 CA--C 1.547 0.834 0 N-CA-C 109.544 -0.539 . . . . 1.0 109.544 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -52.95 131.8 44.23 Favored 'Trans proline' 0 N--CA 1.501 1.927 0 C-N-CA 121.463 1.442 . . . . 1.0 112.277 178.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -158.58 146.14 12.72 Favored Glycine 0 N--CA 1.468 0.788 0 N-CA-C 111.474 -0.65 . . . . 1.0 111.474 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.415 HG22 ' HB2' ' A' ' 20' ' ' ALA . 40.7 mm -67.6 -26.05 34.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.455 -0.373 . . . . 1.0 110.418 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 99.47 45.6 2.12 Favored Glycine 0 N--CA 1.475 1.255 0 N-CA-C 110.684 -0.966 . . . . 1.0 110.684 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 38.4 pt -145.15 166.89 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 N-CA-C 109.863 -0.421 . . . . 1.0 109.863 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 77.0 m -127.25 127.07 43.82 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 109.253 -0.647 . . . . 1.0 109.253 177.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.1 mp -99.39 146.69 26.03 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 120.797 0.332 . . . . 1.0 110.525 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.7 p . . . . . 0 N--CA 1.477 0.917 0 CA-C-N 115.777 -0.647 . . . . 1.0 109.744 -179.042 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 48.7 p-10 . . . . . 0 N--CA 1.453 -0.308 0 N-CA-C 109.366 -0.605 . . . . 1.0 109.366 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -69.66 -160.17 2.52 Favored Glycine 0 CA--C 1.52 0.376 0 N-CA-C 110.122 -1.191 . . . . 1.0 110.122 179.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.9 m -112.82 132.41 61.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 N-CA-C 109.362 -0.607 . . . . 1.0 109.362 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -92.27 132.37 36.74 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 115.791 -0.64 . . . . 1.0 110.588 -178.244 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 57.3 t -77.56 134.55 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.126 0 N-CA-C 107.335 -1.357 . . . . 1.0 107.335 177.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.3 tt -81.03 -51.19 8.77 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.056 0.455 . . . . 1.0 111.163 -178.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.0 m -163.61 159.79 22.19 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.151 0.5 . . . . 1.0 111.343 -179.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 26.4 t -109.24 134.75 50.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-N 114.992 -1.004 . . . . 1.0 109.134 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -63.86 -36.55 84.29 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 116.4 -0.364 . . . . 1.0 110.675 -179.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 73.38 25.91 2.1 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.5 1.12 . . . . 1.0 111.835 -179.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -145.75 35.23 1.04 Allowed 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 108.709 -0.848 . . . . 1.0 108.709 178.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.446 HG23 ' HB3' ' A' ' 20' ' ' ALA . 6.5 m -145.08 158.06 52.74 Favored Pre-proline 0 N--CA 1.476 0.851 0 CA-C-N 115.903 -0.589 . . . . 1.0 110.238 -178.306 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -50.88 -15.08 1.57 Allowed 'Trans proline' 0 N--CA 1.505 2.171 0 C-N-CA 121.781 1.654 . . . . 1.0 112.17 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.525 ' HB2' HG22 ' A' ' 85' ' ' ILE . . . -64.55 -35.17 80.12 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.966 0.412 . . . . 1.0 110.591 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.56 129.71 41.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.924 -0.58 . . . . 1.0 111.313 -178.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.44 -7.52 75.06 Favored Glycine 0 N--CA 1.47 0.942 0 N-CA-C 111.109 -0.796 . . . . 1.0 111.109 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 52.9 mt -115.54 -50.61 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 CA-C-O 120.769 0.318 . . . . 1.0 110.498 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 28.4 mt -113.53 153.54 28.59 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.091 0.556 . . . . 1.0 110.101 -179.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 67.6 m80 -144.12 157.03 44.55 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.86 -0.609 . . . . 1.0 111.001 -179.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.05 140.3 38.4 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.924 -0.58 . . . . 1.0 111.134 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 91.81 -4.38 78.74 Favored Glycine 0 N--CA 1.471 0.972 0 N-CA-C 111.283 -0.727 . . . . 1.0 111.283 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -67.63 124.85 24.4 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 109.425 -0.583 . . . . 1.0 109.425 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 10.6 mt -96.61 122.28 39.36 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 109.095 -0.706 . . . . 1.0 109.095 179.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 33.7 mm -83.62 116.48 27.68 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 109.124 -0.695 . . . . 1.0 109.124 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 71.7 p -90.56 -39.78 12.34 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 116.278 -0.419 . . . . 1.0 111.436 -179.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -146.32 148.78 32.75 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 109.826 -0.435 . . . . 1.0 109.826 -179.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.418 ' O ' ' N ' ' A' ' 35' ' ' GLY . 3.6 mt -129.59 128.86 66.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 108.709 -0.848 . . . . 1.0 108.709 179.211 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 26.5 t0 45.8 14.47 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 112.131 0.419 . . . . 1.0 112.131 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 33' ' ' ILE . . . 65.73 17.9 65.48 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.937 -0.865 . . . . 1.0 110.937 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 . . . . . 0 N--CA 1.477 0.884 0 CA-C-O 120.932 0.396 . . . . 1.0 110.625 -179.002 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.5 t . . . . . 0 C--O 1.233 0.189 0 CA-C-O 121.227 0.537 . . . . 1.0 110.122 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 73.1 m -75.93 -33.01 59.84 Favored 'General case' 0 C--O 1.218 -0.566 0 CA-C-N 115.702 -0.681 . . . . 1.0 109.917 179.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.407 ' NE2' ' OD2' ' A' ' 46' ' ' ASP . 0.0 OUTLIER -74.05 -45.4 49.74 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 120.948 0.404 . . . . 1.0 111.187 -178.897 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -56.56 -20.86 22.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.123 -0.489 . . . . 1.0 110.49 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -72.1 -52.18 17.99 Favored 'General case' 0 N--CA 1.461 0.097 0 C-N-CA 120.542 -0.463 . . . . 1.0 110.406 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.7 mp -54.05 -31.8 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 N-CA-C 108.651 -0.87 . . . . 1.0 108.651 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.407 ' OD2' ' NE2' ' A' ' 42' ' ' GLN . 61.8 m-20 -72.0 -32.57 67.32 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.018 -0.992 . . . . 1.0 111.227 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 77.3 t80 -69.23 -52.57 26.4 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 120.875 0.369 . . . . 1.0 111.479 -179.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -54.92 -25.63 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 N-CA-C 109.53 -0.545 . . . . 1.0 109.53 -177.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 42.5 m170 -94.15 -18.12 22.07 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.58 -0.737 . . . . 1.0 110.558 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 27.6 t -66.75 -22.43 66.04 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.712 0.291 . . . . 1.0 111.448 -178.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -90.48 -169.06 2.27 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 109.649 -0.5 . . . . 1.0 109.649 179.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.9 mptp? -122.46 168.29 12.29 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 122.958 0.503 . . . . 1.0 110.658 -179.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 22.1 t -65.2 135.1 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-N 115.738 -0.665 . . . . 1.0 110.732 -178.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.97 -0.88 86.54 Favored Glycine 0 N--CA 1.474 1.172 0 N-CA-C 110.968 -0.853 . . . . 1.0 110.968 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -73.54 147.18 44.2 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 110.235 -0.283 . . . . 1.0 110.235 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 80.7 p -86.51 150.33 24.33 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 109.574 -0.528 . . . . 1.0 109.574 178.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.409 HG12 ' O ' ' A' ' 72' ' ' ILE . 0.3 OUTLIER -141.93 161.58 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 CA-C-O 120.933 0.397 . . . . 1.0 111.244 -179.367 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 49.9 mtmt -123.4 114.52 20.26 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.011 -0.995 . . . . 1.0 108.734 177.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 35.3 mm -106.87 140.14 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 CA-C-O 121.004 0.431 . . . . 1.0 110.378 -179.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -131.99 115.77 16.26 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 106.942 -1.503 . . . . 1.0 106.942 177.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 29.5 p90 -143.12 164.23 30.71 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-N 116.123 -0.49 . . . . 1.0 110.073 -176.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 21.2 ttpp -127.31 114.84 18.12 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 123.423 0.452 . . . . 1.0 110.641 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -99.92 108.68 20.98 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 108.075 -1.083 . . . . 1.0 108.075 178.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 74.82 -114.28 4.31 Favored Glycine 0 CA--C 1.532 1.132 0 N-CA-C 111.128 -0.789 . . . . 1.0 111.128 -179.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -113.12 -10.91 13.38 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 122.674 0.39 . . . . 1.0 111.638 -179.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -99.23 133.77 43.04 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-O 120.706 0.289 . . . . 1.0 110.745 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 18.4 p30 -97.15 128.84 44.44 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.902 0.382 . . . . 1.0 110.133 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 74.1 mt-10 -132.94 155.01 49.89 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 115.738 -0.664 . . . . 1.0 109.854 -179.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -140.7 138.09 33.98 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.843 -0.617 . . . . 1.0 110.523 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -146.89 151.38 36.96 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.766 -0.652 . . . . 1.0 110.613 -179.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 50.5 m -102.67 134.02 46.72 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.353 -0.84 . . . . 1.0 109.166 179.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.409 ' O ' HG12 ' A' ' 57' ' ' VAL . 7.6 mt -135.7 139.94 45.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 CA-C-O 121.298 0.57 . . . . 1.0 110.494 -177.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 52.0 pttt -82.47 141.51 32.64 Favored 'General case' 0 C--N 1.327 -0.376 0 O-C-N 121.905 -0.497 . . . . 1.0 110.192 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -68.62 143.38 54.84 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 120.97 0.414 . . . . 1.0 110.082 178.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 80.5 p -136.32 162.96 31.57 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 115.809 -0.632 . . . . 1.0 110.433 179.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -78.44 122.84 26.34 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.885 -0.598 . . . . 1.0 109.713 179.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.433 ' CG1' ' N ' ' A' ' 78' ' ' ASP . 3.6 pt -96.06 -53.44 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-N 116.795 -0.184 . . . . 1.0 110.587 179.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.433 ' N ' ' CG1' ' A' ' 77' ' ' ILE . 44.3 t0 -98.08 169.65 9.46 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 121.365 0.602 . . . . 1.0 111.579 -178.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 47.0 mmtm -61.82 -23.9 66.53 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 114.902 -1.044 . . . . 1.0 111.904 -178.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 35.6 pttt -77.53 -15.55 59.2 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 120.479 0.18 . . . . 1.0 110.626 -178.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 83.03 40.18 9.53 Favored Glycine 0 N--CA 1.467 0.753 0 C-N-CA 121.424 -0.417 . . . . 1.0 112.075 178.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 53.2 m -81.21 120.16 77.74 Favored Pre-proline 0 CA--C 1.545 0.753 0 N-CA-C 109.324 -0.621 . . . . 1.0 109.324 179.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -52.79 130.88 39.35 Favored 'Trans proline' 0 N--CA 1.497 1.717 0 C-N-CA 121.142 1.228 . . . . 1.0 112.909 178.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -169.14 155.03 25.03 Favored Glycine 0 N--CA 1.461 0.318 0 N-CA-C 110.666 -0.974 . . . . 1.0 110.666 178.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.525 HG22 ' HB2' ' A' ' 20' ' ' ALA . 3.3 mt -89.66 26.4 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 N-CA-C 109.501 -0.555 . . . . 1.0 109.501 -179.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 50.52 63.62 4.27 Favored Glycine 0 CA--C 1.531 1.056 0 N-CA-C 111.782 -0.527 . . . . 1.0 111.782 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 18.7 pt -146.62 164.6 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 N-CA-C 109.353 -0.61 . . . . 1.0 109.353 179.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 86.1 m -130.36 125.5 34.77 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 115.477 -0.783 . . . . 1.0 109.581 177.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 12.7 mt -111.01 134.7 52.4 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.282 0.633 . . . . 1.0 109.801 -179.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 16.0 m . . . . . 0 C--N 1.327 -0.385 0 N-CA-C 108.367 -0.975 . . . . 1.0 108.367 179.156 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 41.5 t0 . . . . . 0 N--CA 1.472 0.648 0 N-CA-C 109.747 -0.464 . . . . 1.0 109.747 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -171.23 -159.34 17.11 Favored Glycine 0 CA--C 1.521 0.461 0 N-CA-C 109.948 -1.261 . . . . 1.0 109.948 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 16.6 m -117.96 128.81 75.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 CA-C-O 121.297 0.57 . . . . 1.0 109.731 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -86.7 146.17 26.4 Favored 'General case' 0 C--O 1.221 -0.396 0 N-CA-C 108.639 -0.874 . . . . 1.0 108.639 -178.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 57.0 t -107.96 132.06 56.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 108.951 -0.759 . . . . 1.0 108.951 179.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.513 HD23 HG11 ' A' ' 90' ' ' VAL . 0.2 OUTLIER -84.61 -50.83 7.33 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 116.287 -0.415 . . . . 1.0 111.245 -179.571 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 99.7 p -167.79 163.73 14.14 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 121.173 0.511 . . . . 1.0 111.301 -179.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 39.8 t -107.09 128.74 61.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 CA-C-N 115.128 -0.942 . . . . 1.0 108.497 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.413 ' O ' ' CB ' ' A' ' 16' ' ' GLU . 63.6 mttp -59.91 -36.75 77.64 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-N 116.099 -0.501 . . . . 1.0 110.55 -178.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.435 ' C ' ' H ' ' A' ' 18' ' ' VAL . 59.5 tt0 93.84 163.93 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.338 0 O-C-N 124.742 1.277 . . . . 1.0 111.129 178.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 70.59 -4.97 1.51 Allowed 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.496 -0.775 . . . . 1.0 109.567 -179.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.435 ' H ' ' C ' ' A' ' 16' ' ' GLU . 11.4 m -96.3 155.61 37.86 Favored Pre-proline 0 CA--C 1.541 0.604 0 CA-C-N 115.727 -0.669 . . . . 1.0 110.44 -178.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -55.92 -23.03 40.82 Favored 'Trans proline' 0 N--CA 1.503 2.058 0 C-N-CA 121.953 1.769 . . . . 1.0 112.226 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.44 -23.73 67.38 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.649 0.261 . . . . 1.0 110.852 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.5 136.0 44.1 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.306 -0.406 . . . . 1.0 110.887 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 91.28 -23.64 23.45 Favored Glycine 0 N--CA 1.469 0.89 0 N-CA-C 111.243 -0.743 . . . . 1.0 111.243 179.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 67.9 mt -102.12 -50.21 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 122.32 0.248 . . . . 1.0 110.489 -179.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 23.5 mt -109.89 157.15 19.53 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-O 121.077 0.465 . . . . 1.0 109.895 -179.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 50.3 t-80 -139.0 153.5 48.15 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.44 -0.8 . . . . 1.0 110.591 -179.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.42 144.39 31.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.369 -0.832 . . . . 1.0 110.812 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 89.01 -11.2 70.03 Favored Glycine 0 CA--C 1.528 0.898 0 N-CA-C 111.06 -0.816 . . . . 1.0 111.06 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -68.27 144.17 54.97 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 110.249 -0.278 . . . . 1.0 110.249 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.5 mp -117.75 121.45 40.87 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 110.127 -0.323 . . . . 1.0 110.127 -179.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 25.4 mm -80.36 125.88 39.29 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 N-CA-C 109.177 -0.675 . . . . 1.0 109.177 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 73.8 p -88.13 -47.36 8.54 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.169 -0.468 . . . . 1.0 110.449 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 71.9 tt0 -155.96 146.54 21.89 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.974 0.416 . . . . 1.0 111.222 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 12.6 tt -141.96 131.76 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 109.404 -0.591 . . . . 1.0 109.404 179.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.412 ' OD2' ' CE1' ' A' ' 47' ' ' TYR . 57.8 m-20 56.82 20.84 5.5 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.112 -0.494 . . . . 1.0 111.581 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.86 2.54 86.36 Favored Glycine 0 N--CA 1.472 1.063 0 CA-C-N 116.483 -0.326 . . . . 1.0 112.384 178.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 . . . . . 0 N--CA 1.474 0.769 0 CA-C-N 117.361 0.58 . . . . 1.0 111.008 -179.917 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.5 m . . . . . 0 N--CA 1.477 0.907 0 CA-C-O 120.798 0.332 . . . . 1.0 110.757 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 50.3 m -52.52 -31.6 36.28 Favored 'General case' 0 N--CA 1.457 -0.089 0 N-CA-C 109.389 -0.597 . . . . 1.0 109.389 178.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.5 tm0? -55.38 -35.18 65.0 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 115.452 -0.795 . . . . 1.0 110.144 179.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -57.98 -27.86 63.85 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 115.963 -0.562 . . . . 1.0 109.779 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -72.59 -47.47 47.66 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.978 -0.555 . . . . 1.0 109.722 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 27.4 mm -63.55 -28.86 45.87 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 CA-C-N 115.797 -0.638 . . . . 1.0 109.833 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -62.62 -37.52 86.62 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.611 -0.722 . . . . 1.0 109.975 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.412 ' CE1' ' OD2' ' A' ' 34' ' ' ASP . 0.0 OUTLIER -66.62 -45.66 78.38 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.059 -0.519 . . . . 1.0 110.681 179.182 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 49.5 mt -60.61 -45.35 97.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 116.518 -0.31 . . . . 1.0 111.016 -176.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -74.16 -22.56 59.38 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.457 -0.338 . . . . 1.0 111.187 -178.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 46.6 t -85.81 -6.76 59.05 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-O 120.566 0.222 . . . . 1.0 111.217 -177.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.4 tptm -99.26 164.91 11.94 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-N 116.188 -0.46 . . . . 1.0 109.869 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -121.58 170.42 9.71 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 123.964 0.79 . . . . 1.0 109.893 -179.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 22.0 t -70.91 132.57 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-N 115.448 -0.797 . . . . 1.0 111.125 -178.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.37 -5.18 80.73 Favored Glycine 0 N--CA 1.469 0.854 0 N-CA-C 111.054 -0.818 . . . . 1.0 111.054 179.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -67.98 144.39 55.19 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.763 0.316 . . . . 1.0 110.751 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 36.3 m -90.19 153.72 20.29 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 108.988 -0.745 . . . . 1.0 108.988 178.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.469 HG12 ' O ' ' A' ' 72' ' ' ILE . 0.5 OUTLIER -140.13 161.27 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 CA-C-O 121.402 0.62 . . . . 1.0 110.599 -179.568 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -117.15 115.68 25.81 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 107.647 -1.242 . . . . 1.0 107.647 177.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.565 HG22 ' O ' ' A' ' 70' ' ' ALA . 2.9 tp -103.18 143.13 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 122.332 0.253 . . . . 1.0 111.018 -178.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 6.9 tppt? -133.1 112.75 12.03 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 108.383 -0.969 . . . . 1.0 108.383 178.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 33.8 p90 -149.15 149.2 30.64 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.906 -0.405 . . . . 1.0 109.906 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -110.18 114.12 27.35 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 110.239 -0.282 . . . . 1.0 110.239 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 51.3 t-80 -91.91 112.0 23.76 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 108.013 -1.106 . . . . 1.0 108.013 178.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 62.17 -114.45 6.8 Favored Glycine 0 CA--C 1.532 1.152 0 N-CA-C 110.7 -0.96 . . . . 1.0 110.7 -179.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 23.0 p-10 -112.99 -0.5 14.75 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 122.476 0.31 . . . . 1.0 111.365 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.437 ' NZ ' ' OE2' ' A' ' 68' ' ' GLU . 10.8 ptmm? -110.73 123.42 50.0 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 121.421 0.629 . . . . 1.0 110.75 -179.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 46.4 p-10 -81.93 128.24 33.85 Favored 'General case' 0 C--N 1.339 0.13 0 CA-C-O 121.363 0.601 . . . . 1.0 110.353 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.437 ' OE2' ' NZ ' ' A' ' 66' ' ' LYS . 81.0 mm-40 -126.11 148.83 49.28 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 115.23 -0.895 . . . . 1.0 109.523 -179.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -140.86 135.2 31.11 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 109.186 -0.672 . . . . 1.0 109.186 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.565 ' O ' HG22 ' A' ' 59' ' ' ILE . . . -148.1 142.22 26.04 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-O 121.537 0.684 . . . . 1.0 111.222 -179.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 91.5 p -85.7 135.03 33.93 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 108.781 -0.822 . . . . 1.0 108.781 178.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.469 ' O ' HG12 ' A' ' 57' ' ' VAL . 67.2 mt -129.28 122.37 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 CA-C-O 121.289 0.566 . . . . 1.0 109.963 -178.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 22.3 ttpp -82.29 138.3 34.61 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 109.64 -0.504 . . . . 1.0 109.64 179.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -69.68 143.97 53.0 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.373 0.606 . . . . 1.0 110.304 -178.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 69.7 p -143.28 172.25 13.0 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.064 -0.971 . . . . 1.0 110.435 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -89.3 140.83 29.1 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.343 -0.844 . . . . 1.0 109.583 179.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.822 ' H ' HD13 ' A' ' 77' ' ' ILE . 0.1 OUTLIER -131.92 -41.98 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 122.672 0.389 . . . . 1.0 110.839 -179.625 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -98.62 157.84 15.99 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 121.521 0.677 . . . . 1.0 110.729 -179.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -52.37 -27.09 14.25 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.845 -1.07 . . . . 1.0 112.046 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.544 ' HZ2' ' CB ' ' A' ' 82' ' ' THR . 18.1 pttp -81.4 13.24 3.07 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 116.303 -0.408 . . . . 1.0 111.039 -179.379 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 47.85 39.59 17.92 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 121.343 -0.456 . . . . 1.0 112.046 178.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.544 ' CB ' ' HZ2' ' A' ' 80' ' ' LYS . 86.8 m -80.17 122.09 82.55 Favored Pre-proline 0 CA--C 1.545 0.779 0 CA-C-N 117.101 0.451 . . . . 1.0 110.215 -179.159 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -57.03 114.86 2.11 Favored 'Trans proline' 0 N--CA 1.505 2.168 0 C-N-CA 121.401 1.4 . . . . 1.0 111.332 177.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -179.8 179.64 48.82 Favored Glycine 0 N--CA 1.463 0.449 0 N-CA-C 111.081 -0.808 . . . . 1.0 111.081 179.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.7 pt -105.69 177.5 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 N-CA-C 109.665 -0.495 . . . . 1.0 109.665 179.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -108.31 84.45 0.37 Allowed Glycine 0 N--CA 1.472 1.079 0 N-CA-C 111.05 -0.82 . . . . 1.0 111.05 -178.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.467 ' O ' HD12 ' A' ' 87' ' ' ILE . 1.2 pp -146.77 168.3 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-O 121.272 0.558 . . . . 1.0 109.645 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 62.3 m -132.23 131.39 42.06 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 115.424 -0.807 . . . . 1.0 109.557 179.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 29.2 mt -110.52 147.51 33.99 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.711 -0.677 . . . . 1.0 109.267 -179.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.513 HG11 HD23 ' A' ' 12' ' ' LEU . 30.8 m . . . . . 0 N--CA 1.476 0.872 0 CA-C-N 115.773 -0.649 . . . . 1.0 110.395 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 36.3 p-10 . . . . . 0 N--CA 1.463 0.193 0 CA-C-O 121.004 0.43 . . . . 1.0 110.049 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 153.67 -175.38 32.03 Favored Glycine 0 N--CA 1.467 0.75 0 N-CA-C 109.858 -1.297 . . . . 1.0 109.858 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 38.9 t -111.64 127.42 68.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 N-CA-C 109.18 -0.674 . . . . 1.0 109.18 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -86.85 143.36 27.49 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 115.962 -0.563 . . . . 1.0 109.634 -178.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 39.0 t -107.93 132.95 54.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 115.405 -0.816 . . . . 1.0 109.208 179.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.584 HD23 HG11 ' A' ' 90' ' ' VAL . 0.2 OUTLIER -81.67 -44.39 17.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.814 -0.63 . . . . 1.0 111.971 -179.547 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 99.9 p -165.8 162.39 18.47 Favored 'General case' 0 CA--C 1.506 -0.727 0 CA-C-N 116.061 -0.518 . . . . 1.0 110.953 -179.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.44 ' O ' ' O ' ' A' ' 15' ' ' LYS . 40.3 t -120.42 137.62 53.62 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 114.728 -1.124 . . . . 1.0 108.732 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.44 ' O ' ' O ' ' A' ' 14' ' ' VAL . 3.9 mmmm -54.43 -116.6 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.477 0 O-C-N 123.815 0.697 . . . . 1.0 110.294 179.129 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 78.1 tt0 -162.32 -70.13 0.05 Allowed 'General case' 0 C--N 1.33 -0.269 0 O-C-N 121.755 -0.591 . . . . 1.0 111.445 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 29.2 p-10 -89.97 51.7 2.12 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.346 -0.388 . . . . 1.0 110.569 -178.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 32.8 m -124.99 156.71 68.81 Favored Pre-proline 0 N--CA 1.471 0.616 0 CA-C-N 115.841 -0.618 . . . . 1.0 110.151 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -58.86 -13.18 17.3 Favored 'Trans proline' 0 N--CA 1.499 1.827 0 C-N-CA 121.751 1.634 . . . . 1.0 112.054 178.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.402 ' HB2' HG22 ' A' ' 85' ' ' ILE . . . -81.99 -27.46 33.15 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.068 0.461 . . . . 1.0 110.381 -179.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.91 130.5 41.17 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 115.694 -0.685 . . . . 1.0 110.134 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 98.57 -15.03 61.55 Favored Glycine 0 N--CA 1.472 1.054 0 N-CA-C 111.197 -0.761 . . . . 1.0 111.197 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 71.1 mt -115.23 -52.24 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 CA-C-N 116.616 0.208 . . . . 1.0 110.459 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.423 HD21 HD13 ' A' ' 59' ' ' ILE . 12.7 mt -102.0 149.77 23.9 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 109.816 -0.439 . . . . 1.0 109.816 -179.245 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 42.5 p-80 -141.11 154.89 46.13 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.389 0.614 . . . . 1.0 110.433 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.05 134.43 55.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.18 -0.918 . . . . 1.0 110.617 -179.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.27 -4.09 62.16 Favored Glycine 0 N--CA 1.471 0.983 0 N-CA-C 111.197 -0.761 . . . . 1.0 111.197 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -77.85 130.17 36.31 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 117.274 0.537 . . . . 1.0 110.264 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 14.3 mt -99.91 120.05 39.17 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 109.508 -0.552 . . . . 1.0 109.508 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.61 HD13 HD11 ' A' ' 59' ' ' ILE . 75.8 mt -92.34 137.51 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 N-CA-C 108.975 -0.75 . . . . 1.0 108.975 179.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 51.9 p -102.41 -43.93 5.52 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 116.13 -0.486 . . . . 1.0 111.216 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 73.0 tt0 -153.72 163.09 40.59 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.337 0.589 . . . . 1.0 111.176 -178.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 16.9 tt -149.61 142.56 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-N 115.906 -0.588 . . . . 1.0 110.028 179.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 28.3 t70 50.19 19.99 0.58 Allowed 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 120.994 0.426 . . . . 1.0 111.74 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.95 19.64 77.21 Favored Glycine 0 N--CA 1.47 0.955 0 N-CA-C 111.919 -0.472 . . . . 1.0 111.919 178.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 . . . . . 0 N--CA 1.47 0.552 0 O-C-N 122.473 -0.427 . . . . 1.0 110.329 -179.034 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 30.6 t . . . . . 0 N--CA 1.481 1.089 0 CA-C-O 120.576 0.227 . . . . 1.0 111.128 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 78.0 p -61.93 -48.65 79.47 Favored 'General case' 0 CA--C 1.513 -0.468 0 N-CA-C 109.404 -0.591 . . . . 1.0 109.404 -178.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 69.3 tp60 -51.43 -38.52 54.03 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.046 -0.525 . . . . 1.0 110.345 -178.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.8 tp10 -65.31 -32.64 74.39 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.347 -0.612 . . . . 1.0 109.347 179.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 27.8 t80 -72.11 -50.23 29.74 Favored 'General case' 0 C--O 1.219 -0.523 0 CA-C-N 116.337 -0.392 . . . . 1.0 110.204 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.7 mp -59.92 -37.18 70.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 109.247 -0.649 . . . . 1.0 109.247 179.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -60.49 -35.69 76.52 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.652 -0.704 . . . . 1.0 110.408 -178.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 44.4 t80 -68.08 -48.89 64.29 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.213 -0.449 . . . . 1.0 111.621 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 33.6 mt -52.78 -34.28 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-O 120.906 0.384 . . . . 1.0 110.427 -176.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 45.3 m170 -85.9 -22.54 27.43 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.036 -0.529 . . . . 1.0 111.121 -179.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 71.7 p -70.87 -17.98 62.71 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.645 -0.252 . . . . 1.0 111.269 -178.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 18.4 mmmt -90.48 -171.61 3.13 Favored 'General case' 0 CA--C 1.512 -0.492 0 N-CA-C 110.054 -0.35 . . . . 1.0 110.054 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -128.37 168.58 15.36 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 123.618 0.574 . . . . 1.0 110.148 -178.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 25.9 t -70.86 134.99 29.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.448 -0.796 . . . . 1.0 110.946 -178.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 90.31 -4.52 82.68 Favored Glycine 0 N--CA 1.47 0.938 0 N-CA-C 110.637 -0.985 . . . . 1.0 110.637 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -70.34 147.09 50.02 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 110.09 -0.337 . . . . 1.0 110.09 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 23.1 m -105.1 139.29 40.0 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 109.363 -0.606 . . . . 1.0 109.363 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 34.5 m -138.27 164.45 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 CA-C-N 116.12 -0.491 . . . . 1.0 111.535 -179.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.83 117.88 27.6 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 115.065 -0.971 . . . . 1.0 108.972 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.61 HD11 HD13 ' A' ' 30' ' ' ILE . 18.9 tt -97.72 141.79 15.39 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.201 0 O-C-N 123.314 0.384 . . . . 1.0 111.343 -178.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -121.43 119.91 33.43 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 107.721 -1.214 . . . . 1.0 107.721 178.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 18.7 p90 -147.75 161.26 41.59 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 110.065 -0.346 . . . . 1.0 110.065 -179.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 26.1 mtmm -128.27 117.84 22.22 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 123.464 0.477 . . . . 1.0 110.677 179.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 17.2 t-80 -107.64 112.15 24.73 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 108.37 -0.974 . . . . 1.0 108.37 178.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 73.19 -118.34 6.27 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.944 -0.862 . . . . 1.0 110.944 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 68.0 m-80 -115.95 14.04 16.07 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 122.704 0.401 . . . . 1.0 111.802 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -126.28 119.79 28.29 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 120.82 0.343 . . . . 1.0 110.938 -179.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 61.3 t-20 -84.74 133.16 34.37 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-N 116.116 -0.493 . . . . 1.0 109.845 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -128.67 161.34 29.9 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 115.228 -0.897 . . . . 1.0 110.015 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -141.08 139.79 34.1 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 115.454 -0.794 . . . . 1.0 110.149 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -150.65 161.48 42.51 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 115.664 -0.698 . . . . 1.0 110.493 -178.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 91.0 p -128.27 138.28 52.35 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 109.096 -0.705 . . . . 1.0 109.096 179.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.721 ' N ' HD13 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -138.22 147.27 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-O 121.491 0.662 . . . . 1.0 110.535 -178.189 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 7.8 ttpm? -86.57 135.21 33.52 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.387 -0.824 . . . . 1.0 109.846 179.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -68.98 147.58 51.4 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.151 0.5 . . . . 1.0 110.498 179.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 18.6 p -141.17 168.61 19.36 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 115.187 -0.915 . . . . 1.0 110.659 -179.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -80.25 148.34 30.83 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.192 -0.913 . . . . 1.0 109.887 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.446 HG13 ' H ' ' A' ' 78' ' ' ASP . 1.6 pt -128.89 -55.92 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 CA-C-N 115.996 -0.547 . . . . 1.0 110.782 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.446 ' H ' HG13 ' A' ' 77' ' ' ILE . 68.5 m-20 -96.33 165.81 12.02 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 121.466 0.65 . . . . 1.0 110.987 -178.077 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 24.1 pttm -57.03 -18.5 14.2 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.685 -1.143 . . . . 1.0 111.502 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -81.54 -13.95 57.46 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 116.834 -0.166 . . . . 1.0 111.351 -179.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 77.72 30.75 51.84 Favored Glycine 0 N--CA 1.469 0.897 0 N-CA-C 111.366 -0.694 . . . . 1.0 111.366 179.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 85.8 m -79.26 125.51 83.16 Favored Pre-proline 0 CA--C 1.546 0.797 0 C-N-CA 120.455 -0.498 . . . . 1.0 109.761 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_exo -50.73 128.97 25.73 Favored 'Trans proline' 0 N--CA 1.501 1.914 0 C-N-CA 121.595 1.53 . . . . 1.0 112.553 178.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -152.14 130.07 2.98 Favored Glycine 0 N--CA 1.468 0.809 0 N-CA-C 111.078 -0.809 . . . . 1.0 111.078 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.402 HG22 ' HB2' ' A' ' 20' ' ' ALA . 96.1 mt -59.68 -25.52 32.15 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 N-CA-C 110.47 -0.196 . . . . 1.0 110.47 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 100.01 46.69 1.86 Allowed Glycine 0 N--CA 1.481 1.659 0 N-CA-C 111.211 -0.755 . . . . 1.0 111.211 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.471 HD13 HD21 ' A' ' 89' ' ' LEU . 1.1 pp -146.93 164.98 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 N-CA-C 109.67 -0.492 . . . . 1.0 109.67 -178.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 15.9 m -128.76 121.94 29.5 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 115.408 -0.814 . . . . 1.0 110.584 178.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.775 HD22 ' N ' ' A' ' 89' ' ' LEU . 0.4 OUTLIER -99.73 139.37 35.49 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.389 0.676 . . . . 1.0 109.759 -179.861 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.584 HG11 HD23 ' A' ' 12' ' ' LEU . 9.1 m . . . . . 0 C--N 1.324 -0.539 0 CA-C-N 114.884 -1.053 . . . . 1.0 109.424 -179.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 34.0 t0 . . . . . 0 CA--C 1.528 0.124 0 N-CA-C 109.544 -0.539 . . . . 1.0 109.544 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -77.53 -161.33 14.76 Favored Glycine 0 N--CA 1.464 0.521 0 N-CA-C 110.243 -1.143 . . . . 1.0 110.243 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.6 t -111.93 129.65 67.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 N-CA-C 109.722 -0.473 . . . . 1.0 109.722 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -85.87 141.65 29.44 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.385 -0.598 . . . . 1.0 109.385 -178.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.6 t -100.45 136.0 33.84 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.31 0 CA-C-N 115.121 -0.945 . . . . 1.0 109.521 179.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 42.3 tp -89.72 -51.84 5.31 Favored 'General case' 0 N--CA 1.458 -0.071 0 CA-C-N 116.052 -0.522 . . . . 1.0 110.778 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 44.4 m -158.6 151.86 22.8 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.285 0.564 . . . . 1.0 110.845 -178.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.4 p -137.42 135.2 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-N 114.821 -1.081 . . . . 1.0 109.623 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -71.28 152.92 42.8 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.93 -0.767 . . . . 1.0 108.93 178.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -96.14 15.3 21.22 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 116.778 -0.192 . . . . 1.0 111.377 -178.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -133.77 41.62 3.01 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 109.132 -0.692 . . . . 1.0 109.132 179.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 8.7 m -141.31 153.13 65.87 Favored Pre-proline 0 CA--C 1.542 0.66 0 CA-C-N 115.786 -0.643 . . . . 1.0 110.0 -179.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.718 ' O ' HD13 ' A' ' 23' ' ' ILE . 80.9 Cg_exo -45.1 -30.85 5.17 Favored 'Trans proline' 0 N--CA 1.496 1.633 0 C-N-CA 122.178 1.919 . . . . 1.0 113.109 179.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.79 -23.82 67.43 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.059 0.457 . . . . 1.0 110.314 -178.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.0 107.44 1.25 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.81 -0.632 . . . . 1.0 110.144 179.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.542 ' C ' HD12 ' A' ' 23' ' ' ILE . . . 108.05 -4.62 33.84 Favored Glycine 0 N--CA 1.476 1.304 0 N-CA-C 111.317 -0.713 . . . . 1.0 111.317 -179.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.718 HD13 ' O ' ' A' ' 19' ' ' PRO . 3.3 mp -117.19 -50.15 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 122.461 0.304 . . . . 1.0 110.787 179.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 12.1 mt -112.03 150.46 30.6 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 121.242 0.544 . . . . 1.0 110.314 -179.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 -145.46 158.55 43.82 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.293 -0.867 . . . . 1.0 110.852 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.41 124.64 20.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.46 -0.791 . . . . 1.0 110.276 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 99.64 -4.44 58.02 Favored Glycine 0 N--CA 1.471 1.028 0 N-CA-C 111.129 -0.788 . . . . 1.0 111.129 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -74.96 141.94 43.98 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.979 0.39 . . . . 1.0 110.038 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 25.6 mt -115.96 121.13 41.36 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 109.958 -0.386 . . . . 1.0 109.958 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 62.4 mt -91.69 135.94 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 N-CA-C 107.883 -1.154 . . . . 1.0 107.883 178.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 3.0 p -123.72 -23.3 4.74 Favored 'General case' 0 N--CA 1.479 0.978 0 O-C-N 123.416 0.447 . . . . 1.0 111.408 -178.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 59.1 tt0 -152.27 147.21 26.09 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 120.924 -0.311 . . . . 1.0 110.536 -178.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.467 ' O ' ' N ' ' A' ' 35' ' ' GLY . 4.1 mp -135.89 137.11 49.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 N-CA-C 108.742 -0.836 . . . . 1.0 108.742 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 42.73 17.29 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 122.893 0.477 . . . . 1.0 112.118 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 33' ' ' ILE . . . 64.29 17.89 62.28 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 111.493 -0.643 . . . . 1.0 111.493 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.445 ' OE1' ' CE1' ' A' ' 47' ' ' TYR . 12.0 pt20 . . . . . 0 N--CA 1.469 0.491 0 O-C-N 122.532 -0.393 . . . . 1.0 111.81 -178.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 44.2 m . . . . . 0 N--CA 1.473 0.693 0 CA-C-O 121.176 0.512 . . . . 1.0 110.486 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 78.4 p -60.58 -29.82 69.42 Favored 'General case' 0 C--O 1.215 -0.717 0 N-CA-C 109.312 -0.625 . . . . 1.0 109.312 178.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -64.17 -30.71 71.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.925 -0.579 . . . . 1.0 110.741 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -60.33 -26.94 66.96 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.775 0.322 . . . . 1.0 110.444 -178.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -72.28 -51.13 22.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.997 0.427 . . . . 1.0 110.233 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.551 HD12 ' N ' ' A' ' 45' ' ' ILE . 1.7 mp -57.39 -28.77 31.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 108.979 -0.749 . . . . 1.0 108.979 -179.042 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -70.64 -33.77 71.35 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.487 -0.779 . . . . 1.0 110.808 -178.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.445 ' CE1' ' OE1' ' A' ' 36' ' ' GLN . 84.0 t80 -69.48 -52.21 28.7 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 120.69 -0.404 . . . . 1.0 111.888 -178.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -67.08 -39.62 83.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-N 116.257 -0.428 . . . . 1.0 109.996 -178.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 81.0 t60 -59.59 -13.73 10.55 Favored 'General case' 0 CA--C 1.503 -0.838 0 CA-C-N 116.25 -0.432 . . . . 1.0 111.088 -178.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 21.6 t -96.74 -142.68 0.28 Allowed 'General case' 0 N--CA 1.434 -1.251 0 CA-C-O 122.008 0.909 . . . . 1.0 109.042 178.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 30.1 mmtp 48.2 -169.84 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 114.26 -1.336 . . . . 1.0 110.049 -177.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -131.58 154.89 48.38 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.121 0.486 . . . . 1.0 110.319 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.6 t -59.88 142.57 15.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.578 -0.737 . . . . 1.0 111.03 -179.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 102.17 -20.45 45.15 Favored Glycine 0 N--CA 1.474 1.189 0 N-CA-C 110.596 -1.002 . . . . 1.0 110.596 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 -62.0 -174.13 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.794 0.331 . . . . 1.0 110.525 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.9 t -148.9 145.51 27.46 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 109.623 -0.51 . . . . 1.0 109.623 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 23.0 m -140.66 165.82 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 CA-C-O 121.116 0.484 . . . . 1.0 111.442 -178.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -119.68 120.03 35.44 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 114.877 -1.056 . . . . 1.0 108.385 178.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.5 tt -103.82 147.3 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 123.026 0.53 . . . . 1.0 110.907 -178.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 33.3 ttmt -131.02 117.27 18.93 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 108.207 -1.034 . . . . 1.0 108.207 177.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 26.1 p90 -136.49 165.33 26.1 Favored 'General case' 0 C--N 1.34 0.195 0 CA-C-N 115.92 -0.582 . . . . 1.0 110.581 -177.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -121.17 139.25 53.61 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.308 -0.86 . . . . 1.0 110.466 -179.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 80.2 t60 -130.64 101.23 5.6 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.756 -0.656 . . . . 1.0 109.336 178.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 60.98 -110.41 3.03 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 110.702 -0.959 . . . . 1.0 110.702 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -112.82 13.72 19.76 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 122.578 0.351 . . . . 1.0 111.396 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 7.6 ttpm? -130.39 116.18 17.91 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 116.636 -0.256 . . . . 1.0 110.546 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 41.5 m-20 -100.85 135.77 41.76 Favored 'General case' 0 C--N 1.341 0.236 0 N-CA-C 109.722 -0.473 . . . . 1.0 109.722 179.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -135.47 166.56 22.9 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 109.303 -0.628 . . . . 1.0 109.303 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.418 ' N ' ' CD ' ' A' ' 69' ' ' GLU . 3.0 pm0 -141.24 140.45 33.93 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.706 -0.679 . . . . 1.0 110.574 -179.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.4 ' HB3' HG23 ' A' ' 23' ' ' ILE . . . -149.92 154.63 38.61 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.794 -0.639 . . . . 1.0 110.681 -178.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 29.6 m -115.86 139.76 49.89 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 115.181 -0.918 . . . . 1.0 109.352 179.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -136.59 146.86 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-O 121.384 0.612 . . . . 1.0 110.469 -178.089 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -82.39 138.74 34.37 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.201 -0.908 . . . . 1.0 109.576 179.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.491 HD22 ' N ' ' A' ' 74' ' ' LEU . 4.1 mm? -67.24 146.45 54.16 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.442 0.639 . . . . 1.0 110.874 -179.356 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 45.4 p -140.91 160.1 40.8 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.052 -0.976 . . . . 1.0 110.796 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -80.32 131.71 35.69 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.346 -0.843 . . . . 1.0 109.537 179.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 10.7 pt -122.68 -44.98 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 122.677 0.391 . . . . 1.0 111.05 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.401 ' OD2' ' NZ ' ' A' ' 80' ' ' LYS . 30.6 t70 -99.81 156.98 16.82 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 121.636 0.732 . . . . 1.0 110.908 -179.118 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 10.3 mmpt? -48.44 -32.3 7.52 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.647 -1.161 . . . . 1.0 111.759 -179.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.401 ' NZ ' ' OD2' ' A' ' 78' ' ' ASP . 29.2 mtmm -82.72 12.42 4.76 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.415 -0.357 . . . . 1.0 111.375 -178.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 56.12 47.32 81.8 Favored Glycine 0 C--N 1.334 0.422 0 N-CA-C 111.635 -0.586 . . . . 1.0 111.635 178.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 86.5 m -79.87 120.37 79.71 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 120.491 -0.484 . . . . 1.0 110.471 -179.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -56.03 132.36 51.51 Favored 'Trans proline' 0 N--CA 1.498 1.787 0 C-N-CA 121.703 1.602 . . . . 1.0 111.738 177.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 154.98 179.41 30.14 Favored Glycine 0 N--CA 1.468 0.774 0 N-CA-C 110.62 -0.992 . . . . 1.0 110.62 178.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.417 HD13 ' N ' ' A' ' 85' ' ' ILE . 0.0 OUTLIER -103.92 -177.57 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 N-CA-C 109.037 -0.727 . . . . 1.0 109.037 -179.566 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -103.84 78.61 0.29 Allowed Glycine 0 C--N 1.339 0.699 0 N-CA-C 110.667 -0.973 . . . . 1.0 110.667 -179.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 49.7 pt -138.08 163.4 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 C-N-CA 122.796 0.438 . . . . 1.0 109.988 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 84.8 m -130.13 128.04 41.0 Favored 'General case' 0 N--CA 1.478 0.948 0 O-C-N 123.72 0.637 . . . . 1.0 109.777 177.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 54.1 mt -110.42 146.16 36.34 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 123.183 0.593 . . . . 1.0 110.153 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 33.7 m . . . . . 0 N--CA 1.473 0.685 0 CA-C-N 115.606 -0.724 . . . . 1.0 110.176 -179.128 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 . . . . . 0 N--CA 1.473 0.722 0 N-CA-C 110.054 -0.35 . . . . 1.0 110.054 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 42.73 -146.38 0.82 Allowed Glycine 0 N--CA 1.473 1.132 0 N-CA-C 111.294 -0.722 . . . . 1.0 111.294 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.9 t -135.23 127.53 47.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 N-CA-C 108.628 -0.879 . . . . 1.0 108.628 178.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.46 ' CZ ' HD13 ' A' ' 29' ' ' LEU . 97.1 m-85 -102.08 132.69 47.79 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 121.256 0.55 . . . . 1.0 110.255 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 61.2 t -76.87 132.1 33.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 N-CA-C 108.152 -1.055 . . . . 1.0 108.152 179.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.432 ' O ' HD23 ' A' ' 12' ' ' LEU . 1.7 tt -76.14 -51.66 11.71 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-O 121.558 0.694 . . . . 1.0 110.71 -178.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 92.4 p -155.75 153.05 29.29 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.641 -0.709 . . . . 1.0 111.253 -179.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 51.7 t -136.84 113.77 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 108.706 -0.85 . . . . 1.0 108.706 178.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 34.3 mtmm -70.87 163.62 27.0 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 109.662 -0.496 . . . . 1.0 109.662 179.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 28.8 mp0 -98.83 46.36 0.99 Allowed 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 116.402 -0.363 . . . . 1.0 111.199 -179.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -158.36 35.15 0.24 Allowed 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 109.96 -0.385 . . . . 1.0 109.96 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 15.8 m -142.49 157.45 62.46 Favored Pre-proline 0 N--CA 1.481 1.09 0 N-CA-C 108.847 -0.797 . . . . 1.0 108.847 -179.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -45.8 -37.96 17.09 Favored 'Trans proline' 0 N--CA 1.507 2.31 0 CA-C-N 121.049 1.41 . . . . 1.0 112.807 179.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.26 -15.63 60.48 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.159 -0.473 . . . . 1.0 111.589 -179.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.95 139.41 46.74 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-O 121.195 0.521 . . . . 1.0 111.499 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 79.69 -11.13 34.82 Favored Glycine 0 N--CA 1.463 0.469 0 CA-C-N 115.352 -0.84 . . . . 1.0 111.94 176.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 67.2 mt -115.2 -50.85 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 N-CA-C 109.88 -0.415 . . . . 1.0 109.88 -178.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 15.0 mt -107.36 134.36 50.53 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 115.756 -0.656 . . . . 1.0 110.032 -179.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -110.84 132.7 53.98 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.784 -0.644 . . . . 1.0 109.525 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -47.64 137.14 9.56 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 120.751 0.31 . . . . 1.0 111.606 -178.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 94.93 -3.3 67.16 Favored Glycine 0 N--CA 1.471 0.969 0 N-CA-C 111.039 -0.824 . . . . 1.0 111.039 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -65.18 123.72 20.27 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 120.912 0.387 . . . . 1.0 110.545 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.46 HD13 ' CZ ' ' A' ' 10' ' ' TYR . 37.8 tp -88.16 131.5 34.7 Favored 'General case' 0 C--O 1.208 -1.087 0 CA-C-O 118.085 -0.959 . . . . 1.0 109.024 179.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 18.3 mm -87.96 125.4 41.45 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 119.485 1.039 . . . . 1.0 108.988 178.196 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 82.0 p -97.03 -36.26 10.57 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 122.449 0.3 . . . . 1.0 111.223 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -153.5 149.5 27.77 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 109.867 -0.42 . . . . 1.0 109.867 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.504 HD13 ' H ' ' A' ' 34' ' ' ASP . 0.3 OUTLIER -147.17 139.67 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 N-CA-C 107.84 -1.17 . . . . 1.0 107.84 -179.998 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.504 ' H ' HD13 ' A' ' 33' ' ' ILE . 36.1 t70 47.79 22.05 0.32 Allowed 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 112.139 0.422 . . . . 1.0 112.139 178.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.34 -8.0 54.9 Favored Glycine 0 CA--C 1.529 0.92 0 N-CA-C 111.411 -0.675 . . . . 1.0 111.411 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 . . . . . 0 N--CA 1.473 0.691 0 N-CA-C 110.016 -0.364 . . . . 1.0 110.016 179.809 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.1 p . . . . . 0 N--CA 1.469 0.482 0 N-CA-C 109.368 -0.604 . . . . 1.0 109.368 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 79.8 p -77.72 -51.78 10.01 Favored 'General case' 0 C--O 1.223 -0.293 0 CA-C-N 116.4 -0.364 . . . . 1.0 110.189 179.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -52.16 -42.38 63.36 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 122.099 -0.376 . . . . 1.0 111.27 -177.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -66.57 -31.34 71.98 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.218 -0.66 . . . . 1.0 109.218 178.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -73.98 -48.97 26.62 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.773 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.8 mp -55.6 -33.94 34.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 N-CA-C 108.319 -0.993 . . . . 1.0 108.319 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -64.4 -38.57 91.48 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.809 -0.632 . . . . 1.0 111.471 -179.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 77.3 t80 -67.57 -52.1 42.63 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 120.748 -0.381 . . . . 1.0 111.653 -178.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -67.78 -44.35 85.7 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 CA-C-O 120.553 0.216 . . . . 1.0 110.714 -179.321 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 63.8 t-80 -65.0 -16.94 64.0 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.668 -0.242 . . . . 1.0 111.365 -178.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 90.2 p -104.97 -4.2 22.36 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 122.319 0.248 . . . . 1.0 111.329 -178.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.449 ' HZ1' ' CG ' ' A' ' 55' ' ' ASP . 14.3 tptp -87.54 135.67 33.25 Favored 'General case' 0 C--O 1.211 -0.95 0 N-CA-C 108.711 -0.848 . . . . 1.0 108.711 179.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -69.03 153.55 43.59 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 111.884 0.327 . . . . 1.0 111.884 -178.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.6 t -64.74 141.12 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-N 116.388 -0.369 . . . . 1.0 110.931 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 89.95 -23.74 19.05 Favored Glycine 0 N--CA 1.469 0.865 0 CA-C-N 116.011 -0.54 . . . . 1.0 111.963 177.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.449 ' CG ' ' HZ1' ' A' ' 51' ' ' LYS . 11.7 t70 -53.7 151.9 5.76 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-N 117.354 0.577 . . . . 1.0 111.377 -178.4 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.0 m -104.96 128.63 53.32 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 121.376 0.607 . . . . 1.0 110.075 179.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 30.7 m -117.61 171.62 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 124.383 1.073 . . . . 1.0 109.829 -178.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 18.1 ttmm -125.43 113.9 18.13 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 107.376 -1.342 . . . . 1.0 107.376 178.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.566 HG22 ' O ' ' A' ' 70' ' ' ALA . 1.6 tp -97.55 141.9 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 122.643 0.377 . . . . 1.0 110.53 -178.188 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.11 112.24 10.99 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 107.379 -1.341 . . . . 1.0 107.379 177.218 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 24.5 p90 -144.77 160.89 40.52 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 110.36 -0.237 . . . . 1.0 110.36 -178.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -134.76 136.9 42.97 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 109.154 -0.684 . . . . 1.0 109.154 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 61.6 t-80 -128.42 126.43 40.56 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 107.835 -1.172 . . . . 1.0 107.835 178.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 62.82 -117.18 10.66 Favored Glycine 0 CA--C 1.531 1.041 0 N-CA-C 110.65 -0.98 . . . . 1.0 110.65 -179.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -113.47 -21.58 10.78 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 122.845 0.458 . . . . 1.0 110.856 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -90.89 123.31 34.31 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 121.593 0.711 . . . . 1.0 111.598 -178.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 57.4 m-20 -92.96 135.94 33.71 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 109.446 -0.575 . . . . 1.0 109.446 -179.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 64.7 mt-10 -137.76 142.1 40.93 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 109.98 -0.378 . . . . 1.0 109.98 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -140.66 138.23 34.15 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 110.067 -0.346 . . . . 1.0 110.067 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.566 ' O ' HG22 ' A' ' 59' ' ' ILE . . . -151.16 147.43 27.03 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-O 121.547 0.689 . . . . 1.0 112.778 -177.304 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 90.6 p -90.97 127.87 36.58 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 109.485 -0.561 . . . . 1.0 109.485 177.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.4 mp -130.44 129.06 64.48 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 N-CA-C 108.772 -0.825 . . . . 1.0 108.772 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 5.4 ptpt -81.38 142.92 32.56 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 122.023 -0.423 . . . . 1.0 110.517 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.419 HD22 ' N ' ' A' ' 74' ' ' LEU . 3.5 mm? -61.32 145.14 52.46 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 109.936 -0.394 . . . . 1.0 109.936 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 72.3 p -134.82 155.1 51.22 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 115.972 -0.558 . . . . 1.0 110.259 178.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -79.93 122.28 26.5 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 108.752 -0.833 . . . . 1.0 108.752 178.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.789 ' H ' HD13 ' A' ' 77' ' ' ILE . 0.1 OUTLIER -118.07 -14.19 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 C-N-CA 122.597 0.359 . . . . 1.0 111.689 -178.714 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -120.02 145.72 46.56 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.052 0.453 . . . . 1.0 110.347 -179.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 24.0 pttm -47.72 -27.16 1.84 Allowed 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 115.658 -0.701 . . . . 1.0 112.343 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 14.4 pttm -81.29 -16.3 52.91 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-O 120.751 0.31 . . . . 1.0 110.343 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 81.81 50.56 4.89 Favored Glycine 0 N--CA 1.468 0.826 0 N-CA-C 111.891 -0.483 . . . . 1.0 111.891 179.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 32.4 m -81.68 119.42 75.37 Favored Pre-proline 0 CA--C 1.549 0.917 0 CA-C-O 118.915 -0.564 . . . . 1.0 110.062 179.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_exo -53.09 118.32 4.69 Favored 'Trans proline' 0 N--CA 1.505 2.165 0 CA-C-N 120.744 1.301 . . . . 1.0 111.369 177.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 173.1 -174.74 46.0 Favored Glycine 0 N--CA 1.469 0.866 0 C-N-CA 120.581 -0.818 . . . . 1.0 112.676 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -116.48 170.79 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 N-CA-C 107.258 -1.386 . . . . 1.0 107.258 178.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -90.91 42.67 2.87 Favored Glycine 0 N--CA 1.475 1.262 0 CA-C-N 118.1 0.409 . . . . 1.0 112.479 -177.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 48.8 pt -111.68 176.09 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 122.405 0.282 . . . . 1.0 110.341 -178.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 62.9 m -132.33 130.18 40.44 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 115.805 -0.634 . . . . 1.0 109.844 178.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 69.1 mt -104.65 143.54 32.94 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.022 0.529 . . . . 1.0 109.927 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.1 m . . . . . 0 N--CA 1.483 1.195 0 C-N-CA 123.379 0.672 . . . . 1.0 111.333 -177.475 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.456 ' CG ' ' H ' ' A' ' 8' ' ' GLY . 9.6 p30 . . . . . 0 CA--C 1.54 0.566 0 N-CA-C 109.798 -0.445 . . . . 1.0 109.798 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.456 ' H ' ' CG ' ' A' ' 7' ' ' ASP . . . 178.61 -159.31 24.41 Favored Glycine 0 CA--C 1.519 0.332 0 N-CA-C 109.86 -1.296 . . . . 1.0 109.86 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.7 m -111.54 128.39 68.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 N-CA-C 109.125 -0.695 . . . . 1.0 109.125 179.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.463 ' N ' ' O ' ' A' ' 90' ' ' VAL . 11.5 m-85 -88.45 132.23 34.56 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 121.329 0.585 . . . . 1.0 109.527 -178.015 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 83.7 t -76.46 134.54 28.69 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.227 0 N-CA-C 107.337 -1.357 . . . . 1.0 107.337 179.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.52 -51.57 6.1 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.578 0.227 . . . . 1.0 110.707 -178.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 40.2 t -154.03 150.68 28.5 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.004 0.431 . . . . 1.0 111.003 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 46.7 t -110.56 113.22 43.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-N 115.191 -0.913 . . . . 1.0 108.952 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.407 ' O ' ' O ' ' A' ' 16' ' ' GLU . 62.5 mttp -86.37 92.19 8.74 Favored 'General case' 0 C--O 1.221 -0.411 0 N-CA-C 108.384 -0.969 . . . . 1.0 108.384 179.327 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.47 ' CD ' ' H ' ' A' ' 16' ' ' GLU . 3.3 pm0 -44.77 -179.24 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.489 0 O-C-N 124.073 0.858 . . . . 1.0 112.689 -178.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 26.7 t70 62.73 30.0 16.78 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.683 -0.69 . . . . 1.0 109.763 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 28.3 m -133.6 157.13 78.72 Favored Pre-proline 0 N--CA 1.484 1.247 0 CA-C-N 115.954 -0.566 . . . . 1.0 110.558 -179.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -49.5 -38.57 44.48 Favored 'Trans proline' 0 N--CA 1.503 2.049 0 C-N-CA 121.253 1.302 . . . . 1.0 112.874 178.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.44 -17.33 62.57 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.505 -0.316 . . . . 1.0 110.929 -178.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.06 118.14 9.4 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 110.352 -0.24 . . . . 1.0 110.352 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 98.83 -3.76 59.0 Favored Glycine 0 N--CA 1.473 1.123 0 N-CA-C 111.604 -0.598 . . . . 1.0 111.604 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 65.1 mt -114.29 -50.48 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 CA-C-N 116.973 0.386 . . . . 1.0 110.247 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 48.1 mt -110.43 151.43 27.5 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.099 0.56 . . . . 1.0 110.114 -179.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.407 ' HE2' ' CE1' ' A' ' 63' ' ' HIS . 18.4 p-80 -143.5 155.1 44.24 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.403 -0.817 . . . . 1.0 110.105 -179.193 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.74 139.14 40.3 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 115.373 -0.831 . . . . 1.0 111.101 -179.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 91.82 -3.48 77.8 Favored Glycine 0 CA--C 1.528 0.889 0 N-CA-C 111.179 -0.769 . . . . 1.0 111.179 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -79.68 126.53 31.05 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 117.148 0.474 . . . . 1.0 110.501 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 17.5 mt -102.54 129.86 49.21 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 109.069 -0.715 . . . . 1.0 109.069 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 30.8 mm -85.17 127.39 39.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 N-CA-C 109.417 -0.586 . . . . 1.0 109.417 179.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 66.4 p -93.12 -42.13 9.56 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 116.599 -0.273 . . . . 1.0 110.708 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 73.1 tt0 -153.71 152.58 30.94 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.694 0.283 . . . . 1.0 110.379 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.534 HD13 ' H ' ' A' ' 34' ' ' ASP . 0.3 OUTLIER -137.87 138.53 43.9 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 N-CA-C 108.951 -0.759 . . . . 1.0 108.951 -179.218 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.534 ' H ' HD13 ' A' ' 33' ' ' ILE . 37.6 t70 46.46 25.85 0.43 Allowed 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.211 0.529 . . . . 1.0 111.732 179.329 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.94 4.62 49.09 Favored Glycine 0 CA--C 1.527 0.815 0 CA-C-N 115.812 -0.631 . . . . 1.0 111.579 179.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 . . . . . 0 N--CA 1.47 0.54 0 CA-C-O 120.999 0.428 . . . . 1.0 110.635 -179.458 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 96.0 p . . . . . 0 N--CA 1.48 1.051 0 N-CA-C 111.635 0.235 . . . . 1.0 111.635 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 81.2 p -58.71 -50.8 72.55 Favored 'General case' 0 C--O 1.22 -0.45 0 C-N-CA 120.464 -0.494 . . . . 1.0 110.039 -178.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -48.88 -42.65 37.46 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.462 0.172 . . . . 1.0 111.244 -178.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.1 tp10 -69.79 -32.04 70.29 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.315 -0.624 . . . . 1.0 109.315 178.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -71.29 -49.77 39.42 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.9 0.381 . . . . 1.0 110.75 -179.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 38.4 mm -58.53 -29.07 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 115.516 -0.765 . . . . 1.0 109.639 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -66.92 -35.56 80.27 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.703 -0.681 . . . . 1.0 110.702 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -68.68 -46.91 67.82 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-O 121.223 0.535 . . . . 1.0 111.248 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 42.7 mt -52.66 -41.5 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-N 115.687 -0.688 . . . . 1.0 110.267 -175.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 32.3 m-70 -83.91 -18.97 35.6 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.074 -0.512 . . . . 1.0 111.275 -179.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 24.8 t -63.64 -24.94 68.0 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 111.646 0.239 . . . . 1.0 111.646 -178.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 48.7 mttm -94.23 -174.81 3.48 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 120.961 0.41 . . . . 1.0 110.107 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -130.63 161.58 31.27 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 115.46 -0.791 . . . . 1.0 110.536 -178.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 26.2 t -65.81 138.55 22.85 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-N 115.462 -0.79 . . . . 1.0 111.226 -178.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 99.76 -2.36 57.06 Favored Glycine 0 N--CA 1.477 1.421 0 N-CA-C 110.897 -0.881 . . . . 1.0 110.897 179.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -76.65 -172.8 2.35 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.695 -0.483 . . . . 1.0 109.695 179.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.8 t -148.05 141.13 24.96 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 109.479 -0.563 . . . . 1.0 109.479 179.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 27.7 m -142.3 165.88 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 CA-C-N 116.002 -0.545 . . . . 1.0 111.597 -178.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -118.32 121.94 41.63 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 108.003 -1.11 . . . . 1.0 108.003 178.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 13.2 tt -101.8 143.26 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 122.648 0.379 . . . . 1.0 110.887 -178.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -134.04 118.47 17.82 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 107.549 -1.278 . . . . 1.0 107.549 178.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 49.3 p90 -139.35 161.96 36.17 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-N 116.16 -0.473 . . . . 1.0 109.775 -178.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 7.8 ttpm? -118.77 112.83 20.23 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 123.342 0.401 . . . . 1.0 110.346 179.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.407 ' CE1' ' HE2' ' A' ' 25' ' ' HIS . 34.5 t60 -106.78 107.63 18.73 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 108.012 -1.107 . . . . 1.0 108.012 178.302 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 72.27 -115.99 5.65 Favored Glycine 0 CA--C 1.53 1.015 0 N-CA-C 111.054 -0.818 . . . . 1.0 111.054 -178.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -113.51 1.66 15.1 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 122.983 0.513 . . . . 1.0 111.407 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -124.02 124.29 42.23 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-O 121.48 0.657 . . . . 1.0 111.009 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 38.6 p-10 -101.86 143.19 32.06 Favored 'General case' 0 C--N 1.343 0.324 0 N-CA-C 109.33 -0.618 . . . . 1.0 109.33 179.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 68.5 mt-10 -130.5 167.14 19.13 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 115.542 -0.753 . . . . 1.0 109.285 -179.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 78.6 tt0 -136.0 137.68 41.46 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 109.466 -0.568 . . . . 1.0 109.466 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.11 157.32 43.29 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.56 -0.745 . . . . 1.0 110.394 -178.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 94.9 p -122.14 137.54 54.79 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 108.425 -0.954 . . . . 1.0 108.425 179.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.2 mp -135.93 140.32 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 CA-C-N 116.501 -0.318 . . . . 1.0 110.243 -177.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -80.39 137.51 36.54 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 109.061 -0.718 . . . . 1.0 109.061 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.465 HD22 ' N ' ' A' ' 74' ' ' LEU . 3.8 mm? -68.26 144.85 54.72 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.935 -0.575 . . . . 1.0 109.978 -179.329 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 79.8 p -139.08 166.16 25.23 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 115.335 -0.848 . . . . 1.0 109.787 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -94.37 146.46 24.04 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.331 -0.85 . . . . 1.0 109.734 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.647 ' H ' HD13 ' A' ' 77' ' ' ILE . 0.1 OUTLIER -144.92 -30.12 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-N 116.323 -0.399 . . . . 1.0 110.914 179.508 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.405 ' H ' HD13 ' A' ' 77' ' ' ILE . 81.8 m-20 -99.44 151.76 20.75 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 121.238 0.542 . . . . 1.0 110.243 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 10.1 ptpp? -48.72 -27.31 2.83 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.268 -0.878 . . . . 1.0 112.628 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -93.08 11.57 27.18 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 120.634 0.254 . . . . 1.0 111.376 -178.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 56.41 41.51 88.07 Favored Glycine 0 CA--C 1.525 0.665 0 C-N-CA 121.068 -0.587 . . . . 1.0 111.856 178.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 16.8 m -80.54 122.88 82.91 Favored Pre-proline 0 CA--C 1.551 0.998 0 CA-C-O 118.882 -0.58 . . . . 1.0 109.975 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.448 ' HB3' HD12 ' A' ' 74' ' ' LEU . 55.1 Cg_exo -51.63 126.75 20.52 Favored 'Trans proline' 0 N--CA 1.503 2.032 0 C-N-CA 121.363 1.375 . . . . 1.0 111.226 177.196 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.545 ' C ' ' H ' ' A' ' 86' ' ' GLY . . . -150.7 -13.59 0.09 OUTLIER Glycine 0 N--CA 1.478 1.473 0 C-N-CA 121.334 -0.46 . . . . 1.0 111.956 -179.024 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 41.4 mt 66.07 -30.05 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 O-C-N 123.782 0.342 . . . . 1.0 111.146 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.545 ' H ' ' C ' ' A' ' 84' ' ' GLY . . . 115.18 37.86 1.08 Allowed Glycine 0 N--CA 1.477 1.369 0 N-CA-C 110.473 -1.051 . . . . 1.0 110.473 -179.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 48.4 pt -140.87 163.94 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 122.599 0.36 . . . . 1.0 110.288 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 8.9 t -134.3 129.94 36.29 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.663 -0.699 . . . . 1.0 109.511 178.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.696 HD22 ' N ' ' A' ' 89' ' ' LEU . 1.3 mm? -106.36 135.31 48.07 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 108.253 -1.018 . . . . 1.0 108.253 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.463 ' O ' ' N ' ' A' ' 10' ' ' TYR . 52.3 t . . . . . 0 C--O 1.217 -0.608 0 N-CA-C 108.395 -0.965 . . . . 1.0 108.395 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 35.0 t0 . . . . . 0 N--CA 1.472 0.64 0 N-CA-C 110.053 -0.351 . . . . 1.0 110.053 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 154.38 -159.67 29.02 Favored Glycine 0 N--CA 1.466 0.634 0 N-CA-C 109.191 -1.563 . . . . 1.0 109.191 -179.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 12.4 m -129.43 127.42 64.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 N-CA-C 108.789 -0.819 . . . . 1.0 108.789 178.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -91.08 127.85 36.67 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 110.028 -0.36 . . . . 1.0 110.028 -177.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 60.4 t -76.41 135.27 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 N-CA-C 107.142 -1.429 . . . . 1.0 107.142 178.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.8 tt -78.8 -51.11 10.22 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 121.119 0.485 . . . . 1.0 110.139 -178.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 95.3 p -157.37 153.3 27.08 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.036 0.446 . . . . 1.0 110.996 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 58.4 t -111.57 136.26 48.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 CA-C-N 115.419 -0.81 . . . . 1.0 108.972 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -96.41 121.74 38.54 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 108.845 -0.798 . . . . 1.0 108.845 178.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.435 ' N ' ' OE1' ' A' ' 16' ' ' GLU . 14.4 pm0 -85.66 63.28 7.97 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 120.85 0.357 . . . . 1.0 111.399 -178.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -163.45 27.18 0.09 Allowed 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.335 0.588 . . . . 1.0 109.568 179.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -143.64 160.61 50.16 Favored Pre-proline 0 N--CA 1.479 0.991 0 N-CA-C 108.85 -0.796 . . . . 1.0 108.85 -177.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -53.87 -25.76 36.72 Favored 'Trans proline' 0 N--CA 1.498 1.757 0 C-N-CA 121.358 1.372 . . . . 1.0 112.463 179.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.23 -12.96 62.13 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 120.724 0.297 . . . . 1.0 110.95 179.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.57 135.08 45.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 1.0 111.775 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.34 -4.36 85.75 Favored Glycine 0 N--CA 1.468 0.783 0 CA-C-N 115.908 -0.587 . . . . 1.0 111.951 178.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 67.6 mt -112.76 -50.48 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 CA-C-N 117.028 0.414 . . . . 1.0 109.957 -179.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 21.4 mt -105.78 150.34 25.64 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 115.834 -0.621 . . . . 1.0 109.981 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 63.7 t-80 -127.98 140.24 52.1 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 115.825 -0.625 . . . . 1.0 110.302 -179.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -49.98 140.73 11.8 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.896 0.379 . . . . 1.0 111.428 -179.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 86.7 -7.11 80.98 Favored Glycine 0 N--CA 1.471 0.986 0 N-CA-C 111.116 -0.794 . . . . 1.0 111.116 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.41 ' OD2' ' CD1' ' A' ' 61' ' ' TYR . 23.3 t0 -65.03 134.06 53.03 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 109.937 -0.394 . . . . 1.0 109.937 179.101 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 5.0 mp -95.65 135.42 37.36 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 108.875 -0.787 . . . . 1.0 108.875 179.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 38.6 mm -93.19 131.07 41.23 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 N-CA-C 108.955 -0.757 . . . . 1.0 108.955 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 54.1 p -85.95 -54.43 4.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.863 -0.608 . . . . 1.0 110.181 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 74.7 tt0 -154.92 160.13 40.93 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 120.851 0.357 . . . . 1.0 110.941 -179.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 20.6 tt -143.54 143.96 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 N-CA-C 108.699 -0.852 . . . . 1.0 108.699 178.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 35.0 t70 46.06 17.59 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 112.24 0.459 . . . . 1.0 112.24 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.52 5.35 49.8 Favored Glycine 0 CA--C 1.529 0.961 0 N-CA-C 111.164 -0.774 . . . . 1.0 111.164 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 21.4 mm100 . . . . . 0 N--CA 1.481 1.078 0 CA-C-O 120.826 0.346 . . . . 1.0 110.614 -179.301 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 10.7 t . . . . . 0 N--CA 1.48 1.06 0 CA-C-O 120.886 0.374 . . . . 1.0 110.12 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 11.9 t -73.67 -51.13 17.73 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.106 -0.497 . . . . 1.0 110.718 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -63.44 -39.11 93.61 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.37 -0.377 . . . . 1.0 111.134 -178.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -56.16 -24.2 39.77 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.649 0.262 . . . . 1.0 110.657 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 38.6 t80 -72.36 -46.68 54.35 Favored 'General case' 0 C--O 1.225 -0.236 0 CA-C-O 120.926 0.393 . . . . 1.0 110.305 178.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.462 HD12 ' N ' ' A' ' 45' ' ' ILE . 1.7 mp -59.78 -31.37 47.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 N-CA-C 108.788 -0.819 . . . . 1.0 108.788 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -63.58 -37.98 89.38 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 116.104 -0.498 . . . . 1.0 110.613 -179.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -64.49 -43.78 93.06 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.716 0.293 . . . . 1.0 111.297 178.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 38.2 mt -55.43 -42.92 69.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 120.213 -0.595 . . . . 1.0 109.996 -174.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 38.8 m170 -78.29 -22.3 48.44 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.368 -0.378 . . . . 1.0 111.432 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 37.7 m -66.6 -14.75 62.8 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.236 0.458 . . . . 1.0 112.236 -178.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -111.57 147.71 34.84 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 108.754 -0.832 . . . . 1.0 108.754 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -91.39 171.12 9.43 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.182 0.593 . . . . 1.0 111.274 -178.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 14.6 t -67.06 137.72 24.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.218 -179.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 100.82 -27.3 21.17 Favored Glycine 0 N--CA 1.468 0.82 0 N-CA-C 111.369 -0.693 . . . . 1.0 111.369 178.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -55.73 149.64 14.08 Favored 'General case' 0 C--O 1.226 -0.166 0 CA-C-N 117.728 0.764 . . . . 1.0 111.568 -178.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 70.0 p -87.55 136.38 32.97 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 108.557 -0.905 . . . . 1.0 108.557 178.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -121.06 163.17 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 O-C-N 123.529 0.518 . . . . 1.0 110.641 -177.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -129.79 110.85 12.07 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 107.307 -1.368 . . . . 1.0 107.307 178.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 40.6 mm -100.52 137.84 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 109.743 -0.465 . . . . 1.0 109.743 -178.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 6.8 tppt? -128.27 113.87 16.2 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 106.776 -1.564 . . . . 1.0 106.776 177.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.41 ' CD1' ' OD2' ' A' ' 28' ' ' ASP . 27.2 p90 -145.5 157.85 43.93 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.929 0.395 . . . . 1.0 109.939 -178.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 25.5 pttm -130.07 135.62 48.44 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 115.757 -0.656 . . . . 1.0 109.733 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 59.4 t-80 -129.31 120.47 25.7 Favored 'General case' 0 C--N 1.347 0.464 0 N-CA-C 107.005 -1.479 . . . . 1.0 107.005 178.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 71.23 -117.18 6.63 Favored Glycine 0 CA--C 1.535 1.338 0 N-CA-C 110.777 -0.929 . . . . 1.0 110.777 -179.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -113.68 -19.93 11.38 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 122.86 0.464 . . . . 1.0 111.557 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 59.5 pttt -99.43 132.43 44.77 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-O 121.015 0.436 . . . . 1.0 111.236 -179.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -102.27 144.37 30.87 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 109.473 -0.565 . . . . 1.0 109.473 179.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -134.29 141.04 46.81 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 109.057 -0.72 . . . . 1.0 109.057 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -124.36 131.22 53.5 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 109.468 -0.567 . . . . 1.0 109.468 179.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -146.31 144.93 30.13 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.965 -0.561 . . . . 1.0 110.278 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 48.7 m -99.12 133.56 43.23 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 108.514 -0.921 . . . . 1.0 108.514 178.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 5.6 mt -138.57 138.97 42.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 CA-C-O 120.77 0.319 . . . . 1.0 111.33 -177.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 47.3 mttm -82.97 141.32 32.2 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 121.78 -0.575 . . . . 1.0 109.897 178.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.42 HD22 ' N ' ' A' ' 74' ' ' LEU . 3.5 mm? -62.04 148.32 44.42 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 109.262 -0.644 . . . . 1.0 109.262 179.119 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 66.9 p -135.93 162.14 33.68 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.15 0.58 . . . . 1.0 109.549 178.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -82.1 116.09 21.52 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 109.302 -0.629 . . . . 1.0 109.302 178.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.724 ' H ' HD13 ' A' ' 77' ' ' ILE . 0.1 OUTLIER -102.0 -18.53 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 C-N-CA 122.415 0.286 . . . . 1.0 111.273 -179.753 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -123.08 145.55 48.45 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-O 121.159 0.504 . . . . 1.0 110.915 -179.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 24.6 pttm -49.41 -18.8 0.43 Allowed 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.633 -0.712 . . . . 1.0 112.345 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 30.7 mtmm -80.44 -16.62 53.96 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 120.825 0.345 . . . . 1.0 110.908 -178.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 83.15 39.98 9.6 Favored Glycine 0 N--CA 1.468 0.818 0 N-CA-C 111.778 -0.529 . . . . 1.0 111.778 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 88.7 m -81.98 123.64 79.72 Favored Pre-proline 0 CA--C 1.553 1.058 0 CA-C-O 118.696 -0.668 . . . . 1.0 109.573 179.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -50.54 131.79 33.73 Favored 'Trans proline' 0 N--CA 1.506 2.24 0 C-N-CA 121.357 1.371 . . . . 1.0 111.986 177.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -172.4 163.74 35.92 Favored Glycine 0 CA--C 1.529 0.963 0 N-CA-C 111.136 -0.786 . . . . 1.0 111.136 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -111.87 35.51 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 CA-C-O 121.482 0.658 . . . . 1.0 109.432 -179.263 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.5 ' H ' HG21 ' A' ' 77' ' ' ILE . . . 53.17 58.9 10.42 Favored Glycine 0 N--CA 1.468 0.805 0 N-CA-C 111.083 -0.807 . . . . 1.0 111.083 179.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 21.6 pt -143.27 162.8 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-N 114.628 -0.786 . . . . 1.0 109.984 179.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 93.3 m -135.05 116.17 14.3 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-N 114.825 -1.08 . . . . 1.0 111.127 178.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 9.6 mp -97.74 135.99 38.73 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 122.925 0.49 . . . . 1.0 110.226 179.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 12.9 m . . . . . 0 N--CA 1.472 0.636 0 N-CA-C 108.918 -0.771 . . . . 1.0 108.918 178.031 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.0 ptt? . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 109.324 -0.621 . . . . 1.0 109.324 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.6 t -73.16 94.72 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-O 120.872 0.367 . . . . 1.0 110.03 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -87.31 63.1 7.58 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.148 -0.478 . . . . 1.0 109.887 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 12.0 p -67.01 137.38 24.93 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-N 116.2 -0.455 . . . . 1.0 109.781 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 70.1 p -99.27 160.7 14.09 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 109.65 -0.5 . . . . 1.0 109.65 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.402 ' CD2' ' O ' ' A' ' 6' ' ' TYR . 76.8 t80 -168.36 55.01 0.06 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.239 0.542 . . . . 1.0 109.714 179.58 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -150.25 81.35 1.36 Allowed 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.707 -0.679 . . . . 1.0 110.031 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -84.18 -148.71 9.23 Favored Glycine 0 C--N 1.339 0.709 0 N-CA-C 110.003 -1.239 . . . . 1.0 110.003 179.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.7 p -127.85 134.59 65.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 N-CA-C 109.014 -0.736 . . . . 1.0 109.014 178.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -89.52 149.41 22.91 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 109.484 -0.562 . . . . 1.0 109.484 -178.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 49.1 t -98.31 128.71 49.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 N-CA-C 108.793 -0.817 . . . . 1.0 108.793 179.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 8.2 tp -75.83 -39.89 55.88 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.986 0.422 . . . . 1.0 110.8 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.2 t -167.55 161.04 13.5 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.9 -0.591 . . . . 1.0 111.859 -178.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 44.0 t -132.87 115.7 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 CA-C-N 115.367 -0.833 . . . . 1.0 109.239 179.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.402 ' O ' ' N ' ' A' ' 17' ' ' ASP . 74.1 mmtt -73.26 105.21 4.57 Favored 'General case' 0 C--O 1.221 -0.404 0 N-CA-C 108.906 -0.776 . . . . 1.0 108.906 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -64.94 64.29 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 120.875 0.369 . . . . 1.0 111.698 -178.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.402 ' N ' ' O ' ' A' ' 15' ' ' LYS . 37.0 t70 -175.97 45.68 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 108.136 -1.061 . . . . 1.0 108.136 179.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 23.0 m -150.19 160.88 32.45 Favored Pre-proline 0 N--CA 1.483 1.19 0 CA-C-O 118.995 -0.526 . . . . 1.0 109.731 -178.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -47.3 -33.32 16.18 Favored 'Trans proline' 0 N--CA 1.506 2.242 0 C-N-CA 121.252 1.301 . . . . 1.0 112.543 177.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.06 -22.77 67.07 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 116.761 -0.2 . . . . 1.0 111.39 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.59 124.61 21.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.016 0.436 . . . . 1.0 111.008 -178.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.85 -9.71 70.61 Favored Glycine 0 N--CA 1.473 1.138 0 CA-C-N 115.663 -0.699 . . . . 1.0 111.633 179.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 71.0 mt -114.31 -50.9 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 C-N-CA 122.633 0.373 . . . . 1.0 110.289 -179.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 42.7 mt -113.18 148.38 35.54 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 108.777 -0.823 . . . . 1.0 108.777 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -139.92 154.33 47.2 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 115.745 -0.661 . . . . 1.0 110.023 -179.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.44 139.66 52.57 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.858 -0.61 . . . . 1.0 110.918 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 94.55 -6.84 71.14 Favored Glycine 0 N--CA 1.473 1.107 0 N-CA-C 111.083 -0.807 . . . . 1.0 111.083 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -74.49 150.89 39.65 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 109.637 -0.505 . . . . 1.0 109.637 179.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 5.0 mp -120.91 120.66 36.13 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 109.696 -0.483 . . . . 1.0 109.696 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 61.4 mt -89.39 134.63 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 N-CA-C 107.959 -1.126 . . . . 1.0 107.959 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 65.1 p -97.2 -49.2 5.06 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 116.741 -0.208 . . . . 1.0 111.279 -178.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.8 tp10 -154.05 159.83 41.73 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 121.256 0.55 . . . . 1.0 111.3 -178.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.424 ' O ' ' N ' ' A' ' 35' ' ' GLY . 4.7 mp -135.85 129.59 48.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 N-CA-C 107.611 -1.255 . . . . 1.0 107.611 179.192 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 41.57 20.14 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 113.077 0.769 . . . . 1.0 113.077 179.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 33' ' ' ILE . . . 69.22 6.56 54.16 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 111.101 -0.8 . . . . 1.0 111.101 179.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -86.85 134.49 33.54 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 120.82 0.343 . . . . 1.0 110.233 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 43.9 t -154.86 157.35 37.72 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 109.214 -0.661 . . . . 1.0 109.214 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -148.27 -26.14 0.33 Allowed 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.202 -0.454 . . . . 1.0 110.004 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -167.28 -108.37 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.898 0 CA-C-N 116.694 -0.23 . . . . 1.0 110.759 179.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 15.0 m -110.69 -141.8 0.38 Allowed 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.666 0.786 . . . . 1.0 110.084 -178.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 11.7 t -56.21 -40.7 74.43 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.507 0.194 . . . . 1.0 110.543 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -53.8 -28.68 36.69 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.367 -0.379 . . . . 1.0 110.719 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -58.86 -35.31 72.75 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.887 0.375 . . . . 1.0 110.393 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -68.85 -47.53 65.73 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 116.255 -0.43 . . . . 1.0 110.436 -179.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.513 HD12 ' N ' ' A' ' 45' ' ' ILE . 1.7 mp -52.69 -31.87 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 N-CA-C 108.998 -0.742 . . . . 1.0 108.998 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 47.3 m-20 -70.98 -37.87 72.74 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.797 -0.638 . . . . 1.0 111.431 -179.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 80.1 t80 -66.79 -52.68 41.19 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 120.8 0.333 . . . . 1.0 111.607 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -62.46 -26.05 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 N-CA-C 109.362 -0.607 . . . . 1.0 109.362 -178.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -90.66 -21.96 21.41 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 116.342 -0.39 . . . . 1.0 111.392 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 47.4 m -81.77 -13.62 57.49 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 122.422 -0.174 . . . . 1.0 111.295 -178.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 43.7 mmtm -95.27 -168.97 1.89 Allowed 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 109.992 -0.373 . . . . 1.0 109.992 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 3.6 mmpt? -131.23 159.26 38.31 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.184 0.594 . . . . 1.0 110.526 -178.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.5 t -64.59 140.43 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-N 115.764 -0.653 . . . . 1.0 110.33 -179.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 94.27 -12.9 68.34 Favored Glycine 0 N--CA 1.476 1.305 0 N-CA-C 110.843 -0.903 . . . . 1.0 110.843 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -67.85 -165.25 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 109.618 -0.512 . . . . 1.0 109.618 179.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 77.3 p -140.75 153.97 46.1 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 108.932 -0.766 . . . . 1.0 108.932 178.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 3.2 p -140.55 154.72 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 CA-C-O 121.102 0.477 . . . . 1.0 110.716 -179.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 49.4 mtmt -121.74 112.39 18.34 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 107.954 -1.128 . . . . 1.0 107.954 177.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.431 HD13 HD11 ' A' ' 72' ' ' ILE . 4.4 mp -99.2 138.65 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 N-CA-C 109.05 -0.722 . . . . 1.0 109.05 -178.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -111.19 113.31 25.72 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 105.607 -1.997 . . . . 1.0 105.607 177.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 17.8 p90 -149.84 156.87 42.53 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 109.611 -0.514 . . . . 1.0 109.611 -178.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 22.7 pttm -125.96 118.2 24.88 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 121.261 0.553 . . . . 1.0 110.053 -179.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -89.63 101.82 14.5 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 107.642 -1.244 . . . . 1.0 107.642 179.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 83.76 -111.94 3.5 Favored Glycine 0 CA--C 1.535 1.296 0 N-CA-C 111.475 -0.65 . . . . 1.0 111.475 -178.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -114.52 -2.43 13.16 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 122.826 0.45 . . . . 1.0 111.821 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 58.0 pttt -105.55 134.28 48.93 Favored 'General case' 0 N--CA 1.484 1.269 0 CA-C-O 121.162 0.506 . . . . 1.0 111.052 -179.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -84.08 119.58 25.13 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 109.747 -0.464 . . . . 1.0 109.747 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 69.7 mt-10 -119.9 152.79 36.84 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-N 115.51 -0.768 . . . . 1.0 110.021 -179.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -139.82 133.52 30.47 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 109.253 -0.647 . . . . 1.0 109.253 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -147.03 152.32 38.39 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.946 -0.57 . . . . 1.0 109.952 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.754 ' C ' HD13 ' A' ' 72' ' ' ILE . 17.7 t -125.41 136.53 53.51 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.005 -0.998 . . . . 1.0 108.576 179.024 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.754 HD13 ' C ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -128.68 149.07 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 O-C-N 123.418 0.449 . . . . 1.0 109.965 -178.907 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -78.42 136.34 37.62 Favored 'General case' 0 C--O 1.231 0.084 0 N-CA-C 108.186 -1.042 . . . . 1.0 108.186 178.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.446 HD22 ' N ' ' A' ' 74' ' ' LEU . 3.8 mm? -66.74 147.28 53.47 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.119 0.485 . . . . 1.0 110.598 -178.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 30.6 p -140.87 160.73 39.43 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.648 -0.705 . . . . 1.0 109.747 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -80.23 131.15 35.64 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 108.975 -0.75 . . . . 1.0 108.975 178.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -114.0 -52.66 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 123.127 0.571 . . . . 1.0 110.544 -179.287 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 57.4 p30 -99.61 162.55 12.95 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.327 0.584 . . . . 1.0 110.872 -178.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 59.5 pttt -51.15 -31.92 21.33 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.096 -0.956 . . . . 1.0 112.326 -178.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 26.2 ttmt -80.23 12.06 3.14 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 120.672 0.272 . . . . 1.0 110.762 -179.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 52.72 49.09 55.0 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 120.967 -0.635 . . . . 1.0 111.833 179.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 58.6 m -80.3 120.41 79.39 Favored Pre-proline 0 CA--C 1.54 0.573 0 CA-C-O 118.619 -0.705 . . . . 1.0 109.698 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -58.7 134.84 63.27 Favored 'Trans proline' 0 N--CA 1.497 1.693 0 CA-C-N 120.819 1.328 . . . . 1.0 112.122 177.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 148.81 152.53 5.74 Favored Glycine 0 N--CA 1.473 1.123 0 N-CA-C 112.003 -0.439 . . . . 1.0 112.003 178.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 6.5 pt -72.44 176.95 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 N-CA-C 108.369 -0.974 . . . . 1.0 108.369 177.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -103.27 86.92 0.55 Allowed Glycine 0 N--CA 1.473 1.12 0 N-CA-C 111.817 -0.513 . . . . 1.0 111.817 -179.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 48.8 pt -143.7 166.91 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 CA-C-N 115.504 -0.348 . . . . 1.0 110.17 178.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 95.4 m -128.44 128.99 45.47 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 109.182 -0.673 . . . . 1.0 109.182 177.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 12.9 mt -97.89 163.2 12.89 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.057 0.943 . . . . 1.0 109.853 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 24.2 t -103.05 141.46 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 CA-C-N 116.087 -0.506 . . . . 1.0 109.777 -178.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 22.0 p-10 -163.21 58.14 0.19 Allowed 'General case' 0 C--N 1.334 -0.104 0 CA-C-N 115.696 -0.684 . . . . 1.0 109.542 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 49.7 t0 57.99 107.64 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.213 -0.903 . . . . 1.0 110.592 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 75.6 mt -47.18 -83.24 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 111.858 0.318 . . . . 1.0 111.858 -178.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 49.9 -165.53 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 110.296 -0.261 . . . . 1.0 110.296 -179.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 44.1 m80 -88.19 -21.0 24.8 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 122.462 -0.149 . . . . 1.0 110.868 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 60.3 t-80 40.53 75.28 0.08 Allowed 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 122.577 0.351 . . . . 1.0 111.295 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 50.3 t-80 -166.7 90.71 0.4 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.859 0.362 . . . . 1.0 110.278 -178.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -66.1 -42.8 88.79 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.066 -0.516 . . . . 1.0 109.99 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -168.75 -55.12 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.332 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 56.4 t-80 . . . . . 0 C--O 1.219 -0.509 0 CA-C-O 118.034 -0.984 . . . . 1.0 110.937 -179.607 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.1 mtm . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 108.912 -0.773 . . . . 1.0 108.912 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 23.0 t -74.12 95.0 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 N-CA-C 109.697 -0.483 . . . . 1.0 109.697 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -138.72 -35.91 0.57 Allowed 'General case' 0 N--CA 1.48 1.036 0 CA-C-O 120.946 0.403 . . . . 1.0 110.261 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 12.3 p -65.03 -38.38 82.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.926 -0.579 . . . . 1.0 110.416 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 68.4 p -63.27 137.0 58.05 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.101 -0.499 . . . . 1.0 110.494 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 50.3 70.29 0.53 Allowed 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.362 -0.381 . . . . 1.0 111.259 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 33.7 p-10 -123.52 -130.16 0.26 Allowed 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 122.988 0.515 . . . . 1.0 109.651 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 161.14 -166.09 35.59 Favored Glycine 0 N--CA 1.461 0.318 0 N-CA-C 108.963 -1.655 . . . . 1.0 108.963 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.1 p -125.72 130.78 72.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 N-CA-C 109.222 -0.659 . . . . 1.0 109.222 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.465 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 0.2 OUTLIER -91.12 151.81 20.85 Favored 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 109.303 -0.628 . . . . 1.0 109.303 -178.863 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 56.1 t -106.0 127.48 61.06 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 N-CA-C 108.5 -0.926 . . . . 1.0 108.5 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 41.2 tp -79.97 -49.56 11.67 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-O 121.169 0.509 . . . . 1.0 111.063 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 97.2 p -167.21 163.19 15.44 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.571 -0.741 . . . . 1.0 111.403 -179.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.444 ' O ' ' O ' ' A' ' 15' ' ' LYS . 39.2 t -119.92 138.37 50.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 CA-C-N 114.952 -1.022 . . . . 1.0 109.659 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.444 ' O ' ' O ' ' A' ' 14' ' ' VAL . 36.3 tptt -39.49 -108.75 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 O-C-N 123.981 0.8 . . . . 1.0 111.778 179.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -159.61 20.01 0.17 Allowed 'General case' 0 N--CA 1.482 1.156 0 O-C-N 121.096 -1.002 . . . . 1.0 112.363 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.752 ' O ' ' O ' ' A' ' 18' ' ' VAL . 4.2 p-10 -169.02 -68.06 0.02 OUTLIER 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 107.109 -1.441 . . . . 1.0 107.109 178.035 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.752 ' O ' ' O ' ' A' ' 17' ' ' ASP . 29.3 m 4.46 148.2 0.0 OUTLIER Pre-proline 0 N--CA 1.504 2.237 0 O-C-N 125.874 1.984 . . . . 1.0 114.091 -177.181 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -56.7 9.18 0.04 OUTLIER 'Trans proline' 0 N--CA 1.496 1.673 0 CA-C-N 120.346 1.159 . . . . 1.0 113.206 -178.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.529 ' H ' ' C ' ' A' ' 18' ' ' VAL . . . -106.48 -24.15 12.29 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 109.435 -0.58 . . . . 1.0 109.435 177.07 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.691 ' HB3' ' O ' ' A' ' 17' ' ' ASP . . . -75.36 134.53 40.96 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-O 121.278 0.561 . . . . 1.0 110.247 179.374 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 90.75 -22.03 30.23 Favored Glycine 0 N--CA 1.471 0.977 0 CA-C-N 115.422 -0.808 . . . . 1.0 111.387 179.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 84.9 mt -105.36 -51.32 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 N-CA-C 109.945 -0.391 . . . . 1.0 109.945 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 18.8 mt -99.59 134.42 42.51 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 109.283 -0.636 . . . . 1.0 109.283 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -118.42 144.59 45.84 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 115.919 -0.582 . . . . 1.0 109.659 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -52.48 132.51 35.11 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 116.473 -0.331 . . . . 1.0 110.703 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 101.39 -4.38 54.62 Favored Glycine 0 N--CA 1.474 1.179 0 N-CA-C 111.601 -0.6 . . . . 1.0 111.601 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -72.82 152.38 41.57 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 117.506 0.653 . . . . 1.0 109.599 178.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.4 mp -124.15 122.31 37.48 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 122.753 0.421 . . . . 1.0 110.364 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 31.9 mm -74.78 122.44 28.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 N-CA-C 109.253 -0.647 . . . . 1.0 109.253 179.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 47.8 p -89.85 -43.77 10.4 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 116.4 -0.363 . . . . 1.0 111.023 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 72.9 tt0 -154.69 151.61 28.95 Favored 'General case' 0 N--CA 1.482 1.136 0 CA-C-O 120.991 0.424 . . . . 1.0 111.414 -178.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.41 HD13 ' CE1' ' A' ' 44' ' ' PHE . 1.6 mt -145.49 133.87 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 CA-C-O 120.977 0.417 . . . . 1.0 110.246 178.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 37.7 t70 54.5 34.94 22.19 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.808 -0.633 . . . . 1.0 111.256 178.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.18 -9.15 13.64 Favored Glycine 0 CA--C 1.531 1.058 0 N-CA-C 111.412 -0.675 . . . . 1.0 111.412 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -99.82 130.32 46.01 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 116.802 0.301 . . . . 1.0 110.264 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 90.6 p -103.52 102.71 12.61 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 122.583 0.353 . . . . 1.0 110.068 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -77.14 139.07 39.85 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 110.167 -0.309 . . . . 1.0 110.167 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 30.3 mtmm -94.79 -15.39 23.83 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 116.587 -0.279 . . . . 1.0 111.137 -179.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 49.0 m -129.57 150.46 50.9 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 122.678 0.391 . . . . 1.0 110.214 -179.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 46.6 t -64.26 -51.61 62.74 Favored 'General case' 0 C--O 1.219 -0.533 0 CA-C-N 116.417 -0.356 . . . . 1.0 110.575 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -53.88 -34.41 59.36 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 122.277 -0.265 . . . . 1.0 111.226 -179.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.0 tp10 -64.44 -36.81 85.39 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 109.299 -0.63 . . . . 1.0 109.299 179.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.41 ' CE1' HD13 ' A' ' 33' ' ' ILE . 5.0 t80 -66.69 -48.28 69.76 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.419 0.628 . . . . 1.0 109.537 178.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 26.3 mm -53.62 -27.96 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-N 115.542 -0.754 . . . . 1.0 110.313 -178.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -70.78 -35.23 72.49 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 116.359 -0.382 . . . . 1.0 110.119 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 28.7 t80 -67.18 -46.16 74.76 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.822 0.344 . . . . 1.0 110.997 178.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 25.7 mt -53.74 -38.55 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 115.954 -0.566 . . . . 1.0 109.945 -175.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 52.0 m-70 -80.89 -20.88 41.24 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 116.052 -0.522 . . . . 1.0 110.966 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 11.2 t -78.06 37.14 0.24 Allowed 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 120.748 0.308 . . . . 1.0 111.483 -178.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -146.55 -169.6 3.31 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 109.024 -0.732 . . . . 1.0 109.024 179.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -131.55 166.51 21.24 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 122.955 0.502 . . . . 1.0 109.759 -178.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 22.7 t -68.46 137.76 23.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 115.95 -0.568 . . . . 1.0 110.939 -178.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.75 -2.43 85.93 Favored Glycine 0 N--CA 1.478 1.484 0 N-CA-C 111.217 -0.753 . . . . 1.0 111.217 179.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -62.08 -168.91 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.832 -0.433 . . . . 1.0 109.832 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 23.4 m -146.55 139.88 25.72 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 108.972 -0.751 . . . . 1.0 108.972 179.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.459 HG22 ' N ' ' A' ' 58' ' ' LYS . 6.0 p -141.46 160.79 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 CA-C-N 116.305 -0.407 . . . . 1.0 110.172 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.459 ' N ' HG22 ' A' ' 57' ' ' VAL . 21.8 ttpp -112.71 123.28 49.94 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 108.111 -1.07 . . . . 1.0 108.111 177.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.497 HG22 ' O ' ' A' ' 70' ' ' ALA . 11.5 tt -101.02 143.03 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 C-N-CA 122.776 0.43 . . . . 1.0 111.003 -178.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 17.6 tptp -133.58 113.56 12.56 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 107.661 -1.237 . . . . 1.0 107.661 177.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 25.1 p90 -144.45 157.93 44.0 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 109.226 -0.657 . . . . 1.0 109.226 -179.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -116.24 115.79 26.62 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 117.912 0.324 . . . . 1.0 110.206 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -118.66 115.76 25.18 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 108.108 -1.071 . . . . 1.0 108.108 177.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 73.25 -133.63 18.48 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 110.716 -0.953 . . . . 1.0 110.716 -178.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -107.26 2.1 24.38 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 122.82 0.448 . . . . 1.0 111.072 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 20.8 pttp -122.37 119.5 31.23 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-O 121.593 0.711 . . . . 1.0 111.145 -179.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -82.97 123.92 29.89 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 109.386 -0.598 . . . . 1.0 109.386 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -114.51 142.03 46.94 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.062 0.545 . . . . 1.0 109.943 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -124.87 136.69 54.02 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 109.135 -0.691 . . . . 1.0 109.135 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.497 ' O ' HG22 ' A' ' 59' ' ' ILE . . . -148.69 128.42 13.32 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.301 0.572 . . . . 1.0 111.388 -179.168 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 12.2 m -87.03 139.53 30.48 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 109.146 -0.687 . . . . 1.0 109.146 178.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 11.1 pt -140.11 149.86 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-N 116.086 -0.506 . . . . 1.0 110.534 -178.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 18.4 pttp -93.19 139.03 31.04 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.541 -0.754 . . . . 1.0 109.235 178.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.45 HD22 ' N ' ' A' ' 74' ' ' LEU . 3.6 mm? -64.04 150.8 44.59 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 109.665 -0.494 . . . . 1.0 109.665 179.44 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 72.9 p -137.39 159.36 42.15 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 115.894 -0.594 . . . . 1.0 110.188 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -81.44 135.14 35.62 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 109.313 -0.625 . . . . 1.0 109.313 178.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.681 ' H ' HD13 ' A' ' 77' ' ' ILE . 0.1 OUTLIER -134.63 -8.53 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 C-N-CA 122.475 0.31 . . . . 1.0 111.313 -179.363 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -127.66 148.27 50.38 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 122.937 0.495 . . . . 1.0 110.173 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -48.72 -33.26 9.85 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.238 -0.437 . . . . 1.0 111.805 -179.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -79.04 7.45 7.35 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 120.756 0.313 . . . . 1.0 110.846 -179.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 57.4 46.29 92.02 Favored Glycine 0 CA--C 1.529 0.954 0 CA-C-N 116.215 -0.448 . . . . 1.0 112.519 178.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 4.5 m -79.6 119.15 75.9 Favored Pre-proline 0 CA--C 1.551 0.982 0 CA-C-O 118.875 -0.584 . . . . 1.0 109.771 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -52.93 125.98 19.95 Favored 'Trans proline' 0 N--CA 1.504 2.112 0 C-N-CA 121.285 1.323 . . . . 1.0 111.077 177.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 173.74 172.6 39.24 Favored Glycine 0 N--CA 1.469 0.854 0 C-N-CA 120.801 -0.714 . . . . 1.0 112.254 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.19 173.4 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 N-CA-C 106.976 -1.49 . . . . 1.0 106.976 177.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -104.55 83.6 0.4 Allowed Glycine 0 N--CA 1.475 1.264 0 N-CA-C 110.549 -1.02 . . . . 1.0 110.549 -179.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.505 HD13 ' H ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -143.62 168.15 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-O 121.373 0.606 . . . . 1.0 110.746 179.607 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 26.4 m -128.14 132.72 48.91 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 115.099 -0.955 . . . . 1.0 109.344 178.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.665 HD22 ' N ' ' A' ' 89' ' ' LEU . 0.9 OUTLIER -99.61 159.52 14.98 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 123.194 0.598 . . . . 1.0 109.41 -179.99 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.2 m -106.51 150.16 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 CA-C-N 115.672 -0.695 . . . . 1.0 110.018 -178.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 28.9 p-10 -163.38 68.23 0.2 Allowed 'General case' 0 C--O 1.232 0.16 0 CA-C-N 115.726 -0.67 . . . . 1.0 110.305 179.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.479 ' CG ' ' H ' ' A' ' 93' ' ' LEU . 17.8 p-10 -44.45 -79.62 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 115.806 -0.634 . . . . 1.0 111.062 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.479 ' H ' ' CG ' ' A' ' 92' ' ' ASP . 48.0 mt 52.36 64.09 1.99 Allowed 'General case' 0 CA--C 1.54 0.573 0 O-C-N 122.378 -0.201 . . . . 1.0 111.134 178.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 57.04 116.31 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.002 0.43 . . . . 1.0 110.656 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 92.0 m-70 -86.63 -5.38 59.15 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 122.245 -0.284 . . . . 1.0 110.433 -179.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.401 ' O ' ' CD2' ' A' ' 98' ' ' HIS . 96.6 m-70 51.85 39.42 25.71 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.011 0.434 . . . . 1.0 111.102 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 17.9 p80 -64.43 150.06 47.22 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.911 -0.586 . . . . 1.0 110.68 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.401 ' CD2' ' O ' ' A' ' 96' ' ' HIS . 93.4 m-70 -148.25 -34.3 0.23 Allowed 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 116.222 -0.445 . . . . 1.0 110.157 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 85.3 t60 -63.74 -45.61 89.08 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.22 -0.445 . . . . 1.0 110.887 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 63.6 t-80 . . . . . 0 C--O 1.219 -0.515 0 CA-C-O 118.014 -0.993 . . . . 1.0 110.772 -179.2 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.8 mtm . . . . . 0 N--CA 1.491 1.609 0 N-CA-C 109.021 -0.733 . . . . 1.0 109.021 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 27.1 m -67.05 146.21 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-N 116.303 -0.408 . . . . 1.0 110.164 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -153.39 -77.64 0.11 Allowed 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.955 0.407 . . . . 1.0 110.687 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 46.4 t -69.2 131.88 33.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.002 -0.545 . . . . 1.0 109.957 -179.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 57.9 p -68.16 -107.29 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 116.351 -0.386 . . . . 1.0 110.641 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -74.72 124.55 26.96 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.836 0.351 . . . . 1.0 110.074 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -70.12 -78.33 0.07 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.686 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 166.39 -175.36 41.83 Favored Glycine 0 N--CA 1.462 0.418 0 N-CA-C 109.968 -1.253 . . . . 1.0 109.968 -179.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 18.7 m -112.61 130.99 65.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 N-CA-C 108.859 -0.793 . . . . 1.0 108.859 179.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.449 ' CD1' HD22 ' A' ' 29' ' ' LEU . 10.0 m-85 -88.13 137.42 32.34 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 109.828 -0.434 . . . . 1.0 109.828 -177.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 62.1 t -90.28 127.51 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 N-CA-C 108.861 -0.792 . . . . 1.0 108.861 179.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 48.6 tp -81.05 -44.27 18.28 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 120.87 0.366 . . . . 1.0 111.144 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.2 t -163.31 156.87 19.48 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 121.317 0.58 . . . . 1.0 111.187 -178.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.4 p -137.12 134.9 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 CA-C-N 114.969 -1.014 . . . . 1.0 109.314 179.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -76.37 160.22 29.77 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 109.15 -0.685 . . . . 1.0 109.15 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -99.35 -5.63 29.29 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 111.673 0.249 . . . . 1.0 111.673 -178.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 25.0 p-10 -106.68 29.02 7.32 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 122.611 0.364 . . . . 1.0 110.908 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.6 m -130.75 156.13 80.34 Favored Pre-proline 0 N--CA 1.483 1.175 0 C-N-CA 123.137 0.575 . . . . 1.0 109.545 -179.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -56.57 -22.06 41.46 Favored 'Trans proline' 0 N--CA 1.505 2.2 0 C-N-CA 121.688 1.592 . . . . 1.0 112.141 -179.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.415 ' HB2' HG22 ' A' ' 85' ' ' ILE . . . -62.4 -26.96 68.76 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.147 0.499 . . . . 1.0 110.536 -179.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.67 125.36 25.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.572 -0.74 . . . . 1.0 110.935 -178.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 95.5 -15.71 62.68 Favored Glycine 0 N--CA 1.475 1.237 0 N-CA-C 111.478 -0.649 . . . . 1.0 111.478 179.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 81.2 mt -113.55 -49.9 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 N-CA-C 110.039 -0.356 . . . . 1.0 110.039 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 16.2 mt -110.75 147.55 34.19 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 109.613 -0.514 . . . . 1.0 109.613 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.4 ' CD2' ' OD1' ' A' ' 28' ' ' ASP . 13.6 p-80 -143.64 156.61 44.61 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.559 -0.746 . . . . 1.0 110.051 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.07 143.41 32.81 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 115.739 -0.664 . . . . 1.0 111.435 -179.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 95.06 -4.6 67.9 Favored Glycine 0 N--CA 1.474 1.168 0 N-CA-C 111.696 -0.562 . . . . 1.0 111.696 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.4 ' OD1' ' CD2' ' A' ' 25' ' ' HIS . 9.7 m-20 -82.8 123.04 28.97 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 117.145 0.473 . . . . 1.0 110.276 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.449 HD22 ' CD1' ' A' ' 10' ' ' TYR . 20.0 mt -97.92 121.07 39.39 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 109.711 -0.477 . . . . 1.0 109.711 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 16.0 mm -77.43 127.64 38.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 N-CA-C 108.948 -0.76 . . . . 1.0 108.948 -179.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 75.8 p -77.75 -51.95 9.72 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.291 -0.413 . . . . 1.0 110.678 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -155.14 166.28 34.07 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.032 0.444 . . . . 1.0 109.945 -179.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.444 HD11 ' CD1' ' A' ' 59' ' ' ILE . 1.0 OUTLIER -134.04 126.59 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-N 115.064 -0.971 . . . . 1.0 109.931 179.319 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 37.5 t70 48.97 16.91 0.13 Allowed 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.699 -0.682 . . . . 1.0 111.624 179.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.82 14.86 78.15 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 111.331 -0.708 . . . . 1.0 111.331 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -138.91 163.29 32.68 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-O 120.899 0.381 . . . . 1.0 110.297 -179.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 24.3 p 58.09 106.37 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.703 -0.68 . . . . 1.0 111.519 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.415 ' H ' ' H ' ' A' ' 39' ' ' LYS . 27.2 p90 -174.18 -1.05 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.202 -0.454 . . . . 1.0 110.851 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.415 ' H ' ' H ' ' A' ' 38' ' ' PHE . 32.6 mtmm -80.34 9.01 6.35 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.602 -0.272 . . . . 1.0 110.846 -179.199 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 21.2 t -174.29 156.63 2.61 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.49 179.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 50.3 m -65.78 -42.23 91.06 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.042 -0.526 . . . . 1.0 109.846 178.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -64.86 -37.88 89.11 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.069 -0.514 . . . . 1.0 111.067 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -54.82 -25.37 27.98 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.027 0.441 . . . . 1.0 110.037 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -70.29 -45.65 65.92 Favored 'General case' 0 C--O 1.221 -0.429 0 N-CA-C 109.154 -0.684 . . . . 1.0 109.154 179.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.508 HD12 ' N ' ' A' ' 45' ' ' ILE . 1.6 mp -64.28 -30.13 49.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 N-CA-C 108.896 -0.779 . . . . 1.0 108.896 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -63.13 -34.1 76.88 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.237 -179.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 32.2 t80 -69.14 -44.21 72.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.243 -0.435 . . . . 1.0 111.519 179.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 44.0 mt -57.44 -42.5 80.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.319 -0.401 . . . . 1.0 110.275 -175.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 54.2 m-70 -76.52 -18.76 58.55 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.309 -0.405 . . . . 1.0 111.117 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 13.0 t -92.33 46.48 1.26 Allowed 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 111.564 0.209 . . . . 1.0 111.564 -178.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 13.8 mmtm -149.31 175.74 11.16 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 109.242 -0.651 . . . . 1.0 109.242 179.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -130.1 154.1 47.81 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-O 121.067 0.46 . . . . 1.0 109.787 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 28.5 t -60.83 135.43 25.58 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 115.933 -0.576 . . . . 1.0 110.864 -178.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 97.55 -19.59 54.08 Favored Glycine 0 N--CA 1.477 1.422 0 N-CA-C 110.951 -0.86 . . . . 1.0 110.951 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -65.54 143.41 57.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.594 0.235 . . . . 1.0 110.497 -179.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 68.0 p -96.22 152.56 18.45 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 109.153 -0.684 . . . . 1.0 109.153 179.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 6.6 p -140.49 155.42 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 CA-C-O 121.232 0.539 . . . . 1.0 110.757 -179.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 31.6 mtmm -101.18 123.08 44.75 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.319 -0.855 . . . . 1.0 109.486 178.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.506 HG13 HD11 ' A' ' 72' ' ' ILE . 1.0 OUTLIER -117.71 136.06 56.08 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 C-N-CA 122.84 0.456 . . . . 1.0 110.109 179.693 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 12.8 ptpt -135.72 120.51 18.48 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 107.745 -1.206 . . . . 1.0 107.745 178.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 34.7 p90 -146.21 149.28 33.64 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 110.146 -0.316 . . . . 1.0 110.146 -179.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 20.9 pttm -111.57 114.49 27.59 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.355 0.598 . . . . 1.0 110.552 -179.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 70.5 t60 -98.69 120.87 39.85 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 108.045 -1.094 . . . . 1.0 108.045 178.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 61.6 -118.04 13.49 Favored Glycine 0 CA--C 1.531 1.034 0 N-CA-C 111.121 -0.791 . . . . 1.0 111.121 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -114.16 14.55 18.23 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 122.942 0.497 . . . . 1.0 111.544 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 17.1 ptmt -122.75 121.16 35.66 Favored 'General case' 0 N--CA 1.485 1.309 0 CA-C-O 121.38 0.61 . . . . 1.0 111.157 -179.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 30.6 m120 -77.01 124.38 27.71 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 116.079 -0.51 . . . . 1.0 109.889 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -127.81 140.56 51.96 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 115.863 -0.608 . . . . 1.0 110.052 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.4 ' CD ' ' N ' ' A' ' 69' ' ' GLU . 1.9 pm0 -142.18 136.09 29.62 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 115.813 -0.63 . . . . 1.0 110.58 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -161.28 129.44 4.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.788 -0.642 . . . . 1.0 111.188 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 9.4 t -85.54 146.18 27.03 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 108.915 -0.772 . . . . 1.0 108.915 178.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.723 ' N ' HD13 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -134.55 149.83 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 CA-C-O 121.425 0.631 . . . . 1.0 110.329 -178.981 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.6 ttmp? -81.2 139.47 35.51 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 115.11 -0.95 . . . . 1.0 109.268 179.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -73.64 149.73 41.81 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.193 0.521 . . . . 1.0 110.0 179.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 27.3 p -140.73 164.17 30.91 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.398 -0.819 . . . . 1.0 110.123 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -79.97 131.95 35.92 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 109.271 -0.641 . . . . 1.0 109.271 178.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.3 pt -109.63 -55.88 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 CA-C-N 115.946 -0.57 . . . . 1.0 109.794 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.416 ' OD2' ' NZ ' ' A' ' 80' ' ' LYS . 40.9 t0 -98.41 171.53 8.11 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 121.507 0.67 . . . . 1.0 111.48 -178.095 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -60.16 -28.56 68.02 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.811 -1.086 . . . . 1.0 112.045 -179.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.416 ' NZ ' ' OD2' ' A' ' 78' ' ' ASP . 19.6 pttm -80.09 14.58 1.8 Allowed 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 120.619 0.247 . . . . 1.0 110.517 -179.374 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 49.24 41.15 30.77 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 112.169 -0.372 . . . . 1.0 112.169 178.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 15.9 m -80.02 120.51 80.0 Favored Pre-proline 0 CA--C 1.547 0.834 0 N-CA-C 109.544 -0.539 . . . . 1.0 109.544 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -52.95 131.8 44.23 Favored 'Trans proline' 0 N--CA 1.501 1.927 0 C-N-CA 121.463 1.442 . . . . 1.0 112.277 178.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -158.58 146.14 12.72 Favored Glycine 0 N--CA 1.468 0.788 0 N-CA-C 111.474 -0.65 . . . . 1.0 111.474 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.415 HG22 ' HB2' ' A' ' 20' ' ' ALA . 40.7 mm -67.6 -26.05 34.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.455 -0.373 . . . . 1.0 110.418 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 99.47 45.6 2.12 Favored Glycine 0 N--CA 1.475 1.255 0 N-CA-C 110.684 -0.966 . . . . 1.0 110.684 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 38.4 pt -145.15 166.89 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 N-CA-C 109.863 -0.421 . . . . 1.0 109.863 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 77.0 m -127.25 127.07 43.82 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 109.253 -0.647 . . . . 1.0 109.253 177.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.1 mp -99.39 146.69 26.03 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 120.797 0.332 . . . . 1.0 110.525 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.484 HG22 ' H ' ' A' ' 92' ' ' ASP . 7.7 p -104.99 164.11 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 CA-C-N 115.777 -0.647 . . . . 1.0 109.744 -179.042 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.463 ' N ' HG22 ' A' ' 90' ' ' VAL . 28.7 t70 -155.94 38.73 0.36 Allowed 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.043 0.449 . . . . 1.0 110.131 -179.154 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.484 ' H ' HG22 ' A' ' 90' ' ' VAL . 73.9 m-20 54.93 44.5 28.2 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.84 -0.618 . . . . 1.0 110.838 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 60.6 mt -59.29 -67.05 0.41 Allowed 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.1 -0.5 . . . . 1.0 110.356 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 69.5 mt-10 53.85 21.13 2.62 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.124 -0.489 . . . . 1.0 111.278 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . 0.419 ' O ' ' N ' ' A' ' 97' ' ' HIS . 65.4 m80 -88.83 -17.81 28.96 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 116.36 -0.382 . . . . 1.0 110.315 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.408 ' O ' ' N ' ' A' ' 98' ' ' HIS . 83.1 t60 54.08 -86.58 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.501 -0.318 . . . . 1.0 111.297 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . 0.419 ' N ' ' O ' ' A' ' 95' ' ' HIS . 83.1 t60 -65.96 72.87 0.07 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.952 0.406 . . . . 1.0 110.586 -179.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.537 ' CG ' ' H ' ' A' ' 99' ' ' HIS . 17.1 t-80 51.48 -122.9 2.05 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 116.322 -0.399 . . . . 1.0 110.977 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . 0.537 ' H ' ' CG ' ' A' ' 98' ' ' HIS . 8.7 t60 -68.99 -44.84 72.02 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 120.65 0.262 . . . . 1.0 111.077 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . 0.401 ' O ' ' CG ' ' A' ' 100' ' ' HIS . 82.2 t60 . . . . . 0 N--CA 1.469 0.483 0 CA-C-O 117.985 -1.007 . . . . 1.0 110.445 -178.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.3 ptt? . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.015 -0.735 . . . . 1.0 109.015 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 56.9 t -61.74 -44.14 98.3 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 N-CA-C 110.265 -0.272 . . . . 1.0 110.265 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -71.02 137.76 49.3 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.382 -0.372 . . . . 1.0 110.103 -179.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 41.1 t -141.88 83.09 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 N-CA-C 110.059 -0.348 . . . . 1.0 110.059 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 22.9 m -65.24 -51.69 59.24 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.443 -0.344 . . . . 1.0 111.483 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 52.3 p90 -69.29 146.6 52.11 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 120.77 0.319 . . . . 1.0 110.578 -179.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 48.7 p-10 -162.56 148.26 12.53 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.366 -0.605 . . . . 1.0 109.366 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -69.66 -160.17 2.52 Favored Glycine 0 CA--C 1.52 0.376 0 N-CA-C 110.122 -1.191 . . . . 1.0 110.122 179.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.9 m -112.82 132.41 61.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 N-CA-C 109.362 -0.607 . . . . 1.0 109.362 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -92.27 132.37 36.74 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 115.791 -0.64 . . . . 1.0 110.588 -178.244 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 57.3 t -77.56 134.55 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.126 0 N-CA-C 107.335 -1.357 . . . . 1.0 107.335 177.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.3 tt -81.03 -51.19 8.77 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.056 0.455 . . . . 1.0 111.163 -178.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.0 m -163.61 159.79 22.19 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.151 0.5 . . . . 1.0 111.343 -179.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 26.4 t -109.24 134.75 50.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-N 114.992 -1.004 . . . . 1.0 109.134 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -63.86 -36.55 84.29 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 116.4 -0.364 . . . . 1.0 110.675 -179.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 73.38 25.91 2.1 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.5 1.12 . . . . 1.0 111.835 -179.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -145.75 35.23 1.04 Allowed 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 108.709 -0.848 . . . . 1.0 108.709 178.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.446 HG23 ' HB3' ' A' ' 20' ' ' ALA . 6.5 m -145.08 158.06 52.74 Favored Pre-proline 0 N--CA 1.476 0.851 0 CA-C-N 115.903 -0.589 . . . . 1.0 110.238 -178.306 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -50.88 -15.08 1.57 Allowed 'Trans proline' 0 N--CA 1.505 2.171 0 C-N-CA 121.781 1.654 . . . . 1.0 112.17 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.525 ' HB2' HG22 ' A' ' 85' ' ' ILE . . . -64.55 -35.17 80.12 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.966 0.412 . . . . 1.0 110.591 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.56 129.71 41.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.924 -0.58 . . . . 1.0 111.313 -178.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.44 -7.52 75.06 Favored Glycine 0 N--CA 1.47 0.942 0 N-CA-C 111.109 -0.796 . . . . 1.0 111.109 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 52.9 mt -115.54 -50.61 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 CA-C-O 120.769 0.318 . . . . 1.0 110.498 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 28.4 mt -113.53 153.54 28.59 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.091 0.556 . . . . 1.0 110.101 -179.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 67.6 m80 -144.12 157.03 44.55 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.86 -0.609 . . . . 1.0 111.001 -179.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.05 140.3 38.4 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.924 -0.58 . . . . 1.0 111.134 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 91.81 -4.38 78.74 Favored Glycine 0 N--CA 1.471 0.972 0 N-CA-C 111.283 -0.727 . . . . 1.0 111.283 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -67.63 124.85 24.4 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 109.425 -0.583 . . . . 1.0 109.425 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 10.6 mt -96.61 122.28 39.36 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 109.095 -0.706 . . . . 1.0 109.095 179.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 33.7 mm -83.62 116.48 27.68 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 109.124 -0.695 . . . . 1.0 109.124 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 71.7 p -90.56 -39.78 12.34 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 116.278 -0.419 . . . . 1.0 111.436 -179.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.433 ' OE2' ' CD2' ' A' ' 38' ' ' PHE . 4.4 tp10 -146.32 148.78 32.75 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 109.826 -0.435 . . . . 1.0 109.826 -179.083 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.418 ' O ' ' N ' ' A' ' 35' ' ' GLY . 3.6 mt -129.59 128.86 66.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 108.709 -0.848 . . . . 1.0 108.709 179.211 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 26.5 t0 45.8 14.47 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 112.131 0.419 . . . . 1.0 112.131 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 33' ' ' ILE . . . 65.73 17.9 65.48 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.937 -0.865 . . . . 1.0 110.937 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -139.59 163.3 32.92 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-O 120.932 0.396 . . . . 1.0 110.625 -179.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.467 ' O ' ' CG ' ' A' ' 38' ' ' PHE . 46.7 t 63.44 -99.99 0.08 Allowed 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.189 -0.914 . . . . 1.0 110.862 -179.246 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.467 ' CG ' ' O ' ' A' ' 37' ' ' SER . 33.3 p90 44.59 13.32 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 112.27 0.47 . . . . 1.0 112.27 -178.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.462 ' N ' ' O ' ' A' ' 37' ' ' SER . 22.5 pttp -92.11 5.32 50.76 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.026 0.53 . . . . 1.0 111.289 -179.291 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.5 t -169.43 151.41 4.47 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.227 0.537 . . . . 1.0 110.122 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 73.1 m -75.93 -33.01 59.84 Favored 'General case' 0 C--O 1.218 -0.566 0 CA-C-N 115.702 -0.681 . . . . 1.0 109.917 179.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.407 ' NE2' ' OD2' ' A' ' 46' ' ' ASP . 0.0 OUTLIER -74.05 -45.4 49.74 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 120.948 0.404 . . . . 1.0 111.187 -178.897 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -56.56 -20.86 22.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.123 -0.489 . . . . 1.0 110.49 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -72.1 -52.18 17.99 Favored 'General case' 0 N--CA 1.461 0.097 0 C-N-CA 120.542 -0.463 . . . . 1.0 110.406 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.7 mp -54.05 -31.8 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 N-CA-C 108.651 -0.87 . . . . 1.0 108.651 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.407 ' OD2' ' NE2' ' A' ' 42' ' ' GLN . 61.8 m-20 -72.0 -32.57 67.32 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.018 -0.992 . . . . 1.0 111.227 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 77.3 t80 -69.23 -52.57 26.4 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 120.875 0.369 . . . . 1.0 111.479 -179.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -54.92 -25.63 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 N-CA-C 109.53 -0.545 . . . . 1.0 109.53 -177.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 42.5 m170 -94.15 -18.12 22.07 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.58 -0.737 . . . . 1.0 110.558 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 27.6 t -66.75 -22.43 66.04 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.712 0.291 . . . . 1.0 111.448 -178.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -90.48 -169.06 2.27 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 109.649 -0.5 . . . . 1.0 109.649 179.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.9 mptp? -122.46 168.29 12.29 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 122.958 0.503 . . . . 1.0 110.658 -179.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 22.1 t -65.2 135.1 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-N 115.738 -0.665 . . . . 1.0 110.732 -178.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.97 -0.88 86.54 Favored Glycine 0 N--CA 1.474 1.172 0 N-CA-C 110.968 -0.853 . . . . 1.0 110.968 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -73.54 147.18 44.2 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 110.235 -0.283 . . . . 1.0 110.235 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 80.7 p -86.51 150.33 24.33 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 109.574 -0.528 . . . . 1.0 109.574 178.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.409 HG12 ' O ' ' A' ' 72' ' ' ILE . 0.3 OUTLIER -141.93 161.58 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 CA-C-O 120.933 0.397 . . . . 1.0 111.244 -179.367 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 49.9 mtmt -123.4 114.52 20.26 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.011 -0.995 . . . . 1.0 108.734 177.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 35.3 mm -106.87 140.14 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 CA-C-O 121.004 0.431 . . . . 1.0 110.378 -179.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -131.99 115.77 16.26 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 106.942 -1.503 . . . . 1.0 106.942 177.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 29.5 p90 -143.12 164.23 30.71 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-N 116.123 -0.49 . . . . 1.0 110.073 -176.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 21.2 ttpp -127.31 114.84 18.12 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 123.423 0.452 . . . . 1.0 110.641 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -99.92 108.68 20.98 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 108.075 -1.083 . . . . 1.0 108.075 178.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 74.82 -114.28 4.31 Favored Glycine 0 CA--C 1.532 1.132 0 N-CA-C 111.128 -0.789 . . . . 1.0 111.128 -179.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -113.12 -10.91 13.38 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 122.674 0.39 . . . . 1.0 111.638 -179.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -99.23 133.77 43.04 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-O 120.706 0.289 . . . . 1.0 110.745 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 18.4 p30 -97.15 128.84 44.44 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.902 0.382 . . . . 1.0 110.133 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 74.1 mt-10 -132.94 155.01 49.89 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 115.738 -0.664 . . . . 1.0 109.854 -179.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -140.7 138.09 33.98 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.843 -0.617 . . . . 1.0 110.523 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -146.89 151.38 36.96 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.766 -0.652 . . . . 1.0 110.613 -179.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 50.5 m -102.67 134.02 46.72 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.353 -0.84 . . . . 1.0 109.166 179.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.409 ' O ' HG12 ' A' ' 57' ' ' VAL . 7.6 mt -135.7 139.94 45.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 CA-C-O 121.298 0.57 . . . . 1.0 110.494 -177.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 52.0 pttt -82.47 141.51 32.64 Favored 'General case' 0 C--N 1.327 -0.376 0 O-C-N 121.905 -0.497 . . . . 1.0 110.192 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -68.62 143.38 54.84 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 120.97 0.414 . . . . 1.0 110.082 178.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 80.5 p -136.32 162.96 31.57 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 115.809 -0.632 . . . . 1.0 110.433 179.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -78.44 122.84 26.34 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.885 -0.598 . . . . 1.0 109.713 179.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.433 ' CG1' ' N ' ' A' ' 78' ' ' ASP . 3.6 pt -96.06 -53.44 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-N 116.795 -0.184 . . . . 1.0 110.587 179.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.433 ' N ' ' CG1' ' A' ' 77' ' ' ILE . 44.3 t0 -98.08 169.65 9.46 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 121.365 0.602 . . . . 1.0 111.579 -178.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 47.0 mmtm -61.82 -23.9 66.53 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 114.902 -1.044 . . . . 1.0 111.904 -178.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 35.6 pttt -77.53 -15.55 59.2 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 120.479 0.18 . . . . 1.0 110.626 -178.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 83.03 40.18 9.53 Favored Glycine 0 N--CA 1.467 0.753 0 C-N-CA 121.424 -0.417 . . . . 1.0 112.075 178.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 53.2 m -81.21 120.16 77.74 Favored Pre-proline 0 CA--C 1.545 0.753 0 N-CA-C 109.324 -0.621 . . . . 1.0 109.324 179.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -52.79 130.88 39.35 Favored 'Trans proline' 0 N--CA 1.497 1.717 0 C-N-CA 121.142 1.228 . . . . 1.0 112.909 178.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -169.14 155.03 25.03 Favored Glycine 0 N--CA 1.461 0.318 0 N-CA-C 110.666 -0.974 . . . . 1.0 110.666 178.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.525 HG22 ' HB2' ' A' ' 20' ' ' ALA . 3.3 mt -89.66 26.4 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 N-CA-C 109.501 -0.555 . . . . 1.0 109.501 -179.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 50.52 63.62 4.27 Favored Glycine 0 CA--C 1.531 1.056 0 N-CA-C 111.782 -0.527 . . . . 1.0 111.782 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 18.7 pt -146.62 164.6 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 N-CA-C 109.353 -0.61 . . . . 1.0 109.353 179.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 86.1 m -130.36 125.5 34.77 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 115.477 -0.783 . . . . 1.0 109.581 177.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 12.7 mt -111.01 134.7 52.4 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.282 0.633 . . . . 1.0 109.801 -179.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.412 ' O ' ' C ' ' A' ' 91' ' ' ASP . 16.0 m -154.81 137.39 6.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 108.367 -0.975 . . . . 1.0 108.367 179.156 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.412 ' C ' ' O ' ' A' ' 90' ' ' VAL . 83.8 m-20 -25.68 -86.87 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.342 0.657 . . . . 1.0 112.541 179.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -169.67 41.03 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.013 0.435 . . . . 1.0 110.585 178.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 49.7 mt 55.56 71.5 0.54 Allowed 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.857 -0.611 . . . . 1.0 110.49 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -132.94 108.13 8.72 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 115.779 -0.646 . . . . 1.0 110.178 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -88.45 -18.64 27.86 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 116.455 -0.339 . . . . 1.0 110.539 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 73.9 m80 -71.58 128.82 37.06 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.284 -0.416 . . . . 1.0 109.954 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 78.7 t60 -168.6 29.23 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.823 0.344 . . . . 1.0 110.219 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 77.3 m80 -64.45 -40.68 96.19 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.402 -0.363 . . . . 1.0 110.056 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 59.9 t-80 -163.74 143.4 8.24 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.81 0.338 . . . . 1.0 110.594 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 55.7 t-80 . . . . . 0 C--O 1.221 -0.417 0 CA-C-O 117.976 -1.012 . . . . 1.0 111.028 179.992 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.2 mtm . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.17 -0.678 . . . . 1.0 109.17 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 27.9 m -66.1 146.13 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 N-CA-C 109.802 -0.444 . . . . 1.0 109.802 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 18.5 tptp -59.98 116.06 3.88 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.292 -179.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.3 t -90.41 98.35 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 N-CA-C 110.092 -0.336 . . . . 1.0 110.092 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 81.6 p -67.29 -81.04 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.586 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -71.18 150.05 45.73 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.828 0.347 . . . . 1.0 110.115 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -133.53 91.82 2.9 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 115.765 -0.652 . . . . 1.0 109.747 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -171.23 -159.34 17.11 Favored Glycine 0 CA--C 1.521 0.461 0 N-CA-C 109.948 -1.261 . . . . 1.0 109.948 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 16.6 m -117.96 128.81 75.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 CA-C-O 121.297 0.57 . . . . 1.0 109.731 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -86.7 146.17 26.4 Favored 'General case' 0 C--O 1.221 -0.396 0 N-CA-C 108.639 -0.874 . . . . 1.0 108.639 -178.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 57.0 t -107.96 132.06 56.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 108.951 -0.759 . . . . 1.0 108.951 179.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.513 HD23 HG11 ' A' ' 90' ' ' VAL . 0.2 OUTLIER -84.61 -50.83 7.33 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 116.287 -0.415 . . . . 1.0 111.245 -179.571 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 99.7 p -167.79 163.73 14.14 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 121.173 0.511 . . . . 1.0 111.301 -179.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 39.8 t -107.09 128.74 61.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 CA-C-N 115.128 -0.942 . . . . 1.0 108.497 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.413 ' O ' ' CB ' ' A' ' 16' ' ' GLU . 63.6 mttp -59.91 -36.75 77.64 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-N 116.099 -0.501 . . . . 1.0 110.55 -178.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.435 ' C ' ' H ' ' A' ' 18' ' ' VAL . 59.5 tt0 93.84 163.93 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.338 0 O-C-N 124.742 1.277 . . . . 1.0 111.129 178.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 70.59 -4.97 1.51 Allowed 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.496 -0.775 . . . . 1.0 109.567 -179.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.435 ' H ' ' C ' ' A' ' 16' ' ' GLU . 11.4 m -96.3 155.61 37.86 Favored Pre-proline 0 CA--C 1.541 0.604 0 CA-C-N 115.727 -0.669 . . . . 1.0 110.44 -178.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -55.92 -23.03 40.82 Favored 'Trans proline' 0 N--CA 1.503 2.058 0 C-N-CA 121.953 1.769 . . . . 1.0 112.226 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.44 -23.73 67.38 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.649 0.261 . . . . 1.0 110.852 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.5 136.0 44.1 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.306 -0.406 . . . . 1.0 110.887 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 91.28 -23.64 23.45 Favored Glycine 0 N--CA 1.469 0.89 0 N-CA-C 111.243 -0.743 . . . . 1.0 111.243 179.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 67.9 mt -102.12 -50.21 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 122.32 0.248 . . . . 1.0 110.489 -179.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 23.5 mt -109.89 157.15 19.53 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-O 121.077 0.465 . . . . 1.0 109.895 -179.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 50.3 t-80 -139.0 153.5 48.15 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.44 -0.8 . . . . 1.0 110.591 -179.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.42 144.39 31.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.369 -0.832 . . . . 1.0 110.812 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 89.01 -11.2 70.03 Favored Glycine 0 CA--C 1.528 0.898 0 N-CA-C 111.06 -0.816 . . . . 1.0 111.06 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -68.27 144.17 54.97 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 110.249 -0.278 . . . . 1.0 110.249 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.5 mp -117.75 121.45 40.87 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 110.127 -0.323 . . . . 1.0 110.127 -179.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 25.4 mm -80.36 125.88 39.29 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 N-CA-C 109.177 -0.675 . . . . 1.0 109.177 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 73.8 p -88.13 -47.36 8.54 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.169 -0.468 . . . . 1.0 110.449 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 71.9 tt0 -155.96 146.54 21.89 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.974 0.416 . . . . 1.0 111.222 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 12.6 tt -141.96 131.76 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 109.404 -0.591 . . . . 1.0 109.404 179.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.412 ' OD2' ' CE1' ' A' ' 47' ' ' TYR . 57.8 m-20 56.82 20.84 5.5 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.112 -0.494 . . . . 1.0 111.581 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.86 2.54 86.36 Favored Glycine 0 N--CA 1.472 1.063 0 CA-C-N 116.483 -0.326 . . . . 1.0 112.384 178.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -149.94 143.65 25.38 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 117.361 0.58 . . . . 1.0 111.008 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.458 ' OG ' ' N ' ' A' ' 38' ' ' PHE . 95.9 p -169.44 -66.18 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.204 0.526 . . . . 1.0 110.015 179.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.458 ' N ' ' OG ' ' A' ' 37' ' ' SER . 0.5 OUTLIER -54.48 179.29 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.262 -0.881 . . . . 1.0 110.137 179.736 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.439 ' O ' ' CB ' ' A' ' 40' ' ' SER . 3.4 tmtp? 66.49 64.83 0.49 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.215 -0.902 . . . . 1.0 110.816 179.645 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.439 ' CB ' ' O ' ' A' ' 39' ' ' LYS . 1.5 m 92.78 111.31 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.293 0.637 . . . . 1.0 110.757 179.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 50.3 m -52.52 -31.6 36.28 Favored 'General case' 0 N--CA 1.457 -0.089 0 N-CA-C 109.389 -0.597 . . . . 1.0 109.389 178.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.5 tm0? -55.38 -35.18 65.0 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 115.452 -0.795 . . . . 1.0 110.144 179.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -57.98 -27.86 63.85 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 115.963 -0.562 . . . . 1.0 109.779 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -72.59 -47.47 47.66 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.978 -0.555 . . . . 1.0 109.722 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 27.4 mm -63.55 -28.86 45.87 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 CA-C-N 115.797 -0.638 . . . . 1.0 109.833 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -62.62 -37.52 86.62 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.611 -0.722 . . . . 1.0 109.975 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.412 ' CE1' ' OD2' ' A' ' 34' ' ' ASP . 0.0 OUTLIER -66.62 -45.66 78.38 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.059 -0.519 . . . . 1.0 110.681 179.182 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 49.5 mt -60.61 -45.35 97.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 116.518 -0.31 . . . . 1.0 111.016 -176.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -74.16 -22.56 59.38 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.457 -0.338 . . . . 1.0 111.187 -178.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 46.6 t -85.81 -6.76 59.05 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-O 120.566 0.222 . . . . 1.0 111.217 -177.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.4 tptm -99.26 164.91 11.94 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-N 116.188 -0.46 . . . . 1.0 109.869 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -121.58 170.42 9.71 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 123.964 0.79 . . . . 1.0 109.893 -179.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 22.0 t -70.91 132.57 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-N 115.448 -0.797 . . . . 1.0 111.125 -178.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.37 -5.18 80.73 Favored Glycine 0 N--CA 1.469 0.854 0 N-CA-C 111.054 -0.818 . . . . 1.0 111.054 179.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -67.98 144.39 55.19 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.763 0.316 . . . . 1.0 110.751 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 36.3 m -90.19 153.72 20.29 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 108.988 -0.745 . . . . 1.0 108.988 178.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.469 HG12 ' O ' ' A' ' 72' ' ' ILE . 0.5 OUTLIER -140.13 161.27 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 CA-C-O 121.402 0.62 . . . . 1.0 110.599 -179.568 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -117.15 115.68 25.81 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 107.647 -1.242 . . . . 1.0 107.647 177.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.565 HG22 ' O ' ' A' ' 70' ' ' ALA . 2.9 tp -103.18 143.13 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 122.332 0.253 . . . . 1.0 111.018 -178.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 6.9 tppt? -133.1 112.75 12.03 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 108.383 -0.969 . . . . 1.0 108.383 178.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 33.8 p90 -149.15 149.2 30.64 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.906 -0.405 . . . . 1.0 109.906 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -110.18 114.12 27.35 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 110.239 -0.282 . . . . 1.0 110.239 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 51.3 t-80 -91.91 112.0 23.76 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 108.013 -1.106 . . . . 1.0 108.013 178.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 62.17 -114.45 6.8 Favored Glycine 0 CA--C 1.532 1.152 0 N-CA-C 110.7 -0.96 . . . . 1.0 110.7 -179.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 23.0 p-10 -112.99 -0.5 14.75 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 122.476 0.31 . . . . 1.0 111.365 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.437 ' NZ ' ' OE2' ' A' ' 68' ' ' GLU . 10.8 ptmm? -110.73 123.42 50.0 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 121.421 0.629 . . . . 1.0 110.75 -179.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 46.4 p-10 -81.93 128.24 33.85 Favored 'General case' 0 C--N 1.339 0.13 0 CA-C-O 121.363 0.601 . . . . 1.0 110.353 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.437 ' OE2' ' NZ ' ' A' ' 66' ' ' LYS . 81.0 mm-40 -126.11 148.83 49.28 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 115.23 -0.895 . . . . 1.0 109.523 -179.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -140.86 135.2 31.11 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 109.186 -0.672 . . . . 1.0 109.186 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.565 ' O ' HG22 ' A' ' 59' ' ' ILE . . . -148.1 142.22 26.04 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-O 121.537 0.684 . . . . 1.0 111.222 -179.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 91.5 p -85.7 135.03 33.93 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 108.781 -0.822 . . . . 1.0 108.781 178.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.469 ' O ' HG12 ' A' ' 57' ' ' VAL . 67.2 mt -129.28 122.37 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 CA-C-O 121.289 0.566 . . . . 1.0 109.963 -178.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 22.3 ttpp -82.29 138.3 34.61 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 109.64 -0.504 . . . . 1.0 109.64 179.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -69.68 143.97 53.0 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.373 0.606 . . . . 1.0 110.304 -178.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 69.7 p -143.28 172.25 13.0 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.064 -0.971 . . . . 1.0 110.435 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -89.3 140.83 29.1 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.343 -0.844 . . . . 1.0 109.583 179.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.822 ' H ' HD13 ' A' ' 77' ' ' ILE . 0.1 OUTLIER -131.92 -41.98 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 122.672 0.389 . . . . 1.0 110.839 -179.625 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -98.62 157.84 15.99 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 121.521 0.677 . . . . 1.0 110.729 -179.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -52.37 -27.09 14.25 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.845 -1.07 . . . . 1.0 112.046 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.544 ' HZ2' ' CB ' ' A' ' 82' ' ' THR . 18.1 pttp -81.4 13.24 3.07 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 116.303 -0.408 . . . . 1.0 111.039 -179.379 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 47.85 39.59 17.92 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 121.343 -0.456 . . . . 1.0 112.046 178.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.544 ' CB ' ' HZ2' ' A' ' 80' ' ' LYS . 86.8 m -80.17 122.09 82.55 Favored Pre-proline 0 CA--C 1.545 0.779 0 CA-C-N 117.101 0.451 . . . . 1.0 110.215 -179.159 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -57.03 114.86 2.11 Favored 'Trans proline' 0 N--CA 1.505 2.168 0 C-N-CA 121.401 1.4 . . . . 1.0 111.332 177.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -179.8 179.64 48.82 Favored Glycine 0 N--CA 1.463 0.449 0 N-CA-C 111.081 -0.808 . . . . 1.0 111.081 179.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.7 pt -105.69 177.5 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 N-CA-C 109.665 -0.495 . . . . 1.0 109.665 179.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -108.31 84.45 0.37 Allowed Glycine 0 N--CA 1.472 1.079 0 N-CA-C 111.05 -0.82 . . . . 1.0 111.05 -178.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.467 ' O ' HD12 ' A' ' 87' ' ' ILE . 1.2 pp -146.77 168.3 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-O 121.272 0.558 . . . . 1.0 109.645 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 62.3 m -132.23 131.39 42.06 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 115.424 -0.807 . . . . 1.0 109.557 179.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 29.2 mt -110.52 147.51 33.99 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.711 -0.677 . . . . 1.0 109.267 -179.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.513 HG11 HD23 ' A' ' 12' ' ' LEU . 30.8 m -111.96 171.02 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-N 115.773 -0.649 . . . . 1.0 110.395 -179.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 29.8 t70 62.26 33.39 16.65 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.266 -0.879 . . . . 1.0 110.535 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 21.7 p-10 -156.02 10.0 0.26 Allowed 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 116.171 -0.468 . . . . 1.0 111.051 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.43 ' O ' ' N ' ' A' ' 95' ' ' HIS . 1.8 pp -90.51 -27.5 19.16 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 116.094 -0.503 . . . . 1.0 110.358 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 78.6 tt0 -63.81 76.19 0.03 OUTLIER 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.548 -0.297 . . . . 1.0 110.222 -179.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . 0.43 ' N ' ' O ' ' A' ' 93' ' ' LEU . 57.2 t-80 -113.88 -0.21 14.23 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 122.471 0.309 . . . . 1.0 110.55 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 44.3 p-80 -157.9 -162.76 1.2 Allowed 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.776 0.322 . . . . 1.0 110.523 -179.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 77.4 t60 54.28 82.15 0.09 Allowed 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.084 -0.507 . . . . 1.0 111.093 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 34.6 p-80 -68.27 152.99 44.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.176 -0.466 . . . . 1.0 110.034 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . 0.433 ' CG ' ' N ' ' A' ' 100' ' ' HIS . 78.3 t60 56.99 162.83 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.929 -0.578 . . . . 1.0 111.833 179.518 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . 0.433 ' N ' ' CG ' ' A' ' 99' ' ' HIS . 31.6 p-80 . . . . . 0 C--O 1.22 -0.479 0 CA-C-N 115.031 -0.986 . . . . 1.0 109.354 179.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.1 ptt? . . . . . 0 N--CA 1.489 1.481 0 N-CA-C 109.364 -0.606 . . . . 1.0 109.364 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.1 p -63.03 -32.84 57.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-N 116.416 -0.357 . . . . 1.0 110.433 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -64.09 -10.49 22.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.991 -178.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 28.6 m -135.38 157.92 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 CA-C-O 121.189 0.519 . . . . 1.0 110.303 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.433 ' OG1' ' N ' ' A' ' 6' ' ' TYR . 2.8 t -82.26 179.42 7.81 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 115.404 -0.816 . . . . 1.0 110.58 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.433 ' N ' ' OG1' ' A' ' 5' ' ' THR . 59.4 t80 -67.86 121.91 17.03 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.966 -0.561 . . . . 1.0 110.25 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 36.3 p-10 -169.41 79.91 0.12 Allowed 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.905 -0.588 . . . . 1.0 110.049 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 153.67 -175.38 32.03 Favored Glycine 0 N--CA 1.467 0.75 0 N-CA-C 109.858 -1.297 . . . . 1.0 109.858 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 38.9 t -111.64 127.42 68.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 N-CA-C 109.18 -0.674 . . . . 1.0 109.18 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -86.85 143.36 27.49 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 115.962 -0.563 . . . . 1.0 109.634 -178.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 39.0 t -107.93 132.95 54.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 115.405 -0.816 . . . . 1.0 109.208 179.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.584 HD23 HG11 ' A' ' 90' ' ' VAL . 0.2 OUTLIER -81.67 -44.39 17.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.814 -0.63 . . . . 1.0 111.971 -179.547 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 99.9 p -165.8 162.39 18.47 Favored 'General case' 0 CA--C 1.506 -0.727 0 CA-C-N 116.061 -0.518 . . . . 1.0 110.953 -179.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.44 ' O ' ' O ' ' A' ' 15' ' ' LYS . 40.3 t -120.42 137.62 53.62 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 114.728 -1.124 . . . . 1.0 108.732 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.44 ' O ' ' O ' ' A' ' 14' ' ' VAL . 3.9 mmmm -54.43 -116.6 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.477 0 O-C-N 123.815 0.697 . . . . 1.0 110.294 179.129 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 78.1 tt0 -162.32 -70.13 0.05 Allowed 'General case' 0 C--N 1.33 -0.269 0 O-C-N 121.755 -0.591 . . . . 1.0 111.445 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 29.2 p-10 -89.97 51.7 2.12 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.346 -0.388 . . . . 1.0 110.569 -178.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 32.8 m -124.99 156.71 68.81 Favored Pre-proline 0 N--CA 1.471 0.616 0 CA-C-N 115.841 -0.618 . . . . 1.0 110.151 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -58.86 -13.18 17.3 Favored 'Trans proline' 0 N--CA 1.499 1.827 0 C-N-CA 121.751 1.634 . . . . 1.0 112.054 178.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.402 ' HB2' HG22 ' A' ' 85' ' ' ILE . . . -81.99 -27.46 33.15 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.068 0.461 . . . . 1.0 110.381 -179.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.91 130.5 41.17 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 115.694 -0.685 . . . . 1.0 110.134 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 98.57 -15.03 61.55 Favored Glycine 0 N--CA 1.472 1.054 0 N-CA-C 111.197 -0.761 . . . . 1.0 111.197 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 71.1 mt -115.23 -52.24 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 CA-C-N 116.616 0.208 . . . . 1.0 110.459 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.423 HD21 HD13 ' A' ' 59' ' ' ILE . 12.7 mt -102.0 149.77 23.9 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 109.816 -0.439 . . . . 1.0 109.816 -179.245 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 42.5 p-80 -141.11 154.89 46.13 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.389 0.614 . . . . 1.0 110.433 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.05 134.43 55.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.18 -0.918 . . . . 1.0 110.617 -179.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.27 -4.09 62.16 Favored Glycine 0 N--CA 1.471 0.983 0 N-CA-C 111.197 -0.761 . . . . 1.0 111.197 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -77.85 130.17 36.31 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 117.274 0.537 . . . . 1.0 110.264 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 14.3 mt -99.91 120.05 39.17 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 109.508 -0.552 . . . . 1.0 109.508 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.61 HD13 HD11 ' A' ' 59' ' ' ILE . 75.8 mt -92.34 137.51 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 N-CA-C 108.975 -0.75 . . . . 1.0 108.975 179.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 51.9 p -102.41 -43.93 5.52 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 116.13 -0.486 . . . . 1.0 111.216 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 73.0 tt0 -153.72 163.09 40.59 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.337 0.589 . . . . 1.0 111.176 -178.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 16.9 tt -149.61 142.56 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-N 115.906 -0.588 . . . . 1.0 110.028 179.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 28.3 t70 50.19 19.99 0.58 Allowed 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 120.994 0.426 . . . . 1.0 111.74 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.95 19.64 77.21 Favored Glycine 0 N--CA 1.47 0.955 0 N-CA-C 111.919 -0.472 . . . . 1.0 111.919 178.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -149.65 168.96 22.13 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 122.473 -0.427 . . . . 1.0 110.329 -179.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 81.52 112.44 0.06 Allowed 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.388 -0.823 . . . . 1.0 109.819 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.443 ' CD1' ' N ' ' A' ' 38' ' ' PHE . 0.5 OUTLIER -86.95 -152.99 0.2 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.901 0.382 . . . . 1.0 110.118 -179.068 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.414 ' O ' ' C ' ' A' ' 40' ' ' SER . 31.6 ttmt -59.63 -59.24 5.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.029 -0.532 . . . . 1.0 111.779 -178.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.414 ' C ' ' O ' ' A' ' 39' ' ' LYS . 30.6 t -27.28 117.07 0.08 Allowed 'General case' 0 N--CA 1.481 1.089 0 O-C-N 124.304 1.002 . . . . 1.0 111.128 -178.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 78.0 p -61.93 -48.65 79.47 Favored 'General case' 0 CA--C 1.513 -0.468 0 N-CA-C 109.404 -0.591 . . . . 1.0 109.404 -178.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 69.3 tp60 -51.43 -38.52 54.03 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.046 -0.525 . . . . 1.0 110.345 -178.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.8 tp10 -65.31 -32.64 74.39 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.347 -0.612 . . . . 1.0 109.347 179.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 27.8 t80 -72.11 -50.23 29.74 Favored 'General case' 0 C--O 1.219 -0.523 0 CA-C-N 116.337 -0.392 . . . . 1.0 110.204 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.7 mp -59.92 -37.18 70.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 109.247 -0.649 . . . . 1.0 109.247 179.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -60.49 -35.69 76.52 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.652 -0.704 . . . . 1.0 110.408 -178.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 44.4 t80 -68.08 -48.89 64.29 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.213 -0.449 . . . . 1.0 111.621 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 33.6 mt -52.78 -34.28 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-O 120.906 0.384 . . . . 1.0 110.427 -176.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 45.3 m170 -85.9 -22.54 27.43 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.036 -0.529 . . . . 1.0 111.121 -179.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 71.7 p -70.87 -17.98 62.71 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.645 -0.252 . . . . 1.0 111.269 -178.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 18.4 mmmt -90.48 -171.61 3.13 Favored 'General case' 0 CA--C 1.512 -0.492 0 N-CA-C 110.054 -0.35 . . . . 1.0 110.054 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -128.37 168.58 15.36 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 123.618 0.574 . . . . 1.0 110.148 -178.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 25.9 t -70.86 134.99 29.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.448 -0.796 . . . . 1.0 110.946 -178.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 90.31 -4.52 82.68 Favored Glycine 0 N--CA 1.47 0.938 0 N-CA-C 110.637 -0.985 . . . . 1.0 110.637 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -70.34 147.09 50.02 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 110.09 -0.337 . . . . 1.0 110.09 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 23.1 m -105.1 139.29 40.0 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 109.363 -0.606 . . . . 1.0 109.363 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 34.5 m -138.27 164.45 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 CA-C-N 116.12 -0.491 . . . . 1.0 111.535 -179.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.83 117.88 27.6 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 115.065 -0.971 . . . . 1.0 108.972 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.61 HD11 HD13 ' A' ' 30' ' ' ILE . 18.9 tt -97.72 141.79 15.39 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.201 0 O-C-N 123.314 0.384 . . . . 1.0 111.343 -178.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -121.43 119.91 33.43 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 107.721 -1.214 . . . . 1.0 107.721 178.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 18.7 p90 -147.75 161.26 41.59 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 110.065 -0.346 . . . . 1.0 110.065 -179.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 26.1 mtmm -128.27 117.84 22.22 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 123.464 0.477 . . . . 1.0 110.677 179.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 17.2 t-80 -107.64 112.15 24.73 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 108.37 -0.974 . . . . 1.0 108.37 178.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 73.19 -118.34 6.27 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.944 -0.862 . . . . 1.0 110.944 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 68.0 m-80 -115.95 14.04 16.07 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 122.704 0.401 . . . . 1.0 111.802 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -126.28 119.79 28.29 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 120.82 0.343 . . . . 1.0 110.938 -179.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 61.3 t-20 -84.74 133.16 34.37 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-N 116.116 -0.493 . . . . 1.0 109.845 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -128.67 161.34 29.9 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 115.228 -0.897 . . . . 1.0 110.015 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -141.08 139.79 34.1 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 115.454 -0.794 . . . . 1.0 110.149 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -150.65 161.48 42.51 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 115.664 -0.698 . . . . 1.0 110.493 -178.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 91.0 p -128.27 138.28 52.35 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 109.096 -0.705 . . . . 1.0 109.096 179.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.721 ' N ' HD13 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -138.22 147.27 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-O 121.491 0.662 . . . . 1.0 110.535 -178.189 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 7.8 ttpm? -86.57 135.21 33.52 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.387 -0.824 . . . . 1.0 109.846 179.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -68.98 147.58 51.4 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.151 0.5 . . . . 1.0 110.498 179.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 18.6 p -141.17 168.61 19.36 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 115.187 -0.915 . . . . 1.0 110.659 -179.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -80.25 148.34 30.83 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.192 -0.913 . . . . 1.0 109.887 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.446 HG13 ' H ' ' A' ' 78' ' ' ASP . 1.6 pt -128.89 -55.92 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 CA-C-N 115.996 -0.547 . . . . 1.0 110.782 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.446 ' H ' HG13 ' A' ' 77' ' ' ILE . 68.5 m-20 -96.33 165.81 12.02 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 121.466 0.65 . . . . 1.0 110.987 -178.077 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 24.1 pttm -57.03 -18.5 14.2 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.685 -1.143 . . . . 1.0 111.502 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -81.54 -13.95 57.46 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 116.834 -0.166 . . . . 1.0 111.351 -179.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 77.72 30.75 51.84 Favored Glycine 0 N--CA 1.469 0.897 0 N-CA-C 111.366 -0.694 . . . . 1.0 111.366 179.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 85.8 m -79.26 125.51 83.16 Favored Pre-proline 0 CA--C 1.546 0.797 0 C-N-CA 120.455 -0.498 . . . . 1.0 109.761 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_exo -50.73 128.97 25.73 Favored 'Trans proline' 0 N--CA 1.501 1.914 0 C-N-CA 121.595 1.53 . . . . 1.0 112.553 178.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -152.14 130.07 2.98 Favored Glycine 0 N--CA 1.468 0.809 0 N-CA-C 111.078 -0.809 . . . . 1.0 111.078 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.402 HG22 ' HB2' ' A' ' 20' ' ' ALA . 96.1 mt -59.68 -25.52 32.15 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 N-CA-C 110.47 -0.196 . . . . 1.0 110.47 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 100.01 46.69 1.86 Allowed Glycine 0 N--CA 1.481 1.659 0 N-CA-C 111.211 -0.755 . . . . 1.0 111.211 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.471 HD13 HD21 ' A' ' 89' ' ' LEU . 1.1 pp -146.93 164.98 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 N-CA-C 109.67 -0.492 . . . . 1.0 109.67 -178.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 15.9 m -128.76 121.94 29.5 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 115.408 -0.814 . . . . 1.0 110.584 178.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.775 HD22 ' N ' ' A' ' 89' ' ' LEU . 0.4 OUTLIER -99.73 139.37 35.49 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.389 0.676 . . . . 1.0 109.759 -179.861 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.584 HG11 HD23 ' A' ' 12' ' ' LEU . 9.1 m -107.38 177.41 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 114.884 -1.053 . . . . 1.0 109.424 -179.325 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 64.75 42.05 4.8 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 124.433 1.083 . . . . 1.0 110.325 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 48.0 p30 -92.5 175.7 6.73 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 115.942 -0.572 . . . . 1.0 110.539 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 60.1 mt -64.38 -39.41 93.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.561 -0.745 . . . . 1.0 110.944 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -64.25 149.23 48.42 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.079 -0.509 . . . . 1.0 109.653 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -88.16 -6.83 57.65 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.464 -0.335 . . . . 1.0 110.815 -179.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 55.0 t-80 57.11 115.14 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.352 0 O-C-N 123.519 0.512 . . . . 1.0 110.924 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 85.1 t60 53.3 87.52 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.303 -0.408 . . . . 1.0 111.124 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 40.5 p-80 -68.87 165.29 20.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.19 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 39.9 p-80 -156.78 160.07 38.89 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.238 0.542 . . . . 1.0 111.303 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 83.8 t60 . . . . . 0 C--O 1.22 -0.474 0 CA-C-O 117.961 -1.019 . . . . 1.0 109.104 178.924 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mpt? . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 108.902 -0.777 . . . . 1.0 108.902 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 18.8 t 55.42 74.44 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-N 116.259 -0.428 . . . . 1.0 110.565 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -65.2 -35.55 81.42 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.325 -0.398 . . . . 1.0 110.842 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 35.7 m -62.52 145.32 13.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.934 -0.575 . . . . 1.0 110.727 -179.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 23.9 m -61.96 -50.28 72.74 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.229 -0.441 . . . . 1.0 111.324 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 71.1 t80 55.4 104.2 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 120.829 0.347 . . . . 1.0 110.638 -179.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 34.0 t0 -169.4 111.25 0.48 Allowed 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.544 -0.539 . . . . 1.0 109.544 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -77.53 -161.33 14.76 Favored Glycine 0 N--CA 1.464 0.521 0 N-CA-C 110.243 -1.143 . . . . 1.0 110.243 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.6 t -111.93 129.65 67.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 N-CA-C 109.722 -0.473 . . . . 1.0 109.722 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -85.87 141.65 29.44 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.385 -0.598 . . . . 1.0 109.385 -178.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.6 t -100.45 136.0 33.84 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.31 0 CA-C-N 115.121 -0.945 . . . . 1.0 109.521 179.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 42.3 tp -89.72 -51.84 5.31 Favored 'General case' 0 N--CA 1.458 -0.071 0 CA-C-N 116.052 -0.522 . . . . 1.0 110.778 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 44.4 m -158.6 151.86 22.8 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.285 0.564 . . . . 1.0 110.845 -178.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.4 p -137.42 135.2 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-N 114.821 -1.081 . . . . 1.0 109.623 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -71.28 152.92 42.8 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.93 -0.767 . . . . 1.0 108.93 178.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -96.14 15.3 21.22 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 116.778 -0.192 . . . . 1.0 111.377 -178.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -133.77 41.62 3.01 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 109.132 -0.692 . . . . 1.0 109.132 179.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 8.7 m -141.31 153.13 65.87 Favored Pre-proline 0 CA--C 1.542 0.66 0 CA-C-N 115.786 -0.643 . . . . 1.0 110.0 -179.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.718 ' O ' HD13 ' A' ' 23' ' ' ILE . 80.9 Cg_exo -45.1 -30.85 5.17 Favored 'Trans proline' 0 N--CA 1.496 1.633 0 C-N-CA 122.178 1.919 . . . . 1.0 113.109 179.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.79 -23.82 67.43 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.059 0.457 . . . . 1.0 110.314 -178.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.0 107.44 1.25 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.81 -0.632 . . . . 1.0 110.144 179.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.542 ' C ' HD12 ' A' ' 23' ' ' ILE . . . 108.05 -4.62 33.84 Favored Glycine 0 N--CA 1.476 1.304 0 N-CA-C 111.317 -0.713 . . . . 1.0 111.317 -179.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.718 HD13 ' O ' ' A' ' 19' ' ' PRO . 3.3 mp -117.19 -50.15 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 122.461 0.304 . . . . 1.0 110.787 179.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 12.1 mt -112.03 150.46 30.6 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 121.242 0.544 . . . . 1.0 110.314 -179.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 -145.46 158.55 43.82 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.293 -0.867 . . . . 1.0 110.852 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.41 124.64 20.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.46 -0.791 . . . . 1.0 110.276 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 99.64 -4.44 58.02 Favored Glycine 0 N--CA 1.471 1.028 0 N-CA-C 111.129 -0.788 . . . . 1.0 111.129 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -74.96 141.94 43.98 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.979 0.39 . . . . 1.0 110.038 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 25.6 mt -115.96 121.13 41.36 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 109.958 -0.386 . . . . 1.0 109.958 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 62.4 mt -91.69 135.94 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 N-CA-C 107.883 -1.154 . . . . 1.0 107.883 178.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 3.0 p -123.72 -23.3 4.74 Favored 'General case' 0 N--CA 1.479 0.978 0 O-C-N 123.416 0.447 . . . . 1.0 111.408 -178.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 59.1 tt0 -152.27 147.21 26.09 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 120.924 -0.311 . . . . 1.0 110.536 -178.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.467 ' O ' ' N ' ' A' ' 35' ' ' GLY . 4.1 mp -135.89 137.11 49.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 N-CA-C 108.742 -0.836 . . . . 1.0 108.742 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 42.73 17.29 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 122.893 0.477 . . . . 1.0 112.118 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 33' ' ' ILE . . . 64.29 17.89 62.28 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 111.493 -0.643 . . . . 1.0 111.493 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.445 ' OE1' ' CE1' ' A' ' 47' ' ' TYR . 12.0 pt20 -82.96 166.48 18.81 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 122.532 -0.393 . . . . 1.0 111.81 -178.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 49.4 m -83.75 161.7 20.91 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.848 -0.615 . . . . 1.0 109.842 178.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.437 ' CE2' ' O ' ' A' ' 36' ' ' GLN . 1.3 p90 -172.59 -174.63 1.19 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.457 -0.792 . . . . 1.0 109.437 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -141.75 -68.76 0.38 Allowed 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.869 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 44.2 m -98.29 165.63 11.78 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.176 0.512 . . . . 1.0 110.486 -179.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 78.4 p -60.58 -29.82 69.42 Favored 'General case' 0 C--O 1.215 -0.717 0 N-CA-C 109.312 -0.625 . . . . 1.0 109.312 178.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -64.17 -30.71 71.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.925 -0.579 . . . . 1.0 110.741 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -60.33 -26.94 66.96 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.775 0.322 . . . . 1.0 110.444 -178.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -72.28 -51.13 22.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.997 0.427 . . . . 1.0 110.233 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.551 HD12 ' N ' ' A' ' 45' ' ' ILE . 1.7 mp -57.39 -28.77 31.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 108.979 -0.749 . . . . 1.0 108.979 -179.042 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -70.64 -33.77 71.35 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.487 -0.779 . . . . 1.0 110.808 -178.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.445 ' CE1' ' OE1' ' A' ' 36' ' ' GLN . 84.0 t80 -69.48 -52.21 28.7 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 120.69 -0.404 . . . . 1.0 111.888 -178.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -67.08 -39.62 83.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-N 116.257 -0.428 . . . . 1.0 109.996 -178.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 81.0 t60 -59.59 -13.73 10.55 Favored 'General case' 0 CA--C 1.503 -0.838 0 CA-C-N 116.25 -0.432 . . . . 1.0 111.088 -178.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 21.6 t -96.74 -142.68 0.28 Allowed 'General case' 0 N--CA 1.434 -1.251 0 CA-C-O 122.008 0.909 . . . . 1.0 109.042 178.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 30.1 mmtp 48.2 -169.84 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 114.26 -1.336 . . . . 1.0 110.049 -177.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -131.58 154.89 48.38 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.121 0.486 . . . . 1.0 110.319 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.6 t -59.88 142.57 15.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.578 -0.737 . . . . 1.0 111.03 -179.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 102.17 -20.45 45.15 Favored Glycine 0 N--CA 1.474 1.189 0 N-CA-C 110.596 -1.002 . . . . 1.0 110.596 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 -62.0 -174.13 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.794 0.331 . . . . 1.0 110.525 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.9 t -148.9 145.51 27.46 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 109.623 -0.51 . . . . 1.0 109.623 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 23.0 m -140.66 165.82 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 CA-C-O 121.116 0.484 . . . . 1.0 111.442 -178.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -119.68 120.03 35.44 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 114.877 -1.056 . . . . 1.0 108.385 178.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.5 tt -103.82 147.3 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 123.026 0.53 . . . . 1.0 110.907 -178.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 33.3 ttmt -131.02 117.27 18.93 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 108.207 -1.034 . . . . 1.0 108.207 177.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 26.1 p90 -136.49 165.33 26.1 Favored 'General case' 0 C--N 1.34 0.195 0 CA-C-N 115.92 -0.582 . . . . 1.0 110.581 -177.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -121.17 139.25 53.61 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.308 -0.86 . . . . 1.0 110.466 -179.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 80.2 t60 -130.64 101.23 5.6 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.756 -0.656 . . . . 1.0 109.336 178.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 60.98 -110.41 3.03 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 110.702 -0.959 . . . . 1.0 110.702 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -112.82 13.72 19.76 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 122.578 0.351 . . . . 1.0 111.396 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 7.6 ttpm? -130.39 116.18 17.91 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 116.636 -0.256 . . . . 1.0 110.546 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 41.5 m-20 -100.85 135.77 41.76 Favored 'General case' 0 C--N 1.341 0.236 0 N-CA-C 109.722 -0.473 . . . . 1.0 109.722 179.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -135.47 166.56 22.9 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 109.303 -0.628 . . . . 1.0 109.303 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.418 ' N ' ' CD ' ' A' ' 69' ' ' GLU . 3.0 pm0 -141.24 140.45 33.93 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.706 -0.679 . . . . 1.0 110.574 -179.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.4 ' HB3' HG23 ' A' ' 23' ' ' ILE . . . -149.92 154.63 38.61 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.794 -0.639 . . . . 1.0 110.681 -178.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 29.6 m -115.86 139.76 49.89 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 115.181 -0.918 . . . . 1.0 109.352 179.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -136.59 146.86 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-O 121.384 0.612 . . . . 1.0 110.469 -178.089 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -82.39 138.74 34.37 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.201 -0.908 . . . . 1.0 109.576 179.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.491 HD22 ' N ' ' A' ' 74' ' ' LEU . 4.1 mm? -67.24 146.45 54.16 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.442 0.639 . . . . 1.0 110.874 -179.356 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 45.4 p -140.91 160.1 40.8 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.052 -0.976 . . . . 1.0 110.796 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -80.32 131.71 35.69 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.346 -0.843 . . . . 1.0 109.537 179.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 10.7 pt -122.68 -44.98 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 122.677 0.391 . . . . 1.0 111.05 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.401 ' OD2' ' NZ ' ' A' ' 80' ' ' LYS . 30.6 t70 -99.81 156.98 16.82 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 121.636 0.732 . . . . 1.0 110.908 -179.118 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 10.3 mmpt? -48.44 -32.3 7.52 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.647 -1.161 . . . . 1.0 111.759 -179.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.401 ' NZ ' ' OD2' ' A' ' 78' ' ' ASP . 29.2 mtmm -82.72 12.42 4.76 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.415 -0.357 . . . . 1.0 111.375 -178.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 56.12 47.32 81.8 Favored Glycine 0 C--N 1.334 0.422 0 N-CA-C 111.635 -0.586 . . . . 1.0 111.635 178.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 86.5 m -79.87 120.37 79.71 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 120.491 -0.484 . . . . 1.0 110.471 -179.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -56.03 132.36 51.51 Favored 'Trans proline' 0 N--CA 1.498 1.787 0 C-N-CA 121.703 1.602 . . . . 1.0 111.738 177.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 154.98 179.41 30.14 Favored Glycine 0 N--CA 1.468 0.774 0 N-CA-C 110.62 -0.992 . . . . 1.0 110.62 178.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.417 HD13 ' N ' ' A' ' 85' ' ' ILE . 0.0 OUTLIER -103.92 -177.57 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 N-CA-C 109.037 -0.727 . . . . 1.0 109.037 -179.566 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -103.84 78.61 0.29 Allowed Glycine 0 C--N 1.339 0.699 0 N-CA-C 110.667 -0.973 . . . . 1.0 110.667 -179.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 49.7 pt -138.08 163.4 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 C-N-CA 122.796 0.438 . . . . 1.0 109.988 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 84.8 m -130.13 128.04 41.0 Favored 'General case' 0 N--CA 1.478 0.948 0 O-C-N 123.72 0.637 . . . . 1.0 109.777 177.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 54.1 mt -110.42 146.16 36.34 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 123.183 0.593 . . . . 1.0 110.153 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 33.7 m -107.05 171.57 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-N 115.606 -0.724 . . . . 1.0 110.176 -179.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -163.19 32.98 0.09 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.733 -0.667 . . . . 1.0 110.452 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.442 ' C ' ' H ' ' A' ' 94' ' ' GLU . 29.6 t0 58.09 164.4 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.752 -0.658 . . . . 1.0 110.814 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 37.6 mt 57.77 4.18 0.25 Allowed 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.281 -0.418 . . . . 1.0 111.049 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.442 ' H ' ' C ' ' A' ' 92' ' ' ASP . 48.3 tp10 -78.09 -36.57 47.99 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 116.308 -0.405 . . . . 1.0 110.378 -179.341 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 61.7 t-80 -87.78 -19.95 26.81 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.576 0.227 . . . . 1.0 110.712 -178.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 34.5 m-70 -70.18 -71.1 0.25 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.77 0.319 . . . . 1.0 110.44 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -78.66 161.37 26.97 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.275 -0.42 . . . . 1.0 110.671 -179.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 80.8 t60 -162.27 52.66 0.21 Allowed 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.139 -0.482 . . . . 1.0 110.053 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 41.2 m170 -66.18 -40.21 90.31 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.917 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 41.7 p-80 . . . . . 0 C--O 1.218 -0.557 0 CA-C-O 117.795 -1.097 . . . . 1.0 109.443 179.767 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.2 ptt? . . . . . 0 N--CA 1.492 1.66 0 N-CA-C 108.958 -0.756 . . . . 1.0 108.958 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.6 p -61.9 -29.62 46.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.956 -0.565 . . . . 1.0 110.387 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 50.3 mtmt -61.19 109.96 1.26 Allowed 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.258 -0.428 . . . . 1.0 110.47 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 10.2 p -64.38 147.23 12.55 Favored 'Isoleucine or valine' 0 C--O 1.232 0.158 0 CA-C-N 116.45 -0.341 . . . . 1.0 110.233 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 33.4 m -152.27 -50.54 0.11 Allowed 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 116.274 -0.421 . . . . 1.0 109.961 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -66.72 145.19 55.81 Favored 'General case' 0 N--CA 1.463 0.184 0 N-CA-C 109.957 -0.386 . . . . 1.0 109.957 179.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -135.48 -33.41 0.88 Allowed 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 116.247 -0.433 . . . . 1.0 110.054 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 42.73 -146.38 0.82 Allowed Glycine 0 N--CA 1.473 1.132 0 N-CA-C 111.294 -0.722 . . . . 1.0 111.294 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.9 t -135.23 127.53 47.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 N-CA-C 108.628 -0.879 . . . . 1.0 108.628 178.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.46 ' CZ ' HD13 ' A' ' 29' ' ' LEU . 97.1 m-85 -102.08 132.69 47.79 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 121.256 0.55 . . . . 1.0 110.255 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 61.2 t -76.87 132.1 33.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 N-CA-C 108.152 -1.055 . . . . 1.0 108.152 179.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.432 ' O ' HD23 ' A' ' 12' ' ' LEU . 1.7 tt -76.14 -51.66 11.71 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-O 121.558 0.694 . . . . 1.0 110.71 -178.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 92.4 p -155.75 153.05 29.29 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.641 -0.709 . . . . 1.0 111.253 -179.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 51.7 t -136.84 113.77 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 108.706 -0.85 . . . . 1.0 108.706 178.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 34.3 mtmm -70.87 163.62 27.0 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 109.662 -0.496 . . . . 1.0 109.662 179.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 28.8 mp0 -98.83 46.36 0.99 Allowed 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 116.402 -0.363 . . . . 1.0 111.199 -179.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -158.36 35.15 0.24 Allowed 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 109.96 -0.385 . . . . 1.0 109.96 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 15.8 m -142.49 157.45 62.46 Favored Pre-proline 0 N--CA 1.481 1.09 0 N-CA-C 108.847 -0.797 . . . . 1.0 108.847 -179.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -45.8 -37.96 17.09 Favored 'Trans proline' 0 N--CA 1.507 2.31 0 CA-C-N 121.049 1.41 . . . . 1.0 112.807 179.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.26 -15.63 60.48 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.159 -0.473 . . . . 1.0 111.589 -179.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.95 139.41 46.74 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-O 121.195 0.521 . . . . 1.0 111.499 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 79.69 -11.13 34.82 Favored Glycine 0 N--CA 1.463 0.469 0 CA-C-N 115.352 -0.84 . . . . 1.0 111.94 176.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 67.2 mt -115.2 -50.85 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 N-CA-C 109.88 -0.415 . . . . 1.0 109.88 -178.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 15.0 mt -107.36 134.36 50.53 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 115.756 -0.656 . . . . 1.0 110.032 -179.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -110.84 132.7 53.98 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.784 -0.644 . . . . 1.0 109.525 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -47.64 137.14 9.56 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 120.751 0.31 . . . . 1.0 111.606 -178.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 94.93 -3.3 67.16 Favored Glycine 0 N--CA 1.471 0.969 0 N-CA-C 111.039 -0.824 . . . . 1.0 111.039 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -65.18 123.72 20.27 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 120.912 0.387 . . . . 1.0 110.545 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.46 HD13 ' CZ ' ' A' ' 10' ' ' TYR . 37.8 tp -88.16 131.5 34.7 Favored 'General case' 0 C--O 1.208 -1.087 0 CA-C-O 118.085 -0.959 . . . . 1.0 109.024 179.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 18.3 mm -87.96 125.4 41.45 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 119.485 1.039 . . . . 1.0 108.988 178.196 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 82.0 p -97.03 -36.26 10.57 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 122.449 0.3 . . . . 1.0 111.223 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -153.5 149.5 27.77 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 109.867 -0.42 . . . . 1.0 109.867 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.504 HD13 ' H ' ' A' ' 34' ' ' ASP . 0.3 OUTLIER -147.17 139.67 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 N-CA-C 107.84 -1.17 . . . . 1.0 107.84 -179.998 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.504 ' H ' HD13 ' A' ' 33' ' ' ILE . 36.1 t70 47.79 22.05 0.32 Allowed 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 112.139 0.422 . . . . 1.0 112.139 178.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.34 -8.0 54.9 Favored Glycine 0 CA--C 1.529 0.92 0 N-CA-C 111.411 -0.675 . . . . 1.0 111.411 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -87.84 159.39 18.42 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 110.016 -0.364 . . . . 1.0 110.016 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 81.2 p -97.92 -93.6 0.23 Allowed 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 116.308 -0.406 . . . . 1.0 111.42 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 59.2 139.95 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 122.822 0.449 . . . . 1.0 110.863 -178.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -132.46 85.35 2.22 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-O 121.085 0.469 . . . . 1.0 110.26 -179.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.1 p 176.52 156.07 0.25 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.622 -1.172 . . . . 1.0 109.368 178.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 79.8 p -77.72 -51.78 10.01 Favored 'General case' 0 C--O 1.223 -0.293 0 CA-C-N 116.4 -0.364 . . . . 1.0 110.189 179.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -52.16 -42.38 63.36 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 122.099 -0.376 . . . . 1.0 111.27 -177.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -66.57 -31.34 71.98 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.218 -0.66 . . . . 1.0 109.218 178.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -73.98 -48.97 26.62 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.773 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.8 mp -55.6 -33.94 34.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 N-CA-C 108.319 -0.993 . . . . 1.0 108.319 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -64.4 -38.57 91.48 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.809 -0.632 . . . . 1.0 111.471 -179.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 77.3 t80 -67.57 -52.1 42.63 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 120.748 -0.381 . . . . 1.0 111.653 -178.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -67.78 -44.35 85.7 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 CA-C-O 120.553 0.216 . . . . 1.0 110.714 -179.321 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 63.8 t-80 -65.0 -16.94 64.0 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.668 -0.242 . . . . 1.0 111.365 -178.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 90.2 p -104.97 -4.2 22.36 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 122.319 0.248 . . . . 1.0 111.329 -178.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.449 ' HZ1' ' CG ' ' A' ' 55' ' ' ASP . 14.3 tptp -87.54 135.67 33.25 Favored 'General case' 0 C--O 1.211 -0.95 0 N-CA-C 108.711 -0.848 . . . . 1.0 108.711 179.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -69.03 153.55 43.59 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 111.884 0.327 . . . . 1.0 111.884 -178.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.6 t -64.74 141.12 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-N 116.388 -0.369 . . . . 1.0 110.931 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 89.95 -23.74 19.05 Favored Glycine 0 N--CA 1.469 0.865 0 CA-C-N 116.011 -0.54 . . . . 1.0 111.963 177.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.449 ' CG ' ' HZ1' ' A' ' 51' ' ' LYS . 11.7 t70 -53.7 151.9 5.76 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-N 117.354 0.577 . . . . 1.0 111.377 -178.4 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.0 m -104.96 128.63 53.32 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 121.376 0.607 . . . . 1.0 110.075 179.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 30.7 m -117.61 171.62 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 124.383 1.073 . . . . 1.0 109.829 -178.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 18.1 ttmm -125.43 113.9 18.13 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 107.376 -1.342 . . . . 1.0 107.376 178.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.566 HG22 ' O ' ' A' ' 70' ' ' ALA . 1.6 tp -97.55 141.9 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 122.643 0.377 . . . . 1.0 110.53 -178.188 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.11 112.24 10.99 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 107.379 -1.341 . . . . 1.0 107.379 177.218 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 24.5 p90 -144.77 160.89 40.52 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 110.36 -0.237 . . . . 1.0 110.36 -178.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -134.76 136.9 42.97 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 109.154 -0.684 . . . . 1.0 109.154 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 61.6 t-80 -128.42 126.43 40.56 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 107.835 -1.172 . . . . 1.0 107.835 178.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 62.82 -117.18 10.66 Favored Glycine 0 CA--C 1.531 1.041 0 N-CA-C 110.65 -0.98 . . . . 1.0 110.65 -179.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -113.47 -21.58 10.78 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 122.845 0.458 . . . . 1.0 110.856 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -90.89 123.31 34.31 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 121.593 0.711 . . . . 1.0 111.598 -178.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 57.4 m-20 -92.96 135.94 33.71 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 109.446 -0.575 . . . . 1.0 109.446 -179.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 64.7 mt-10 -137.76 142.1 40.93 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 109.98 -0.378 . . . . 1.0 109.98 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -140.66 138.23 34.15 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 110.067 -0.346 . . . . 1.0 110.067 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.566 ' O ' HG22 ' A' ' 59' ' ' ILE . . . -151.16 147.43 27.03 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-O 121.547 0.689 . . . . 1.0 112.778 -177.304 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 90.6 p -90.97 127.87 36.58 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 109.485 -0.561 . . . . 1.0 109.485 177.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.4 mp -130.44 129.06 64.48 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 N-CA-C 108.772 -0.825 . . . . 1.0 108.772 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 5.4 ptpt -81.38 142.92 32.56 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 122.023 -0.423 . . . . 1.0 110.517 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.419 HD22 ' N ' ' A' ' 74' ' ' LEU . 3.5 mm? -61.32 145.14 52.46 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 109.936 -0.394 . . . . 1.0 109.936 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 72.3 p -134.82 155.1 51.22 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 115.972 -0.558 . . . . 1.0 110.259 178.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -79.93 122.28 26.5 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 108.752 -0.833 . . . . 1.0 108.752 178.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.789 ' H ' HD13 ' A' ' 77' ' ' ILE . 0.1 OUTLIER -118.07 -14.19 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 C-N-CA 122.597 0.359 . . . . 1.0 111.689 -178.714 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -120.02 145.72 46.56 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.052 0.453 . . . . 1.0 110.347 -179.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 24.0 pttm -47.72 -27.16 1.84 Allowed 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 115.658 -0.701 . . . . 1.0 112.343 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 14.4 pttm -81.29 -16.3 52.91 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-O 120.751 0.31 . . . . 1.0 110.343 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 81.81 50.56 4.89 Favored Glycine 0 N--CA 1.468 0.826 0 N-CA-C 111.891 -0.483 . . . . 1.0 111.891 179.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 32.4 m -81.68 119.42 75.37 Favored Pre-proline 0 CA--C 1.549 0.917 0 CA-C-O 118.915 -0.564 . . . . 1.0 110.062 179.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_exo -53.09 118.32 4.69 Favored 'Trans proline' 0 N--CA 1.505 2.165 0 CA-C-N 120.744 1.301 . . . . 1.0 111.369 177.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 173.1 -174.74 46.0 Favored Glycine 0 N--CA 1.469 0.866 0 C-N-CA 120.581 -0.818 . . . . 1.0 112.676 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -116.48 170.79 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 N-CA-C 107.258 -1.386 . . . . 1.0 107.258 178.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -90.91 42.67 2.87 Favored Glycine 0 N--CA 1.475 1.262 0 CA-C-N 118.1 0.409 . . . . 1.0 112.479 -177.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 48.8 pt -111.68 176.09 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 122.405 0.282 . . . . 1.0 110.341 -178.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 62.9 m -132.33 130.18 40.44 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 115.805 -0.634 . . . . 1.0 109.844 178.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 69.1 mt -104.65 143.54 32.94 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.022 0.529 . . . . 1.0 109.927 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.1 m -103.88 178.24 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 C-N-CA 123.379 0.672 . . . . 1.0 111.333 -177.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.3 t70 88.56 -27.16 0.06 Allowed 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 114.336 -1.302 . . . . 1.0 109.428 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 42.4 p30 -54.45 176.21 0.04 OUTLIER 'General case' 0 CA--C 1.529 0.164 0 CA-C-O 121.054 0.454 . . . . 1.0 111.388 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 46.4 mt -67.5 -40.41 85.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.606 -0.725 . . . . 1.0 110.336 179.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -65.83 100.86 0.59 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.318 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 20.5 p80 -88.87 -18.74 26.97 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.484 -0.325 . . . . 1.0 110.621 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 21.1 p80 -68.62 147.17 52.3 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.315 -0.402 . . . . 1.0 110.522 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -161.0 9.95 0.09 Allowed 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.412 -0.358 . . . . 1.0 110.555 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 84.8 t60 53.69 89.39 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.308 -0.406 . . . . 1.0 111.127 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 61.4 m80 54.33 -179.5 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.097 -0.502 . . . . 1.0 111.192 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 60.3 t-80 . . . . . 0 C--O 1.221 -0.435 0 CA-C-O 117.975 -1.012 . . . . 1.0 110.397 179.949 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.1 mmt . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.306 -0.628 . . . . 1.0 109.306 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 8.2 p -168.47 -27.97 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 CA-C-N 116.351 -0.386 . . . . 1.0 110.443 179.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -70.27 4.86 1.97 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.616 0.246 . . . . 1.0 110.613 -179.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 25.2 t 55.16 83.58 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-N 116.491 -0.322 . . . . 1.0 110.38 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 25.6 m -61.76 -48.24 81.55 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.53 -0.304 . . . . 1.0 111.098 -179.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -119.19 -92.58 0.53 Allowed 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 122.866 0.466 . . . . 1.0 110.428 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.456 ' CG ' ' H ' ' A' ' 8' ' ' GLY . 9.6 p30 -177.03 -99.24 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 109.798 -0.445 . . . . 1.0 109.798 -179.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.456 ' H ' ' CG ' ' A' ' 7' ' ' ASP . . . 178.61 -159.31 24.41 Favored Glycine 0 CA--C 1.519 0.332 0 N-CA-C 109.86 -1.296 . . . . 1.0 109.86 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.7 m -111.54 128.39 68.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 N-CA-C 109.125 -0.695 . . . . 1.0 109.125 179.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.463 ' N ' ' O ' ' A' ' 90' ' ' VAL . 11.5 m-85 -88.45 132.23 34.56 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 121.329 0.585 . . . . 1.0 109.527 -178.015 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 83.7 t -76.46 134.54 28.69 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.227 0 N-CA-C 107.337 -1.357 . . . . 1.0 107.337 179.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.52 -51.57 6.1 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.578 0.227 . . . . 1.0 110.707 -178.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 40.2 t -154.03 150.68 28.5 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.004 0.431 . . . . 1.0 111.003 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 46.7 t -110.56 113.22 43.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-N 115.191 -0.913 . . . . 1.0 108.952 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.407 ' O ' ' O ' ' A' ' 16' ' ' GLU . 62.5 mttp -86.37 92.19 8.74 Favored 'General case' 0 C--O 1.221 -0.411 0 N-CA-C 108.384 -0.969 . . . . 1.0 108.384 179.327 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.47 ' CD ' ' H ' ' A' ' 16' ' ' GLU . 3.3 pm0 -44.77 -179.24 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.489 0 O-C-N 124.073 0.858 . . . . 1.0 112.689 -178.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 26.7 t70 62.73 30.0 16.78 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.683 -0.69 . . . . 1.0 109.763 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 28.3 m -133.6 157.13 78.72 Favored Pre-proline 0 N--CA 1.484 1.247 0 CA-C-N 115.954 -0.566 . . . . 1.0 110.558 -179.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -49.5 -38.57 44.48 Favored 'Trans proline' 0 N--CA 1.503 2.049 0 C-N-CA 121.253 1.302 . . . . 1.0 112.874 178.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.44 -17.33 62.57 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.505 -0.316 . . . . 1.0 110.929 -178.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.06 118.14 9.4 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 110.352 -0.24 . . . . 1.0 110.352 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 98.83 -3.76 59.0 Favored Glycine 0 N--CA 1.473 1.123 0 N-CA-C 111.604 -0.598 . . . . 1.0 111.604 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 65.1 mt -114.29 -50.48 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 CA-C-N 116.973 0.386 . . . . 1.0 110.247 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 48.1 mt -110.43 151.43 27.5 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.099 0.56 . . . . 1.0 110.114 -179.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.407 ' HE2' ' CE1' ' A' ' 63' ' ' HIS . 18.4 p-80 -143.5 155.1 44.24 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.403 -0.817 . . . . 1.0 110.105 -179.193 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.74 139.14 40.3 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 115.373 -0.831 . . . . 1.0 111.101 -179.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 91.82 -3.48 77.8 Favored Glycine 0 CA--C 1.528 0.889 0 N-CA-C 111.179 -0.769 . . . . 1.0 111.179 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -79.68 126.53 31.05 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 117.148 0.474 . . . . 1.0 110.501 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 17.5 mt -102.54 129.86 49.21 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 109.069 -0.715 . . . . 1.0 109.069 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 30.8 mm -85.17 127.39 39.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 N-CA-C 109.417 -0.586 . . . . 1.0 109.417 179.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 66.4 p -93.12 -42.13 9.56 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 116.599 -0.273 . . . . 1.0 110.708 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 73.1 tt0 -153.71 152.58 30.94 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.694 0.283 . . . . 1.0 110.379 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.534 HD13 ' H ' ' A' ' 34' ' ' ASP . 0.3 OUTLIER -137.87 138.53 43.9 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 N-CA-C 108.951 -0.759 . . . . 1.0 108.951 -179.218 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.534 ' H ' HD13 ' A' ' 33' ' ' ILE . 37.6 t70 46.46 25.85 0.43 Allowed 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.211 0.529 . . . . 1.0 111.732 179.329 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.94 4.62 49.09 Favored Glycine 0 CA--C 1.527 0.815 0 CA-C-N 115.812 -0.631 . . . . 1.0 111.579 179.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -81.88 130.91 35.22 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 120.999 0.428 . . . . 1.0 110.635 -179.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 98.5 p -61.19 -117.61 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.752 -0.658 . . . . 1.0 111.081 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 56.88 171.55 0.04 OUTLIER 'General case' 0 CA--C 1.52 -0.176 0 CA-C-O 120.768 0.318 . . . . 1.0 110.309 -179.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 32.9 tptt -153.6 -69.43 0.14 Allowed 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 120.918 -0.313 . . . . 1.0 110.266 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 96.0 p -30.47 137.74 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.051 0 O-C-N 123.98 0.8 . . . . 1.0 111.635 -178.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 81.2 p -58.71 -50.8 72.55 Favored 'General case' 0 C--O 1.22 -0.45 0 C-N-CA 120.464 -0.494 . . . . 1.0 110.039 -178.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -48.88 -42.65 37.46 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.462 0.172 . . . . 1.0 111.244 -178.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.1 tp10 -69.79 -32.04 70.29 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.315 -0.624 . . . . 1.0 109.315 178.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -71.29 -49.77 39.42 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.9 0.381 . . . . 1.0 110.75 -179.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 38.4 mm -58.53 -29.07 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 115.516 -0.765 . . . . 1.0 109.639 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -66.92 -35.56 80.27 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.703 -0.681 . . . . 1.0 110.702 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -68.68 -46.91 67.82 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-O 121.223 0.535 . . . . 1.0 111.248 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 42.7 mt -52.66 -41.5 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-N 115.687 -0.688 . . . . 1.0 110.267 -175.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 32.3 m-70 -83.91 -18.97 35.6 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.074 -0.512 . . . . 1.0 111.275 -179.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 24.8 t -63.64 -24.94 68.0 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 111.646 0.239 . . . . 1.0 111.646 -178.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 48.7 mttm -94.23 -174.81 3.48 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 120.961 0.41 . . . . 1.0 110.107 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -130.63 161.58 31.27 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 115.46 -0.791 . . . . 1.0 110.536 -178.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 26.2 t -65.81 138.55 22.85 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-N 115.462 -0.79 . . . . 1.0 111.226 -178.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 99.76 -2.36 57.06 Favored Glycine 0 N--CA 1.477 1.421 0 N-CA-C 110.897 -0.881 . . . . 1.0 110.897 179.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -76.65 -172.8 2.35 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.695 -0.483 . . . . 1.0 109.695 179.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.8 t -148.05 141.13 24.96 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 109.479 -0.563 . . . . 1.0 109.479 179.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 27.7 m -142.3 165.88 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 CA-C-N 116.002 -0.545 . . . . 1.0 111.597 -178.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -118.32 121.94 41.63 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 108.003 -1.11 . . . . 1.0 108.003 178.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 13.2 tt -101.8 143.26 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 122.648 0.379 . . . . 1.0 110.887 -178.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -134.04 118.47 17.82 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 107.549 -1.278 . . . . 1.0 107.549 178.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 49.3 p90 -139.35 161.96 36.17 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-N 116.16 -0.473 . . . . 1.0 109.775 -178.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 7.8 ttpm? -118.77 112.83 20.23 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 123.342 0.401 . . . . 1.0 110.346 179.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.407 ' CE1' ' HE2' ' A' ' 25' ' ' HIS . 34.5 t60 -106.78 107.63 18.73 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 108.012 -1.107 . . . . 1.0 108.012 178.302 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 72.27 -115.99 5.65 Favored Glycine 0 CA--C 1.53 1.015 0 N-CA-C 111.054 -0.818 . . . . 1.0 111.054 -178.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -113.51 1.66 15.1 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 122.983 0.513 . . . . 1.0 111.407 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -124.02 124.29 42.23 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-O 121.48 0.657 . . . . 1.0 111.009 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 38.6 p-10 -101.86 143.19 32.06 Favored 'General case' 0 C--N 1.343 0.324 0 N-CA-C 109.33 -0.618 . . . . 1.0 109.33 179.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 68.5 mt-10 -130.5 167.14 19.13 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 115.542 -0.753 . . . . 1.0 109.285 -179.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 78.6 tt0 -136.0 137.68 41.46 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 109.466 -0.568 . . . . 1.0 109.466 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.11 157.32 43.29 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.56 -0.745 . . . . 1.0 110.394 -178.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 94.9 p -122.14 137.54 54.79 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 108.425 -0.954 . . . . 1.0 108.425 179.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.2 mp -135.93 140.32 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 CA-C-N 116.501 -0.318 . . . . 1.0 110.243 -177.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -80.39 137.51 36.54 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 109.061 -0.718 . . . . 1.0 109.061 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.465 HD22 ' N ' ' A' ' 74' ' ' LEU . 3.8 mm? -68.26 144.85 54.72 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.935 -0.575 . . . . 1.0 109.978 -179.329 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 79.8 p -139.08 166.16 25.23 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 115.335 -0.848 . . . . 1.0 109.787 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -94.37 146.46 24.04 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.331 -0.85 . . . . 1.0 109.734 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.647 ' H ' HD13 ' A' ' 77' ' ' ILE . 0.1 OUTLIER -144.92 -30.12 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-N 116.323 -0.399 . . . . 1.0 110.914 179.508 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.405 ' H ' HD13 ' A' ' 77' ' ' ILE . 81.8 m-20 -99.44 151.76 20.75 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 121.238 0.542 . . . . 1.0 110.243 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 10.1 ptpp? -48.72 -27.31 2.83 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.268 -0.878 . . . . 1.0 112.628 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -93.08 11.57 27.18 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 120.634 0.254 . . . . 1.0 111.376 -178.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 56.41 41.51 88.07 Favored Glycine 0 CA--C 1.525 0.665 0 C-N-CA 121.068 -0.587 . . . . 1.0 111.856 178.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 16.8 m -80.54 122.88 82.91 Favored Pre-proline 0 CA--C 1.551 0.998 0 CA-C-O 118.882 -0.58 . . . . 1.0 109.975 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.448 ' HB3' HD12 ' A' ' 74' ' ' LEU . 55.1 Cg_exo -51.63 126.75 20.52 Favored 'Trans proline' 0 N--CA 1.503 2.032 0 C-N-CA 121.363 1.375 . . . . 1.0 111.226 177.196 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.545 ' C ' ' H ' ' A' ' 86' ' ' GLY . . . -150.7 -13.59 0.09 OUTLIER Glycine 0 N--CA 1.478 1.473 0 C-N-CA 121.334 -0.46 . . . . 1.0 111.956 -179.024 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 41.4 mt 66.07 -30.05 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 O-C-N 123.782 0.342 . . . . 1.0 111.146 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.545 ' H ' ' C ' ' A' ' 84' ' ' GLY . . . 115.18 37.86 1.08 Allowed Glycine 0 N--CA 1.477 1.369 0 N-CA-C 110.473 -1.051 . . . . 1.0 110.473 -179.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 48.4 pt -140.87 163.94 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 122.599 0.36 . . . . 1.0 110.288 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 8.9 t -134.3 129.94 36.29 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.663 -0.699 . . . . 1.0 109.511 178.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.696 HD22 ' N ' ' A' ' 89' ' ' LEU . 1.3 mm? -106.36 135.31 48.07 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 108.253 -1.018 . . . . 1.0 108.253 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.463 ' O ' ' N ' ' A' ' 10' ' ' TYR . 52.3 t -154.87 132.67 2.51 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.608 0 N-CA-C 108.395 -0.965 . . . . 1.0 108.395 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -99.27 90.61 4.62 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 109.162 -0.681 . . . . 1.0 109.162 177.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -79.08 106.83 11.4 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 109.577 -0.527 . . . . 1.0 109.577 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 54.6 mt -71.3 70.3 0.58 Allowed 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 116.194 -0.457 . . . . 1.0 111.0 -178.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -154.41 25.64 0.46 Allowed 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 116.356 -0.384 . . . . 1.0 110.697 -179.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . 0.423 ' CD2' ' OH ' ' A' ' 10' ' ' TYR . 57.2 t-80 -87.93 -8.8 55.22 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 110.435 -0.209 . . . . 1.0 110.435 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 33.2 m80 54.35 -170.95 0.05 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.401 -0.363 . . . . 1.0 111.208 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 78.8 m80 -60.13 -41.63 93.08 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.833 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 18.9 t-80 -166.53 -68.98 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.813 0.339 . . . . 1.0 110.115 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 53.15 86.14 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.083 -0.508 . . . . 1.0 110.832 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 81.5 t60 . . . . . 0 C--O 1.219 -0.52 0 CA-C-O 118.046 -0.978 . . . . 1.0 110.927 -179.746 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.1 ttt . . . . . 0 N--CA 1.492 1.662 0 N-CA-C 109.059 -0.719 . . . . 1.0 109.059 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 28.7 t 54.89 100.91 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 CA-C-N 116.339 -0.392 . . . . 1.0 110.485 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -136.3 161.16 36.57 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 109.743 -0.466 . . . . 1.0 109.743 -179.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.1 p -60.26 -36.29 67.61 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-N 115.815 -0.63 . . . . 1.0 110.706 -179.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.5 m -68.93 156.25 38.87 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.193 0.52 . . . . 1.0 109.903 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -76.06 -91.43 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.685 -0.689 . . . . 1.0 109.633 179.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -137.79 -111.56 0.17 Allowed 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 122.684 0.394 . . . . 1.0 110.053 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 154.38 -159.67 29.02 Favored Glycine 0 N--CA 1.466 0.634 0 N-CA-C 109.191 -1.563 . . . . 1.0 109.191 -179.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 12.4 m -129.43 127.42 64.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 N-CA-C 108.789 -0.819 . . . . 1.0 108.789 178.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -91.08 127.85 36.67 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 110.028 -0.36 . . . . 1.0 110.028 -177.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 60.4 t -76.41 135.27 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 N-CA-C 107.142 -1.429 . . . . 1.0 107.142 178.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.8 tt -78.8 -51.11 10.22 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 121.119 0.485 . . . . 1.0 110.139 -178.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 95.3 p -157.37 153.3 27.08 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.036 0.446 . . . . 1.0 110.996 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 58.4 t -111.57 136.26 48.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 CA-C-N 115.419 -0.81 . . . . 1.0 108.972 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -96.41 121.74 38.54 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 108.845 -0.798 . . . . 1.0 108.845 178.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.435 ' N ' ' OE1' ' A' ' 16' ' ' GLU . 14.4 pm0 -85.66 63.28 7.97 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 120.85 0.357 . . . . 1.0 111.399 -178.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -163.45 27.18 0.09 Allowed 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.335 0.588 . . . . 1.0 109.568 179.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -143.64 160.61 50.16 Favored Pre-proline 0 N--CA 1.479 0.991 0 N-CA-C 108.85 -0.796 . . . . 1.0 108.85 -177.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -53.87 -25.76 36.72 Favored 'Trans proline' 0 N--CA 1.498 1.757 0 C-N-CA 121.358 1.372 . . . . 1.0 112.463 179.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.23 -12.96 62.13 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 120.724 0.297 . . . . 1.0 110.95 179.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.57 135.08 45.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 1.0 111.775 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.34 -4.36 85.75 Favored Glycine 0 N--CA 1.468 0.783 0 CA-C-N 115.908 -0.587 . . . . 1.0 111.951 178.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 67.6 mt -112.76 -50.48 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 CA-C-N 117.028 0.414 . . . . 1.0 109.957 -179.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 21.4 mt -105.78 150.34 25.64 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 115.834 -0.621 . . . . 1.0 109.981 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 63.7 t-80 -127.98 140.24 52.1 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 115.825 -0.625 . . . . 1.0 110.302 -179.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -49.98 140.73 11.8 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.896 0.379 . . . . 1.0 111.428 -179.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 86.7 -7.11 80.98 Favored Glycine 0 N--CA 1.471 0.986 0 N-CA-C 111.116 -0.794 . . . . 1.0 111.116 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.41 ' OD2' ' CD1' ' A' ' 61' ' ' TYR . 23.3 t0 -65.03 134.06 53.03 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 109.937 -0.394 . . . . 1.0 109.937 179.101 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 5.0 mp -95.65 135.42 37.36 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 108.875 -0.787 . . . . 1.0 108.875 179.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 38.6 mm -93.19 131.07 41.23 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 N-CA-C 108.955 -0.757 . . . . 1.0 108.955 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 54.1 p -85.95 -54.43 4.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.863 -0.608 . . . . 1.0 110.181 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 74.7 tt0 -154.92 160.13 40.93 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 120.851 0.357 . . . . 1.0 110.941 -179.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 20.6 tt -143.54 143.96 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 N-CA-C 108.699 -0.852 . . . . 1.0 108.699 178.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 35.0 t70 46.06 17.59 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 112.24 0.459 . . . . 1.0 112.24 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.52 5.35 49.8 Favored Glycine 0 CA--C 1.529 0.961 0 N-CA-C 111.164 -0.774 . . . . 1.0 111.164 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 21.4 mm100 -142.57 164.55 29.81 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-O 120.826 0.346 . . . . 1.0 110.614 -179.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 10.3 t 61.47 102.82 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.664 -0.698 . . . . 1.0 111.623 179.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -174.56 -17.55 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.71 -0.677 . . . . 1.0 111.79 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -54.39 -55.66 26.46 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.12 0.486 . . . . 1.0 111.141 -178.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 10.7 t -105.14 164.62 11.68 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 115.165 -0.925 . . . . 1.0 110.12 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 11.9 t -73.67 -51.13 17.73 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.106 -0.497 . . . . 1.0 110.718 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -63.44 -39.11 93.61 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.37 -0.377 . . . . 1.0 111.134 -178.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -56.16 -24.2 39.77 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.649 0.262 . . . . 1.0 110.657 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 38.6 t80 -72.36 -46.68 54.35 Favored 'General case' 0 C--O 1.225 -0.236 0 CA-C-O 120.926 0.393 . . . . 1.0 110.305 178.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.462 HD12 ' N ' ' A' ' 45' ' ' ILE . 1.7 mp -59.78 -31.37 47.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 N-CA-C 108.788 -0.819 . . . . 1.0 108.788 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -63.58 -37.98 89.38 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 116.104 -0.498 . . . . 1.0 110.613 -179.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -64.49 -43.78 93.06 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.716 0.293 . . . . 1.0 111.297 178.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 38.2 mt -55.43 -42.92 69.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 120.213 -0.595 . . . . 1.0 109.996 -174.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 38.8 m170 -78.29 -22.3 48.44 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.368 -0.378 . . . . 1.0 111.432 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 37.7 m -66.6 -14.75 62.8 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.236 0.458 . . . . 1.0 112.236 -178.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -111.57 147.71 34.84 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 108.754 -0.832 . . . . 1.0 108.754 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -91.39 171.12 9.43 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.182 0.593 . . . . 1.0 111.274 -178.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 14.6 t -67.06 137.72 24.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.218 -179.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 100.82 -27.3 21.17 Favored Glycine 0 N--CA 1.468 0.82 0 N-CA-C 111.369 -0.693 . . . . 1.0 111.369 178.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -55.73 149.64 14.08 Favored 'General case' 0 C--O 1.226 -0.166 0 CA-C-N 117.728 0.764 . . . . 1.0 111.568 -178.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 70.0 p -87.55 136.38 32.97 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 108.557 -0.905 . . . . 1.0 108.557 178.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -121.06 163.17 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 O-C-N 123.529 0.518 . . . . 1.0 110.641 -177.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -129.79 110.85 12.07 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 107.307 -1.368 . . . . 1.0 107.307 178.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 40.6 mm -100.52 137.84 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 109.743 -0.465 . . . . 1.0 109.743 -178.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 6.8 tppt? -128.27 113.87 16.2 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 106.776 -1.564 . . . . 1.0 106.776 177.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.41 ' CD1' ' OD2' ' A' ' 28' ' ' ASP . 27.2 p90 -145.5 157.85 43.93 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.929 0.395 . . . . 1.0 109.939 -178.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 25.5 pttm -130.07 135.62 48.44 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 115.757 -0.656 . . . . 1.0 109.733 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 59.4 t-80 -129.31 120.47 25.7 Favored 'General case' 0 C--N 1.347 0.464 0 N-CA-C 107.005 -1.479 . . . . 1.0 107.005 178.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 71.23 -117.18 6.63 Favored Glycine 0 CA--C 1.535 1.338 0 N-CA-C 110.777 -0.929 . . . . 1.0 110.777 -179.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -113.68 -19.93 11.38 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 122.86 0.464 . . . . 1.0 111.557 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 59.5 pttt -99.43 132.43 44.77 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-O 121.015 0.436 . . . . 1.0 111.236 -179.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -102.27 144.37 30.87 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 109.473 -0.565 . . . . 1.0 109.473 179.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -134.29 141.04 46.81 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 109.057 -0.72 . . . . 1.0 109.057 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -124.36 131.22 53.5 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 109.468 -0.567 . . . . 1.0 109.468 179.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -146.31 144.93 30.13 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.965 -0.561 . . . . 1.0 110.278 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 48.7 m -99.12 133.56 43.23 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 108.514 -0.921 . . . . 1.0 108.514 178.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 5.6 mt -138.57 138.97 42.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 CA-C-O 120.77 0.319 . . . . 1.0 111.33 -177.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 47.3 mttm -82.97 141.32 32.2 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 121.78 -0.575 . . . . 1.0 109.897 178.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.42 HD22 ' N ' ' A' ' 74' ' ' LEU . 3.5 mm? -62.04 148.32 44.42 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 109.262 -0.644 . . . . 1.0 109.262 179.119 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 66.9 p -135.93 162.14 33.68 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.15 0.58 . . . . 1.0 109.549 178.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -82.1 116.09 21.52 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 109.302 -0.629 . . . . 1.0 109.302 178.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.724 ' H ' HD13 ' A' ' 77' ' ' ILE . 0.1 OUTLIER -102.0 -18.53 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 C-N-CA 122.415 0.286 . . . . 1.0 111.273 -179.753 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -123.08 145.55 48.45 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-O 121.159 0.504 . . . . 1.0 110.915 -179.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 24.6 pttm -49.41 -18.8 0.43 Allowed 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.633 -0.712 . . . . 1.0 112.345 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 30.7 mtmm -80.44 -16.62 53.96 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 120.825 0.345 . . . . 1.0 110.908 -178.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 83.15 39.98 9.6 Favored Glycine 0 N--CA 1.468 0.818 0 N-CA-C 111.778 -0.529 . . . . 1.0 111.778 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 88.7 m -81.98 123.64 79.72 Favored Pre-proline 0 CA--C 1.553 1.058 0 CA-C-O 118.696 -0.668 . . . . 1.0 109.573 179.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -50.54 131.79 33.73 Favored 'Trans proline' 0 N--CA 1.506 2.24 0 C-N-CA 121.357 1.371 . . . . 1.0 111.986 177.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -172.4 163.74 35.92 Favored Glycine 0 CA--C 1.529 0.963 0 N-CA-C 111.136 -0.786 . . . . 1.0 111.136 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -111.87 35.51 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 CA-C-O 121.482 0.658 . . . . 1.0 109.432 -179.263 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.5 ' H ' HG21 ' A' ' 77' ' ' ILE . . . 53.17 58.9 10.42 Favored Glycine 0 N--CA 1.468 0.805 0 N-CA-C 111.083 -0.807 . . . . 1.0 111.083 179.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 21.6 pt -143.27 162.8 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-N 114.628 -0.786 . . . . 1.0 109.984 179.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 93.3 m -135.05 116.17 14.3 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-N 114.825 -1.08 . . . . 1.0 111.127 178.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 9.6 mp -97.74 135.99 38.73 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 122.925 0.49 . . . . 1.0 110.226 179.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 12.9 m -153.04 136.31 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 N-CA-C 108.918 -0.771 . . . . 1.0 108.918 178.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -74.38 -57.38 3.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.024 0.44 . . . . 1.0 110.049 179.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 34.3 p-10 -169.61 -178.75 3.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.9 -0.591 . . . . 1.0 110.196 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 53.1 mt 44.26 29.87 0.4 Allowed 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 116.073 -0.512 . . . . 1.0 111.34 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 53.87 -122.14 1.94 Allowed 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 116.042 -0.526 . . . . 1.0 110.626 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -91.63 -0.86 57.61 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 110.112 -0.329 . . . . 1.0 110.112 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 50.1 t-80 53.51 80.36 0.11 Allowed 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.99 0.424 . . . . 1.0 110.799 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -73.12 161.76 30.24 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.997 -0.547 . . . . 1.0 110.537 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 71.2 m80 -61.95 169.05 2.81 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.063 -0.517 . . . . 1.0 110.453 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 56.27 95.1 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.934 -0.576 . . . . 1.0 111.507 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 86.0 t60 . . . . . 0 C--O 1.221 -0.407 0 CA-C-O 117.965 -1.017 . . . . 1.0 109.865 179.334 . . . . . . . . 0 0 . 1 stop_ save_